Unnamed: 0,headline,url,publisher,date,stock,Sentiment_DecisionTreeClassifier,Sentiment_finbert,Sentiment_LogisticRegression,Sentiment_KNeighborsClassifier,Sentiment_MultinomialNB,Sentiment_SGDClassifier,Sentiment_GradientBoostingClassifier,Sentiment_XGBClassifier,Sentiment_RandomForestClassifier,Sentiment_VADER
706794,moderna on track to start phase coronavirus vaccine trial in july,https://www.benzinga.com/general/biotech/20/06/16233145/moderna-on-track-to-start-phase-3-coronavirus-vaccine-trial-in-july,Shanthi Rexaline,2020-06-11 10:37:56-04:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706795,shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some us states that have reopened leading to concerns of a second wave of the virus,https://www.benzinga.com/wiim/20/06/16233278/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-followi,Benzinga Newsdesk,2020-06-11 10:22:31-04:00,JNJ,0,1,1,1,1,0,0,1,1,0.79295
706796,its not all covid and the fed lululemon reports after close and airline stocks dive,https://www.benzinga.com/news/earnings/20/06/16232419/its-not-all-covid-19-and-the-fed-lululemon-reports-after-close-and-airline-stocks-dive,JJ Kinahan,2020-06-11 09:38:43-04:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
706797,a peek into the markets us stock futures tumble ahead of jobless claims report,https://www.benzinga.com/news/earnings/20/06/16229965/a-peek-into-the-markets-us-stock-futures-tumble-ahead-of-jobless-claims-report,Lisa Levin,2020-06-11 05:56:56-04:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
706798,johnson johnson to start coronavirus vaccine human trials ahead of schedule in july,https://www.benzinga.com/general/biotech/20/06/16229020/johnson-johnson-to-start-coronavirus-vaccine-human-trials-ahead-of-schedule-in-july,Neer Varshney,2020-06-11 00:16:21-04:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
706799,jj moves up human clinical trails of its covid vaccine to start in july ahead of planned september start,https://www.benzinga.com/news/20/06/16224439/j-j-moves-up-human-clinical-trails-of-its-covid-19-vaccine-to-start-in-july-ahead-of-planned-septemb,Benzinga Newsdesk,2020-06-10 13:05:15-04:00,JNJ,1,2,0,1,1,0,1,1,1,0.625
706800,jj is in talks to begin phase coronavirus vaccine trial ahead of schedule pending phase studies outcome regulatory approval,https://www.benzinga.com/news/20/06/16221456/j-j-is-in-talks-to-begin-phase-3-coronavirus-vaccine-trial-ahead-of-schedule-pending-phase-1-studies,Benzinga Newsdesk,2020-06-10 09:30:10-04:00,JNJ,1,2,1,1,1,1,1,1,1,0.81245
706801,nih official says us plans large studies of experimental coronavirus vaccines from moderna astrazeneca johnson johnson starting in july august september,https://www.benzinga.com/news/20/06/16219224/nih-official-says-u-s-plans-3-large-studies-of-experimental-coronavirus-vaccines-from-moderna-astraz,Charles Gross,2020-06-10 05:34:41-04:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706802,revlon chanel loréal are quietly removing talc from their products as cancer lawsuits mount report,https://www.benzinga.com/news/20/06/16208917/revlon-chanel-lor-al-are-quietly-removing-talc-from-their-products-as-cancer-lawsuits-mount-report,Neer Varshney,2020-06-09 10:15:31-04:00,JNJ,1,1,1,1,1,1,1,1,1,0.14079999999999998
706803,travel stocks lose momentum in premarket after leading yesterdays sharp rally,https://www.benzinga.com/news/20/06/16212137/travel-stocks-lose-momentum-in-pre-market-after-leading-yesterdays-sharp-rally,JJ Kinahan,2020-06-09 09:49:09-04:00,JNJ,1,1,1,1,1,1,1,1,1,0.29905000000000004
706809,update five companies chosen for vaccine finalist are moderna johnson johnson merck pfizer and astrazeneca,https://www.benzinga.com/news/20/06/16171726/update-five-companies-chosen-for-vaccine-finalist-are-moderna-johnson-johnson-merck-pfizer-and-astra,Benzinga Newsdesk,2020-06-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706810,pharma large and midcaps race against covid,https://www.benzinga.com/markets/20/06/16161758/pharma-large-and-mid-caps-race-against-covid-19,IAM Newswire,2020-06-02 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
706811, blue chips that lived up to their title during the pandemic,https://www.benzinga.com/markets/20/06/16161759/4-blue-chips-that-lived-up-to-their-title-during-the-pandemic,IAM Newswire,2020-06-02 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
706812,us army planning to test vaccines from moderna astrazeneca johnson johnson and sanofi army will test its own vaccine candidate in human trials later this summer,https://www.benzinga.com/news/20/06/16161358/u-s-army-planning-to-test-vaccines-from-moderna-astrazeneca-johnson-johnson-and-sanofi-army-will-tes,Benzinga Newsdesk,2020-06-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706813, sector etfs to buy and sell in june,https://www.benzinga.com/trading-ideas/long-ideas/20/06/16151190/4-sector-etfs-to-buy-and-sell-in-june,ETF Professor,2020-06-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706814,novavax begins phase clinical trial of its coronavirus vaccine,https://www.benzinga.com/news/20/05/16103023/novavax-begins-phase-1-clinical-trial-of-its-coronavirus-vaccine,Neer Varshney,2020-05-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706815,us health official says vaccines from jj sanofi merck may be added this summer as they complete phase safety studies,https://www.benzinga.com/general/biotech/20/05/16096380/us-health-official-says-vaccines-from-j-j-sanofi-merck-may-be-added-this-summer-as-they-complete-,Benzinga Newsdesk,2020-05-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.79295
706816,us says will test experimental coronavirus vaccines in people health official says oxford vaccine may be tested side by side with modernas starting in july,https://www.benzinga.com/general/biotech/20/05/16096378/us-says-will-test-experimental-coronavirus-vaccines-in-100-000-people-health-official-says-oxford,Benzinga Newsdesk,2020-05-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706817,johnson johnson pulls talcbased baby powder from us canada as cancer claims kill demand,https://www.benzinga.com/news/20/05/16071449/johnson-johnson-pulls-talc-based-baby-powder-from-us-canada-as-cancer-claims-kill-demand,Neer Varshney,2020-05-20 00:00:00,JNJ,1,1,1,1,1,1,1,0,1,0.05449999999999999
706818,johnson johnson consumer health will wind down commercialization of talcbased johnsons baby powder in the us and canada in coming months,https://www.benzinga.com/news/20/05/16069527/johnson-johnson-consumer-health-will-wind-down-commercialization-of-talc-based-johnsons-baby-powder,Benzinga Newsdesk,2020-05-19 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
706819,in the midst of pandemic traders pin their hopes on these healthcare etfs,https://www.benzinga.com/general/biotech/20/05/16064998/in-the-midst-of-pandemic-traders-pin-their-hopes-on-these-healthcare-etfs,Direxion,2020-05-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
706820,moncef slaoui to divest moderna stake as he joins white house vaccine accelerator,https://www.benzinga.com/general/biotech/20/05/16061412/moncef-slaoui-to-divest-moderna-stake-as-he-joins-white-house-vaccine-accelerator,Neer Varshney,2020-05-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706821,these coronavirus vaccine candidates are the likeliest to succeed says morgan stanley,https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16056298/these-6-coronavirus-vaccine-candidates-are-the-likeliest-to-succeed-says-morgan-sta,Shanthi Rexaline,2020-05-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
706822,janssen gives an update on its phase study on teclistamab in patients with multiple myeloma,https://www.benzinga.com/news/20/05/16053578/janssen-gives-an-update-on-its-phase-1-study-on-teclistamab-in-patients-with-multiple-myeloma,Luke J Jacobi,2020-05-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706823,barrons picks and pans cisco gilead netflix wayfair and more,https://www.benzinga.com/top-stories/20/05/16051966/barrons-picks-and-pans-cisco-gilead-netflix-wayfair-and-more,Nelson Hem,2020-05-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706824,avicanna combines sustainable cultivation methods rd and pharmaceutical standards to offer apis with the aureus brand,https://www.benzinga.com/markets/cannabis/20/05/16045222/avicanna-combines-sustainable-cultivation-methods-r-d-and-pharmaceutical-standards-to-offer-apis,Renato Capelj,2020-05-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706825,novavax analysts say cepi funding speaks volumes about coronavirus vaccine development,https://www.benzinga.com/analyst-ratings/analyst-color/20/05/16013328/novavax-analysts-say-cepi-funding-speaks-volumes-about-coronavirus-vaccine-developm,Shanthi Rexaline,2020-05-12 00:00:00,JNJ,1,2,0,1,1,0,1,0,0,0.5
706826,cruise line earnings later this week could provide insight on brutal quarter for industry,https://www.benzinga.com/news/earnings/20/05/16001483/cruise-line-earnings-later-this-week-could-provide-insight-on-brutal-quarter-for-industry,JJ Kinahan,2020-05-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.18755
706827,provention bios ceo on identifying autoimmune diseases before its too late,https://www.benzinga.com/general/biotech/20/05/15955024/provention-bios-ceo-on-identifying-autoimmune-diseases-before-its-too-late,Elizabeth Balboa,2020-05-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706828,what you should know about alexions b proposed buyout of portola pharma,https://www.benzinga.com/general/biotech/20/05/15954505/what-you-should-know-about-alexions-1-4b-proposed-buyout-of-portola-pharma,Shanthi Rexaline,2020-05-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706829,the daily biotech pulse biorads coronavirus test gets eua beatandraise quarter from genmark adverums positive gene therapy readout,https://www.benzinga.com/general/biotech/20/05/15952712/the-daily-biotech-pulse-bio-rads-coronavirus-test-gets-eua-beat-and-raise-quarter-from-genmark-ad,Shanthi Rexaline,2020-05-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
706830,attention biotech investors mark your calendar for these may pdufa dates,https://www.benzinga.com/general/biotech/20/05/15891850/attention-biotech-investors-mark-your-calendar-for-these-may-pdufa-dates,Shanthi Rexaline,2020-05-03 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
706831,moderna lonza strike deal to manufacture up to billion doses of coronavirus vaccine candidate annually,https://www.benzinga.com/general/biotech/20/05/15932769/moderna-lonza-strike-deal-to-manufacture-coronavirus-vaccine-candidate,Shanthi Rexaline,2020-05-01 00:00:00,JNJ,1,0,1,1,1,0,1,0,1,0.436
706832,the daily biotech pulse gilead slips despite forecastbeating q moderna partners with lonza for coronavirus vaccine production lyra therapeutics ipo,https://www.benzinga.com/general/biotech/20/05/15931110/the-daily-biotech-pulse-gilead-slips-despite-forecast-beating-q1-moderna-partners-with-lonza-for-,Shanthi Rexaline,2020-05-01 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
706833,halozyme highlights janssens receipt of chmp positive opinion for darzalex subcutaneous formulation utilizing halozymes enhanze technology for patients with multiple myeloma,https://www.benzinga.com/general/biotech/20/04/15927946/halozyme-highlights-janssens-receipt-of-chmp-positive-opinion-for-darzalex-subcutaneous-formulati,Benzinga Newsdesk,2020-04-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
706834,johnson johnson announces committee for medicinal products for human use of ema has issued a positive opinion recommending approval for darzalex,https://www.benzinga.com/general/biotech/20/04/15926089/johnson-johnson-announces-committee-for-medicinal-products-for-human-use-of-ema-has-issued-a-posi,Benzinga Newsdesk,2020-04-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.88585
706835,barclays maintains overweight on johnson johnson raises price target to ,https://www.benzinga.com/news/20/04/15909101/barclays-maintains-overweight-on-johnson-johnson-raises-price-target-to-182,vishwanath@benzinga.com,2020-04-29 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.3194
706836,morgan stanley maintains overweight on johnson johnson raises price target to ,https://www.benzinga.com/news/20/04/15906992/morgan-stanley-maintains-overweight-on-johnson-johnson-raises-price-target-to-170,vishwanath@benzinga.com,2020-04-29 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.3194
706837,catalent signs agreement with johnson johnson to be us manufacturing partner for lead coronavirus vaccine candidate,https://www.benzinga.com/general/biotech/20/04/15905925/catalent-signs-agreement-with-johnson-johnson-to-be-us-manufacturing-partner-for-lead-coronavirus,Benzinga Newsdesk,2020-04-29 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.74695
706838,pfizer says coronavirus vaccine could be available by fall us clinical trials to begin next week,https://www.benzinga.com/news/20/04/15903348/pfizer-says-coronavirus-vaccine-could-be-available-by-fall-us-clinical-trials-to-begin-next-week,Neer Varshney,2020-04-28 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.5
706839,ubs downgrades johnson johnson to neutral lowers price target to ,https://www.benzinga.com/news/20/04/15892825/ubs-downgrades-johnson-johnson-to-neutral-lowers-price-target-to-160,Vick Meyer,2020-04-28 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.436
706840,jj says federal judge excludes certain plaintiff expert testimony from talc ovarian cancer trials deeming them not scientifically sound,https://www.benzinga.com/news/20/04/15892610/j-j-says-federal-judge-excludes-certain-plaintiff-expert-testimony-from-talc-ovarian-cancer-trials-d,Charles Gross,2020-04-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.3409
706841,us judge rules jj must defend federal talc lawsuits,https://www.benzinga.com/news/20/04/15887487/u-s-judge-rules-j-j-must-defend-federal-talc-lawsuits,Benzinga Newsdesk,2020-04-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.55135
706842,halozyme announces janssen submits nda in japan for daratumumab subcutaneous formulation utilizing halozymes enhanze technology for patients with multiple myeloma,https://www.benzinga.com/news/20/04/15881965/halozyme-announces-janssen-submits-nda-in-japan-for-daratumumab-subcutaneous-formulation-utilizing-h,Charles Gross,2020-04-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706843,barrons picks and pans albertsons carnival harleydavidson and more,https://www.benzinga.com/media/20/04/15880461/barrons-picks-and-pans-albertsons-carnival-harley-davidson-and-more,Nelson Hem,2020-04-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706844,jjs janssen pharma reports submission of applicats seeking approval of simponi aria for treatment of polyarticular juvenile idiopathic arthritis and juvenile psoriatic arthritis,https://www.benzinga.com/news/20/04/15874150/j-js-janssen-pharma-reports-submission-of-2-applicats-seeking-approval-of-simponi-aria-for-treatment,Benzinga Newsdesk,2020-04-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
706845,the daily biotech pulse fda approves sanofis meningococcal vaccine pluristem secures m in funding for covid treatment oric pharma prices ipo,https://www.benzinga.com/general/biotech/20/04/15873096/the-daily-biotech-pulse-fda-approves-sanofis-meningococcal-vaccine-pluristem-secures-54m-in-fundi,Shanthi Rexaline,2020-04-24 00:00:00,JNJ,1,0,1,1,1,0,1,0,1,0.8062
706846,update tracon says is seeking a licensing partner to develop commercialize trc in china,https://www.benzinga.com/news/20/04/15873565/update-tracon-says-is-seeking-a-licensing-partner-to-develop-commercialize-trc253-in-china,Benzinga Newsdesk,2020-04-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706847,tracon pharma reports retained global rights to trc following completion of phase trial,https://www.benzinga.com/news/20/04/15873562/tracon-pharma-reports-retained-global-rights-to-trc253-following-completion-of-phase-12-trial,Benzinga Newsdesk,2020-04-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5129
706848,six coronavirus vaccines under clinical trials who says,https://www.benzinga.com/news/20/04/15872109/six-coronavirus-vaccines-under-clinical-trials-who-says,Neer Varshney,2020-04-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706849,inovio ceo says its possible for coronavirus vaccine to be ready in to months,https://www.benzinga.com/news/20/04/15871866/inovio-ceo-says-its-possible-for-coronavirus-vaccine-to-be-ready-in-12-to-18-months,Neer Varshney,2020-04-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6806
706850,stocks that hit week highs on thursday,https://www.benzinga.com/news/20/04/15866414/stocks-that-hit-52-week-highs-on-thursday,Benzinga Insights,2020-04-23 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
706851,the daily biotech pulse fda nod for immunomedics lillys solid q beat predictive oncology restructures debt,https://www.benzinga.com/general/biotech/20/04/15863794/the-daily-biotech-pulse-fda-nod-for-immunomedics-lillys-solid-q1-beat-predictive-oncology-restruc,Shanthi Rexaline,2020-04-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.38685
706852,why johnson johnsons stock is trading higher today,https://www.benzinga.com/news/20/04/15858077/why-johnson-johnsons-stock-is-trading-higher-today,Tanzeel Akhtar,2020-04-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706853,benzingas top upgrades downgrades for april ,https://www.benzinga.com/analyst-ratings/upgrades/20/04/15856498/benzingas-top-upgrades-downgrades-for-april-22-2020,Lisa Levin,2020-04-22 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.60115
706854,johnson johnson shares are higher after bank of america upgraded the stock from neutral to buy,https://www.benzinga.com/wiim/20/04/15856265/johnson-johnson-shares-are-higher-after-bank-of-america-upgraded-the-stock-from-neutral-to-buy,Benzinga Newsdesk,2020-04-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
706855,b of a securities upgrades johnson johnson to buy,https://www.benzinga.com/news/20/04/15854763/b-of-a-securities-upgrades-johnson-johnson-to-buy,Vick Meyer,2020-04-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
706856,oxford university coronavirus vaccine clinical trial to start thursday with m government funding,https://www.benzinga.com/news/20/04/15853720/oxford-university-coronavirus-vaccine-clinical-trial-to-start-thursday-with-24-6m-government-funding,Neer Varshney,2020-04-22 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
706857,fda says expanded the indication of ibrutinib imbruvica,https://www.benzinga.com/general/biotech/20/04/15850779/fda-says-expanded-the-indication-of-ibrutinib-imbruvica,Benzinga Newsdesk,2020-04-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706858,how the covid pandemic could end,https://www.benzinga.com/general/biotech/20/04/15744670/how-the-covid-19-pandemic-could-end,Tyree Gorges,2020-04-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706859,the week ahead in biotech april eli lilly biogen earnings on tap sanofi awaits fda decision,https://www.benzinga.com/general/biotech/20/04/15833296/the-week-ahead-in-biotech-april-19-25-eli-lilly-biogen-earnings-on-tap-sanofi-awaits-fda-decision,Shanthi Rexaline,2020-04-19 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.5386
706860,barrons picks and pans dropbox ford johnson johnson teladoc and more,https://www.benzinga.com/media/20/04/15836229/barrons-picks-and-pans-dropbox-ford-johnson-johnson-teladoc-and-more,Nelson Hem,2020-04-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706861,big earnings day as honeywell procter gamble schlumberger among those reporting,https://www.benzinga.com/news/earnings/20/04/15830154/big-earnings-day-as-honeywell-procter-gamble-schlumberger-among-those-reporting,JJ Kinahan,2020-04-17 00:00:00,JNJ,1,0,0,1,1,0,1,1,1,0.5
706862,moderna gets m federal funding for its coronavirus vaccine,https://www.benzinga.com/general/biotech/20/04/15825506/moderna-gets-483m-federal-funding-for-its-coronavirus-vaccine,Neer Varshney,2020-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706863,sp futures up after hours many other stocks moving higher with futures investors reacting favorably to white phase guidelines on reopening economy,https://www.benzinga.com/news/20/04/15824869/s-p-500-futures-up-3-2-after-hours-many-other-stocks-moving-higher-with-futures-investors-reacting-f,Benzinga Newsdesk,2020-04-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.6909
706864,alibaba tesla among cramers stayathome stock ideas,https://www.benzinga.com/trading-ideas/long-ideas/20/04/15819591/alibaba-tesla-among-cramers-stay-at-home-stock-ideas,Craig Jones,2020-04-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706865,why johnson johnson inspires cramers bullishness on disney visa mastercard,https://www.benzinga.com/media/20/04/15814301/why-johnson-johnson-inspires-cramers-bullishness-on-disney-visa-mastercard,Jayson Derrick,2020-04-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7202
706866,every member of trumps great american economic revival industry groups,https://www.benzinga.com/news/20/04/15808727/every-member-of-trumps-great-american-economic-revival-industry-groups,Tanzeel Akhtar,2020-04-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81245
706867,stifel maintains hold on johnson johnson raises price target to ,https://www.benzinga.com/news/20/04/15809036/stifel-maintains-hold-on-johnson-johnson-raises-price-target-to-155,Vick Meyer,2020-04-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706868,wells fargo maintains overweight on johnson johnson raises price target to ,https://www.benzinga.com/news/20/04/15808198/wells-fargo-maintains-overweight-on-johnson-johnson-raises-price-target-to-162,Vick Meyer,2020-04-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
706869, biggest price target changes for wednesday,https://www.benzinga.com/analyst-ratings/price-target/20/04/15807443/10-biggest-price-target-changes-for-wednesday,Lisa Levin,2020-04-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706870,credit suisse reiterates outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/20/04/15807223/credit-suisse-reiterates-outperform-on-johnson-johnson-raises-price-target-to-161,Benzinga_Newsdesk,2020-04-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
706871,citigroup maintains buy on johnson johnson raises price target to ,https://www.benzinga.com/news/20/04/15807172/citigroup-maintains-buy-on-johnson-johnson-raises-price-target-to-165,Vick Meyer,2020-04-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706872,raymond james reiterates outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/20/04/15806265/raymond-james-reiterates-outperform-on-johnson-johnson-raises-price-target-to-157,Benzinga_Newsdesk,2020-04-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
706873,jj expects procedure volumes in areas such as oncology general surgery to rebound sooner,https://www.benzinga.com/news/20/04/15798088/j-j-expects-procedure-volumes-in-areas-such-as-oncology-general-surgery-to-rebound-sooner,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
706874,jpmorgan wells fargo earnings lower than expected but positive tone helps shares,https://www.benzinga.com/news/earnings/20/04/15797851/jp-morgan-wells-fargo-earnings-lower-than-expected-but-positive-tone-helps-shares,JJ Kinahan,2020-04-14 00:00:00,JNJ,0,1,0,1,1,1,0,0,0,0.9500500000000001
706875,jj ceo says china business starting to return to normalcy,https://www.benzinga.com/news/20/04/15797825/j-j-ceo-says-china-business-starting-to-return-to-normalcy,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
706876,tuesdays market minute earnings season begins again,https://www.benzinga.com/news/earnings/20/04/15797567/tuesdays-market-minute-earnings-season-begins-again,TD Ameritrade Network,2020-04-14 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
706877,the daily biotech pulse amarin reports strong q vascepa sales beigene aces latestage lung cancer study glaxo sanofi strike covid vaccine partnership,https://www.benzinga.com/general/biotech/20/04/15795834/the-daily-biotech-pulse-amarin-reports-strong-q1-vascepa-sales-beigene-aces-late-stage-lung-cance,Shanthi Rexaline,2020-04-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.30910000000000004
706878,johnson johnson shares are trading higher after the company reported betterthanexpected q eps and sales results,https://www.benzinga.com/wiim/20/04/15795970/johnson-johnson-shares-are-trading-higher-after-the-company-reported-better-than-expected-q1-eps-and,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
706879,mike khouw saw unusual options activity in johnson johnson ahead of earnings,https://www.benzinga.com/markets/options/20/04/15795264/mike-khouw-saw-unusual-options-activity-in-johnson-johnson-ahead-of-earnings,Craig Jones,2020-04-14 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
706880,johnson johnson q earnings insights,https://www.benzinga.com/news/earnings/20/04/15795350/johnson-johnson-q1-earnings-insights,Benzinga Insights,2020-04-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706881,immunoprecise announces research license agreement with janssen,https://www.benzinga.com/general/biotech/20/04/15795757/immunoprecise-announces-research-license-agreement-with-janssen,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
706882,genmab highlights q net sales of darzalex by johnson and johnson were m genmab will receive royalties on sales under exclusive worldwide license,https://www.benzinga.com/general/biotech/20/04/15795381/genmab-highlights-q1-net-sales-of-darzalex-by-johnson-and-johnson-were-937m-genmab-will-receive-r,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
706883,johnson johnson cuts fy adj eps guidance from to cuts operational sales guidance from bb to bb guidance includes impact of coronavirus and related investments,https://www.benzinga.com/news/20/04/15795365/johnson-johnson-cuts-fy20-adj-eps-guidance-from-8-95-9-10-to-7-50-7-90-cuts-operational-sales-guidan,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.23665000000000003
706884,johnson johnson q adj eps beats estimate sales b beat b estimate,https://www.benzinga.com/news/earnings/20/04/15795333/johnson-johnson-q1-adj-eps-2-300-beats-1-990-estimate-sales-20-691b-beat-19-440b-estimate,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
706885,johnson johnson raises quarterly dividend from to share,https://www.benzinga.com/news/20/04/15795298/johnson-johnson-raises-quarterly-dividend-from-0-95-to-1-91share,Benzinga Newsdesk,2020-04-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
706886, stocks to watch for april ,https://www.benzinga.com/news/earnings/20/04/15794845/5-stocks-to-watch-for-april-14-2020,Lisa Levin,2020-04-14 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
706887,earnings scheduled for april ,https://www.benzinga.com/news/earnings/20/04/15794781/earnings-scheduled-for-april-14-2020,Lisa Levin,2020-04-14 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
706888,financials healthcare in eye of earnings hurricane ahead with bank ceos in spotlight,https://www.benzinga.com/news/earnings/20/04/15788949/financials-healthcare-in-eye-of-earnings-hurricane-ahead-with-bank-ceos-in-spotlight,JJ Kinahan,2020-04-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706889,mondays market minute opec production cut to avoid a glut,https://www.benzinga.com/news/earnings/20/04/15788623/mondays-market-minute-opec-production-cut-to-avoid-a-glut,TD Ameritrade Network,2020-04-13 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.24469999999999997
706890,the week ahead in biotech urogen fda decision amarin jj earnings and more covid updates,https://www.benzinga.com/general/biotech/20/04/15777861/the-week-ahead-in-biotech-urogen-fda-decision-amarin-j-j-earnings-and-more-covid-19-updates,Shanthi Rexaline,2020-04-12 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.625
706891,ftc closes investigation of johnson johnsons proposed acquisition of tachosil from takeda pharmaceutical ftc says jnj abandoned proposed acquisition,https://www.benzinga.com/m-a/20/04/15782759/ftc-closes-investigation-of-johnson-johnsons-proposed-acquisition-of-tachosil-from-takeda-pharmaceut,Charles Gross,2020-04-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2706
706892,coronavirus vaccine developed in short time unlikely to be safe international vaccine institute says,https://www.benzinga.com/news/20/04/15772538/coronavirus-vaccine-developed-in-short-time-unlikely-to-be-safe-international-vaccine-institute-says,Neer Varshney,2020-04-09 00:00:00,JNJ,0,0,1,0,1,1,0,0,0,0.7202
706893,svb leerink maintains outperform on johnson johnson lowers price target to ,https://www.benzinga.com/news/20/04/15767862/svb-leerink-maintains-outperform-on-johnson-johnson-lowers-price-target-to-160,Vick Meyer,2020-04-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.436
706894,materials stocks see more interest amid hopes for federal infrastructure spending,https://www.benzinga.com/news/earnings/20/04/15767034/materials-stocks-see-more-interest-amid-hopes-for-federal-infrastructure-spending,JJ Kinahan,2020-04-08 00:00:00,JNJ,1,0,0,0,0,0,1,1,0,0.8736999999999999
706895,inovio pharmaceuticals begins phase human testing of its covid vaccine,https://www.benzinga.com/general/biotech/20/04/15753240/inovio-pharmaceuticals-begins-phase-1-human-testing-of-its-covid-19-vaccine,Shivdeep Dhaliwal,2020-04-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706896,shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several us hotspots may be peaking a sooner peak could mean a sooner return to economic activity,https://www.benzinga.com/wiim/20/04/15748126/shares-of-several-healthcare-companies-are-trading-higher-as-markets-gain-amid-optimism-that-coronav,Benzinga Newsdesk,2020-04-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.9220999999999999
706897,cramer gives his opinion alteryx johnson johnson and more,https://www.benzinga.com/media/20/04/15746419/cramer-gives-his-opinion-alteryx-johnson-johnson-and-more,Craig Jones,2020-04-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706898,barrons picks and pans postpandemic ideas safe dividends and more,https://www.benzinga.com/short-sellers/20/04/15745752/barrons-picks-and-pans-post-pandemic-ideas-safe-dividends-and-more,Nelson Hem,2020-04-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
706899,the daily biotech pulse fate therapeutics inks cell therapy deal with jj zentalis ipo,https://www.benzinga.com/general/biotech/20/04/15736761/the-daily-biotech-pulse-fate-therapeutics-inks-cell-therapy-deal-with-j-j-zentalis-ipo,Shanthi Rexaline,2020-04-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
706900,global coronavirus cases surge past m medical equipment remains in shortage,https://www.benzinga.com/government/20/04/15735955/global-coronavirus-cases-surge-past-1m-medical-equipment-remains-in-shortage,Neer Varshney,2020-04-03 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.375
706901,moderna coronavirus vaccine phase trials could start in spring chairman says,https://www.benzinga.com/general/biotech/20/04/15734783/moderna-coronavirus-vaccine-phase-2-trials-could-start-in-spring-chairman-says,Neer Varshney,2020-04-03 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
706902,fate therapeutics announces worldwide collaboration with janssen for novel ipscderived cellbased cancer immunotherapies co to receive m upfront and m equity investment and eligible to receive up to b,https://www.benzinga.com/general/biotech/20/04/15732746/fate-therapeutics-announces-worldwide-collaboration-with-janssen-for-novel-ipsc-derived-cell-base,Benzinga Newsdesk,2020-04-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.26165
706903,wells fargo maintains overweight on johnson johnson lowers price target to ,https://www.benzinga.com/news/20/04/15727447/wells-fargo-maintains-overweight-on-johnson-johnson-lowers-price-target-to-150,Benzinga_Newsdesk,2020-04-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.375
706904,credit suisse compiles list of corporations with most and least cash,https://www.benzinga.com/analyst-ratings/analyst-color/20/04/15725759/credit-suisse-compiles-list-of-corporations-with-most-and-least-cash,Benzinga Newsdesk,2020-04-02 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.6909
706905,stifel maintains hold on johnson johnson lowers price target to ,https://www.benzinga.com/news/20/04/15717727/stifel-maintains-hold-on-johnson-johnson-lowers-price-target-to-140,Benzinga_Newsdesk,2020-04-01 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.436
706906,shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the us weigh on equities,https://www.benzinga.com/wiim/20/04/15717065/shares-of-several-healthcare-companies-are-trading-lower-amid-market-weakness-as-growing-coronavirus,Benzinga Newsdesk,2020-04-01 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.3634
706907,the prize no one wanted dow on pace for steepest q loss ever as quarter finally ends,https://www.benzinga.com/news/earnings/20/03/15706610/the-prize-no-one-wanted-dow-on-pace-for-steepest-q1-loss-ever-as-quarter-finally-ends,JJ Kinahan,2020-03-31 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.4742
706908,johnson johnson shares are trading higher on continued strength after the company announced a coronavirus vaccine candidate the company anticipates the first batches of the vaccine could be available for emergency use as early as ,https://www.benzinga.com/wiim/20/03/15706014/johnson-johnson-shares-are-trading-higher-on-continued-strength-after-the-company-announced-a-corona,Benzinga Newsdesk,2020-03-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
706909,afternoon market stats in minutes,https://www.benzinga.com/news/20/03/15696258/afternoon-market-stats-in-5-minutes,Benzinga Insights,2020-03-30 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
706910,update on bz note for jj abbott headline jj earlier suggested promise for potential coronavirus vaccine candidate sees phase human trials starting sept with results from phase trials by end of ,https://www.benzinga.com/news/20/03/15696623/update-on-bz-note-for-j-j-abbott-headline-j-j-earlier-suggested-promise-for-potential-coronavirus-va,Benzinga Newsdesk,2020-03-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8453999999999999
706911,jj abbott shares unaffected amid circulation of headline from ft suggesting cos announce a potential coronavirus vaccine rapid test bz note reminder jj announced details about an isolated coronavirus candidate at am edt mon,https://www.benzinga.com/news/20/03/15696616/j-j-abbott-shares-unaffected-amid-circulation-of-headline-from-ft-suggesting-co-s-announce-a-potenti,Benzinga Newsdesk,2020-03-30 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.7553000000000001
706912,covid vaccine updates jj identifies lead candidate imv eyes clinical testing in summer altimmune partners with university of alabama,https://www.benzinga.com/general/biotech/20/03/15694503/covid-19-vaccine-updates-j-j-identifies-lead-candidate-imv-eyes-clinical-testing-in-summer-altimm,Shanthi Rexaline,2020-03-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
706913,johnson johnson gets boost after announcing september trials of vaccine planned,https://www.benzinga.com/news/20/03/15694812/johnson-johnson-gets-boost-after-announcing-september-trials-of-vaccine-planned,JJ Kinahan,2020-03-30 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.70095
706914,johnson johnson shares are trading higher after the company announces a coronavirus vaccine candidate the company anticipates the first batches of the vaccine could be available for emergency use as early as ,https://www.benzinga.com/wiim/20/03/15694148/johnson-johnson-shares-are-trading-higher-after-the-company-announces-a-coronavirus-vaccine-candidat,Benzinga Newsdesk,2020-03-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.44865
706915,benzinga pros stock to watch for mon mar johnson johnson jnj,https://www.benzinga.com/pre-market-outlook/20/03/15693692/benzinga-pros-stock-to-watch-for-mon-mar-30-2020-johnson-johnson-jnj,Benzinga Newsdesk,2020-03-30 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706916,update johnson johnson anticipates first batches of a vaccine could be available for emergency use authorization in early ,https://www.benzinga.com/general/biotech/20/03/15692861/update-johnson-johnson-anticipates-first-batches-of-a-vaccine-could-be-available-for-emergency-us,Benzinga Newsdesk,2020-03-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.30910000000000004
706917,johnson johnson announces coronavirus vaccine candidate,https://www.benzinga.com/general/biotech/20/03/15692816/johnson-johnson-announces-coronavirus-vaccine-candidate,Benzinga Newsdesk,2020-03-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706918,morgan stanley maintains overweight on johnson johnson lowers price target to ,https://www.benzinga.com/news/20/03/15683075/morgan-stanley-maintains-overweight-on-johnson-johnson-lowers-price-target-to-160,Vick Meyer,2020-03-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.2706
706919,shares of several healthcare companies are trading lower selling off from this weeks strength while the us stimulus legislation has boosted economic optimism demand concerns still exist amid the coronavirus outbreak,https://www.benzinga.com/wiim/20/03/15682782/shares-of-several-healthcare-companies-are-trading-lower-selling-off-from-this-weeks-strength-while,Benzinga Newsdesk,2020-03-27 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.91355
706920,argus research reiterates buy on johnson johnson lowers price target to ,https://www.benzinga.com/news/20/03/15682496/argus-research-reiterates-buy-on-johnson-johnson-lowers-price-target-to-155,Benzinga_Newsdesk,2020-03-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.436
706921,citigroup maintains buy on johnson johnson lowers price target to ,https://www.benzinga.com/news/20/03/15682310/citigroup-maintains-buy-on-johnson-johnson-lowers-price-target-to-150,Vick Meyer,2020-03-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
706922,shares of several healthcare companies are trading higher following senate passage of a trillion economic stimulus package which has lifted stocks across sectors,https://www.benzinga.com/wiim/20/03/15674560/shares-of-several-healthcare-companies-are-trading-higher-following-senate-passage-of-a-2-trillion-e,Benzinga Newsdesk,2020-03-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
706923,eu antitrust regulators open indepth investigation into johnson johnsons buy of takedas surgical patch product tachosil say deal may reduce potential competition innovation for the supply of dual haemostatic set aug deadline for decision,https://www.benzinga.com/government/20/03/15663134/eu-antitrust-regulators-open-in-depth-investigation-into-johnson-johnsons-buy-of-takedas-surgical-pa,Benzinga Newsdesk,2020-03-25 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6909
706924,shares of several healthcare companies are trading higher as equities gain amid hopes of a us stimulus agreement additionally the coronavirus outbreak has increased demand for certain medical supplies,https://www.benzinga.com/wiim/20/03/15653267/shares-of-several-healthcare-companies-are-trading-higher-as-equities-gain-amid-hopes-of-a-us-stimul,Benzinga Newsdesk,2020-03-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.96155
706925,the daily biotech pulse milestone pharma flunks latestage study cytomx strikes cancer drug collaboration barda grant for genmarks covid test,https://www.benzinga.com/general/biotech/20/03/15648204/the-daily-biotech-pulse-milestone-pharma-flunks-late-stage-study-cytomx-strikes-cancer-drug-colla,Shanthi Rexaline,2020-03-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.09899999999999998
706926,shares of several healthcare companies are trading lower amid market volatility sundays fiscal stimulus bill failed a procedural senate vote while the fed monday morning announced further stimulus measures to support liquidity,https://www.benzinga.com/wiim/20/03/15636398/shares-of-several-healthcare-companies-are-trading-lower-amid-market-volatility-sundays-fiscal-stimu,Benzinga Newsdesk,2020-03-23 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.42345
706927,stocks that hit week lows on monday,https://www.benzinga.com/news/20/03/15635758/stocks-that-hit-52-week-lows-on-monday,Lisa Levin,2020-03-23 00:00:00,JNJ,1,1,0,0,0,0,1,1,1,0.39885
706928,covid where its from and where were going,https://www.benzinga.com/news/20/03/15620162/covid-19-where-its-from-and-where-were-going,Andrew Aziz,2020-03-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706929,janssen announces health canada approval of cabenuva first longacting regimen for treatment of hiv studies showed cabenuva was as effective as continuing daily oral antiretroviral regimens in maintaining viral suppression during week study,https://www.benzinga.com/general/biotech/20/03/15616605/janssen-announces-health-canada-approval-of-cabenuva-first-long-acting-regimen-for-treatment-of-h,Benzinga Newsdesk,2020-03-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.86755
706930,the daily biotech pulse pfizers eczema drug aces latestage study orphan drug designation for dicerna dyadics covid connection,https://www.benzinga.com/general/biotech/20/03/15604319/the-daily-biotech-pulse-pfizers-eczema-drug-aces-latestage-study-orphan-drug-designation-for-dice,Shanthi Rexaline,2020-03-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706931,jjs janssen submits ponesimod new drug application as treatment for adults with relapsing multiple sclerosis,https://www.benzinga.com/news/20/03/15584929/j-js-janssen-submits-ponesimod-new-drug-application-as-treatment-for-adults-with-relapsing-multiple,Benzinga Newsdesk,2020-03-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706932,jj hopes to start human trials for coronavirus vaccine in november cnbc,https://www.benzinga.com/general/biotech/20/03/15572528/j-j-hopes-to-start-human-trials-for-coronavirus-vaccine-in-november-cnbc,Benzinga Newsdesk,2020-03-17 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.79295
706933, biotechs with coronavirus vaccines in development,https://www.benzinga.com/general/biotech/20/03/15538017/8-biotechs-with-coronavirus-vaccines-in-development,Shanthi Rexaline,2020-03-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706934,shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus the virus has had a negative impact on the global economy,https://www.benzinga.com/wiim/20/03/15558425/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-on-cont,Benzinga Newsdesk,2020-03-16 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
706935,jj says sees no evidence darunavir has effect against coronavirus infection,https://www.benzinga.com/news/20/03/15558406/j-j-says-sees-no-evidence-darunavir-has-effect-against-coronavirus-infection,Benzinga Newsdesk,2020-03-16 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.4742
706936,jj says experiencing increased consumerdriven demand for products particularly within our self care portfolio including tylenol says it is shipping stock of tylenol in a controlled manner,https://www.benzinga.com/news/20/03/15549165/j-j-says-experiencing-increased-consumer-driven-demand-for-products-particularly-within-our-self-car,Benzinga Newsdesk,2020-03-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.85015
706937,jj reports collaboration with beth israel deaconness medical center to accelerate coronavirus vaccine development,https://www.benzinga.com/news/20/03/15546910/j-j-reports-collaboration-with-beth-israel-deaconness-medical-center-to-accelerate-coronavirus-vacci,Benzinga Newsdesk,2020-03-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
706938,shares of several healthcare companies are trading higher as the market rebounds following thursdays selloff note since the coronavirus outbreak the healthcare sector has been extremely volatile,https://www.benzinga.com/wiim/20/03/15546640/shares-of-several-healthcare-companies-are-trading-higher-as-the-market-rebounds-following-thursdays,Benzinga Newsdesk,2020-03-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
706939,jj says does not expect pharma supply interruptions related to coronavirus,https://www.benzinga.com/news/20/03/15546331/j-j-says-does-not-expect-pharma-supply-interruptions-related-to-coronavirus,Benzinga Newsdesk,2020-03-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.41105
706940,stocks that hit week lows on thursday,https://www.benzinga.com/news/20/03/15538835/stocks-that-hit-52-week-lows-on-thursday,Lisa Levin,2020-03-12 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.39885
706941,shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns the virus has caused global economic disruption and negatively impacted stocks across sectors,https://www.benzinga.com/wiim/20/03/15536124/shares-of-several-healthcare-companies-are-trading-lower-as-equities-sell-off-amid-continued-global,Benzinga Newsdesk,2020-03-12 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.3194
706942,the daily biotech pulse ny state endorses mallinckrodts opioid settlement kamada to work on covid treatment,https://www.benzinga.com/general/biotech/20/03/15525229/the-daily-biotech-pulse-ny-state-endorses-mallinckrodts-opioid-settlement-kamada-to-work-on-covid,Shanthi Rexaline,2020-03-11 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.67
706943,shares of several healthcare companies are trading lower movement appears market related amid selloff in equities the global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors,https://www.benzinga.com/wiim/20/03/15525133/shares-of-several-healthcare-companies-are-trading-lower-movement-appears-market-related-amid-sellof,luke@benzinga.com,2020-03-11 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.5
706944,how close are biotechs to bringing a covid treatment to market,https://www.benzinga.com/analyst-ratings/analyst-color/20/03/15470079/how-close-are-biotechs-to-bringing-a-covid-19-treatment-to-market,Shanthi Rexaline,2020-03-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706945,jjs janssen announces fda breakthrough therapy designation granted for jnj for the treatment of nonsmall cell lung cancer,https://www.benzinga.com/news/20/03/15521020/anssen-announces-fda-breakthrough-therapy-designation-granted-for-jnj-6372-for-the-treatment-of-non,luke@benzinga.com,2020-03-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.23665000000000003
706946,shares of several healthcare companies are trading higher as markets rebound following mondays selloff us president trump on monday indicated the us may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak,https://www.benzinga.com/wiim/20/03/15515220/shares-of-several-healthcare-companies-are-trading-higher-as-markets-rebound-following-mondays-sello,luke@benzinga.com,2020-03-10 00:00:00,JNJ,1,0,1,1,0,1,1,1,0,0.70095
706947, healthcare stocks moving in mondays premarket session,https://www.benzinga.com/pre-market-outlook/20/03/15506193/52-healthcare-stocks-moving-in-mondays-pre-market-session,Lisa Levin,2020-03-09 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
706948,what you need to know about publiclytraded psychedelics companies,https://www.benzinga.com/markets/cannabis/20/03/15491694/what-you-need-to-know-about-publicly-traded-psychedelics-companies,DoubleBlind Mag,2020-03-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706949,credit suisse maintains outperform on johnson johnson lowers price target to ,https://www.benzinga.com/news/20/03/15498310/credit-suisse-maintains-outperform-on-johnson-johnson-lowers-price-target-to-159,Vick Meyer,2020-03-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6366
706950,benzingas top upgrades downgrades for march ,https://www.benzinga.com/analyst-ratings/upgrades/20/03/15489272/benzingas-top-upgrades-downgrades-for-march-5-2020,Lisa Levin,2020-03-05 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.60115
706951,citigroup initiates coverage on johnson johnson with buy rating announces price target,https://www.benzinga.com/news/20/03/15486043/citigroup-initiates-coverage-on-johnson-johnson-with-buy-rating-announces-163-price-target,Vick Meyer,2020-03-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706952,hearing citi initiates coverage on jj boston scientific zimmer biomet stryker medtronic insulet with buy ratings,https://www.benzinga.com/news/20/03/15484392/hearing-citi-initiates-coverage-on-j-j-boston-scientific-zimmer-biomet-stryker-medtronic-insulet-wit,Benzinga Newsdesk,2020-03-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
706953,the daily biotech pulse takeda jumps into the covid fray exact sciences buys cancer diagnostics companies,https://www.benzinga.com/general/biotech/20/03/15477152/the-daily-biotech-pulse-takeda-jumps-into-the-covid-19-fray-exact-sciences-buys-cancer-diagnostic,Shanthi Rexaline,2020-03-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.17015000000000002
706954,shares of several healthcarerelated companies are trading higher after joe biden secured several key wins in super tuesday bidens more moderate healthcare policies have been seen as more favorable for the sector,https://www.benzinga.com/wiim/20/03/15476997/shares-of-several-healthcare-related-companies-are-trading-higher-after-joe-biden-secured-several-ke,luke@benzinga.com,2020-03-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.9711000000000001
706955,janssen submits ema application for ponesimod for treatment of adults with relapsing ms,https://www.benzinga.com/news/20/03/15476410/janssen-submits-ema-application-for-ponesimod-for-treatment-of-adults-with-relapsing-ms,Charles Gross,2020-03-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706956,shares of several healthcare companies are trading lower in sympathy with the overall market the fed cut rates to combat the coronavirus outbreak which caused an initial spike but then continued to trade lower,https://www.benzinga.com/wiim/20/03/15468873/shares-of-several-healthcare-companies-are-trading-lower-in-sympathy-with-the-overall-market-the-fed,Benzinga Newsdesk,2020-03-03 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.24469999999999997
706957,pfizer works on compounds that may help stop coronaviruses,https://www.benzinga.com/news/20/03/15463297/pfizer-works-on-compounds-that-may-help-stop-coronaviruses,Shivdeep Dhaliwal,2020-03-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
706958,how the covid outbreak is benefiting biotech investors,https://www.benzinga.com/general/biotech/20/03/15438824/how-the-covid-19-outbreak-is-benefiting-biotech-investors,Shanthi Rexaline,2020-03-02 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706959,shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook,https://www.benzinga.com/wiim/20/02/15440922/shares-of-several-healthcare-companies-are-trading-lower-as-the-global-coronavirus-spread-continues,Benzinga Newsdesk,2020-02-28 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.2798
706960,jj issues press release to highlight launch of janssen pharmas open enrollment for heartline study with apple will explore if heartline study app on iphone heart health features on apple watch can improve health outcomes,https://www.benzinga.com/news/20/02/15403924/j-j-issues-press-release-to-highlight-launch-of-janssen-pharmas-open-enrollment-for-heartline-study,Benzinga Newsdesk,2020-02-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8714999999999999
706961,some market stats in minutes,https://www.benzinga.com/news/20/02/15386713/some-market-stats-in-5-minutes,Benzinga Newsdesk,2020-02-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706962,jj shares at session highs with broader stock market hearing cos janssen pharma to expand its existing partnership with barda to seek treatment solutions for coronavirus,https://www.benzinga.com/news/20/02/15355225/j-j-shares-at-session-highs-with-broader-stock-market-hearing-co-s-janssen-pharma-to-expand-its-exis,Benzinga Newsdesk,2020-02-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.86755
706963, states reject b offer from drug wholesalers to settle opioid litigation,https://www.benzinga.com/government/20/02/15337033/21-states-reject-18b-offer-from-drug-wholesalers-to-settle-opioid-litigation,Benzinga Newsdesk,2020-02-14 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.22885
706964,the daily biotech pulse epizymes tazemetostat snda accepted for priority review eisai to withdraw weight loss drug solgel prices offering,https://www.benzinga.com/general/biotech/20/02/15334758/the-daily-biotech-pulse-epizymes-tazemetostat-snda-accepted-for-priority-review-eisai-to-withdraw,Shanthi Rexaline,2020-02-14 00:00:00,JNJ,0,2,0,1,1,1,1,0,1,0.4742
706965,the daily biotech pulse jj intensifies efforts on covid cure adamas reports positive longterm gocovri data,https://www.benzinga.com/general/biotech/20/02/15308201/the-daily-biotech-pulse-j-j-intensifies-efforts-on-covid-19-cure-adamas-reports-positive-long-ter,Shanthi Rexaline,2020-02-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8404
706966,johnson johnson announces collaboration with us department of health human services to accelerate development of a potential novel coronavirus vaccine,https://www.benzinga.com/general/biotech/20/02/15304566/johnson-johnson-announces-collaboration-with-us-department-of-health-human-services-to-accelerate,Benzinga Newsdesk,2020-02-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
706967,the daily biotech pulse logicbio slapped with clinical hold agile inks debt deal ahead of twirla approval gilead builds stake in sierra oncology,https://www.benzinga.com/general/biotech/20/02/15296635/the-daily-biotech-pulse-logicbio-slapped-with-clinical-hold-agile-inks-debt-deal-ahead-of-twirla-,Shanthi Rexaline,2020-02-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.57655
706968,new york opioid case a significant risk for pharma stocks says bearish bofa,https://www.benzinga.com/analyst-ratings/analyst-color/20/02/15291531/new-york-opioid-case-a-significant-risk-for-pharma-stocks-says-bearish-bofa,Dave Royse,2020-02-10 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.4614
706969, leveraged healthcare etfs soaring this month,https://www.benzinga.com/general/biotech/20/02/15286183/3-leveraged-healthcare-etfs-soaring-this-month,ETF Professor,2020-02-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706970,johnson johnson hit with m punitive damages verdict for failing to warn about cancercausing asbestos in talc products,https://www.benzinga.com/government/20/02/15281588/johnson-johnson-hit-with-750m-punitive-damages-verdict-for-failing-to-warn-about-cancer-causing-asbe,Benzinga Newsdesk,2020-02-07 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.07405
706971,the daily biotech pulse assertio to sell opioid pain drug milestone payment for aduro myriad genetics ceo resigns,https://www.benzinga.com/general/biotech/20/02/15277159/the-daily-biotech-pulse-assertio-to-sell-opioid-pain-drug-milestone-payment-for-aduro-myriad-gene,Shanthi Rexaline,2020-02-07 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.15960000000000002
706972,jj says judge reducing nj talc verdict to m,https://www.benzinga.com/news/20/02/15273506/j-j-says-judge-reducing-nj-talc-verdict-to-185m,Benzinga Newsdesk,2020-02-06 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.6909
706973,jj ordered to pay m in punitive damage over talc case,https://www.benzinga.com/news/20/02/15273063/j-j-ordered-to-pay-750m-in-punitive-damage-over-talc-case,Benzinga Newsdesk,2020-02-06 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.1452
706974,stocks that hit week highs on thursday,https://www.benzinga.com/news/20/02/15270346/stocks-that-hit-52-week-highs-on-thursday,Lisa Levin,2020-02-06 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
706975,the daily biotech pulse tonix slumps on failed study applied genetic announces offering beam therapeutics ppd price ipos,https://www.benzinga.com/general/biotech/20/02/15266453/the-daily-biotech-pulse-tonix-slumps-on-failed-study-applied-genetic-announces-offering-beam-ther,Shanthi Rexaline,2020-02-06 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.24469999999999997
706976,who says theres no effective coronavirus treatment yet,https://www.benzinga.com/news/20/02/15260484/who-says-theres-no-effective-coronavirus-treatment-yet,Tanzeel Akhtar,2020-02-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
706977,stocks that hit week highs on wednesday,https://www.benzinga.com/news/20/02/15259090/stocks-that-hit-52-week-highs-on-wednesday,Lisa Levin,2020-02-05 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
706978,the daily biotech pulse merck spins off slowgrowth businesses ziopharm announces offering phasebio data,https://www.benzinga.com/general/biotech/20/02/15256778/the-daily-biotech-pulse-merck-spins-off-slow-growth-businesses-ziopharm-announces-offering-phaseb,Shanthi Rexaline,2020-02-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706979,stocks that hit week highs on tuesday,https://www.benzinga.com/news/20/02/15247386/stocks-that-hit-52-week-highs-on-tuesday,Lisa Levin,2020-02-04 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
706980,barrons picks and pans intel johnson johnson tmobile and more,https://www.benzinga.com/media/20/02/15233177/barrons-picks-and-pans-intel-johnson-johnson-t-mobile-and-more,Nelson Hem,2020-02-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706981,the daily biotech pulse sanofi reports positive readout tonix vaccine candidate aces animal study hologixs weak guidance,https://www.benzinga.com/general/biotech/20/01/15215233/the-daily-biotech-pulse-sanofi-reports-positive-readout-tonix-vaccine-candidate-aces-animal-study,Shanthi Rexaline,2020-01-30 00:00:00,JNJ,1,1,1,1,1,1,1,1,0,0.58895
706982,johnson johnson also says providing supplies of antiviral medicines to china for investigational use,https://www.benzinga.com/general/biotech/20/01/15207640/johnson-johnson-also-says-providing-supplies-of-antiviral-medicines-to-china-for-investigational-,Benzinga Newsdesk,2020-01-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706983,johnson johnson says initiating coronavirus vaccine development,https://www.benzinga.com/general/biotech/20/01/15207633/johnson-johnson-says-initiating-coronavirus-vaccine-development,Benzinga Newsdesk,2020-01-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
706984,the daily biotech pulse novartis earnings hepions nash candidate beats rival drugs annovis bio to debut,https://www.benzinga.com/general/biotech/20/01/15206079/the-daily-biotech-pulse-novartis-earnings-hepions-nash-candidate-beats-rival-drugs-annovis-bio-to,Shanthi Rexaline,2020-01-29 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
706985,health canada approves new indication for invokana to reduce risks associated with diabetic kidney disease in patients with type diabetes,https://www.benzinga.com/general/biotech/20/01/15196626/health-canada-approves-new-indication-for-invokana-to-reduce-risks-associated-with-diabetic-kidne,Benzinga Newsdesk,2020-01-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.57655
706986,johnson johnson is confident in ability to treat coronavirus but vaccine could take time,https://www.benzinga.com/news/20/01/15188385/johnson-johnson-is-confident-in-ability-to-treat-coronavirus-but-vaccine-could-take-time,Jayson Derrick,2020-01-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7787
706987, biggest price target changes for monday,https://www.benzinga.com/analyst-ratings/price-target/20/01/15188365/10-biggest-price-target-changes-for-monday,Lisa Levin,2020-01-27 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
706988,health canada has approved janssens stelara for treatment of adult patients with moderately to severely active ulcerative colitis,https://www.benzinga.com/news/20/01/15187497/health-canada-has-approved-janssens-stelara-for-treatment-of-adult-patients-with-moderately-to-sever,Benzinga Newsdesk,2020-01-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6806
706989,credit suisse maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/20/01/15187359/credit-suisse-maintains-outperform-on-johnson-johnson-raises-price-target-to-170,Benzinga_Newsdesk,2020-01-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
706990,janssen announces european commission approves expanded use of stelara for treatment of paediatric patients with moderate to severe plaque psoriasis,https://www.benzinga.com/general/biotech/20/01/15173509/janssen-announces-european-commission-approves-expanded-use-of-stelara-for-treatment-of-paediatri,Benzinga Newsdesk,2020-01-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5129
706991, biggest price target changes for thursday,https://www.benzinga.com/analyst-ratings/price-target/20/01/15171117/10-biggest-price-target-changes-for-thursday,Lisa Levin,2020-01-23 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
706992,raymond james maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/20/01/15170763/raymond-james-maintains-outperform-on-johnson-johnson-raises-price-target-to-161,Vick Meyer,2020-01-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706993,midafternoon market update fuelcell energy falls on downbeat q results neurotrope shares rise,https://www.benzinga.com/news/earnings/20/01/15166386/mid-afternoon-market-update-fuelcell-energy-falls-on-downbeat-q4-results-neurotrope-shares-rise,Lisa Levin,2020-01-22 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7553000000000001
706994,midday market update crude oil down over one stop systems shares surge,https://www.benzinga.com/news/earnings/20/01/15165380/mid-day-market-update-crude-oil-down-over-2-one-stop-systems-shares-surge,Lisa Levin,2020-01-22 00:00:00,JNJ,1,1,0,1,1,0,1,1,1,0.21405000000000002
706995,midmorning market update markets open higher johnson johnson posts mixed q results,https://www.benzinga.com/news/earnings/20/01/15163941/mid-morning-market-update-markets-open-higher-johnson-johnson-posts-mixed-q4-results,Lisa Levin,2020-01-22 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.5
706996,ibm netflix earnings greeted with enthusiasm and texas instruments up later today,https://www.benzinga.com/news/earnings/20/01/15163621/ibm-netflix-earnings-greeted-with-enthusiasm-and-texas-instruments-up-later-today,JJ Kinahan,2020-01-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8062
706997,johnson johnson says independent research continues to find no link between talc and cancer,https://www.benzinga.com/news/earnings/20/01/15162743/johnson-johnson-says-independent-research-continues-to-find-no-link-between-talc-and-cancer,Benzinga Newsdesk,2020-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.1175
706998,johnson johnson says offpatent drugs were able to retain business a little longer than expected in and expects it to continue in ,https://www.benzinga.com/news/earnings/20/01/15162701/johnson-johnson-says-off-patent-drugs-were-able-to-retain-business-a-little-longer-than-expected-in,Benzinga Newsdesk,2020-01-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
706999,johnson johnson exec says forecast does not assume any major acquisitions or other major uses of cash,https://www.benzinga.com/news/earnings/20/01/15162686/johnson-johnson-exec-says-2020-forecast-does-not-assume-any-major-acquisitions-or-other-major-uses-,Benzinga Newsdesk,2020-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707000,the daily biotech pulse johnson johnson earnings fda nod for horizon therapeutics slew of secondary offerings,https://www.benzinga.com/general/biotech/20/01/15161635/the-daily-biotech-pulse-johnson-johnson-earnings-fda-nod-for-horizon-therapeutics-slew-of-seconda,Shanthi Rexaline,2020-01-22 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
707001,heres how much investing in johnson johnson stock back in would be worth today,https://www.benzinga.com/general/education/20/01/15144706/heres-how-much-investing-100-in-johnson-johnson-stock-back-in-2010-would-be-worth-today,Wayne Duggan,2020-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
707002,johnson johnson reports mixed q earnings,https://www.benzinga.com/news/earnings/20/01/15161633/johnson-johnson-reports-mixed-q4-earnings,Tanzeel Akhtar,2020-01-22 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707003,a peek into the markets us stock futures climb ahead of earnings,https://www.benzinga.com/news/earnings/20/01/15161450/a-peek-into-the-markets-us-stock-futures-climb-ahead-of-earnings,Lisa Levin,2020-01-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707004,genmab highlights net darzalex sales by johnson johnson of b,https://www.benzinga.com/general/biotech/20/01/15161333/genmab-highlights-2019-net-darzalex-sales-by-johnson-johnson-of-2-998b,Benzinga Newsdesk,2020-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707005,johnson johnson sees fy adj operational eps operational sales bb,https://www.benzinga.com/news/20/01/15161323/johnson-johnson-sees-fy20-adj-operational-eps-9-00-9-15-operational-sales-85-8b-86-6b,Benzinga Newsdesk,2020-01-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707006,johnson johnson q adj eps beats estimate sales b miss b estimate,https://www.benzinga.com/news/earnings/20/01/15161322/johnson-johnson-q4-adj-eps-1-88-beats-1-87-estimate-sales-20-75b-miss-20-78b-estimate,Benzinga Newsdesk,2020-01-22 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.42345
707007, stocks to watch for january ,https://www.benzinga.com/news/earnings/20/01/15160866/8-stocks-to-watch-for-january-22-2020,Lisa Levin,2020-01-22 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707008,earnings scheduled for january ,https://www.benzinga.com/news/earnings/20/01/15160854/earnings-scheduled-for-january-22-2020,Lisa Levin,2020-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707009,johnson johnsons q earnings outlook,https://www.benzinga.com/news/earnings-previews/20/01/15157183/johnson-johnsons-earnings-outlook,Benzinga Newsdesk,2020-01-21 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707010,stocks that hit week highs on tuesday,https://www.benzinga.com/news/20/01/15155396/stocks-that-hit-52-week-highs-on-tuesday,Lisa Levin,2020-01-21 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707011,coronavirus outbreak imf forecast impeachment trial weigh on investor sentiment,https://www.benzinga.com/news/earnings/20/01/15155134/coronavirus-outbreak-imf-forecast-impeachment-trial-weigh-on-investor-sentiment,JJ Kinahan,2020-01-21 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707012, etfs to consider for the week ahead big earnings for airlines chips and consumers,https://www.benzinga.com/news/earnings/20/01/15150911/3-etfs-to-consider-for-the-week-ahead-big-earnings-for-airlines-chips-and-consumers,ETF Professor,2020-01-21 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707013,the week ahead in biotech focus on epizyme merck ahead of pdufa dates jj to kickstart big pharma earnings,https://www.benzinga.com/general/biotech/20/01/15136889/the-week-ahead-in-biotech-focus-on-epizyme-merck-ahead-of-pdufa-dates-j-j-to-kickstart-big-pharma,Shanthi Rexaline,2020-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707014,hearing johnson johnsons risperdal verdict lowered from b to b,https://www.benzinga.com/news/20/01/15144686/hearing-johnson-johnsons-risperdal-verdict-lowered-from-8b-to-6-8b,Benzinga Newsdesk,2020-01-17 00:00:00,JNJ,1,2,1,1,0,1,1,0,1,0.5129
707015,stocks that hit week highs on friday,https://www.benzinga.com/news/20/01/15144632/stocks-that-hit-52-week-highs-on-friday,Lisa Levin,2020-01-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707016,record run stocks keep rolling to new highs as housing data earnings look solid,https://www.benzinga.com/news/earnings/20/01/15142779/record-run-stocks-keep-rolling-to-new-highs-as-housing-data-earnings-look-solid,JJ Kinahan,2020-01-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.57655
707017,jns janssen announced submission of a type ii variation application to european medicines agency for spravato nasal spray,https://www.benzinga.com/general/biotech/20/01/15125827/j-ns-janssen-announced-submission-of-a-type-ii-variation-application-to-european-medicines-agency,Benzinga Newsdesk,2020-01-15 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5
707018,california gov gavin newsom wants the state to become the first to create its own generic drug label an attempt to create more competition and bring down prices axios from earlier,https://www.benzinga.com/general/biotech/20/01/15106641/california-gov-gavin-newsom-wants-the-state-to-become-the-first-to-create-its-own-generic-drug-la,Benzinga Newsdesk,2020-01-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707019,wells fargo maintains overweight on johnson johnson raises price target to ,https://www.benzinga.com/news/20/01/15097916/wells-fargo-maintains-overweight-on-johnson-johnson-raises-price-target-to-165,Benzinga_Newsdesk,2020-01-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
707020,kaleido biosciences announces collaboration with janssen to explore potential for microbiome metabolic therapies to prevent childhoodonset of atopic immune and metabolic conditions by promoting healthy function of the gut microbiome,https://www.benzinga.com/general/biotech/20/01/15097600/kaleido-biosciences-announces-collaboration-with-janssen-to-explore-potential-for-microbiome-meta,Benzinga Newsdesk,2020-01-09 00:00:00,JNJ,1,0,1,1,1,1,1,0,1,0.87895
707021,jj shares briefly turn positive after us researchers find no clear talc link to ovarian cancer in largest study yet,https://www.benzinga.com/general/health-care/20/01/15085618/j-j-shares-briefly-turn-positive-after-u-s-researchers-find-no-clear-talc-link-to-ovarian-can,Benzinga Newsdesk,2020-01-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
707022,investor movement index summary december ,https://www.benzinga.com/trading-ideas/long-ideas/20/01/15083098/investor-movement-index-summary-december-2019,TD Ameritrade,2020-01-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707023,protagonist therapeutics achieves milestone in janssen collaboration triggering m payment,https://www.benzinga.com/general/biotech/20/01/15082940/protagonist-therapeutics-achieves-milestone-in-janssen-collaboration-triggering-5m-payment,Benzinga Newsdesk,2020-01-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707024,johnson johnson reportedly settles california talc case midtrial,https://www.benzinga.com/news/20/01/15078263/johnson-johnson-reportedly-settles-california-talc-case-midtrial,Tanzeel Akhtar,2020-01-06 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707025,johnson johnson settles california talc case midtrial likely avoiding a huge judgement against them law ,https://www.benzinga.com/news/20/01/15078141/johnson-johnson-settles-california-talc-case-midtrial-likely-avoiding-a-huge-judgement-against-them,Benzinga Newsdesk,2020-01-06 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.4871
707026,speaker of the house nancy pelosi says enough is enough housedemocrats passed the bipartisan lowerdrugcosts now act last year to stop big pharma from charging americans more for our medicines than what they charge for the same drugs overseas,https://www.benzinga.com/general/health-care/20/01/15064126/speaker-of-the-house-nancy-pelosi-says-enough-is-enough-housedemocrats-passed-the-bipartisan-,Benzinga Newsdesk,2020-01-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
707027,washington state sues johnson johnson over opioid epidemic,https://www.benzinga.com/news/20/01/15062771/washington-state-sues-johnson-johnson-over-opioid-epidemic,Benzinga Newsdesk,2020-01-02 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707028,pulmatrix shares soar on licensing agreement with johnson johnson,https://www.benzinga.com/general/biotech/20/01/15062183/pulmatrix-shares-soar-on-licensing-agreement-with-johnson-johnson,Shanthi Rexaline,2020-01-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.82985
707029,pulmatrix announces kinase inhibitor licensing agreement with lung cancer initiative at johnson johnson,https://www.benzinga.com/general/biotech/20/01/15060718/pulmatrix-announces-kinase-inhibitor-licensing-agreement-with-lung-cancer-initiative-at-johnson-j,Benzinga Newsdesk,2020-01-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3194
707030,provention bio k shows co was informed by jjs janssen pharma it no longer intends to take up option to buy back rights for prv compound,https://www.benzinga.com/news/19/12/15044328/provention-bio-8-k-shows-co-was-informed-by-j-js-janssen-pharma-it-no-longer-intends-to-take-up-opti,Benzinga Newsdesk,2019-12-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
707031,how the dow jones industrial average changed over the past decade,https://www.benzinga.com/general/education/19/12/15027623/how-the-dow-jones-industrial-average-changed-over-the-past-decade,Wayne Duggan,2019-12-22 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707032,stocks that hit week highs on friday,https://www.benzinga.com/news/19/12/15026655/stocks-that-hit-52-week-highs-on-friday,Lisa Levin,2019-12-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707033,the daily biotech pulse axovant surges on gene therapy study results fda approves mercks ebola vaccine abeona announces offering,https://www.benzinga.com/general/biotech/19/12/15023225/the-daily-biotech-pulse-axovant-surges-on-gene-therapy-study-results-fda-approves-mercks-ebola-va,Shanthi Rexaline,2019-12-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
707034,jj to purchase remaining stake in verb surgical no terms disclosed,https://www.benzinga.com/m-a/19/12/15023811/j-j-to-purchase-remaining-stake-in-verb-surgical-no-terms-disclosed,Benzinga Newsdesk,2019-12-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4742
707035,premarket prep recap earnings movers finding sellers in johnson johnson,https://www.benzinga.com/trading-ideas/long-ideas/19/12/15019595/premarket-prep-recap-earnings-movers-finding-sellers-in-johnson-johnson,Joel Elconin,2019-12-19 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
707036,benzingas top upgrades downgrades for december ,https://www.benzinga.com/analyst-ratings/upgrades/19/12/15018129/benzingas-top-upgrades-downgrades-for-december-19-2019,Lisa Levin,2019-12-19 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
707037,barclays upgrades johnson johnson to overweight raises price target to ,https://www.benzinga.com/news/19/12/15016262/barclays-upgrades-johnson-johnson-to-overweight-raises-price-target-to-173,Vick Meyer,2019-12-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3194
707038,update morgan stanley upgrades johnson johnson to overweight raises target to notes cos defensiveness is down but not out legal liabilities appear more than reflected the pharma segment should accelerate and the business is now more balanced,https://www.benzinga.com/analyst-ratings/analyst-color/19/12/15004545/update-morgan-stanley-upgrades-johnson-johnson-to-overweight-raises-target-to-170-n,Benzinga_Newsdesk,2019-12-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.42135
707039,benzingas top upgrades downgrades for december ,https://www.benzinga.com/analyst-ratings/upgrades/19/12/15004081/benzingas-top-upgrades-downgrades-for-december-17-2019,Lisa Levin,2019-12-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
707040,benzinga pros top stocks to watch for tues dec ba aapl blph jnj lly,https://www.benzinga.com/pre-market-outlook/19/12/15002311/benzinga-pros-top-5-stocks-to-watch-for-tues-dec-17-2019-ba-aapl-blph-jnj-lly,Benzinga Newsdesk,2019-12-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.60115
707041,morgan stanley upgrades johnson johnson to overweight announces price target,https://www.benzinga.com/news/19/12/15001101/morgan-stanley-upgrades-johnson-johnson-to-overweight-announces-170-price-target,Benzinga_Newsdesk,2019-12-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3194
707042,janssen announces results from phase candor study darzalex regimen showed significant increase in progressionfree survival in treatment of patients with relapsedrefractory multiple myeloma,https://www.benzinga.com/general/biotech/19/12/14961730/janssen-announces-results-from-phase-3-candor-study-darzalex-regimen-showed-significant-increase-,Benzinga Newsdesk,2019-12-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707043,the daily biotech pulse ash meeting wraps fast track designation for equillium pfizer to buy m in contrafect shares,https://www.benzinga.com/general/biotech/19/12/14960785/the-daily-biotech-pulse-ash-meeting-wraps-fast-track-designation-for-equillium-pfizer-to-buy-3m-i,Shanthi Rexaline,2019-12-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707044,johnson johnson emerging out of a dark place,https://www.benzinga.com/news/earnings/19/12/14955433/johnson-johnson-emerging-out-of-a-dark-place,IAM Newswire,2019-12-09 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707045,janssen and hitgent to collaborate on novel dnaencoded libraries,https://www.benzinga.com/news/19/12/14953356/janssen-and-hitgent-to-collaborate-on-novel-dna-encoded-libraries,Benzinga Newsdesk,2019-12-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
707046,vaccine regimen from janssen and bavarian nordic to support republic of rwandas preparedness against ebola outbreak,https://www.benzinga.com/news/19/12/14952203/vaccine-regimen-from-janssen-and-bavarian-nordic-to-support-republic-of-rwandas-preparedness-against,Charles Gross,2019-12-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
707047,janssen presents initial results for bcma cart therapy jnj showing early deep and high responses in the treatment of relapsed or refractory multiple myeloma at ash ,https://www.benzinga.com/news/19/12/14951001/janssen-presents-initial-results-for-bcma-car-t-therapy-jnj-4528-showing-early-deep-and-high-respons,Charles Gross,2019-12-07 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707048,the week ahead in biotech ash presentations pick up steam correvio awaits adcom ruling,https://www.benzinga.com/general/biotech/19/12/14947992/the-week-ahead-in-biotech-ash-presentations-pick-up-steam-correvio-awaits-adcom-ruling,Shanthi Rexaline,2019-12-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5386
707049,xbiotech announces agreement to sell true human antibody bermekimab targeting ila to janssen for m in cash plus milestone payments up to m,https://www.benzinga.com/m-a/19/12/14950740/xbiotech-announces-agreement-to-sell-true-human-antibody-bermekimab-targeting-il-1a-to-janssen-for-7,Charles Gross,2019-12-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8592
707050,johnson johnson option alert jan calls sweep near the ask vs oi earnings before open est ref,https://www.benzinga.com/markets/options/19/12/14945849/johnson-johnson-option-alert-jan-17-145-calls-sweep-2-near-the-ask-3425-1-44-vs-13950-oi-earnings,Charles Gross,2019-12-06 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
707051,genmab achieves m sales milestone in darzalex collaboration with janssen,https://www.benzinga.com/news/19/12/14935633/genmab-achieves-100m-sales-milestone-in-darzalex-collaboration-with-janssen,Charles Gross,2019-12-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707052,johnson johnson option alert dec calls at the ask vs oi earnings before open est ref,https://www.benzinga.com/markets/options/19/12/14932209/johnson-johnson-option-alert-dec-20-140-calls-at-the-ask-2650-1-41-vs-10265-oi-earnings-121-befor,Charles Gross,2019-12-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707053,jj shares tick lower on slighty uptick in volume amid headline fda says it stands by study showing asbestos in jjs baby powder,https://www.benzinga.com/news/19/12/14931919/j-j-shares-tick-lower-on-slighty-uptick-in-volume-amid-headline-fda-says-it-stands-by-study-showing,Benzinga Newsdesk,2019-12-04 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.625
707054,johnson johnson says investigation reaffirmed fda finding of no asbestos in baby powder,https://www.benzinga.com/news/19/12/14925870/johnson-johnson-says-investigation-reaffirmed-fda-finding-of-no-asbestos-in-baby-powder,Benzinga Newsdesk,2019-12-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
707055,us considers scaling back ip protections for big drugmakers to help win democratic support for new trade pact with mexico and canada,https://www.benzinga.com/general/biotech/19/12/14915526/u-s-considers-scaling-back-ip-protections-for-big-drugmakers-to-help-win-democratic-support-for-n,Benzinga Newsdesk,2019-12-02 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.92405
707056,attention biotech investors mark your calendar for these december pdufa dates,https://www.benzinga.com/general/biotech/19/11/14896078/attention-biotech-investors-mark-your-calendar-for-these-december-pdufa-dates,Shanthi Rexaline,2019-11-29 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707057,national business daily reports drugmakers including johnson johnson roche novartis and merck have agreed to massively cut the prices of some drugs to get included in chinas medical reimbursement list,https://www.benzinga.com/news/19/11/14904233/national-business-daily-reports-drugmakers-including-johnson-johnson-roche-novartis-and-merck-have-a,Charles Gross,2019-11-29 00:00:00,JNJ,1,1,0,1,0,0,0,0,1,0.5
707058,health care etfs are breaking out but political risks linger in ,https://www.benzinga.com/analyst-ratings/analyst-color/19/11/14891873/health-care-etfs-are-breaking-out-but-risks-linger-in-2020,ETF Professor,2019-11-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.42969999999999997
707059,pharma companies shares tank as feds investigate opioid crisis,https://www.benzinga.com/government/19/11/14892850/pharma-companies-shares-tank-as-feds-investigate-opioid-crisis,Neer Varshney,2019-11-27 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.2798
707060,mckesson in response to report on probe of opioid makers distributors says information about co getting a subpoena was disclosed in most recent q,https://www.benzinga.com/general/biotech/19/11/14889351/mckesson-in-response-to-report-on-probe-of-opioid-makers-distributors-says-information-about-co-g,Benzinga Newsdesk,2019-11-26 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707061,meg tirrell on cnbc says opioid investigation is not new,https://www.benzinga.com/news/19/11/14888591/meg-tirrell-on-cnbc-says-opioid-investigation-is-not-new,Benzinga Newsdesk,2019-11-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707062,jj million award upheld in court may face addition court hearing for punitive damages,https://www.benzinga.com/news/19/11/14888234/j-j-70-million-award-upheld-in-court-may-face-addition-court-hearing-for-punitive-damages,Benzinga Newsdesk,2019-11-26 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.41105
707063,shares of opioidrelated drugmakers are trading lower on reports federal prosecutors have opened a criminal probe of opioid manufacturers,https://www.benzinga.com/wiim/19/11/14888036/shares-of-opioid-related-drugmakers-are-trading-lower-on-reports-federal-prosecutors-have-opened-a-c,Benzinga Newsdesk,2019-11-26 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.23665000000000003
707064,brooklyn federal prosecutors open criminal probe of opioid manufacturers distributors mallinckrodt amerisourcebergen johnson johnson and amneal say they have received subpoenas,https://www.benzinga.com/news/19/11/14887752/brooklyn-federal-prosecutors-open-criminal-probe-of-opioid-manufacturers-distributors-mallinckrodt-a,Benzinga Newsdesk,2019-11-26 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.23665000000000003
707065,trump says he will release a plan to let states import prescription drugs which are much cheaper,https://www.benzinga.com/general/politics/19/11/14868610/trump-says-he-will-release-a-plan-to-let-states-import-prescription-drugs-which-are-much-cheaper,Benzinga Newsdesk,2019-11-22 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.5
707066,this dividend etf is having its day,https://www.benzinga.com/trading-ideas/long-ideas/19/11/14854643/this-dividend-etf-is-having-its-day,ETF Professor,2019-11-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707067,benzingas top upgrades downgrades for november ,https://www.benzinga.com/analyst-ratings/upgrades/19/11/14848812/benzingas-top-upgrades-downgrades-for-november-20-2019,Lisa Levin,2019-11-20 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.60115
707068,cantor fitzgerald initiates coverage on johnson johnson with overweight rating announces price target,https://www.benzinga.com/news/19/11/14846682/cantor-fitzgerald-initiates-coverage-on-johnson-johnson-with-overweight-rating-announces-160-price-t,Benzinga_Newsdesk,2019-11-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.3194
707069,janssen receives eu marketing authorisation for darzalex in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma who are transplant ineligible,https://www.benzinga.com/general/biotech/19/11/14842344/janssen-receives-eu-marketing-authorisation-for-darzalex-in-combination-with-lenalidomide-and-dex,Benzinga Newsdesk,2019-11-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707070,barrons picks and pans medtronic tesla walmart and more,https://www.benzinga.com/media/19/11/14826131/barrons-picks-and-pans-medtronic-tesla-walmart-and-more,Nelson Hem,2019-11-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707071,jj to appeal revised oklahoma judgment in opioid case argues judgment not supported by facts or the law,https://www.benzinga.com/news/19/11/14823485/j-j-to-appeal-revised-oklahoma-judgment-in-opioid-case-argues-judgment-not-supported-by-facts-or-the,Benzinga Newsdesk,2019-11-15 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.313
707072,oklahoma judge reduces m jj owes in opioid case to m,https://www.benzinga.com/news/19/11/14823286/oklahoma-judge-reduces-572m-j-j-owes-in-opioid-case-to-465m,Benzinga Newsdesk,2019-11-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.625
707073,shares of several healthcare companies are trading higher after president trump discussed transparency around pricing processing in the healthcare industry,https://www.benzinga.com/wiim/19/11/14823250/shares-of-several-healthcare-companies-are-trading-higher-after-president-trump-discussed-transparen,Benzinga Newsdesk,2019-11-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
707074,johnson johnson ebola vaccine begins rollout in congo,https://www.benzinga.com/news/19/11/14806303/johnson-johnson-ebola-vaccine-begins-rollout-in-congo,Charles Gross,2019-11-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707075, dow stocks with at least dividend yields,https://www.benzinga.com/general/education/19/11/14800906/12-dow-stocks-with-at-least-2-dividend-yields,Wayne Duggan,2019-11-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707076,jjs actelion pharmaceuticals withdraws regulatory filings to extend indication of opsumit in cteph,https://www.benzinga.com/general/biotech/19/11/14784298/j-js-actelion-pharmaceuticals-withdraws-regulatory-filings-to-extend-indication-of-opsumit-in-cte,Benzinga Newsdesk,2019-11-12 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.58895
707077,janssen announces new analysis from landmark credence study shows the efficacy and safety profiles of invokana are consistent across various levels of kidney function,https://www.benzinga.com/news/19/11/14774659/janssen-announces-new-analysis-from-landmark-credence-study-shows-the-efficacy-and-safety-profiles-o,Charles Gross,2019-11-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707078,biotech stock on the radar alkermes at a crossroads,https://www.benzinga.com/general/biotech/19/11/14714299/biotech-stock-on-the-radar-alkermes-at-the-crossroads,Shanthi Rexaline,2019-11-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707079,johnson johnson announces submission of european marketing authorisation applications for janssens investigational ebola vaccine regimen,https://www.benzinga.com/news/19/11/14753316/johnson-johnson-announces-submission-of-european-marketing-authorisation-applications-for-janssens-i,Charles Gross,2019-11-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707080,estee lauder reports outstanding first quarter results but cuts estimates,https://www.benzinga.com/news/earnings/19/11/14720360/estee-lauder-reports-outstanding-first-quarter-results-but-cuts-estimates,IAM Newswire,2019-11-04 00:00:00,JNJ,1,1,0,1,0,1,1,0,0,0.4614
707081,jj shares unaffected as hearing co has recalled surgical tool after death of patient serious injuries,https://www.benzinga.com/news/19/10/14702907/j-j-shares-unaffected-as-hearing-co-has-recalled-surgical-tool-after-death-of-patient-serious-injuri,Benzinga Newsdesk,2019-10-31 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.375
707082,johnson johnson says independent labs found no asbestos in recalled powder,https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14690919/johnson-johnson-says-independent-labs-found-no-asbestos-in-recalled-powder,Elizabeth Balboa,2019-10-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
707083,johnson johnson shares are trading higher after the company announced several tests from the same bottle of the companys baby powder that was previously tested by the fda had no asbestos,https://www.benzinga.com/markets/wiim/19/10/14689709/johnson-johnson-shares-are-trading-higher-after-the-company-announced-several-tests-from-the-same-bo,Benzinga Newsdesk,2019-10-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707084,jjs janssen announces health canada approval of darzalex in combination with lenalidomide and dexamethasone for newly diagnosed patients with multiple myeloma who are transplant ineligible,https://www.benzinga.com/general/biotech/19/10/14689006/j-js-janssen-announces-health-canada-approval-of-darzalex-in-combination-with-lenalidomide-and-de,Benzinga Newsdesk,2019-10-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707085, healthcare stocks moving in wednesdays premarket session,https://www.benzinga.com/news/19/10/14688926/13-healthcare-stocks-moving-in-wednesdays-pre-market-session,Lisa Levin,2019-10-30 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707086, stocks moving in wednesdays premarket session,https://www.benzinga.com/news/19/10/14688492/22-stocks-moving-in-wednesdays-pre-market-session,Lisa Levin,2019-10-30 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707087,jjs own expert working for fda found asbestos in baby powder,https://www.benzinga.com/news/19/10/14687837/j-js-own-expert-working-for-fda-found-asbestos-in-baby-powder,Charles Gross,2019-10-30 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707088, stocks moving in tuesdays afterhours session,https://www.benzinga.com/news/earnings/19/10/14685705/8-stocks-moving-in-tuesdays-after-hours-session,Brett Hershman,2019-10-29 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707089,johnson johnson shares are trading higher after the company announced several tests from the same bottle of the companys baby powder that was previously tested by the fda had no asbestos,https://www.benzinga.com/markets/wiim/19/10/14685787/johnson-johnson-shares-are-trading-higher-after-the-company-announced-several-tests-from-the-same-bo,Benzinga Newsdesk,2019-10-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707090,johnson johnson shares resume trade,https://www.benzinga.com/trading-ideas/movers/19/10/14685382/johnson-johnson-shares-resume-trade,Benzinga Newsdesk,2019-10-29 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.648
707091,update lab undertook probe and determined that portable air conditioner in use in auxiliary room was contaminated with asbestos,https://www.benzinga.com/news/19/10/14685021/update-lab-undertook-probe-and-determined-that-portable-air-conditioner-in-use-in-auxiliary-room-was,Benzinga Newsdesk,2019-10-29 00:00:00,JNJ,1,1,0,0,0,0,1,1,1,0.67
707092,update additional new tests of samples from single lot of oct recalled jj baby powder confirm it does not contain asbestos following recall co contracted rdparty laboratories to expedite large number of tests of recalled lot of baby powder,https://www.benzinga.com/news/19/10/14685001/update-additional-48-new-tests-of-samples-from-single-lot-of-oct-18-recalled-j-j-baby-powder-confirm,Benzinga Newsdesk,2019-10-29 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.6591
707093,johnson johnson says new tests from same bottle of cos baby powder previously tested by fda find no asbestos over new tests of recalled lot conducted by two third party laboratories find no asbestos,https://www.benzinga.com/news/19/10/14684983/johnson-johnson-says-15-new-tests-from-same-bottle-of-co-s-baby-powder-previously-tested-by-fda-find,Benzinga Newsdesk,2019-10-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.41105
707094,johnson johnson shares halted news pending,https://www.benzinga.com/hot/19/10/14684839/johnson-johnson-shares-halted-news-pending,Benzinga Newsdesk,2019-10-29 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.648
707095,jj says all product returned to company whether from recalled lot or not will be removed from marketplace permanently,https://www.benzinga.com/news/19/10/14665228/j-j-says-all-product-returned-to-company-whether-from-recalled-lot-or-not-will-be-removed-from-marke,Benzinga Newsdesk,2019-10-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707096,target says has removed all jj baby powder oz bottles from stores and website,https://www.benzinga.com/news/19/10/14664389/target-says-has-removed-all-j-j-baby-powder-22-oz-bottles-from-stores-and-website,Benzinga Newsdesk,2019-10-25 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
707097,rite aid informed its stores to pull all ounce jj baby powder bottles on oct immediately after the recall was announced,https://www.benzinga.com/news/19/10/14659268/rite-aid-informed-its-stores-to-pull-all-22-ounce-j-j-baby-powder-bottles-on-oct-18-immediately-afte,Benzinga Newsdesk,2019-10-24 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.625
707098,jj on cvs health removing jj baby powder says co has been informed by cvs it is a temporary removal in response to the one sku of oz bottles,https://www.benzinga.com/news/19/10/14658290/j-j-on-cvs-health-removing-j-j-baby-powder-says-co-has-been-informed-by-cvs-it-is-a-temporary-remova,Benzinga Newsdesk,2019-10-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.7294
707099,cvs pulling all oz johnson johnson baby powder from shelves amid recall,https://www.benzinga.com/news/19/10/14657945/cvs-pulling-all-22oz-johnson-johnson-baby-powder-from-shelves-amid-recall,Benzinga Newsdesk,2019-10-24 00:00:00,JNJ,1,1,1,1,0,0,1,1,0,0.5
707100,credit suisse maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/19/10/14652642/credit-suisse-maintains-outperform-on-johnson-johnson-raises-price-target-to-163,Benzinga_Newsdesk,2019-10-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707101,jj confirms deal in principle to settle opioid litigation as publicly announced outlined by committee of state attorneys general,https://www.benzinga.com/news/19/10/14650053/j-j-confirms-deal-in-principle-to-settle-opioid-litigation-as-publicly-announced-outlined-by-committ,Benzinga Newsdesk,2019-10-23 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5258
707102,fast money halftime report picks from october ,https://www.benzinga.com/media/19/10/14649539/fast-money-halftime-report-picks-from-october-23,Craig Jones,2019-10-23 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707103,biotech stock on the radar immunomedics long wait for redemption,https://www.benzinga.com/general/biotech/19/10/14630054/biotech-stock-on-the-radar-immunomedics-long-wait-for-redemption,Shanthi Rexaline,2019-10-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707104,jj medical devices unit auris health reports results from benefit study showing safety feasibility of monarch platform,https://www.benzinga.com/news/19/10/14646063/j-j-medical-devices-unit-auris-health-reports-results-from-benefit-study-showing-safety-feasibility,Benzinga Newsdesk,2019-10-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.88915
707105,mixed bag better outlooks from lockheed united technologies but mcdonalds misses,https://www.benzinga.com/news/earnings/19/10/14636560/mixed-bag-better-outlooks-from-lockheed-united-technologies-but-mcdonalds-misses,JJ Kinahan,2019-10-22 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5640000000000001
707106,how much litigation risk is priced into johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14627560/how-much-litigation-risk-is-priced-into-johnson-johnson,Wayne Duggan,2019-10-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.2798
707107,earnings roll on with light schedule today but mcdonalds biogen on tuesday calendar,https://www.benzinga.com/news/earnings/19/10/14627716/earnings-roll-on-with-light-schedule-today-but-mcdonalds-biogen-on-tuesday-calendar,JJ Kinahan,2019-10-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707108,jjs actelion pharma reports safety tolerability findings from trial of opsumit tadalafil combo therapy consistent vs previous trials was well tolerated,https://www.benzinga.com/news/19/10/14627192/j-js-actelion-pharma-reports-safety-tolerability-findings-from-trial-of-opsumit-tadalafil-combo-ther,Benzinga Newsdesk,2019-10-21 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7997000000000001
707109, pharma companies settle opioid lawsuits ahead of trial with ohio counties cases remain,https://www.benzinga.com/news/19/10/14626773/four-pharmas-settle-opioid-lawsuits-ahead-of-trial-with-ohio-counties-2-300-cases-remain,Elizabeth Balboa,2019-10-21 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.42345
707110, biggest movers from friday,https://www.benzinga.com/news/19/10/14625175/46-biggest-movers-from-friday,Lisa Levin,2019-10-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707111,barrons picks and pans boeing comcast conoco emerson and more,https://www.benzinga.com/media/19/10/14624005/barrons-picks-and-pans-boeing-comcast-conoco-emerson-and-more,Nelson Hem,2019-10-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707112,benzingas bulls and bears of the week beyond meat netflix johnson johnson and more,https://www.benzinga.com/trading-ideas/19/10/14623975/benzingas-bulls-and-bears-of-the-week-beyond-meat-netflix-johnson-johnson-and-more,Nelson Hem,2019-10-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707113,wetrader competition round two wrapup,https://www.benzinga.com/news/earnings/19/10/14622521/wetrader-competition-round-two-wrap-up,Chris Dier-Scalise,2019-10-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707114,fda alerts consumers of voluntary recall of johnson johnsons baby powder says that testing has found that a sample for one lot of the product contains chrysotile fibers a type of asbestos,https://www.benzinga.com/news/19/10/14621801/fda-alerts-consumers-of-voluntary-recall-of-johnson-johnsons-baby-powder-says-that-testing-has-found,Benzinga Newsdesk,2019-10-18 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707115, stocks moving in fridays midday session,https://www.benzinga.com/news/19/10/14621163/38-stocks-moving-in-fridays-mid-day-session,Lisa Levin,2019-10-18 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707116,from jj conference call to discuss powder recall probe into asbestos contamination of talc could take up to days or more,https://www.benzinga.com/news/19/10/14620728/from-j-j-conference-call-to-discuss-powder-recall-probe-into-asbestos-contamination-of-talc-could-ta,Benzinga Newsdesk,2019-10-18 00:00:00,JNJ,1,2,0,0,0,0,1,1,0,0.625
707117,johnson johnson voluntarily recalls a batch of baby powder,https://www.benzinga.com/news/19/10/14619288/johnson-johnson-voluntarily-recalls-a-batch-of-baby-powder,Tanzeel Akhtar,2019-10-18 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707118,johnson johnson shares are trading lower after the company recalled lot of baby powder due to trace levels of asbestos,https://www.benzinga.com/markets/wiim/19/10/14619309/johnson-johnson-shares-are-trading-lower-after-the-company-recalled-1-lot-of-baby-powder-due-to-trac,Benzinga Newsdesk,2019-10-18 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.5
707119,update jj reports its consumer units recall of baby powder related to test indicating the presence of subtrace levels of chrysotile asbestos contamination,https://www.benzinga.com/news/19/10/14619066/update-j-j-reports-its-consumer-units-recall-of-baby-powder-related-to-test-indicating-the-presence,Benzinga Newsdesk,2019-10-18 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.625
707120,jjs consumer unit to voluntarily recall lot of johnsons baby powder,https://www.benzinga.com/news/19/10/14619036/j-js-consumer-unit-to-voluntarily-recall1-lot-of-johnsons-baby-powder,Benzinga Newsdesk,2019-10-18 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707121,the daily biotech pulse intuitive surgical earnings paratek pulls out european application for antibiotic amgens evenity in europe,https://www.benzinga.com/general/biotech/19/10/14617565/the-daily-biotech-pulse-intuitive-surgical-earnings-paratek-pulls-out-european-application-for-an,Shanthi Rexaline,2019-10-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707122,european medicines agency reports positive opinion from chmp for jjs combo treatment in adults with treatmentresistant major depressive disorder,https://www.benzinga.com/news/19/10/14618190/european-medicines-agency-reports-positive-opinion-from-chmp-for-j-js-combo-treatment-in-adults-with,Benzinga Newsdesk,2019-10-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.41105
707123,jjs janssen presents fouryear tremfya data showing maintained rates of skin clearance in adult patients with moderate to severe plaque psoriasis,https://www.benzinga.com/general/biotech/19/10/14615440/j-js-janssen-presents-four-year-tremfya-data-showing-maintained-rates-of-skin-clearance-in-adult-,Benzinga Newsdesk,2019-10-17 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.30910000000000004
707124,ohio ag yost says multistate settlement requires johnson johnson ethicon inc to pay about m for deceptive marketing of transvaginal surgical mesh devices,https://www.benzinga.com/news/19/10/14613717/ohio-ag-yost-says-multi-state-settlement-requires-johnson-johnson-ethicon-inc-to-pay-about-117m-for,Benzinga Newsdesk,2019-10-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.44865
707125,ohio ag dave yost announces m multistate settlement with johnson johnson,https://www.benzinga.com/news/19/10/14613691/ohio-ag-dave-yost-announces-117m-multi-state-settlement-with-johnson-johnson,Benzinga Newsdesk,2019-10-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707126,premarket prep recap stormy outlook for cloud stocks opioid makers rally on settlement talks,https://www.benzinga.com/trading-ideas/long-ideas/19/10/14605792/premarket-prep-recap-stormy-outlook-for-cloud-stocks-opioid-makers-rally-on-settlement-t,Joel Elconin,2019-10-16 00:00:00,JNJ,1,1,0,0,0,0,1,1,0,0.5
707127,large option traders arent buying the johnson johnson rally,https://www.benzinga.com/trading-ideas/short-ideas/19/10/14606319/large-option-traders-arent-buying-the-johnson-johnson-rally,Wayne Duggan,2019-10-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707128,benzingas top upgrades downgrades for october ,https://www.benzinga.com/analyst-ratings/upgrades/19/10/14606425/benzingas-top-upgrades-downgrades-for-october-16-2019,Lisa Levin,2019-10-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
707129,analysts investors like johnson johnsons improvement but lawsuits loom,https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14604961/analysts-investors-like-johnson-johnsons-improvement-but-lawsuits-loom,Dave Royse,2019-10-16 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.436
707130,opioid drug companies rally on hopes of broader settlement,https://www.benzinga.com/news/19/10/14604660/opioid-drug-companies-rally-on-hopes-of-broader-settlement,Shanthi Rexaline,2019-10-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.71075
707131,bank of america results keep financial sector flowing with netflix in focus later,https://www.benzinga.com/news/earnings/19/10/14603979/bank-of-america-results-keep-financial-sector-flowing-with-netflix-in-focus-later,JJ Kinahan,2019-10-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707132,credit suisse maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/19/10/14603509/credit-suisse-maintains-outperform-on-johnson-johnson-raises-price-target-to-158,Vick Meyer,2019-10-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707133,wells fargo maintains outperform on johnson johnson lowers price target to ,https://www.benzinga.com/news/19/10/14603214/wells-fargo-maintains-outperform-on-johnson-johnson-lowers-price-target-to-155,Vick Meyer,2019-10-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5640000000000001
707134,johnson johnson shares are trading higher after it was reported the company has offered billion to settle opioid claims atlantic equities analysts also upgraded the companys stock from underweight to neutral,https://www.benzinga.com/markets/wiim/19/10/14602526/johnson-johnson-shares-are-trading-higher-after-it-was-reported-the-company-has-offered-4-billion-to,Benzinga Newsdesk,2019-10-16 00:00:00,JNJ,1,0,1,1,1,0,1,1,0,0.648
707135, healthcare stocks moving in wednesdays premarket session,https://www.benzinga.com/news/19/10/14601880/17-healthcare-stocks-moving-in-wednesdays-pre-market-session,Lisa Levin,2019-10-16 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707136,a peek into the markets us stock futures down bank of america profit tops estimates,https://www.benzinga.com/news/earnings/19/10/14601476/a-peek-into-the-markets-us-stock-futures-down-bank-of-america-profit-tops-estimates,Lisa Levin,2019-10-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.86755
707137,atlantic equities upgrades johnson johnson to neutral,https://www.benzinga.com/news/19/10/14601398/atlantic-equities-upgrades-johnson-johnson-to-neutral,Vick Meyer,2019-10-16 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
707138,jj makes b offer to settle opioid claims,https://www.benzinga.com/news/19/10/14600845/j-j-makes-4b-offer-to-settle-opioid-claims,Charles Gross,2019-10-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707139,update jj also in talks to contribute added money for opioid litigation,https://www.benzinga.com/news/19/10/14598905/update-j-j-also-in-talks-to-contribute-added-money-for-opioid-litigation,Benzinga Newsdesk,2019-10-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5258
707140,missouri appeals court overturns talc case in which jury had awarded m to virginia woman,https://www.benzinga.com/news/19/10/14598169/missouri-appeals-court-overturns-talc-case-in-which-jury-had-awarded-110m-to-virginia-woman,Benzinga Newsdesk,2019-10-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.70095
707141,premarket prep recap impressive bank earnings aphria sparks rally in marijuana sector,https://www.benzinga.com/news/19/10/14597553/premarket-prep-recap-impressive-bank-earnings-aphria-sparks-rally-in-marijuana-sector,Joel Elconin,2019-10-15 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.7553000000000001
707142,bank earnings quartet mostly in tune led by strength at jpmorgan citigroup,https://www.benzinga.com/news/earnings/19/10/14595085/bank-earnings-quartet-mostly-in-tune-led-by-strength-at-jpmorgan-citigroup,JJ Kinahan,2019-10-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707143,relmada shares hit year high as depression drug aces midstage trial,https://www.benzinga.com/general/biotech/19/10/14594431/relmada-shares-hit-4-year-high-as-depression-drug-aces-midstage-trial,Shanthi Rexaline,2019-10-15 00:00:00,JNJ,1,0,0,1,0,1,1,1,1,0.3194
707144,johnson johnson trades higher on q beatandraise despite legal entanglements,https://www.benzinga.com/news/earnings/19/10/14592524/johnson-johnson-trades-higher-on-q3-beat-and-raise-despite-legal-entanglements,Tanzeel Akhtar,2019-10-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.45245
707145, healthcare stocks moving in tuesdays premarket session,https://www.benzinga.com/news/19/10/14593150/22-healthcare-stocks-moving-in-tuesdays-pre-market-session,Lisa Levin,2019-10-15 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707146,the daily biotech pulse reata leaps on positive readout takeda divests fda nod for akorn jj earnings,https://www.benzinga.com/general/biotech/19/10/14591362/the-daily-biotech-pulse-reata-leaps-on-positive-readout-takeda-divests-fda-nod-for-akorn-j-j-earn,Shanthi Rexaline,2019-10-15 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.8404
707147,johnson johnson shares are trading higher after the company reported betterthanexpected q eps and sales results the company also raised its fy eps guidance,https://www.benzinga.com/markets/wiim/19/10/14592448/johnson-johnson-shares-are-trading-higher-after-the-company-reported-better-than-expected-q3-eps-and,Benzinga Newsdesk,2019-10-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
707148,a peek into the markets us stock futures rise ahead of goldman sachs citigroup earnings,https://www.benzinga.com/news/earnings/19/10/14592042/a-peek-into-the-markets-us-stock-futures-rise-ahead-of-goldman-sachs-citigroup-earnings,Lisa Levin,2019-10-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707149,johnson johnson raises fy adj operational eps guidance from to ,https://www.benzinga.com/news/19/10/14591956/johnson-johnson-raises-fy19-adj-eps-guidance-from-8-73-8-83-to-8-84-8-89-vs-8-60-est,Benzinga Newsdesk,2019-10-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707150,johnson johnson q adj eps beats estimate sales b beat b estimate,https://www.benzinga.com/news/earnings/19/10/14591933/johnson-johnson-q3-adj-eps-2-12-beats-2-estimate-sales-20-73b-beat-20-09b-estimate,Benzinga Newsdesk,2019-10-15 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707151, stocks to watch for october ,https://www.benzinga.com/news/earnings/19/10/14591374/10-stocks-to-watch-for-october-15-2019,Lisa Levin,2019-10-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707152,earnings scheduled for october ,https://www.benzinga.com/news/earnings/19/10/14591357/earnings-scheduled-for-october-15-2019,Lisa Levin,2019-10-15 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707153,earnings econ numbers and the beige book pepper the second round of the wetrader competition,https://www.benzinga.com/news/earnings/19/10/14588213/earnings-econ-numbers-and-the-beige-book-pepper-the-second-round-of-the-wetrader-competition,Chris Dier-Scalise,2019-10-14 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707154,raymond james maintains outperform on johnson johnson lowers price target to ,https://www.benzinga.com/news/19/10/14587462/raymond-james-maintains-outperform-on-johnson-johnson-lowers-price-target-to-145,Vick Meyer,2019-10-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.436
707155,congo to begin using jj ebola vaccine in november,https://www.benzinga.com/news/19/10/14586463/congo-to-begin-using-j-j-ebola-vaccine-in-november,Charles Gross,2019-10-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707156,the week ahead in biotech fda decisions johnson johnson among big pharma earnings,https://www.benzinga.com/general/biotech/19/10/14575481/the-week-ahead-in-biotech-fda-decisions-johnson-johnson-among-big-pharma-earnings,Shanthi Rexaline,2019-10-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707157,barrons picks and pans apple boeing ge kellogg and more,https://www.benzinga.com/news/19/10/14585469/barrons-picks-and-pans-apple-boeing-ge-kellogg-and-more,Nelson Hem,2019-10-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707158,benzingas bulls and bears of the week apple boeing facebook nike and more,https://www.benzinga.com/markets/cryptocurrency/19/10/14585493/benzingas-bulls-and-bears-of-the-week-apple-boeing-facebook-nike-and-more,Nelson Hem,2019-10-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707159,shares of several healthcare companies are trading higher after president trump made positive remarks on the uschina trade talks as traders grew more optimistic over the possibility of a limited trade deal trump is scheduled to meet with chinese vice premier liu he at the white house today,https://www.benzinga.com/markets/wiim/19/10/14582266/shares-of-several-healthcare-companies-are-trading-higher-after-president-trump-made-positive-remark,Benzinga Newsdesk,2019-10-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8787
707160,benzingas top upgrades downgrades for october ,https://www.benzinga.com/analyst-ratings/upgrades/19/10/14581570/benzingas-top-upgrades-downgrades-for-october-11-2019,Lisa Levin,2019-10-11 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
707161, healthcare stocks moving in fridays premarket session,https://www.benzinga.com/news/19/10/14580869/28-healthcare-stocks-moving-in-fridays-pre-market-session,Lisa Levin,2019-10-11 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707162,the daily biotech pulse therapix extends merger deadline five prime restructures gileadgalapagos rheumatism drug readout,https://www.benzinga.com/general/biotech/19/10/14579916/the-daily-biotech-pulse-therapix-extends-merger-deadline-five-prime-restructures-gilead-galapagos,Shanthi Rexaline,2019-10-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
707163,bernstein upgrades johnson johnson to outperform,https://www.benzinga.com/news/19/10/14580450/bernstein-upgrades-johnson-johnson-to-outperform,Vick Meyer,2019-10-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707164,midafternoon market update dow rises over points ocugen shares spike higher,https://www.benzinga.com/news/19/10/14569950/mid-afternoon-market-update-dow-rises-over-200-points-ocugen-shares-spike-higher,Lisa Levin,2019-10-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
707165,midday market update crude oil up james river group shares plunge,https://www.benzinga.com/news/19/10/14569167/mid-day-market-update-crude-oil-up-1-james-river-group-shares-plunge,Lisa Levin,2019-10-09 00:00:00,JNJ,1,0,0,0,0,0,1,1,1,0.3194
707166,midmorning market update markets open higher johnson johnson hit with b verdict in risperdal lawsuit,https://www.benzinga.com/news/19/10/14567880/mid-morning-market-update-markets-open-higher-johnson-johnson-hit-with-8b-verdict-in-risperdal-lawsu,Lisa Levin,2019-10-09 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.4614
707167,johnson johnson hit with b verdict in risperdal lawsuit,https://www.benzinga.com/news/19/10/14566819/johnson-johnson-hit-with-8b-verdict-in-risperdal-lawsuit,Elizabeth Balboa,2019-10-09 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.4614
707168, healthcare stocks moving in wednesdays premarket session,https://www.benzinga.com/news/19/10/14566337/13-healthcare-stocks-moving-in-wednesdays-pre-market-session,Lisa Levin,2019-10-09 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707169,jury says jj must pay b in case over male breast growth linked to risperdal,https://www.benzinga.com/general/biotech/19/10/14566317/jury-says-j-j-myst-pay-8b-in-case-over-male-breast-growth-linked-to-risperdal,Benzinga Newsdesk,2019-10-09 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.74695
707170,the daily biotech pulse arbutus halts hepatitis b study positive readout for mei pharmas blood cancer drug ovid offering,https://www.benzinga.com/general/biotech/19/10/14544634/the-daily-biotech-pulse-arbutus-halts-hepatitis-b-study-positive-readout-for-mei-pharmas-blood-ca,Shanthi Rexaline,2019-10-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.39885
707171,jjs janssen reports fda breakthrough therapy designation granted for niraparib for treatment of metastatic castrationresistant prostate cancer,https://www.benzinga.com/news/19/10/14542240/j-js-janssen-reports-fda-breakthrough-therapy-designation-granted-for-niraparib-for-treatment-of-met,Benzinga Newsdesk,2019-10-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.23665000000000003
707172,jjs janssen submits supplemental new drug application to fda for spravato ciii nasal spray for the rapid reduction of depressive symptoms in adults with major depressive disorder who have active suicidal ideation with intent,https://www.benzinga.com/general/biotech/19/10/14533520/j-js-janssen-submits-supplemental-new-drug-application-to-fda-for-spravato-ciii-nasal-spray-for-t,Benzinga Newsdesk,2019-10-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.06709999999999999
707173,sellside positive on johnson johnsons unexpected ohio opioid settlement,https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14531252/sell-side-positive-on-johnson-johnsons-unexpected-ohio-opioid-settlement,Shanthi Rexaline,2019-10-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707174,johnson johnson shares are trading higher after the company reached a settlement agreement with two ohio counties ahead of upcoming opioid trial the company will pay a total of million in relation to the settlement,https://www.benzinga.com/markets/wiim/19/10/14530014/johnson-johnson-shares-are-trading-higher-after-the-company-reached-a-settlement-agreement-with-two,Benzinga Newsdesk,2019-10-02 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.82985
707175,update jnj to pay m of ohio counties legal fees and will direct m to opiodrelated charitable programs,https://www.benzinga.com/news/19/10/14529032/update-jnj-to-pay-5m-of-ohio-counties-legal-fees-and-will-direct-5-4m-to-opiod-related-charitable-pr,Benzinga Newsdesk,2019-10-02 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.71075
707176,the daily biotech pulse jj settles ohio opioid lawsuit teligent explores options for certain assets novartis reports cosentyx data,https://www.benzinga.com/general/biotech/19/10/14527400/the-daily-biotech-pulse-j-j-settles-ohio-opioid-lawsuit-teligent-explores-options-for-certain-ass,Shanthi Rexaline,2019-10-02 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.7202
707177,johnson johnson reaches settlement agreement with two ohio counties ahead of upcoming opioid trial jnj to pay m to cuyahoga and summit counties,https://www.benzinga.com/news/19/10/14527011/johnson-johnson-reaches-settlement-agreement-with-two-ohio-counties-ahead-of-upcoming-opioid-trial-j,Charles Gross,2019-10-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7294
707178,attention biotech investors mark your calendar for these october pdufa dates,https://www.benzinga.com/general/biotech/19/09/14491876/attention-biotech-investors-mark-your-calendar-for-these-october-pdufa-dates,Shanthi Rexaline,2019-09-30 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707179,california jury returns m talc verdict against johnson johnson,https://www.benzinga.com/news/19/09/14513526/california-jury-returns-40m-talc-verdict-against-johnson-johnson,Benzinga Newsdesk,2019-09-30 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.57655
707180,credit suisse reiterates outperform target on johnson johnson as firm notes co appears to be tracking ahead of our q us pharma estimates based on our updated analysis of intraquarter scrips and imsreported sales trends for both july and aug,https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14513065/credit-suisse-reiterates-outperform-156-target-on-johnson-johnson-as-firm-notes-co-,Benzinga_Newsdesk,2019-09-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707181,the daily biotech pulse esmo conference gets underway jjs darzalex snags another approval kaleido biosciences cfo to leave,https://www.benzinga.com/general/biotech/19/09/14503776/the-daily-biotech-pulse-esmo-conference-gets-underway-j-js-darzalex-snags-another-approval-kaleid,Shanthi Rexaline,2019-09-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7202
707182,jns janssen announces receives fda approval for of darzalex daratumumab combination regimen for newly diagnosed transplanteligible patients with multiple myeloma,https://www.benzinga.com/news/19/09/14499850/j-ns-janssen-announces-receives-fda-approval-for-of-darzalex-daratumumab-combination-regimen-for-new,Benzinga Newsdesk,2019-09-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707183,the daily biotech pulse enanta aces midstage nash study takedas ulcerative colitis drug found superior to abbvies decision day for jj,https://www.benzinga.com/general/biotech/19/09/14495112/the-daily-biotech-pulse-enanta-aces-midstage-nash-study-takedas-ulcerative-colitis-drug-found-sup,Shanthi Rexaline,2019-09-26 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.83525
707184,biotech stock on the radar anavex a neurologyfocused precision medicine company,https://www.benzinga.com/analyst-ratings/analyst-color/19/09/14475189/biotech-stock-on-the-radar-anavex-a-neurology-focused-precision-medicine-company,Shanthi Rexaline,2019-09-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707185,barrons picks and pans cocacola mcdonalds ford nike and more,https://www.benzinga.com/media/19/09/14469211/barrons-picks-and-pans-coca-cola-mcdonalds-ford-nike-and-more,Nelson Hem,2019-09-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707186,the week ahead in biotech spotlight on esmo conference,https://www.benzinga.com/general/biotech/19/09/14460216/the-week-ahead-in-biotech-spotlight-on-esmo-conference,Shanthi Rexaline,2019-09-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707187,shares of several drug companies are trading higher after senate majority leader mcconnell suggested a new democratic drug price reform proposal would be dead on arrival,https://www.benzinga.com/markets/wiim/19/09/14466308/shares-of-several-drug-companies-are-trading-higher-after-senate-majority-leader-mcconnell-suggested,Benzinga Newsdesk,2019-09-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.26165
707188,jjs janssen announced new realworld evidence confirming xarelto reduced risk of recurrent venous thromboembolism in patients who are morbidly obese,https://www.benzinga.com/general/biotech/19/09/14464095/j-js-janssen-announced-new-real-world-evidence-confirming-xarelto-reduced-risk-of-recurrent-venou,Benzinga Newsdesk,2019-09-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3634
707189,jj to report q earnings on tues oct before market open,https://www.benzinga.com/news/earnings/19/09/14454102/j-j-to-report-q3-earnings-on-tues-oct-15-2019-before-market-open,Benzinga Newsdesk,2019-09-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.625
707190,axsome shares flirt with record high how much upside is left,https://www.benzinga.com/general/biotech/19/09/14452578/axsome-shares-flirt-with-record-high-how-much-upside-is-left,Shanthi Rexaline,2019-09-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707191,the daily biotech pulse newlink genetics rallies breakthrough designation for roche igm biosciences debuts,https://www.benzinga.com/general/biotech/19/09/14449081/the-daily-biotech-pulse-newlink-genetics-rallies-breakthrough-designation-for-roche-igm-bioscienc,Shanthi Rexaline,2019-09-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707192,purdue pharma files for bankruptcy what you need to know,https://www.benzinga.com/news/19/09/14435816/purdue-pharma-files-for-bankruptcy-what-you-need-to-know,Shanthi Rexaline,2019-09-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707193,morphosys reports licensee janssen rd issued press release highlighting submission of supplemental biologics license application seeking approval of tremfya,https://www.benzinga.com/news/19/09/14434722/morphosys-reports-licensee-janssen-r-d-issued-press-release-highlighting-submission-of-supplemental,Benzinga Newsdesk,2019-09-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
707194,janssen pharmaceutical announces new darzalex data from griffin study show high response rate and depth of response in patients with newly diagnosed multiple myeloma who are transplanteligible,https://www.benzinga.com/news/19/09/14432561/janssen-pharmaceutical-announces-new-darzalex-data-from-griffin-study-show-high-response-rate-and-de,Charles Gross,2019-09-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707195,jj mckesson face b damage demand in ohio opioid trial,https://www.benzinga.com/news/19/09/14432389/j-j-mckesson-face-8b-damage-demand-in-ohio-opioid-trial,Charles Gross,2019-09-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.29905000000000004
707196,jj spokesperson says a new jersey jury has found co liable for m in trial claiming talc powder caused cancer,https://www.benzinga.com/news/19/09/14415399/j-j-spokesperson-says-a-new-jersey-jury-has-found-co-liable-for-37m-in-trial-claiming-talc-powder-ca,Benzinga Newsdesk,2019-09-11 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.23665000000000003
707197,johnson johnson to pay m to group blaming powder for cancers,https://www.benzinga.com/news/19/09/14415206/johnson-johnson-to-pay-37-2m-to-group-blaming-powder-for-cancers,Benzinga Newsdesk,2019-09-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.2213
707198,watching jj shares amid report new headtohead phase data for janssens ponesimod was superior compared to aubagio mg in adults with relapsing multiple sclerosis,https://www.benzinga.com/news/19/09/14414122/watching-j-j-shares-amid-report-new-head-to-head-phase-3-data-for-janssens-ponesimod-was-superior-co,Benzinga Newsdesk,2019-09-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.88585
707199,jj says new data from spravato ciii nasal spray phase studies showed rapid reduction of depressive symptoms in adult patients with major depressive disorder,https://www.benzinga.com/general/biotech/19/09/14397323/j-j-says-new-data-from-spravato-ciii-nasal-spray-phase-3-studies-showed-rapid-reduction-of-depres,Benzinga Newsdesk,2019-09-09 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.1452
707200,european commission has approved expanded use of jjs janssens ustekinumab for treatment of adults with moderately to sever ulcerative colitis,https://www.benzinga.com/news/19/09/14373653/european-commission-has-approved-expanded-use-of-j-js-janssens-ustekinumab-for-treatment-of-adults-w,Benzinga Newsdesk,2019-09-04 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.71075
707201,cardinal health jj shares tick lower as hearing cos must face cities opioidconspiracy claims,https://www.benzinga.com/news/19/09/14368620/cardinal-health-j-j-shares-tick-lower-as-hearing-cos-must-face-cities-opioid-conspiracy-claims,Benzinga Newsdesk,2019-09-03 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.625
707202,the week ahead in biotech cardiology analyst conferences in the spotlight,https://www.benzinga.com/general/biotech/19/09/14350987/the-week-ahead-in-biotech-cardiology-analyst-conferences-in-the-spotlight,Shanthi Rexaline,2019-09-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707203,bulls and bears of the week altria apple netflix slack and more,https://www.benzinga.com/trading-ideas/19/08/14361184/bulls-and-bears-of-the-week-altria-apple-netflix-slack-and-more,Nelson Hem,2019-08-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707204,citi turns bullish on jabil says customer risk concentration played out,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14349890/citi-turns-bullish-on-jabil-says-customer-risk-concentration-played-out,Jayson Derrick,2019-08-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5386
707205,fast money traders give their opinion on johnson johnson and papa johns,https://www.benzinga.com/media/19/08/14345521/fast-money-traders-give-their-opinion-on-johnson-johnson-and-papa-johns,Craig Jones,2019-08-29 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
707206,fitch says oklahomas ruling on jj may not set standard for other companies as other states could employ legal approaches other than public nuisance law,https://www.benzinga.com/news/19/08/14344030/fitch-says-oklahomas-ruling-on-j-j-may-not-set-standard-for-other-companies-as-other-states-could-em,Benzinga Newsdesk,2019-08-28 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.6806
707207,attention biotech investors mark your calendar for these september pdufa dates,https://www.benzinga.com/general/biotech/19/08/14328344/attention-biotech-investors-mark-your-calendar-for-these-september-pdufa-dates,Shanthi Rexaline,2019-08-28 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707208,arrowhead collaborator janssen begins reef phase b combination study in patients with chronic hepatitis b infection arrowhead earns m milestone payment in connection with trial initiation,https://www.benzinga.com/general/biotech/19/08/14339737/arrowhead-collaborator-janssen-begins-reef-1-phase-2b-combination-study-in-patients-with-chronic-,Benzinga Newsdesk,2019-08-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707209, stocks moving in tuesdays midday session,https://www.benzinga.com/news/19/08/14336155/46-stocks-moving-in-tuesdays-mid-day-session,Lisa Levin,2019-08-27 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707210,barclays maintains equal weight target on johnson johnson as firm believes shares are likely to continue to trade at a discount to its sumoftheparts valuation due to the litigation overhang,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14335633/barclays-maintains-equal-weight-140-target-on-johnson-johnson-as-firm-believes-shar,Benzinga_Newsdesk,2019-08-27 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.55135
707211,bmo maintains outperform on johnson johnson maintains target as firm notes we remind investors that litigation is long lengthy and difficult to read and while the amount is less than it could have been we would expect an extended resolution,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14335566/bmo-maintains-outperform-on-johnson-johnson-maintains-157-target-as-firm-notes-we-r,Benzinga_Newsdesk,2019-08-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.24469999999999997
707212,why one johnson johnson analyst sees oklahoma opioid ruling as nearterm sentiment positive,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14333820/why-one-johnson-johnson-analyst-sees-oklahoma-opioid-ruling-as-near-term-sentiment-,Shanthi Rexaline,2019-08-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7787
707213,raymond james on johnson johnson also notes the judge ordered jj to pay m for an abatement plan and the state was looking for b from jj and we believe investor expectations were for b jj ended q with b in net cash,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14334952/raymond-james-on-johnson-johnson-also-notes-the-judge-ordered-j-j-to-pay-572m-for-a,Benzinga_Newsdesk,2019-08-27 00:00:00,JNJ,1,0,1,1,0,1,1,1,0,0.7787
707214,raymond james maintains outperform on johnson johnson as firm notes after speaking with management we remain optimistic in the defense case for jj when heading to the appellate courts,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14334951/raymond-james-maintains-outperform-on-johnson-johnson-as-firm-notes-after-speaking-,Benzinga_Newsdesk,2019-08-27 00:00:00,JNJ,1,0,1,1,0,0,1,1,0,0.79295
707215,a look at benzinga pros mostsearched tickers for august ,https://www.benzinga.com/news/19/08/14334572/a-look-at-benzinga-pros-most-searched-tickers-for-august-27-2019,Sebastian Brown,2019-08-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707216,chubb salesforce and more fast money picks for august ,https://www.benzinga.com/trading-ideas/long-ideas/19/08/14334414/chubb-salesforce-and-more-fast-money-picks-for-august-27,Craig Jones,2019-08-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707217,johnson johnson shares are trading higher after an oklahoma judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic will pay million in damages investors were potentially expecting the company to pay more in fin,https://www.benzinga.com/markets/wiim/19/08/14334030/johnson-johnson-shares-are-trading-higher-after-an-oklahoma-judge-finds-the-company-liable-in-the-la,Benzinga Newsdesk,2019-08-27 00:00:00,JNJ,1,0,0,1,0,1,1,1,0,0.23665000000000003
707218,benzinga pros top mostsearched tickers for morning of tuesday august ,https://www.benzinga.com/trading-ideas/19/08/14333779/benzinga-pros-top-10-most-searched-tickers-for-morning-of-tuesday-august-27-2019,Benzinga Newsdesk,2019-08-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
707219,neutral zone stocks bonds both up as next moves in trade war anxiously awaited,https://www.benzinga.com/government/19/08/14333526/neutral-zone-stocks-bonds-both-up-as-next-moves-in-trade-war-anxiously-awaited,JJ Kinahan,2019-08-27 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.1452
707220,update morgan stanley on johnson johnson also notes given that many investors feared a more substantial judgment against jj we expect opioidexposed specialty pharmaceutical companies to trade higher on tuesday aug ,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14332476/update-morgan-stanley-on-johnson-johnson-also-notes-given-that-many-investors-feare,Benzinga_Newsdesk,2019-08-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.4862
707221,update morgan stanley maintains equalweight on johnson johnson maintains target as firm notes we suggested base case exposure of bn and bear case exposure of bn and yesterdays judgement does not alter our view,https://www.benzinga.com/analyst-ratings/analyst-color/19/08/14332473/update-morgan-stanley-maintains-equal-weight-on-johnson-johnson-maintains-145-targe,Benzinga_Newsdesk,2019-08-27 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707222,morgan stanley maintains equalweight on johnson johnson maintains price target,https://www.benzinga.com/news/19/08/14332456/morgan-stanley-maintains-equal-weight-on-johnson-johnson-maintains-145-price-target,Benzinga_Newsdesk,2019-08-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707223, stocks moving in tuesdays premarket session,https://www.benzinga.com/news/19/08/14332054/26-stocks-moving-in-tuesdays-pre-market-session,Lisa Levin,2019-08-27 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707224,the daily biotech pulse nuvectra explores strategic options jj to contend opioid ruling sesen bio gets new cfo,https://www.benzinga.com/general/biotech/19/08/14331652/the-daily-biotech-pulse-nuvectra-explores-strategic-options-j-j-to-contend-opioid-ruling-sesen-bi,Shanthi Rexaline,2019-08-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707225,everyday health group acquires babycenter from johnson johnson terms not disclosed,https://www.benzinga.com/m-a/19/08/14331555/everyday-health-group-acquires-babycenter-from-johnson-johnson-terms-not-disclosed,Benzinga Newsdesk,2019-08-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707226,judge orders johnson johnson to pay m in opioid case,https://www.benzinga.com/news/19/08/14329310/judge-orders-johnson-johnson-to-pay-572m-in-opioid-case,Dave Royse,2019-08-26 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.44865
707227,johnson johnson shares are trading higher after an oklahoma judge finds the company liable in the lawsuit claiming that it helped fuel opioid epidemic will pay million in damages investors were potentially expecting the company to pay more in fines,https://www.benzinga.com/markets/wiim/19/08/14329249/johnson-johnson-shares-are-trading-higher-after-an-oklahoma-judge-finds-the-company-liable-in-the-la,Benzinga Newsdesk,2019-08-26 00:00:00,JNJ,1,0,0,1,0,1,1,1,0,0.23665000000000003
707228,johnson johnson says it will appeal oklahoma judges ruling in opioid case,https://www.benzinga.com/general/biotech/19/08/14329215/johnson-johnson-says-it-will-appeal-oklahoma-judges-ruling-in-opioid-case,Benzinga Newsdesk,2019-08-26 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707229,oklahoma judge finds johnson johnson liable in lawsuit claiming drugmaker helped fuel opioid epidemic co to pay m in damages,https://www.benzinga.com/general/biotech/19/08/14329091/oklahoma-judge-finds-johnson-johnson-liable-in-lawsuit-claiming-drugmaker-helped-fuel-opioid-epid,Benzinga Newsdesk,2019-08-26 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.18155
707230,johnson johnson shares now falling reversing from spike,https://www.benzinga.com/news/19/08/14329065/johnson-johnson-shares-now-falling-reversing-from-spike,Benzinga Newsdesk,2019-08-26 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.57655
707231,johnson johnson shares spike oklahoma judge preparing to reveal decision in opioid lawsuit,https://www.benzinga.com/news/19/08/14329056/johnson-johnson-shares-spike-oklahoma-judge-preparing-to-reveal-decision-in-opioid-lawsuit,Benzinga Newsdesk,2019-08-26 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.5386
707232,kohls snap and more fast money picks for august ,https://www.benzinga.com/trading-ideas/long-ideas/19/08/14313663/kohls-snap-and-more-fast-money-picks-for-august-22,Craig Jones,2019-08-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707233,the daily biotech pulse viivs longacting hiv drug meets study goal chinese cheer for fibrogen retrophin flunks latestage study,https://www.benzinga.com/general/biotech/19/08/14310766/the-daily-biotech-pulse-viivs-long-acting-hiv-drug-meets-study-goal-chinese-cheer-for-fibrogen-re,Shanthi Rexaline,2019-08-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
707234,oklahoma judge to rule on monday in opioid lawsuit against jj reuters,https://www.benzinga.com/news/19/08/14309307/oklahoma-judge-to-rule-on-monday-in-opioid-lawsuit-against-j-j-reuters,Benzinga Newsdesk,2019-08-21 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.5129
707235,trump says his solution to the epidemic of veteran suicides is some new stimulant produced by johnson johnson that hes instructed the government to buy in large quantities tweets aaron rupar,https://www.benzinga.com/news/19/08/14307709/trump-says-his-solution-to-the-epidemic-of-veteran-suicides-is-some-new-stimulant-produced-by-johnso,Benzinga_Newsdesk,2019-08-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
707236,its a huge thing avicanna receives unique canadian cannabinoid research license,https://www.benzinga.com/markets/cannabis/19/08/14300506/its-a-huge-thing-avicanna-receives-unique-canadian-cannabinoid-research-license,Natan Ponieman,2019-08-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
707237,shares of several healthcare companies are trading higher with the overall market after the us announced it is excluding and delaying the additional tariff on certain products,https://www.benzinga.com/markets/wiim/19/08/14257980/shares-of-several-healthcare-companies-are-trading-higher-with-the-overall-market-after-the-u-s-anno,Benzinga Newsdesk,2019-08-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7553000000000001
707238,lillys psoriasis drug found superior to jjs tremfya in phase study,https://www.benzinga.com/general/biotech/19/08/14256933/lillys-psoriasis-drug-found-superior-to-j-js-tremfya-in-phase-4-study,Shanthi Rexaline,2019-08-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.77115
707239,xoma reports jjs janssen has elected to accelerate base annual license fee obligation will make time m payment to co,https://www.benzinga.com/news/19/08/14246854/xoma-reports-j-js-janssen-has-elected-to-accelerate-base-annual-license-fee-obligation-will-make-1-t,Benzinga Newsdesk,2019-08-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707240,biotech stock on the radar veru a catalystrich biopharma,https://www.benzinga.com/general/biotech/19/07/14167534/biotech-stock-on-the-radar-veru-a-catalyst-rich-biopharma,Shanthi Rexaline,2019-07-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707241,in june ftc issued civil investigative demand to jj on investigation of whether janssens remicade contracting practices violate antitrust laws,https://www.benzinga.com/news/19/07/14154543/in-june-ftc-issued-civil-investigative-demand-to-j-j-on-investigation-of-whether-janssens-remicade-c,Benzinga Newsdesk,2019-07-29 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.29905000000000004
707242,host of earnings loom with beyond meat apple among highlights ahead of fed payrolls,https://www.benzinga.com/news/earnings/19/07/14150824/host-of-earnings-loom-with-beyond-meat-apple-among-highlights-ahead-of-fed-payrolls,JJ Kinahan,2019-07-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.38685
707243,kbl merger corp acquires cannabisfocused biotech company,https://www.benzinga.com/markets/cannabis/19/07/14147513/kbl-merger-corp-acquires-cannabis-focused-biotech-company,Javier Hasse,2019-07-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707244,the daily biotech pulse obseva gets the greenlight verastem climbs on licensing deal merit medical earnings disappoint,https://www.benzinga.com/general/biotech/19/07/14140562/the-daily-biotech-pulse-obseva-gets-the-greenlight-verastem-climbs-on-licensing-deal-merit-medica,Shanthi Rexaline,2019-07-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5129
707245,social media earnings facebook and twitter prepare to share,https://www.benzinga.com/markets/cryptocurrency/19/07/14120135/social-media-earnings-facebook-and-twitter-prepare-to-share,JJ Kinahan,2019-07-23 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.648
707246,with earnings on tap a stir in this leveraged pharmaceuticals etf,https://www.benzinga.com/news/earnings/19/07/14113113/with-earnings-on-tap-a-stir-in-this-leveraged-pharmaceuticals-etf,ETF Professor,2019-07-23 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707247,benzingas bulls and bears apple boeing disney johnson johnson and more,https://www.benzinga.com/trading-ideas/19/07/14106408/benzingas-bulls-and-bears-apple-boeing-disney-johnson-johnson-and-more,Nelson Hem,2019-07-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707248,the week ahead in biotech pharma earnings pick up pace,https://www.benzinga.com/general/biotech/19/07/14096172/the-week-ahead-in-biotech-pharma-earnings-pick-up-pace,Shanthi Rexaline,2019-07-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707249,from coffee to cannabis colombias choice between economic development and cannamercantilism,https://www.benzinga.com/markets/cannabis/19/07/14099378/from-coffee-to-cannabis-colombias-choice-between-economic-development-and-cannamercantilism,Michael Miller - LA Weekly,2019-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707250,intuitive surgicals q performance lauded by bullish analysts,https://www.benzinga.com/analyst-ratings/analyst-color/19/07/14102319/intuitive-surgicals-q2-performance-lauded-by-bullish-analysts,Shanthi Rexaline,2019-07-19 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5
707251,halozyme reports jjs janssen submitted extension application to ema for subcutaneous formulation of darzalex utilizing enhanze technology,https://www.benzinga.com/news/19/07/14101533/halozyme-reports-j-js-janssen-submitted-extension-application-to-ema-for-subcutaneous-formulation-of,Benzinga Newsdesk,2019-07-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707252,janssen seeks ema approval for novel subcutaneous formulation of darzalex,https://www.benzinga.com/news/19/07/14101141/janssen-seeks-ema-approval-for-novel-subcutaneous-formulation-of-darzalex,Charles Gross,2019-07-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.82985
707253,flexshares makes a big low vol etf splash,https://www.benzinga.com/trading-ideas/long-ideas/19/07/14084945/flexshares-makes-a-big-low-vol-etf-splash,ETF Professor,2019-07-17 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.3634
707254,after earnings beat wall street talks johnson johnson litigation risk,https://www.benzinga.com/analyst-ratings/analyst-color/19/07/14089387/after-earnings-beat-wall-street-talks-johnson-johnson-litigation-risk,Wayne Duggan,2019-07-17 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.2798
707255,raymond james maintains outperform on johnson johnson lowers price target to ,https://www.benzinga.com/news/19/07/14086886/raymond-james-maintains-outperform-on-johnson-johnson-lowers-price-target-to-146,Vick Meyer,2019-07-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.436
707256,mostly strong results for big banks and jj another solid earnings performer,https://www.benzinga.com/news/earnings/19/07/14081329/mostly-strong-results-for-big-banks-and-j-j-another-solid-earnings-performer,JJ Kinahan,2019-07-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8548
707257,jj executive says taking a m charge in the quarter related to talc litigation for defense costs only,https://www.benzinga.com/news/19/07/14081327/j-j-executive-says-taking-a-190m-charge-in-the-quarter-related-to-talc-litigation-for-defense-costs,Benzinga Newsdesk,2019-07-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.58895
707258,from jj q earnings conference call exec commenting on oklahoma opioid case says facts do not align with what state is claiming,https://www.benzinga.com/news/19/07/14080966/from-j-j-q2-earnings-conference-call-exec-commenting-on-oklahoma-opioid-case-says-facts-do-not-align,Benzinga Newsdesk,2019-07-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707259,from jj q earnings conference call sees largest impact from generic biosimilars in q has resumed distribution of its surgical staplers to customers in jun following recall,https://www.benzinga.com/news/earnings/19/07/14080712/from-j-j-q2-earnings-conference-call-sees-largest-impact-from-generic-biosimilars-in-q3-has-resumed,Benzinga Newsdesk,2019-07-16 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.625
707260,a peek into the markets us stock futures edge lower ahead of citigroup wells fargo earnings,https://www.benzinga.com/news/earnings/19/07/14079309/a-peek-into-the-markets-us-stock-futures-edge-lower-ahead-of-citigroup-wells-fargo-earnings,Lisa Levin,2019-07-16 00:00:00,JNJ,0,1,0,1,1,0,0,0,0,0.4742
707261,johnson johnson trades higher on q earnings beat,https://www.benzinga.com/news/earnings/19/07/14079123/johnson-johnson-trades-higher-on-q2-earnings-beat,Tanzeel Akhtar,2019-07-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707262,johnson johnson reaffirms fy adj eps guidance of vs est,https://www.benzinga.com/news/19/07/14079076/johnson-johnson-reaffirms-fy19-adj-eps-guidance-of-8-53-8-63-vs-8-60-est,Benzinga Newsdesk,2019-07-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707263,johnson johnson raises fy operational sales guidance from bb to bb raises est reported sales from bb to bb,https://www.benzinga.com/news/19/07/14079075/johnson-johnson-raises-fy19-operational-sales-guidance-from-82b-82-8b-to-82-4b-83-2b-raises-est-repo,Benzinga Newsdesk,2019-07-16 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5
707264,johnson johnson q adj eps beats estimate sales b beat b estimate,https://www.benzinga.com/news/earnings/19/07/14079062/johnson-johnson-q2-adj-eps-2-58-beats-2-43-estimate-sales-20-56b-beat-20-29b-estimate,Benzinga Newsdesk,2019-07-16 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707265, stocks to watch for july ,https://www.benzinga.com/news/earnings/19/07/14078575/11-stocks-to-watch-for-july-16-2019,Lisa Levin,2019-07-16 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707266,earnings scheduled for july ,https://www.benzinga.com/news/earnings/19/07/14078530/earnings-scheduled-for-july-16-2019,Lisa Levin,2019-07-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707267,johnson johnson q earnings outlook,https://www.benzinga.com/news/earnings-previews/19/07/14075895/johnson-johnsons-earnings-outlook,Benzinga Newsdesk,2019-07-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707268,earnings season starts with beat from citigroup other banks netflix report later in week,https://www.benzinga.com/news/earnings/19/07/14074268/earnings-season-starts-with-beat-from-citigroup-other-banks-netflix-report-later-in-week,JJ Kinahan,2019-07-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707269,the week ahead in biotech johnson johnson kickstarts big pharma earnings,https://www.benzinga.com/general/biotech/19/07/14061331/the-week-ahead-in-biotech-johnson-johnson-kickstarts-big-pharma-earnings,Shanthi Rexaline,2019-07-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707270,johnson johnson falls on report of justice department probe,https://www.benzinga.com/news/19/07/14068240/johnson-johnson-falls-on-report-of-justice-department-probe,Jayson Derrick,2019-07-12 00:00:00,JNJ,1,1,0,0,0,1,1,1,1,0.76335
707271,jj in response to report about criminal probe in talc case says implication that there has been a new development in this matter is flatly wrong,https://www.benzinga.com/general/biotech/19/07/14068266/j-j-in-response-to-report-about-criminal-probe-in-talc-case-says-implication-that-there-has-been-,Benzinga Newsdesk,2019-07-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.17149999999999999
707272,halozyme therapeutics reports jjs janssen submitted biologics license application to fda for subcutaneous delivery of darzalex for patients with multiple myeloma,https://www.benzinga.com/news/19/07/14068049/halozyme-therapeutics-reports-j-js-janssen-submitted-biologics-license-application-to-fda-for-subcut,Benzinga Newsdesk,2019-07-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707273,johnson johnson shares are trading lower following reports of a us criminal probe into the companys denial of asbestos in baby powder,https://www.benzinga.com/markets/wiim/19/07/14068001/johnson-johnson-shares-are-trading-lower-following-reports-of-a-us-criminal-probe-into-the-companys,Benzinga Newsdesk,2019-07-12 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.23665000000000003
707274,jj shares fall as hearing co denials of asbestos in baby powder have spurred a us criminal probe,https://www.benzinga.com/news/19/07/14067958/j-j-shares-fall-as-hearing-co-denials-of-asbestos-in-baby-powder-have-spurred-a-us-criminal-probe,Benzinga Newsdesk,2019-07-12 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.4742
707275,jjs janssen says is in the process of submitting regulatory applications to respective health authorities related to preventive hiv vaccine,https://www.benzinga.com/news/19/07/14067304/j-js-janssen-says-is-in-the-process-of-submitting-regulatory-applications-to-respective-health-autho,Benzinga Newsdesk,2019-07-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
707276,novartis amgen scrap pivotal study of alzheimers prevention drug,https://www.benzinga.com/general/biotech/19/07/14067050/novartis-amgen-scrap-pivotal-study-of-alzheimers-prevention-drug,Shanthi Rexaline,2019-07-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707277,benzingas top upgrades downgrades for july ,https://www.benzinga.com/analyst-ratings/upgrades/19/07/14066608/benzingas-top-upgrades-downgrades-for-july-12-2019,Lisa Levin,2019-07-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
707278,credit suisse initiates coverage on johnson johnson with outperform rating announces price target,https://www.benzinga.com/news/19/07/14066161/credit-suisse-initiates-coverage-on-johnson-johnson-with-outperform-rating-announces-156-price-targe,Benzinga_Newsdesk,2019-07-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707279,avicanna gets conditional approval to list on toronto stock exchange senior board as rd issuer,https://www.benzinga.com/markets/cannabis/19/07/14061519/avicanna-gets-conditional-approval-to-list-on-toronto-stock-exchange-senior-board-as-r-d-issuer,Nina Zdinjak,2019-07-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
707280,johnson johnsons stranglehold on the blockbuster drug remicade recent axios article,https://www.benzinga.com/news/19/07/14059948/johnson-johnsons-stranglehold-on-the-blockbuster-drug-remicade-recent-axios-article,Benzinga Newsdesk,2019-07-11 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.7997000000000001
707281,johnson johnson wins new trial in talc case,https://www.benzinga.com/news/19/07/14055676/johnson-johnson-wins-new-trial-in-talc-case,Tanzeel Akhtar,2019-07-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7859499999999999
707282,jj says pleased with the california appellate courts review of the talc case says pleased that court agreed with judge nelsons finding that punitive damages should not have been awarded,https://www.benzinga.com/news/19/07/14055444/j-j-says-pleased-with-the-california-appellate-courts-review-of-the-talc-case-says-pleased-that-cour,Benzinga_Newsdesk,2019-07-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5567
707283,johnson johnson to get trial after m verdict in talc case,https://www.benzinga.com/news/19/07/14055076/johnson-johnson-to-get-trial-after-417m-verdict-in-talc-case,Benzinga Newsdesk,2019-07-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.57655
707284,vaxart enters into research collaboration with janssen to evaluate oral universal influenza vaccine,https://www.benzinga.com/general/biotech/19/07/14045699/vaxart-enters-into-research-collaboration-with-janssen-to-evaluate-oral-universal-influenza-vacci,Benzinga Newsdesk,2019-07-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707285,johnson johnson janssen announces results from phase einsteinjr study of xarelto study met all pre specified endpoints,https://www.benzinga.com/general/biotech/19/07/14038845/johnson-johnson-janssen-announces-results-from-phase-3-einstein-jr-study-of-xarelto-study-met-all,Benzinga Newsdesk,2019-07-08 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.5
707286,jjs janssen reports received positive chmp opinion recommending expanded use of imbruvica for indications,https://www.benzinga.com/news/19/06/14000510/j-js-janssen-reports-received-positive-chmp-opinion-recommending-expanded-use-of-imbruvica-for-2-ind,Benzinga Newsdesk,2019-06-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707287,morphic holding ipo what you need to know,https://www.benzinga.com/general/biotech/19/06/13978246/morphic-holding-ipo-what-you-need-to-know,Shanthi Rexaline,2019-06-26 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707288,minerva spikes higher after novel insomnia drug aces midstage trial,https://www.benzinga.com/general/biotech/19/06/13969110/minerva-spikes-higher-after-novel-insomnia-drug-aces-mid-stage-trial,Shanthi Rexaline,2019-06-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
707289,fitch affirms jj aaa rating,https://www.benzinga.com/news/19/06/13946560/fitch-affirms-j-j-aaa-rating,Benzinga Newsdesk,2019-06-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707290,janssen reports topline phase results for tremfya in adults with active psoriatic arthritis,https://www.benzinga.com/general/biotech/19/06/13924691/janssen-reports-top-line-phase-3-results-for-tremfya-in-adults-with-active-psoriatic-arthritis,Benzinga Newsdesk,2019-06-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
707291,update recent bloomberg report indicates jj and colgate ordered to pay almost m in talc case,https://www.benzinga.com/news/19/06/13911704/update-recent-bloomberg-report-indicates-j-j-and-colgate-ordered-to-pay-almost-10m-in-talc-case,Benzinga Newsdesk,2019-06-12 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.57655
707292,jj colgatepalmolive lose verdict in talccancer case,https://www.benzinga.com/news/19/06/13911682/j-j-colgate-palmolive-lose-verdict-in-talc-cancer-case,Benzinga Newsdesk,2019-06-12 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.4871
707293,jj says co will pursue an appeal because johnsons baby powder does not contain asbestos or cause cancer,https://www.benzinga.com/news/19/06/13911379/j-j-says-co-will-pursue-an-appeal-because-johnsons-baby-powder-does-not-contain-asbestos-or-cause-ca,Benzinga Newsdesk,2019-06-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.23665000000000003
707294,hearing johnson johnson and colgatepalmolive have closed jury verdict in talc cancer case,https://www.benzinga.com/news/19/06/13911099/hearing-johnson-johnson-and-colgate-palmolive-have-closed-jury-verdict-in-talc-cancer-case,Benzinga Newsdesk,2019-06-12 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.20705
707295,janssen invokana incidence rates of adverse events serious adverse events were numerically lower for patients treated with invokana vs placebo,https://www.benzinga.com/news/19/06/13903779/janssen-invokana-incidence-rates-of-adverse-events-serious-adverse-events-were-numerically-lower-for,Benzinga_Newsdesk,2019-06-11 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.12104999999999999
707296,janssen invokana significantly reduced major cardiovascular events kidney failure in patients with type diabetes chronic kidney disease in new credence analysis,https://www.benzinga.com/news/19/06/13903772/janssen-invokana-significantly-reduced-major-cardiovascular-events-kidney-failure-in-patients-with-t,Benzinga_Newsdesk,2019-06-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.24469999999999997
707297,the daily biotech pulse lilly reports positive longterm efficacy data for psoriasis drug provention bio offering,https://www.benzinga.com/general/biotech/19/06/13900223/the-daily-biotech-pulse-lilly-reports-positive-long-term-efficacy-data-for-psoriasis-drug-provent,Shanthi Rexaline,2019-06-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707298,shares of several healthcare companies are trading higher with the overall us market recent comments out of china and mexico has renewed trade optimism and lifted economic outlook,https://www.benzinga.com/markets/wiim/19/06/13859934/shares-of-several-healthcare-companies-are-trading-higher-with-the-overall-us-market-recent-comments,Benzinga Newsdesk,2019-06-04 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.8453999999999999
707299,i believe it is wrong to charge americans astronomical prices for lifesaving drugs developed with taxpayer dollars you will not find me encouraging pharmaceutical companies to continue ripping off americans like my republican colleagues sen sanders,https://www.benzinga.com/news/19/06/13859297/i-believe-it-is-wrong-to-charge-americans-astronomical-prices-for-life-saving-drugs-developed-with-t,Benzinga Newsdesk,2019-06-04 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.23854999999999998
707300,obalon clinches first us patent for obesity treatment placement system,https://www.benzinga.com/general/biotech/19/06/13858172/obalon-clinches-first-us-patent-for-obesity-treatment-placement-system,Shanthi Rexaline,2019-06-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707301,johnson johnsons janssen pharmaceutical highlights presentation of imbruvica longterm data from two pivotal phase studies at asco and eha demonstrating sustained efficacy and safety in patients with chronic lymphocytic leukemia,https://www.benzinga.com/general/biotech/19/06/13849157/johnson-johnsons-janssen-pharmaceutical-highlights-presentation-of-imbruvica-long-term-data-from-,Benzinga Newsdesk,2019-06-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
707302,johnson johnson to pay m in punitive damages in olson talc cancer case,https://www.benzinga.com/news/19/05/13842442/johnson-johnson-to-pay-300m-in-punitive-damages-in-olson-talc-cancer-case,Tanzeel Akhtar,2019-05-31 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.049949999999999994
707303,update jj spokesperson says talc trial had significant legal and evidentiary errors which co believes will warrant reversal amid appeal,https://www.benzinga.com/news/19/05/13842322/update-j-j-spokesperson-says-talc-trial-had-significant-legal-and-evidentiary-errors-which-co-believ,Benzinga Newsdesk,2019-05-31 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.61315
707304,update jj says m punitive award in solson talc trial is on top of m compensatory damages awarded last week,https://www.benzinga.com/news/19/05/13842282/update-j-j-says-300m-punitive-award-in-solson-talc-trial-is-on-top-of-25m-compensatory-damages-award,Benzinga Newsdesk,2019-05-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
707305,hearing jj to pay m punitive award in new york calc case,https://www.benzinga.com/news/19/05/13842162/hearing-j-j-to-pay-300m-punitive-award-in-new-york-calc-case,Benzinga Newsdesk,2019-05-31 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.60115
707306,johnson johnson analyst takeaways on opioid litigation,https://www.benzinga.com/analyst-ratings/analyst-color/19/05/13831917/johnson-johnson-analyst-3-takeaways-on-opioid-litigation,Shanthi Rexaline,2019-05-30 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.39885
707307, biggest movers from yesterday,https://www.benzinga.com/news/19/05/13829283/64-biggest-movers-from-yesterday,Lisa Levin,2019-05-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707308,obalon closes above following questionable takeover rumor,https://www.benzinga.com/news/19/05/13822763/obalon-closes-above-1-following-questionable-takeover-rumor,Tanzeel Akhtar,2019-05-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
707309, stocks moving in wednesdays midday session,https://www.benzinga.com/news/19/05/13824017/42-stocks-moving-in-wednesdays-mid-day-session,Lisa Levin,2019-05-29 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707310,shares of several healthcare companies are trading lower after the us state of oklahoma filed a multibillion dollar lawsuit against johnson johnson relating to opioid abuse oklahoma settled an opioid lawsuit with teva pharmaceuticals earlier this week,https://www.benzinga.com/markets/wiim/19/05/13822959/shares-of-several-healthcare-companies-are-trading-lower-after-the-us-state-of-oklahoma-filed-a-mult,Benzinga Newsdesk,2019-05-29 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.10470000000000002
707311,johnson johnson shares are trading lower after the companys trial in oklahoma regarding its role in opioid addiction began on tuesday,https://www.benzinga.com/markets/wiim/19/05/13822740/johnson-johnson-shares-are-trading-lower-after-the-companys-trial-in-oklahoma-regarding-its-role-in,Benzinga Newsdesk,2019-05-29 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.5
707312,obalon therapeutics shares up just after wednesdays open chatter of earlier questionable unconfirmed seeking alpha blogpost from stellar wealth mgmt jnj makes bid for obln at share,https://www.benzinga.com/news/19/05/13822110/obalon-therapeutics-shares-up-15-just-after-wednesdays-open-earlier-questionable-unconfirmed-seeking,Benzinga Newsdesk,2019-05-29 00:00:00,JNJ,1,0,1,1,0,1,1,1,0,0.7997000000000001
707313,fda grants priority review for jjs janssen pharmas invokana,https://www.benzinga.com/news/19/05/13788286/fda-grants-priority-review-for-j-js-janssen-pharmas-invokana,Benzinga Newsdesk,2019-05-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
707314,the daily biotech pulse tocagen tumbles oncosec offering novartis asthma combo drug study,https://www.benzinga.com/general/biotech/19/05/13786495/the-daily-biotech-pulse-tocagen-tumbles-oncosec-offering-novartis-asthma-combo-drug-study,Shanthi Rexaline,2019-05-22 00:00:00,JNJ,1,2,1,0,0,0,1,1,1,0.5
707315,jj shares indicated slightly lower on no volume amid report co said south carolina jury cleared co of its liability in suit alleging asbestos in talc caused womens cancer,https://www.benzinga.com/news/19/05/13784879/j-j-shares-indicated-slightly-lower-on-no-volume-amid-report-co-said-south-carolina-jury-cleared-co,Benzinga Newsdesk,2019-05-21 00:00:00,JNJ,0,1,0,1,0,1,0,0,0,0.1678
707316,johnson johnson issues statement on may verdict in new york says the trial suffered from significant legal and evidentiary errors says it believes the errors will warrant a reversal on appeal,https://www.benzinga.com/news/19/05/13783037/johnson-johnson-issues-statement-on-may-21-verdict-in-new-york-says-the-trial-suffered-from-signific,Benzinga_Newsdesk,2019-05-21 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.18755
707317,jj shares fall midday amid report co lost a m verdict in new york over talc powder,https://www.benzinga.com/news/19/05/13782427/j-j-shares-fall-midday-amid-report-co-lost-a-25m-verdict-in-new-york-over-talc-powder,Benzinga Newsdesk,2019-05-21 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.6806
707318,premarket prep opening nyse imbalance update ge k shares to sell alibaba k to sell pfizer k to sell cocacola k to sell jj k to sell,https://www.benzinga.com/news/19/05/13771698/premarket-prep-opening-nyse-imbalance-update-ge-215k-shares-to-sell-alibaba-69k-to-sell-pfizer-131k,Benzinga Newsdesk,2019-05-20 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.74695
707319,bulls and bears of the week apple chevron fedex uber and more,https://www.benzinga.com/trading-ideas/19/05/13769455/bulls-and-bears-of-the-week-apple-chevron-fedex-uber-and-more,Nelson Hem,2019-05-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707320,fda has identified ethicons recall of circular staplers as class i recall,https://www.benzinga.com/news/19/05/13764622/fda-has-identified-ethicons-recall-of-circular-staplers-as-class-i-recall,Benzinga Newsdesk,2019-05-17 00:00:00,JNJ,1,2,0,0,0,0,1,1,1,0.5
707321,fbi targets johnson johnson siemens ge philips in brazil graft case reuters,https://www.benzinga.com/news/19/05/13762787/fbi-targets-johnson-johnson-siemens-ge-philips-in-brazil-graft-case-reuters,Benzinga Newsdesk,2019-05-17 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
707322,johnson johnson analysts laud accelerating pharma business,https://www.benzinga.com/analyst-ratings/analyst-color/19/05/13756161/johnson-johnson-analysts-laud-accelerating-pharma-business,Shanthi Rexaline,2019-05-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707323,credit suisse maintains outperform on johnson johnson common stock raises price target to ,https://www.benzinga.com/news/19/05/13756015/credit-suisse-maintains-outperform-on-johnson-johnson-common-stock-raises-price-target-to-156,Vick Meyer,2019-05-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6909
707324,jj highlights will host meeting today with industry analysts to review the strategy of its janssen pharmaceutical companies to deliver abovemarket compound annual growth through ,https://www.benzinga.com/news/19/05/13742391/j-j-highlights-will-host-meeting-today-with-industry-analysts-to-review-the-strategy-of-its-janssen,Benzinga Newsdesk,2019-05-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707325,jj patent on zytiga ruled invalid by us appeals court,https://www.benzinga.com/news/19/05/13734648/j-j-patent-on-zytiga-ruled-invalid-by-us-appeals-court,Benzinga Newsdesk,2019-05-14 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.625
707326,minerva neurosciences sinks to lowest level in a year on cloudy midstage trial results for depression drug,https://www.benzinga.com/general/biotech/19/05/13725197/minerva-neurosciences-sinks-to-lowest-level-in-a-year-on-cloudy-midstage-trial-results-for-depres,Shanthi Rexaline,2019-05-13 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.1285
707327,the daily biotech pulse fibrogen kidney disease trial disappoints medtronic to buy titan spine pumas weak breast cancer drug sales,https://www.benzinga.com/general/biotech/19/05/13713890/the-daily-biotech-pulse-fibrogen-kidney-disease-trial-disappoints-medtronic-to-buy-titan-spine-pu,Shanthi Rexaline,2019-05-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.064
707328,drug prices will be included in tv ads under new trump admin rule,https://www.benzinga.com/government/19/05/13707088/drug-prices-will-be-included-in-tv-ads-under-new-trump-admin-rule,Elizabeth Balboa,2019-05-09 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707329,jj shares unaffected as whos strategic advisory group recommended a change in ebola vaccine strategy has expanded eligible population and introduced cos experimental vaccine,https://www.benzinga.com/news/19/05/13684177/j-j-shares-unaffected-as-whos-strategic-advisory-group-recommended-a-change-in-ebola-vaccine-strateg,Benzinga Newsdesk,2019-05-07 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.8062
707330,jj will pay b to resolve pinnaclehip suits,https://www.benzinga.com/news/19/05/13683384/j-j-will-pay-1b-to-resolve-pinnacle-hip-suits,Benzinga Newsdesk,2019-05-07 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.74695
707331,shares of several healthcare companies are trading lower after several companies in the space reported weak earnings with mylan leading the selloff,https://www.benzinga.com/markets/wiim/19/05/13683024/shares-of-several-healthcare-companies-are-trading-lower-after-several-companies-in-the-space-report,Benzinga Newsdesk,2019-05-07 00:00:00,JNJ,0,1,0,1,1,0,0,0,0,0.2798
707332,premarket prep opening nyse imbalance update alibaba k shares to sell citigroup k to sell bank of america k to sell jp morgan k to sell ge k to sell johnson johnson k to sell,https://www.benzinga.com/news/19/05/13671683/premarket-prep-opening-nyse-imbalance-update-alibaba-316k-shares-to-sell-citigroup-67k-to-sell-bank,Benzinga Newsdesk,2019-05-06 00:00:00,JNJ,1,2,0,0,0,0,1,0,1,0.7294
707333, new etfs for biblically responsible investing,https://www.benzinga.com/trading-ideas/long-ideas/19/05/13647742/2-new-etfs-for-biblically-responsible-investing,ETF Professor,2019-05-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
707334,vistagen shares fall under after depression drug flunks midstage trial,https://www.benzinga.com/general/biotech/19/05/13653478/vistagen-shares-fall-under-1-after-depression-drug-flunks-midstage-trial,Shanthi Rexaline,2019-05-02 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.17570000000000002
707335,attention biotech investors mark your calendar for these may pdufa dates,https://www.benzinga.com/general/biotech/19/04/13598788/attention-biotech-investors-mark-your-calendar-for-these-may-pdufa-dates,Shanthi Rexaline,2019-04-30 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707336,jj raises qtr dividend from to share,https://www.benzinga.com/news/19/04/13597139/j-j-raises-qtr-dividend-from-0-90-to-0-95share,Benzinga Newsdesk,2019-04-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707337,jim cramer gives his opinion on barrick gold canopy growth ea johnson johnson and more,https://www.benzinga.com/media/19/04/13584064/jim-cramer-gives-his-opinion-on-barrick-gold-canopy-growth-ea-johnson-johnson-and-more,Craig Jones,2019-04-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
707338,shares of several healthcare stocks are trading higher in a potential rebound from last weeks selloff in an upgrade of hca healthcare raymond james analysts noted the selloff was based on legislation that has almost no chance of passing,https://www.benzinga.com/markets/wiim/19/04/13579798/shares-of-several-healthcare-stocks-are-trading-higher-in-a-potential-rebound-from-last-weeks-sellof,Benzinga Newsdesk,2019-04-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6267
707339,urogen pharma reports earlystage feasibility deal with jjs janssen no terms disclosed,https://www.benzinga.com/news/19/04/13576964/urogen-pharma-reports-early-stage-feasibility-deal-with-j-js-janssen-no-terms-disclosed,Benzinga Newsdesk,2019-04-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
707340, cannabis execs on the strengths of their businesses,https://www.benzinga.com/markets/cannabis/19/04/13563929/6-cannabis-execs-on-the-strengths-of-their-businesses,Jayson Derrick,2019-04-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
707341, options trading ideas for the upcoming earnings season,https://www.benzinga.com/news/earnings/19/04/13570924/3-options-trading-ideas-for-the-upcoming-earnings-season,Chris Dier-Scalise,2019-04-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707342,the week ahead in biotech conferences clinical trial readouts earnings and ipos,https://www.benzinga.com/general/biotech/19/04/13553795/the-week-ahead-in-biotech-conferences-clinical-trial-readouts-earnings-and-ipos,Shanthi Rexaline,2019-04-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707343,buyers remorse otc stock zoom technologies zooms higher amid potential buyer confusion,https://www.benzinga.com/news/19/04/13562181/buyers-remorse-otc-stock-zoom-technologies-zooms-higher-amid-potential-buyer-confusion,Wayne Duggan,2019-04-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.24469999999999997
707344,analysts view johnson johnsons organic growth guidance as conservative,https://www.benzinga.com/analyst-ratings/analyst-color/19/04/13551858/analysts-view-johnson-johnsons-organic-growth-guidance-as-conservative,Shanthi Rexaline,2019-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707345,bmo capital maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/19/04/13552617/bmo-capital-maintains-outperform-on-johnson-johnson-raises-price-target-to-157,Vick Meyer,2019-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707346,credit suisse maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/19/04/13552331/credit-suisse-maintains-outperform-on-johnson-johnson-raises-price-target-to-152,Vick Meyer,2019-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707347,morgan stanley maintains equalweight on johnson johnson raises price target to ,https://www.benzinga.com/news/19/04/13552160/morgan-stanley-maintains-equal-weight-on-johnson-johnson-raises-price-target-to-145,Vick Meyer,2019-04-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707348,hot fresh earnings on the menu as netflix morgan stanley results in focus,https://www.benzinga.com/news/earnings/19/04/13552161/hot-fresh-earnings-on-the-menu-as-netflix-morgan-stanley-results-in-focus,JJ Kinahan,2019-04-17 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.6591
707349,raymond james maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/19/04/13551439/raymond-james-maintains-outperform-on-johnson-johnson-raises-price-target-to-147,Vick Meyer,2019-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707350,fda determines boston scientific hasnt showed reasonable assurance of safety effectiveness for surgical meshes,https://www.benzinga.com/general/biotech/19/04/13546687/fda-determines-boston-scientific-hasnt-showed-reasonable-assurance-of-safety-effectiveness-for-su,Wayne Duggan,2019-04-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.59675
707351,banks on parade bank of america becomes latest big financial company to report,https://www.benzinga.com/news/19/04/13544788/banks-on-parade-bank-of-america-becomes-latest-big-financial-company-to-report,JJ Kinahan,2019-04-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707352,jj expects to see largest impact from generic and biosimilar erosion in ,https://www.benzinga.com/general/health-care/19/04/13544331/j-j-expects-to-see-largest-impact-from-generic-and-biosimilar-erosion-in-2019,Benzinga Newsdesk,2019-04-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
707353,jj says sites now certified for new depression drug spravato,https://www.benzinga.com/general/health-care/19/04/13544329/j-j-says-800-sites-now-certified-for-new-depression-drug-spravato,Benzinga Newsdesk,2019-04-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.29905000000000004
707354,johnson johnson shares are trading higher after the company reported betterthanexpected q eps and revenue results and issued fy adjusted eps guidance above the analyst estimate,https://www.benzinga.com/markets/wiim/19/04/13543195/johnson-johnson-shares-are-trading-higher-after-the-company-reported-better-than-expected-q1-eps-and,Benzinga Newsdesk,2019-04-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,0,0.648
707355,the daily biotech pulse jj earnings fda nod for medicinova proteon to explore strategic alternatives,https://www.benzinga.com/general/biotech/19/04/13541554/the-daily-biotech-pulse-j-j-earnings-fda-nod-for-mediconova-proteon-to-explore-strategic-alternat,Shanthi Rexaline,2019-04-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707356,a peek into the markets us stock futures higher ahead of earnings,https://www.benzinga.com/news/19/04/13542209/a-peek-into-the-markets-us-stock-futures-higher-ahead-of-earnings,Lisa Levin,2019-04-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707357,johnson johnson raises fy adj eps guidance from to vs est raises sales guidance from bb to bb vs b est,https://www.benzinga.com/news/19/04/13542190/johnson-johnson-raises-fy19-adj-eps-guidance-from-8-65-8-80-to-8-73-8-83-vs-8-58-est-raises-sales-gu,Benzinga Newsdesk,2019-04-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707358,johnson johnson q adj eps beats estimate sales b beat b estimate,https://www.benzinga.com/news/earnings/19/04/13542183/johnson-johnson-q1-adj-eps-2-1-beats-2-08-estimate-sales-20-02b-beat-19-63b-estimate,Benzinga Newsdesk,2019-04-16 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707359, stocks to watch for april ,https://www.benzinga.com/news/earnings/19/04/13541846/10-stocks-to-watch-for-april-16-2019,Lisa Levin,2019-04-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707360,earnings scheduled for april ,https://www.benzinga.com/news/earnings/19/04/13541813/earnings-scheduled-for-april-16-2019,Lisa Levin,2019-04-16 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707361,earnings parade rolls along as citigroup goldman sachs report and spx now tops ,https://www.benzinga.com/news/earnings/19/04/13536912/earnings-parade-rolls-along-as-citigroup-goldman-sachs-report-and-spx-now-tops-2900,JJ Kinahan,2019-04-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7553000000000001
707362,granted accelerated approval to johnson johnsons balversa targeted therapy for metastatic bladder cancer,https://www.benzinga.com/news/19/04/13530990/granted-accelerated-approval-to-johnson-johnsons-balversa-targeted-therapy-for-metastatic-bladder-ca,Benzinga Newsdesk,2019-04-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.4614
707363,nanocap biotech tracon falls after shelving study,https://www.benzinga.com/general/biotech/19/04/13529039/nanocap-biotech-tracon-falls-50-after-shelving-study,Shanthi Rexaline,2019-04-12 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707364,jjs janssen presents new data from first phase trial of singletablet regimen in rapid initiation model of care,https://www.benzinga.com/news/19/04/13521416/j-js-janssen-presents-new-data-from-first-phase-3-trial-of-single-tablet-regimen-in-rapid-initiation,Benzinga Newsdesk,2019-04-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.74695
707365,gerons blood cancer candidate creates buying opportunity needham says in upgrade,https://www.benzinga.com/analyst-ratings/analyst-color/19/04/13508673/gerons-blood-cancer-candidate-creates-buying-opportunity-needham-says-in-upgrade,Shanthi Rexaline,2019-04-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
707366,premarket prep opening nyse imbalance update ge k shares to sell exxonmobil k shares to sell bofa to sell citi k to sell pg k sell jj k to sell pfizer k to sell,https://www.benzinga.com/news/19/04/13507296/premarket-prep-opening-nyse-imbalance-update-ge-652k-shares-to-sell-exxonmobil-66k-shares-to-sell-bo,Benzinga Newsdesk,2019-04-09 00:00:00,JNJ,1,2,0,0,0,0,1,1,0,0.82985
707367,whats been going on with emerald bioscience,https://www.benzinga.com/markets/cannabis/19/04/13494986/whats-been-going-on-with-emerald-bioscience,Javier Hasse,2019-04-08 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707368,immunomedics reports promotion deal in which co will provide detailing services to jjs janssen for erdafitinib in us,https://www.benzinga.com/news/19/04/13500834/immunomedics-reports-promotion-deal-in-which-co-will-provide-detailing-services-to-j-js-janssen-for,Benzinga Newsdesk,2019-04-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707369,janssen announces investigational cart therapy jnj granted prime designation by ema,https://www.benzinga.com/news/19/04/13484708/janssen-announces-investigational-car-t-therapy-jnj-68284528-granted-prime-designation-by-ema,Charles Gross,2019-04-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
707370,johnson johnson says tv ads for bloodthinner xarelto to give a month list price starting friday,https://www.benzinga.com/news/19/03/13441751/johnson-johnson-says-tv-ads-for-bloodthinner-xarelto-to-give-448-a-month-list-pr,Benzinga_Newsdesk,2019-03-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707371,jjs janssen reports fda submission of supplemental new drug application for invokana for treatment of chronic kidney disease in patients with type diabetes,https://www.benzinga.com/news/19/03/13439614/j-js-janssen-reports-fda-submission-of-supplemental-new-drug-application-for-inv,Benzinga Newsdesk,2019-03-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707372,plaintiff lawyer says johnson johnson has settled three mesothelioma talc cases brought in state courts,https://www.benzinga.com/news/19/03/13436811/plaintiff-lawyer-says-johnson-johnson-has-settled-three-mesothelioma-talc-cases-,Charles Gross,2019-03-27 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707373,jj spokesperson says jersey jury cleared co of liability in mesothelioma talc trial,https://www.benzinga.com/news/19/03/13434106/j-j-spokesperson-says-jersey-jury-cleared-co-of-liability-in-mesothelioma-talc-t,Benzinga Newsdesk,2019-03-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.57655
707374, gene therapy ma targets on the radar,https://www.benzinga.com/general/biotech/19/03/13361229/6-gene-therapy-m-a-targets-on-the-radar,Shanthi Rexaline,2019-03-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707375,axsome adds to strong gains after fda grants breakthrough designation for depression drug,https://www.benzinga.com/general/biotech/19/03/13431961/axsome-adds-to-strong-gains-after-fda-grants-breakthrough-designation,Shanthi Rexaline,2019-03-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
707376,janssen seeks expanded use of darzalex daratumumab combination therapy for newly diagnosed transplant eligible patients with multiple myeloma,https://www.benzinga.com/news/19/03/13429839/janssen-seeks-expanded-use-of-darzalex-daratumumab-combination-therapy-for-newly,Charles Gross,2019-03-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707377,jjs janssen reports submission of application for darzalex combo thearpy,https://www.benzinga.com/news/19/03/13424161/j-js-janssen-reports-submission-of-application-for-darzalex-combo-thearpy,Benzinga Newsdesk,2019-03-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707378,genmab reports fda submission of supplemental biologics license application for daratumumab in combo with bortezomib thalidomide dexamethasone says jj sees publishing detailed data from phase cassiopeia study this year,https://www.benzinga.com/news/19/03/13424025/genmab-reports-fda-submission-of-supplemental-biologics-license-application-for-,Benzinga Newsdesk,2019-03-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707379,oxycontin manufacturer purdue agrees to settlement in oklahoma lawsuit,https://www.benzinga.com/news/19/03/13421460/oxycontin-manufacturer-purdue-agrees-to-settlement-in-oklahoma-lawsuit,Charles Gross,2019-03-26 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.4871
707380,raymond james expects johnson johnsons growth to accelerate into ,https://www.benzinga.com/analyst-ratings/analyst-color/19/03/13416856/raymond-james-expects-johnson-johnsons-growth-to-accele,Priya Nigam,2019-03-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707381,court records show bayer jj have settled xarelto litigation for m,https://www.benzinga.com/news/19/03/13416600/court-records-show-bayer-j-j-have-settled-xarelto-litigation-for-775m,Benzinga Newsdesk,2019-03-25 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.5258
707382,a new look for the barrons etf,https://www.benzinga.com/trading-ideas/long-ideas/19/03/13381958/a-new-look-for-the-barrons-400-etf,ETF Professor,2019-03-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707383,actelion pharmaceuticalspatients treated with opsumit showed significant improvement in right ventricular function reduced pulmonary vascular resistance,https://www.benzinga.com/general/biotech/19/03/13369577/actelion-pharmaceuticals-patients-treated-with-opsumit-showed-signifi,Benzinga Newsdesk,2019-03-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.79295
707384,the daily biotech pulse aeterna zentaris explores options verastem plunges on weak copiktra sales fda nod for aerie,https://www.benzinga.com/general/biotech/19/03/13349498/the-daily-biotech-pulse-aeterna-zentaris-explores-options-verastem-pl,Shanthi Rexaline,2019-03-13 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.2798
707385,jjs janssen submits application seeking approval of darzalex combo for patients with newlydiagnosed multiple myeloma who are transplant ineligible,https://www.benzinga.com/news/19/03/13347326/j-js-janssen-submits-application-seeking-approval-of-darzalex-combo-for-patients,Benzinga Newsdesk,2019-03-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707386,oklahoma says johnson johnson was the kingpin behind the opioid crisis axios,https://www.benzinga.com/news/19/03/13341554/oklahoma-says-johnson-johnson-was-the-kingpin-behind-the-opioid-crisis-axios,Benzinga Newsdesk,2019-03-12 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.18755
707387,janssens phase study of stelara met its primary and some secondary endpoints,https://www.benzinga.com/news/19/03/13333852/janssens-phase-3-study-of-stelara-met-its-primary-and-some-secondary-endpoints,Benzinga Newsdesk,2019-03-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707388,the week ahead in biotech conferences pdufa dates earnings ipos,https://www.benzinga.com/general/biotech/19/03/13329237/the-week-ahead-in-biotech-conferences-pdufa-dates-earnings-ipos,Shanthi Rexaline,2019-03-10 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707389,another esg etf enters the fold,https://www.benzinga.com/trading-ideas/long-ideas/19/03/13314705/another-esg-etf-enters-the-fold,ETF Professor,2019-03-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707390,jjs janssen reports results of phase studies which showed longacting injectable hiv treatment regimen of rilpivirine cabotegravir showed comparable safety efficacy to daily oral hiv therapy,https://www.benzinga.com/news/19/03/13320865/j-js-janssen-reports-results-of-2-phase-3-studies-which-showed-long-acting-injec,Benzinga Newsdesk,2019-03-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
707391,allergans depression drug letdown largely expected analysts focus on remainder of pipeline,https://www.benzinga.com/analyst-ratings/analyst-color/19/03/13318237/allergans-depression-drug-letdown-largely-expected-anal,Shanthi Rexaline,2019-03-07 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.21405000000000002
707392,daily biotech pulse allergans depression drug flunks latestage trial apellis offering shockwave medical ipo,https://www.benzinga.com/general/biotech/19/03/13315697/daily-biotech-pulse-allergans-depression-drug-flunks-late-stage-trial,Shanthi Rexaline,2019-03-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.12104999999999999
707393,jj says weighted average cost of spravato is treatment session,https://www.benzinga.com/news/19/03/13311096/j-j-says-weighted-average-cost-of-spravato-is-590-885treatment-session,Benzinga Newsdesk,2019-03-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707394,johnson johnson option alert mar calls sweep near the ask vs oi earnings before open est ref,https://www.benzinga.com/markets/options/19/03/13311095/johnson-johnson-option-alert-mar-15-142-calls-sweep-2-near-the-ask-10,Charles Gross,2019-03-06 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
707395,fda approves major novel depression drug for first time in decades,https://www.benzinga.com/general/biotech/19/03/13309108/fda-approves-major-novel-depression-drug-for-first-time-in-3-decades,Shanthi Rexaline,2019-03-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5386
707396,the daily biotech pulse horizon pharma under doj radar fda greenlights jjs depression drug endologix reverse split,https://www.benzinga.com/general/biotech/19/03/13307490/the-daily-biotech-pulse-horizon-pharma-under-doj-radar-fda-greenlight,Shanthi Rexaline,2019-03-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.21405000000000002
707397,the daily biotech pulse novartis psoriasis drug found superior ascendis offering adamas earnings,https://www.benzinga.com/general/biotech/19/03/13296855/the-daily-biotech-pulse-novartis-psoriasis-drug-found-superior-ascend,Shanthi Rexaline,2019-03-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.77115
707398,attention biotech investors mark your calendar for these march pdufa dates,https://www.benzinga.com/general/biotech/19/03/13286016/attention-biotech-investors-mark-your-calendar-for-these-march-pdufa-,Shanthi Rexaline,2019-03-04 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.5
707399,the week ahead in biotech conferences pdufa dates clinical trials earnings ipos,https://www.benzinga.com/general/biotech/19/03/13279888/the-week-ahead-in-biotech-conferences-pdufa-dates-clinical-trials-ear,Shanthi Rexaline,2019-03-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707400,it could be time for this pharma etf,https://www.benzinga.com/trading-ideas/long-ideas/19/02/13241310/it-could-be-time-for-this-pharma-etf,ETF Professor,2019-02-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707401,citigroup maintains neutral on johnson johnson raises price target to ,https://www.benzinga.com/news/19/02/13236802/citigroup-maintains-neutral-on-johnson-johnson-raises-price-target-to-147,Vick Meyer,2019-02-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707402,the latest from johnson johnsons asbestos scandal,https://www.benzinga.com/news/19/02/13219035/the-latest-from-johnson-johnsons-asbestos-scandal,Jayson Derrick,2019-02-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2798
707403,johnson johnson receives federal subpoenas related to baby powder litigation reuters earlier reported,https://www.benzinga.com/news/19/02/13217581/johnson-johnson-receives-federal-subpoenas-related-to-baby-powder-litigation-reu,Benzinga Newsdesk,2019-02-21 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.39885
707404,a chat with the ceo behind the cannabis company with the boss ticker there isnt a single route to success,https://www.benzinga.com/markets/cannabis/19/02/13141441/a-chat-with-the-ceo-behind-the-cannabis-company-with-the-boss-ticker,Javier Hasse,2019-02-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
707405,morphic therapeutic reports integrin rd collaboration with jjs janssen janssen to pay co undisclosed upfront payment will fund research activities co will receive from janssen multiple preclinical development clinical commercial milestones,https://www.benzinga.com/news/19/02/13216858/morphic-therapeutic-reports-integrin-r-d-collaboration-with-j-js-janssen-janssen,Benzinga Newsdesk,2019-02-21 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.44865
707406,supreme court rejects marylands bid to revive a law aimed at preventing price gouging by pharmaceutical companies reuters reports,https://www.benzinga.com/general/biotech/19/02/13200385/supreme-court-rejects-marylands-bid-to-revive-a-law-aimed-at-preventi,Benzinga Newsdesk,2019-02-19 00:00:00,JNJ,1,1,1,1,0,0,1,0,0,0.70095
707407,pot stocks etfs top news and data from the cannabis industry this week,https://www.benzinga.com/markets/cannabis/19/02/13191201/pot-stocks-etfs-top-news-and-data-from-the-cannabis-industry-this-we,Javier Hasse,2019-02-15 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.60115
707408,the week ahead in biotech conferences clinical trials and earnings,https://www.benzinga.com/general/biotech/19/02/13175206/the-week-ahead-in-biotech-conferences-clinical-trials-and-earnings,Shanthi Rexaline,2019-02-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707409,jjs talc supplier seeks bankruptcy,https://www.benzinga.com/news/19/02/13163591/j-js-talc-supplier-seeks-bankruptcy,Benzinga Newsdesk,2019-02-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707410,penny stock auris medical spikes on case of mistaken identity,https://www.benzinga.com/general/biotech/19/02/13161470/penny-stock-auris-medical-spikes-on-case-of-mistaken-identity,Wayne Duggan,2019-02-13 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.3194
707411,johnson johnson wins fda panel backing for nasal spray depression drug pdufa date awaits,https://www.benzinga.com/general/biotech/19/02/13159735/johnson-johnson-wins-fda-panel-backing-for-nasal-spray-depression-dru,Shanthi Rexaline,2019-02-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.55135
707412,johnson johnson to acquire auris health for b in cash with additional contingent payments of b upon certain milestones,https://www.benzinga.com/news/19/02/13160104/johnson-johnson-to-acquire-auris-health-for-3-4b-in-cash-with-additional-conting,Benzinga Newsdesk,2019-02-13 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.6366
707413,the daily biotech pulse exelixis q results fda panel greenlights jjs depression drug macrogenics prices offering,https://www.benzinga.com/general/biotech/19/02/13159037/the-daily-biotech-pulse-exelixis-q4-results-fda-panel-greenlights-j-j,Shanthi Rexaline,2019-02-13 00:00:00,JNJ,1,2,1,1,1,0,1,0,1,0.21405000000000002
707414,fda panel votes in favor of johnson johnsons nasal spray for treatmentresistant depression says benefits outweigh risks,https://www.benzinga.com/news/19/02/13152939/fda-panel-votes-in-favor-of-johnson-johnsons-nasal-spray-for-treatment-resistant,Benzinga Newsdesk,2019-02-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.436
707415,the daily biotech pulse nash disappointment for gilead xeris to offer shares,https://www.benzinga.com/general/biotech/19/02/13146122/the-daily-biotech-pulse-nash-disappointment-for-gilead-xeris-to-offer,Shanthi Rexaline,2019-02-12 00:00:00,JNJ,1,1,0,0,0,1,1,1,1,0.3634
707416,fda panel reviews johnson johnsons treatmentresistant depression candidate what to expect,https://www.benzinga.com/general/biotech/19/02/13140477/fda-panel-reviews-johnson-johnsons-treatment-resistant-depression-can,Shanthi Rexaline,2019-02-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.21405000000000002
707417,the week ahead in biotech conferences pdufa dates and clinical trials,https://www.benzinga.com/general/biotech/19/02/13113062/the-week-ahead-in-biotech-conferences-pdufa-dates-and-clinical-trials,Shanthi Rexaline,2019-02-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707418,the daily biotech pulse big miss for seattle genetics hematology conference presentations gossamer bio harpoon ipos,https://www.benzinga.com/general/biotech/19/02/13126681/the-daily-biotech-pulse-big-miss-for-seattle-genetics-hematology-conf,Shanthi Rexaline,2019-02-08 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.42345
707419,drugmakers offered cb in price cuts freeze of drug prices in response to proposed crackdown by canada regulator,https://www.benzinga.com/news/19/02/13108194/drugmakers-offered-c-9-6b-in-price-cuts-freeze-of-drug-prices-in-response-to-pro,Charles Gross,2019-02-06 00:00:00,JNJ,1,1,0,1,1,0,1,0,0,0.375
707420,research announcement moodys talcrelated lawsuits could increase risk to johnson johnsons strong credit profile moodys,https://www.benzinga.com/news/19/02/13102292/research-announcement-moodys-talc-related-lawsuits-could-increase-risk-to-johnso,Benzinga_Newsdesk,2019-02-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.83525
707421,johnson johnson talcrelated lawsuits could increase risk to johnson johnsons strong credit profile,https://www.benzinga.com/news/19/02/13102274/johnson-johnson-talc-related-lawsuits-could-increase-risk-to-johnson-johnsons-st,Benzinga_Newsdesk,2019-02-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.83525
707422,jjs janssen reports global collaboration license deal with meiragtx to develop gene therapy programs for inherited retinal diseases,https://www.benzinga.com/news/19/01/13071673/j-js-janssen-reports-global-collaboration-license-deal-with-meiragtx-to-develop-,Benzinga Newsdesk,2019-01-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707423,janssen enters worldwide collaboration and license agreement with meiragtx to develop gene therapy programs for inherited retinal diseases,https://www.benzinga.com/news/19/01/13071531/janssen-enters-worldwide-collaboration-and-license-agreement-with-meiragtx-to-de,Charles Gross,2019-01-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707424,the week ahead in biotech conferences pdufa dates clinical trials and earnings,https://www.benzinga.com/general/biotech/19/01/13033939/the-week-ahead-in-biotech-conferences-pdufa-dates-clinical-trials-and,Shanthi Rexaline,2019-01-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707425,geopolitics aside how about those earnings investors appear to switch focus,https://www.benzinga.com/news/earnings/19/01/13024398/geopolitics-aside-how-about-those-earnings-investors-appear-to-switch-f,JJ Kinahan,2019-01-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707426,analysts stand by johnson johnson despite earnings pullback,https://www.benzinga.com/analyst-ratings/analyst-color/19/01/13023262/analysts-stand-by-johnson-johnson-despite-earnings-pull,Elizabeth Balboa,2019-01-23 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5
707427,johnson johnson said to be pursuing acquisition of auris health,https://www.benzinga.com/news/19/01/13021712/johnson-johnson-said-to-be-pursuing-acquisition-of-auris-health,Charles Gross,2019-01-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707428,midafternoon market update dow down over points uqm technologies shares spike higher,https://www.benzinga.com/news/19/01/13019040/mid-afternoon-market-update-dow-down-over-400-points-uqm-technologies-shares-spi,Lisa Levin,2019-01-22 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
707429,midday market update crude oil down over staffing solutions shares jump,https://www.benzinga.com/news/19/01/13017897/mid-day-market-update-crude-oil-down-over-3-staffing-360-solutions-shares-jump,Lisa Levin,2019-01-22 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.39885
707430,wakeup call world china growth data fail to impress pushing down global markets,https://www.benzinga.com/news/earnings/19/01/13016877/wakeup-call-world-china-growth-data-fail-to-impress-pushing-down-global,JJ Kinahan,2019-01-22 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
707431,midmorning market update markets open lower johnson johnson profit tops expectations,https://www.benzinga.com/news/19/01/13016870/mid-morning-market-update-markets-open-lower-johnson-johnson-profit-tops-expecta,Lisa Levin,2019-01-22 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.8062
707432,jj executive says does not see longrun strategic impact to its consumer business related to talc,https://www.benzinga.com/news/19/01/13016541/j-j-executive-says-does-not-see-long-run-strategic-impact-to-its-consumer-busine,Benzinga_Newsdesk,2019-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707433,from jj conference call cfo says co plans for continued price decreases on a net basis in the near future,https://www.benzinga.com/news/19/01/13016426/from-j-j-conference-call-cfo-says-co-plans-for-continued-price-decreases-on-a-ne,Benzinga Newsdesk,2019-01-22 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
707434,jj cfo says stronger us dollar will likely result in negative impact on reported results in ,https://www.benzinga.com/news/19/01/13016373/j-j-cfo-says-stronger-us-dollar-will-likely-result-in-negative-impact-on-reporte,Benzinga Newsdesk,2019-01-22 00:00:00,JNJ,1,1,0,0,0,0,1,0,0,0.4871
707435,a peek into the markets us stock futures drop ahead of earnings,https://www.benzinga.com/news/19/01/13014364/a-peek-into-the-markets-us-stock-futures-drop-ahead-of-earnings,Lisa Levin,2019-01-22 00:00:00,JNJ,1,1,1,1,1,0,0,0,0,0.3634
707436,johnson johnson sees fy adj eps vs est sales bb vs b est,https://www.benzinga.com/news/19/01/13014359/johnson-johnson-sees-fy19-adj-eps-8-50-8-65-vs-8-61-est-sales-80-4b-81-2b-vs-82-,Benzinga Newsdesk,2019-01-22 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707437,johnson johnson q adj eps beats estimate sales b beat b estimate,https://www.benzinga.com/news/earnings/19/01/13014357/johnson-johnson-q4-adj-eps-1-97-beats-1-95-estimate-sales-20-4b-beat-20,Benzinga Newsdesk,2019-01-22 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707438, stocks to watch for january ,https://www.benzinga.com/news/earnings/19/01/13013800/10-stocks-to-watch-for-january-22-2019,Lisa Levin,2019-01-22 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707439,earnings scheduled for january ,https://www.benzinga.com/news/earnings/19/01/13013736/earnings-scheduled-for-january-22-2019,Lisa Levin,2019-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707440,the daily biotech pulse regulatory roadblock for immunomedics adcom split on lexicons diabetes drug,https://www.benzinga.com/general/biotech/19/01/13004869/the-daily-biotech-pulse-regulatory-roadblock-for-immunomedics-adcom-s,Shanthi Rexaline,2019-01-18 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707441,medipharm labs pure global cannabis weekend unlimited plus products trulieve make elevator pitches,https://www.benzinga.com/markets/cannabis/19/01/12999024/medipharm-labs-pure-global-cannabis-weekend-unlimited-plus-products-,Brad Slaughter,2019-01-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707442,johnson johnson announces research study with apple watch to help improve afib outcomes including stroke prevention,https://www.benzinga.com/general/biotech/19/01/12999004/johnson-johnson-announces-research-study-with-apple-watch-to-help-imp,Benzinga Newsdesk,2019-01-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8404
707443,the daily biotech pulse fda panel backs amgens hypertension drug adamis allergy drug launched in us,https://www.benzinga.com/general/biotech/19/01/12997681/the-daily-biotech-pulse-fda-panel-backs-amgens-hypertension-drug-adam,Shanthi Rexaline,2019-01-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5386
707444,johnson johnsons actelion pharmaceuticals receives complete response letter from fda regarding its new drug application for opsumit letter indicates additional data needed to evaluate drug for cteph treatment,https://www.benzinga.com/news/19/01/12996056/johnson-johnsons-actelion-pharmaceuticals-receives-complete-response-letter-from,Benzinga Newsdesk,2019-01-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707445,jjs janssen pharma says european commission approved erleada for nonmetastatic castrationresistance prostate cancer patients,https://www.benzinga.com/news/19/01/12991882/j-js-janssen-pharma-says-european-commission-approved-erleada-for-non-metastatic,Benzinga Newsdesk,2019-01-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.30910000000000004
707446,cannabis company avicanna eyes canadian ipo,https://www.benzinga.com/markets/cannabis/19/01/12983729/cannabis-company-avicanna-eyes-canadian-ipo,Alex Oleinic,2019-01-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707447,hearing dealreporter says jnj may be gearing up for a takeover of boston scientific,https://www.benzinga.com/news/19/01/12985733/hearing-dealreporter-says-jnj-may-be-gearing-up-for-a-takeover-of-boston-scienti,Benzinga Newsdesk,2019-01-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707448,how to approach q earnings the global perspective,https://www.benzinga.com/news/earnings/19/01/12979370/how-to-approach-q4-earnings-the-global-perspective,Chris Dier-Scalise,2019-01-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707449, biggest price target changes for monday,https://www.benzinga.com/analyst-ratings/price-target/19/01/12978579/10-biggest-price-target-changes-for-monday,Lisa Levin,2019-01-14 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707450,wells fargo maintains outperform on johnson johnson lowers price target to ,https://www.benzinga.com/news/19/01/12978230/wells-fargo-maintains-outperform-on-johnson-johnson-lowers-price-target-to-152,Vick Meyer,2019-01-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5640000000000001
707451,jj recommends rejection of belowmarket minitender offer by peer peri llc,https://www.benzinga.com/news/19/01/12974150/j-j-recommends-rejection-of-below-market-mini-tender-offer-by-peer-peri-llc,Benzinga Newsdesk,2019-01-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.42345
707452,johnson johnson raised us prices on two dozen prescription drugs on thursday,https://www.benzinga.com/news/19/01/12969687/johnson-johnson-raised-u-s-prices-on-two-dozen-prescription-drugs-on-thursday,Charles Gross,2019-01-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707453, women set to dominate the international cannabis space in ,https://www.benzinga.com/markets/cannabis/19/01/12955055/20-women-set-to-dominate-the-international-cannabis-space-in-2019,Javier Hasse,2019-01-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
707454,halftime report picks for january mastercard twilio and more,https://www.benzinga.com/intraday-update/19/01/12945539/halftime-report-picks-for-january-7-mastercard-twilio-and-more,Craig Jones,2019-01-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707455,jon najarian sees big options activity in johnson johnson nvidia,https://www.benzinga.com/markets/options/19/01/12945446/jon-najarian-sees-big-options-activity-in-johnson-johnson-nvidia,Craig Jones,2019-01-07 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707456,barrons picks and pans apple exxon morgan stanley and more,https://www.benzinga.com/top-stories/19/01/12939719/barrons-picks-and-pans-apple-exxon-morgan-stanley-and-more,Nelson Hem,2019-01-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707457,india government may offer more compensation to jj faulty hip implant patients,https://www.benzinga.com/news/19/01/12932830/india-government-may-offer-more-compensation-to-j-j-faulty-hip-implant-patients,Charles Gross,2019-01-04 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.4953
707458,veracyte shares are trading up after the company announced a strategic collaboration with jj innovation for lung cancer detection,https://www.benzinga.com/markets/wiim/19/01/12926394/veracyte-shares-are-trading-up-after-the-company-announced-a-strategic-c,Benzinga_Newsdesk,2019-01-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.55135
707459,update veracyte reports will combine clinical study cohorts involving k patients multiple years of clinical outcome data,https://www.benzinga.com/news/19/01/12924241/update-veracyte-reports-will-combine-clinical-study-cohorts-involving-5k-patient,Benzinga Newsdesk,2019-01-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707460,veracyte reports strategic collaboration with jj innovation for lung cancer detection,https://www.benzinga.com/news/19/01/12924237/veracyte-reports-strategic-collaboration-with-j-j-innovation-for-lung-cancer-det,Benzinga Newsdesk,2019-01-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.39885
707461,morgan stanley maintains equalweight on johnson johnson lowers price target to ,https://www.benzinga.com/news/19/01/12918311/morgan-stanley-maintains-equal-weight-on-johnson-johnson-lowers-price-target-to-,Vick Meyer,2019-01-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
707462,johnson johnson option alert jan calls at the ask vs oi earnings before open ref,https://www.benzinga.com/markets/options/18/12/12904681/johnson-johnson-option-alert-jan-18-150-calls-at-the-ask-10000-0-03-v,Charles Gross,2018-12-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707463,barrons picks and pans unicorns european treasures health care bargains and more,https://www.benzinga.com/startups/18/12/12894202/barrons-picks-and-pans-unicorns-european-treasures-health-care-bargains-and-,Nelson Hem,2018-12-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8592
707464,the daily biotech pulse proteostasis delays data akron gets new ceo pfizer halts vaccine trial,https://www.benzinga.com/general/biotech/18/12/12886868/the-daily-biotech-pulse-proteostasis-delays-data-akron-gets-new-ceo-p,Shanthi Rexaline,2018-12-21 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707465,bangladesh to collect test samples of johnson johnson baby powder,https://www.benzinga.com/news/18/12/12887199/bangladesh-to-collect-test-samples-of-johnson-johnson-baby-powder,Charles Gross,2018-12-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707466,jjs janssen reports submission of application for stelara for treatment of moderately to severely active ulcerative colitis,https://www.benzinga.com/news/18/12/12885375/j-js-janssen-reports-submission-of-application-for-stelara-for-treatment-of-mode,Benzinga Newsdesk,2018-12-20 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.4614
707467,jj says is in full compliance with current regulatory requirements for manufacturing testing of its talc in india,https://www.benzinga.com/news/18/12/12883558/j-j-says-is-in-full-compliance-with-current-regulatory-requirements-for-manufact,Benzinga Newsdesk,2018-12-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
707468,indian drugs regulator orders johnson johnson to stop using raw material at two baby power factories in india says co cant produce baby powder with current raw materials until it is shown to be free of asbestos,https://www.benzinga.com/news/18/12/12881562/indian-drugs-regulator-orders-johnson-johnson-to-stop-using-raw-material-at-two-,Benzinga Newsdesk,2018-12-20 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6366
707469,jnj that was not an appeal in mo it was a request to overturn to the same judge who first ruled against them now it will be appealed to a higher court cnbcs jim cramer tweets,https://www.benzinga.com/news/18/12/12876358/jnj-that-was-not-an-appeal-in-mo-it-was-a-request-to-overturn-to-the-same-judge-,Benzinga Newsdesk,2018-12-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707470,hearing morgan stanley on johnson johnson baby powder verdict clarifies that co lost some post trials motions which are customary after verdict but notes co has been successful in other post trial motions,https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12876317/hearing-morgan-stanley-on-johnson-johnson-baby-powder-v,Benzinga Newsdesk,2018-12-19 00:00:00,JNJ,1,0,1,1,1,1,0,0,0,0.8825000000000001
707471,jury upholds b verdict in johnson johnson baby powder case,https://www.benzinga.com/news/18/12/12875981/jury-upholds-4-69b-verdict-in-johnson-johnson-baby-powder-case,Jayson Derrick,2018-12-19 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.57655
707472,jj shares fall following ny times article johnson johnson loses bid to overturn a billion baby powder verdict,https://www.benzinga.com/news/18/12/12875702/j-j-shares-fall-0-5-following-ny-times-article-johnson-johnson-loses-bid-to-over,Benzinga Newsdesk,2018-12-19 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.6806
707473,jj shares unaffected midday amid ny times report johnson johnson loses bid to overturn a billion baby powder verdict,https://www.benzinga.com/news/18/12/12875691/j-j-shares-unaffected-midday-amid-ny-times-report-johnson-johnson-loses-bid-to-o,Benzinga Newsdesk,2018-12-19 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.6806
707474,jj to report q earnings on tues jan before market open,https://www.benzinga.com/news/earnings/18/12/12875089/j-j-to-report-q4-earnings-on-tues-jan-22-2019-before-market-open,Benzinga Newsdesk,2018-12-19 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.625
707475,jj says indian authorities visited some of its facilities on wednesday says unequivocally stand by the safety of our products are fully compliant with regulatory standards and requirements in india,https://www.benzinga.com/news/18/12/12871983/j-j-says-indian-authorities-visited-some-of-its-facilities-on-wednesday-says-une,Charles Gross,2018-12-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.79295
707476,benzinga pros top mostsearched tickers for afternoon of tues dec ,https://www.benzinga.com/news/18/12/12869054/benzinga-pros-top-10-most-searched-tickers-for-afternoon-of-tues-dec-18-2018,Benzinga Newsdesk,2018-12-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.60115
707477,johnson johnson and imerys to pay more than m in talc case,https://www.benzinga.com/news/18/12/12868379/hearing-johynson-johnson-and-imerys-to-pay-more-than-1-5m-in-talc-case,Benzinga Newsdesk,2018-12-18 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.44865
707478,fed meeting starts with market off to worst december start in years,https://www.benzinga.com/news/earnings/18/12/12867512/fed-meeting-starts-with-market-off-to-worst-december-start-in-38-years,JJ Kinahan,2018-12-18 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.18755
707479,hearing cnbcs jim cramer on squawk on the street called jj absolutely a buy,https://www.benzinga.com/news/18/12/12866202/hearing-cnbcs-jim-cramer-on-squawk-on-the-street-called-j-j-absolutely-a-buy,Benzinga Newsdesk,2018-12-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707480,benzinga pros top mostsearched tickers for morning of tues dec ,https://www.benzinga.com/news/18/12/12866182/benzinga-pros-top-10-most-searched-tickers-for-morning-of-tues-dec-18-2018,Benzinga Newsdesk,2018-12-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
707481,johnson johnson ceo tells cramer thousands of studies refute asbestos allegations,https://www.benzinga.com/top-stories/18/12/12865506/johnson-johnson-ceo-tells-cramer-thousands-of-studies-refute-asbestos-all,Jayson Derrick,2018-12-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707482,the daily biotech pulse puma aces latestage trial chinese cheer for fibrogen jj b buyback plan,https://www.benzinga.com/general/biotech/18/12/12864137/the-daily-biotech-pulse-puma-aces-late-stage-trial-chinese-cheer-for-,Shanthi Rexaline,2018-12-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.8243
707483,exclusive johnson johnson ceo alex gorsky tells cnbcs jimcramer that we unequivocally believe that our talc our baby powder does not contain asbestos cnbc,https://www.benzinga.com/general/biotech/18/12/12862881/exclusive-johnson-johnson-ceo-alex-gorsky-tells-cnbcs-jimcramer-that-,Benzinga Newsdesk,2018-12-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
707484,jj reaffirms fy outlook adj eps vs estimate sales bb vs b est,https://www.benzinga.com/news/18/12/12862709/j-j-reaffirms-fy18-outlook-adj-eps-8-13-8-18-vs-8-16-estimate-sales-81b-81-4b-vs,Benzinga Newsdesk,2018-12-17 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.625
707485,johnson johnson reports b buyback,https://www.benzinga.com/news/18/12/12862362/johnson-johnson-reports-5b-buyback,Benzinga Newsdesk,2018-12-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707486,johnson johnson ceo alex gorsky issues video message in defense of cos baby powder,https://www.benzinga.com/news/18/12/12861308/johnson-johnson-ceo-alex-gorsky-issues-video-message-in-defense-of-co-s-baby-pow,Benzinga Newsdesk,2018-12-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5640000000000001
707487,johnson johnson shares are trading lower on continued weakness following friday reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products note some analysts have are out defending the stock,https://www.benzinga.com/markets/wiim/18/12/12861057/johnson-johnson-shares-are-trading-lower-on-continued-weakness-following,Benzinga Newsdesk,2018-12-17 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.28925
707488,benzinga pros top mostsearched tickers for morning of mon dec ,https://www.benzinga.com/news/18/12/12860305/benzinga-pros-top-10-most-searched-tickers-for-morning-of-mon-dec-17-2018,Benzinga Newsdesk,2018-12-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
707489,johnson johnsons asbestos woes experts speak up,https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12859759/johnson-johnsons-asbestos-woes-experts-speak-up,Wayne Duggan,2018-12-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2798
707490,hearing johnson johnson ceo alex gorsky to appear on jim cramers mad money tonight,https://www.benzinga.com/news/18/12/12859669/hearing-johnson-johnson-ceo-alex-gorsky-to-appear-on-jim-cramers-mad-money-tonig,Benzinga Newsdesk,2018-12-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.25305
707491,bmo on johnson johnson firm thinks the stock move was an overreaction notes the last time jnj finished down more than was on july declining it recovered six days later reiterates outperform target,https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12859378/bmo-on-johnson-johnson-firm-thinks-the-stock-move-was-a,Benzinga_Newsdesk,2018-12-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.41105
707492,morgan stanley on johnson johnson believes the stock reaction is not supported by science and may inflate potential legal exposure sees comparisons to recent legal issues at bayer bayry as flawed maintains overweight target,https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12858224/morgan-stanley-on-johnson-johnson-believes-the-stock-re,Benzinga_Newsdesk,2018-12-17 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.3234
707493, biggest movers from friday,https://www.benzinga.com/news/18/12/12857144/41-biggest-movers-from-friday,Lisa Levin,2018-12-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707494,wells fargo note cites bausch health acquiring shower to shower body powder from jj named as defendant in lawsuits,https://www.benzinga.com/news/18/12/12853842/wells-fargo-note-cites-bausch-health-acquiring-shower-to-shower-body-powder-name,Charles Gross,2018-12-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.67
707495,hearing wells fargo out negative on bausch health off jj reuters report,https://www.benzinga.com/news/18/12/12853831/hearing-wells-fargo-out-negative-on-bausch-health-off-jnj-reuters-report,Charles Gross,2018-12-14 00:00:00,JNJ,1,1,1,0,1,1,1,0,0,0.41105
707496,jj issues statement on reuters talc report article is onesided false and inflammatory simply put the reuters story is an absurd conspiracy theory,https://www.benzinga.com/news/18/12/12853609/j-j-issues-statement-on-reuters-talc-report-article-is-one-sided-false-and-infla,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.32999999999999996
707497,citi says jj has completely refuted premise of reuters article related to talc,https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12853202/citi-says-j-j-has-completely-refuted-premise-of-reuters,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
707498,hearing jp morgan now also out giving defensive comments on jj,https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12853138/hearing-jp-morgan-now-also-out-giving-defensive-comment,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8243
707499, stocks moving in fridays midday session,https://www.benzinga.com/news/18/12/12853133/26-stocks-moving-in-fridays-mid-day-session,Lisa Levin,2018-12-14 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707500,hearing wells fargo analyst said jj shares appear oversold amid talc report,https://www.benzinga.com/analyst-ratings/analyst-color/18/12/12852934/hearing-wells-fargo-analyst-said-j-j-shares-appear-over,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.81845
707501,johnson johnson falls following baby powder asbestos report,https://www.benzinga.com/news/18/12/12852851/johnson-johnson-falls-following-baby-powder-asbestos-report,Wayne Duggan,2018-12-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707502,hearing susquehanna says jj has been facing talc litigation for years,https://www.benzinga.com/news/18/12/12852397/hearing-susquehanna-j-j-has-been-facing-talc-litigation-for-years,Charles Gross,2018-12-14 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5258
707503,johnson johnson shares are trading lower following reports indicating the company did not disclose prior knowledge of asbestos in its baby powder products,https://www.benzinga.com/markets/wiim/18/12/12852330/johnson-johnson-shares-are-trading-lower-following-reports-indicating-th,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,0,1,0,0,0,1,0,0,0,0.5
707504,johnson johnson option alert fri puts sweep near the ask vs oi earnings before open est ref,https://www.benzinga.com/news/18/12/12851948/johnson-johnson-option-alert-fri-145-puts-sweep-3-near-the-ask-1713-1-5-vs-2434-,Charles Gross,2018-12-14 00:00:00,JNJ,1,0,1,1,0,0,1,0,0,0.648
707505,jj says thousands of independent tests show talc is safe,https://www.benzinga.com/news/18/12/12851867/j-j-says-thousands-of-independent-tests-show-talc-is-safe,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7997000000000001
707506,jj failed to tell fda of talc tests showing asbestos from s,https://www.benzinga.com/news/18/12/12851847/j-j-failed-to-tell-fda-of-talc-tests-showing-asbestos-from-1970s,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.3409
707507,jjs janssen reports submitted supplemental new drug application to fda for xarelto to prevent venous thromboembolism in acute medically ill patients,https://www.benzinga.com/news/18/12/12851481/j-js-janssen-reports-submitted-supplemental-new-drug-application-to-fda-for-xare,Benzinga Newsdesk,2018-12-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.29905000000000004
707508,jj drafted into a fight over shareholder suits co asked sec to omit proposal from proxy statement,https://www.benzinga.com/18/12/12848733/j-j-drafted-into-a-fight-over-shareholder-suits-co-asked-sec-to-omit-proposal-from-20,Benzinga Newsdesk,2018-12-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.42345
707509,hearing jnj to pay average of k per pinnaclehip case,https://www.benzinga.com/news/18/12/12840752/hearing-jnj-to-pay-average-of-125k-per-pinnacle-hip-case,Benzinga Newsdesk,2018-12-12 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.44865
707510,novartis exec on jj call to discuss tremfya says we believe data from eclipse trialwill have limited clinical relevance,https://www.benzinga.com/news/18/12/12838785/novartis-exec-on-j-j-call-to-discuss-tremfya-says-we-believe-data-from-eclipse-t,Benzinga Newsdesk,2018-12-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5129
707511,biomx enters collaboration with johnson johnson innovation for discovery of microbiomebased biomakers for ibd,https://www.benzinga.com/general/biotech/18/12/12836982/biomx-enters-collaboration-with-johnson-johnson-innovation-for-discov,Benzinga Newsdesk,2018-12-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707512,the daily biotech pulse abbvie halts lung cancer trial oncomed merges with mereo momenta offering,https://www.benzinga.com/general/biotech/18/12/12805307/the-daily-biotech-pulse-abbvie-halts-lung-cancer-trial-oncomed-merges,Shanthi Rexaline,2018-12-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.17015000000000002
707513,jjs janssen reports new phase cassini data presented on use of xarelto composite primary endpoint of vte occurrence did not reach statistical significance during fullstudy period,https://www.benzinga.com/news/18/12/12795924/j-js-janssen-reports-new-phase-3-cassini-data-presented-on-use-of-xarelto-compos,Benzinga Newsdesk,2018-12-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.38825
707514,jjs janssen reports new darzalex phase study showed efficacy safety data on anticd monoclonal activity in newlydiagnosed transplant patients says median progressionfree survival has not yet been reached,https://www.benzinga.com/news/18/12/12795905/j-js-janssen-reports-new-darzalex-phase-3-study-showed-efficacy-safety-data-on-a,Benzinga Newsdesk,2018-12-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.681
707515,the daily biotech pulse ash presentations take the spotlight eiger gets a new cfo,https://www.benzinga.com/general/biotech/18/12/12792932/the-daily-biotech-pulse-ash-presentations-take-the-spotlight-eiger-ge,Shanthi Rexaline,2018-12-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707516,janssen affiliate cilag gmbh international enters worldwide collaboration and license agreement with argenx for cancer immunotherapy cusatuzumab,https://www.benzinga.com/news/18/12/12784713/janssen-affiliate-cilag-gmbh-international-enters-worldwide-collaboration-and-li,Charles Gross,2018-12-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.352
707517,the week ahead in biotech ash presentations pick up pace pdufa dates clinical trials and ipos,https://www.benzinga.com/general/biotech/18/12/12781512/the-week-ahead-in-biotech-ash-presentations-pick-up-pace-pdufa-dates-,Shanthi Rexaline,2018-12-02 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707518,glaxosmithkline and jjs hiv drug juluca received approval in japan,https://www.benzinga.com/news/18/11/12757301/glaxosmithkline-and-j-js-hiv-drug-juluca-received-approval-in-japan,Zacks,2018-11-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707519,stocks trading ex dividend for mon nov ,https://www.benzinga.com/news/18/11/12750162/stocks-trading-ex-dividend-for-mon-nov-26-2018,Benzinga Newsdesk,2018-11-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707520, policy catalysts for health care investors to watch before years end,https://www.benzinga.com/analyst-ratings/analyst-color/18/11/12745249/9-policy-catalysts-for-health-care-investors-to-watch-b,Wayne Duggan,2018-11-25 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.74695
707521,stocks that will be trading ex dividend mon nov ,https://www.benzinga.com/news/18/11/12745085/stocks-that-will-be-trading-ex-dividend-mon-nov-26-2018,Benzinga Newsdesk,2018-11-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707522,a us appeals court has declined to block the sale of generic versions of jjs zytiga,https://www.benzinga.com/news/18/11/12740670/a-us-appeals-court-has-declined-to-block-the-sale-of-generic-versions-of-j-js-zy,Benzinga Newsdesk,2018-11-21 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.2798
707523,stocks which set new week high yesterday tues nov ,https://www.benzinga.com/news/18/11/12738198/stocks-which-set-new-52-week-high-yesterday-tues-nov-20-2018,Benzinga Newsdesk,2018-11-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707524,hearing appeals court says jnj cant prevent sales of generic zytiga says teva mylan can enter market,https://www.benzinga.com/general/biotech/18/11/12734761/hearing-appeals-court-says-jnj-cant-prevent-sales-of-generic-zytiga-s,Benzinga Newsdesk,2018-11-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.49045
707525,stocks which set new week high yesterday mon nov ,https://www.benzinga.com/news/18/11/12731510/stocks-which-set-new-52-week-high-yesterday-mon-nov-19-2018,Benzinga Newsdesk,2018-11-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707526,the daily biotech pulse denalis positive results novartis substance abuse therapy launch medtronic earnings,https://www.benzinga.com/general/biotech/18/11/12729398/the-daily-biotech-pulse-denalis-positive-results-novartis-substance-a,Shanthi Rexaline,2018-11-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.42345
707527,chmp says jjs janssen pharmas erleada receive positive opinion for treatment of nonmetastatic castration resistant prostate cancer,https://www.benzinga.com/news/18/11/12715151/chmp-says-j-js-janssen-pharmas-erleada-receive-positive-opinion-for-treatment-of,Benzinga Newsdesk,2018-11-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.39885
707528,johnson johnson vision announces health canada has announced medical device license for cuvue oasys contact lens with transitions light intelligent technology,https://www.benzinga.com/general/biotech/18/11/12651732/johnson-johnson-vision-announces-health-canada-has-announced-medical-,Benzinga Newsdesk,2018-11-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8062
707529,fundstrat reality shares partner on new multifactor etf,https://www.benzinga.com/trading-ideas/long-ideas/18/11/12627224/fundstrat-reality-shares-partner-on-new-multi-factor-etf,ETF Professor,2018-11-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707530,eli lilly gets ready for first report postelanco ipo,https://www.benzinga.com/news/earnings/18/11/12632088/eli-lilly-gets-ready-for-first-report-post-elanco-ipo,JJ Kinahan,2018-11-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6806
707531,why apple will likely remain sole member of trillion club for a while,https://www.benzinga.com/general/education/18/11/12601254/why-apple-will-likely-remain-sole-member-of-1-trillion-club-for-a-w,Wayne Duggan,2018-11-04 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707532,these are the biggest stocks reporting earnings this week and their recent track records,https://www.benzinga.com/news/earnings/18/10/12583325/these-are-the-biggest-stocks-reporting-earnings-next-week-and-their-rec,Chris Dier-Scalise,2018-10-29 00:00:00,JNJ,1,2,0,0,1,0,1,1,1,0.5
707533,johnson johnson late friday reported a us district court ruled invalidated all asserted claims of patent for zytiga johnson johnson said strongly disagrees with courts decision,https://www.benzinga.com/news/18/10/12582021/johnson-johnson-late-friday-reported-a-us-district-court-ruled-invalidated-all-a,Benzinga Newsdesk,2018-10-29 00:00:00,JNJ,1,1,0,0,0,0,1,0,1,0.4742
707534,tesaro announces achievement of zejula prostate cancer development milestones by janssen receives m milestone payment from janssen,https://www.benzinga.com/general/biotech/18/10/12581753/tesaro-announces-achievement-of-zejula-prostate-cancer-development-mi,Benzinga Newsdesk,2018-10-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.17015000000000002
707535,a new way to treat the brain stanford university scientists launch cannabis pharma company,https://www.benzinga.com/general/biotech/18/10/12576542/a-new-way-to-treat-the-brain-stanford-university-scientists-launch-ca,Javier Hasse,2018-10-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
707536,janssens stelara demonstrated sustained efficiency in improving clinical remission rates in chrons patients throughout three years safety events were not higher amongst all ustekinumabtreated patients entering longterm extension study vs placebo,https://www.benzinga.com/general/biotech/18/10/12555804/janssens-stelara-demonstrated-sustained-efficiency-in-improving-clini,Benzinga_Newsdesk,2018-10-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8982
707537, kids dead sick in viral outbreak at new jersey rehabilitation center abc ny,https://www.benzinga.com/news/18/10/12551717/6-kids-dead-12-sick-in-viral-outbreak-at-new-jersey-rehabilitation-center-abc-7-,Benzinga Newsdesk,2018-10-23 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.08875
707538,johnson johnson announces offer to acquire ciz holdings co for b,https://www.benzinga.com/news/18/10/12546393/johnson-johnson-announces-offer-to-acquire-ci-z-holdings-co-for-230b,Charles Gross,2018-10-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707539,citigroup maintains neutral on johnson johnson raises price target to ,https://www.benzinga.com/news/18/10/12542663/citigroup-maintains-neutral-on-johnson-johnson-raises-price-target-to-148,Vick Meyer,2018-10-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707540,jjs janssen reports year tremfya data showed stably maintained rates of skin clearance in patients with moderate to severe plaque psoriasis,https://www.benzinga.com/news/18/10/12533985/j-js-janssen-reports-3-year-tremfya-data-showed-stably-maintained-rates-of-skin-,Benzinga Newsdesk,2018-10-19 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.30910000000000004
707541,credit suisse maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/18/10/12521086/credit-suisse-maintains-outperform-on-johnson-johnson-raises-price-target-to-152,Vick Meyer,2018-10-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707542,after basking in the glow of netflix results and tuesday rally pressure seems possible,https://www.benzinga.com/news/earnings/18/10/12520657/after-basking-in-the-glow-of-netflix-results-and-tuesday-rally-pressure,JJ Kinahan,2018-10-17 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.352
707543,watching boston scientific as traders circulate speculation from dealreporter jj could be interested in co,https://www.benzinga.com/news/18/10/12520293/watching-boston-scientific-as-traders-circulate-speculation-from-dealreporter-j-,Benzinga Newsdesk,2018-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
707544,raymond james maintains outperform on johnson johnson raises price target to ,https://www.benzinga.com/news/18/10/12519874/raymond-james-maintains-outperform-on-johnson-johnson-raises-price-target-to-149,Vick Meyer,2018-10-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707545,a peek into the markets us stock futures down ahead of fed minutes,https://www.benzinga.com/news/18/10/12518753/a-peek-into-the-markets-us-stock-futures-down-ahead-of-fed-minutes,Lisa Levin,2018-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707546,jjs janssen says health canada has approved invokana for reduction of major adverse cardiovascular events,https://www.benzinga.com/general/biotech/18/10/12518710/janssen-says-health-canada-has-approved-invokana-for-reduction-of-maj,Benzinga_Newsdesk,2018-10-17 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5386
707547,bank earnings to the rescue market seeing some green after strong results,https://www.benzinga.com/news/earnings/18/10/12513800/bank-earnings-to-the-rescue-market-seeing-some-green-after-strong-resul,JJ Kinahan,2018-10-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8825000000000001
707548,jj cfo on conference call says not satisfied with the performance in medical devices,https://www.benzinga.com/general/biotech/18/10/12513061/j-j-cfo-on-conference-call-says-not-satisfied-with-the-performance-in,Benzinga_Newsdesk,2018-10-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.4573
707549,the daily biotech pulse enzos q loss sanofis positive trial results immunocellular to delist,https://www.benzinga.com/general/biotech/18/10/12511641/the-daily-biotech-pulse-enzos-q4-loss-sanofis-positive-trial-results-,Shanthi Rexaline,2018-10-16 00:00:00,JNJ,0,1,1,1,1,1,1,1,1,0.6591
707550,a peek into the markets us stock futures rise,https://www.benzinga.com/news/18/10/12511444/a-peek-into-the-markets-us-stock-futures-rise,Lisa Levin,2018-10-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707551,johnson johnson raises fy adj eps outlook from to vs est sees fy sales bb vs b est,https://www.benzinga.com/news/18/10/12511179/johnson-johnson-raises-fy18-adj-eps-outlook-from-8-07-8-1-to-8-13-8-18-vs-8-15-e,Benzinga_Newsdesk,2018-10-16 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5
707552,jj raises guidance,https://www.benzinga.com/news/18/10/12511165/j-j-raises-guidance,Benzinga Newsdesk,2018-10-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707553,johnson johnson q eps beats estimate sales b beat b estimate,https://www.benzinga.com/news/earnings/18/10/12511164/johnson-johnson-q3-eps-2-05-beats-2-03-estimate-sales-20-348b-beat-20-0,Benzinga Newsdesk,2018-10-16 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707554, stocks to watch for october ,https://www.benzinga.com/news/earnings/18/10/12510683/12-stocks-to-watch-for-october-16-2018,Lisa Levin,2018-10-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707555,earnings scheduled for october ,https://www.benzinga.com/news/earnings/18/10/12510587/earnings-scheduled-for-october-16-2018,Lisa Levin,2018-10-16 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707556,johnson johnson q earnings preview,https://www.benzinga.com/news/earnings-previews/18/10/12507672/earnings-roundup-for-johnson-johnson,Benzinga Newsdesk,2018-10-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707557,the week ahead q earnings season canada decriminalizes cannabis,https://www.benzinga.com/news/18/10/12505868/the-week-ahead-q3-earnings-season-canada-decriminalizes-cannabis,Taylor Cox,2018-10-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707558,as new week begins markets still seem to be playing d amid host of earnings,https://www.benzinga.com/news/earnings/18/10/12505835/as-new-week-begins-markets-still-seem-to-be-playing-d-amid-host-of-earn,JJ Kinahan,2018-10-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
707559, major market opportunities for the cannabis industry,https://www.benzinga.com/analyst-ratings/analyst-color/18/10/12479521/4-major-market-opportunities-for-the-cannabis-industry,Hannah Genig,2018-10-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
707560,fda approves janssen pharmaceuticals xarelto to reduce risk of major cardiovascular events,https://www.benzinga.com/general/biotech/18/10/12495500/fda-approves-janssen-pharmaceuticals-xarelto-to-reduce-risk-of-major-,Benzinga_Newsdesk,2018-10-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.57655
707561,morgan stanley maintains equalweight on johnson johnson raises price target to ,https://www.benzinga.com/news/18/10/12492308/morgan-stanley-maintains-equal-weight-on-johnson-johnson-raises-price-target-to-,Vick Meyer,2018-10-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707562,fda commissioner scott gottlieb issues statement on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines,https://www.benzinga.com/news/18/10/12478199/fda-commissioner-scott-gottlieb-issues-statement-on-new-efforts-to-advance-the-d,Benzinga Newsdesk,2018-10-09 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7202
707563,analysts react to arrowheads janssen collaboration downside in stock may be misguided,https://www.benzinga.com/analyst-ratings/analyst-color/18/10/12460074/analysts-react-to-arrowheads-janssen-collaboration-down,Wayne Duggan,2018-10-04 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.375
707564,arrowhead announces b license agreement with janssen for genesilencing drug,https://www.benzinga.com/general/biotech/18/10/12458336/arrowhead-announces-3-7b-license-agreement-with-janssen-for-gene-sile,Hannah Genig,2018-10-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707565,arrowhead pharmaceuticals on conference call says working on hbv with jj not going to create a competing hbv product,https://www.benzinga.com/general/biotech/18/10/12457526/arrowhead-pharmaceuticals-on-conference-call-says-working-on-hbv-with,Benzinga_Newsdesk,2018-10-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.524
707566,the daily biotech pulse atricures guidance guardant health and kodiak to debut,https://www.benzinga.com/general/biotech/18/10/12455944/the-daily-biotech-pulse-atricures-guidance-guardant-health-and-kodiak,Shanthi Rexaline,2018-10-04 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707567,jim cramer shares his thoughts on abbvie clorox sirius xm and more,https://www.benzinga.com/media/18/10/12456011/jim-cramer-shares-his-thoughts-on-abbvie-clorox-sirius-xm-and-more,Craig Jones,2018-10-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707568,arrowhead reports b license collaboration deal with jjs janssen,https://www.benzinga.com/news/18/10/12456798/arrowhead-reports-3-7b-license-collaboration-deal-with-j-js-janssen,Benzinga Newsdesk,2018-10-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707569,jjs janssen pharmaceuticals reports switching to symtuza results in maintained high virologic suppression and no resistance development up to weeks in virologically suppressed adults with hiv,https://www.benzinga.com/general/biotech/18/10/12453228/j-js-janssen-pharmaceuticals-reports-switching-to-symtuza-results-in-,Benzinga_Newsdesk,2018-10-03 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.352
707570,the week ahead in biotech conferences pdufa dates clinical trial results and ipos,https://www.benzinga.com/general/biotech/18/09/12412034/the-week-ahead-in-biotech-conferences-pdufa-dates-clinical-trial-resu,Shanthi Rexaline,2018-09-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707571,geron plunges as johnson johnson unit discontinues blood cancer drug collaboration,https://www.benzinga.com/general/biotech/18/09/12417200/geron-plunges-as-johnson-johnson-unit-discontinues-blood-cancer-drug-,Shanthi Rexaline,2018-09-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.17015000000000002
707572,the daily biotech pulse hologic goes shopping johnson johnson snaps ties with geron,https://www.benzinga.com/general/biotech/18/09/12415125/the-daily-biotech-pulse-hologic-goes-shopping-johnson-johnson-snaps-t,Shanthi Rexaline,2018-09-27 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707573,geron reports discontinuation of imetelstat collaboration with janssen,https://www.benzinga.com/news/18/09/12415819/geron-reports-discontinuation-of-imetelstat-collaboration-with-janssen,Benzinga Newsdesk,2018-09-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707574,geron to provide an update on the imetelstat collaboration with janssen on september ,https://www.benzinga.com/news/18/09/12414860/geron-to-provide-an-update-on-the-imetelstat-collaboration-with-janssen-on-septe,Charles Gross,2018-09-26 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707575,hearing johnson johnson california talcum powder case has ended in mistrial unconfirmed,https://www.benzinga.com/news/18/09/12397789/hearing-johnson-johnson-california-talcum-powder-case-has-ended-in-mistrial-unco,Benzinga Newsdesk,2018-09-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.436
707576,the week ahead in biotech conferences pdufa dates clinical trial results and ipos,https://www.benzinga.com/general/biotech/18/09/12390472/the-week-ahead-in-biotech-sept-23-29-conferences-pdufa-dates-clinical,Shanthi Rexaline,2018-09-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707577,johnson johnson option alert jun calls at the bid vs oi earnings before open ref,https://www.benzinga.com/markets/options/18/09/12384399/johnson-johnson-option-alert-jun-21-160-calls-at-the-bid-500-2-0-vs-7,Charles Gross,2018-09-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707578,the daily biotech pulse johnson johnsons generic unit files nda for urinary tract cancer drug g therapeutics prices offering,https://www.benzinga.com/general/biotech/18/09/12374793/the-daily-biotech-pulse-johnson-johnsons-generic-unit-files-nda-for-u,Shanthi Rexaline,2018-09-19 00:00:00,JNJ,1,2,1,1,0,1,1,0,1,0.17015000000000002
707579,the week ahead in biotech sept conferences pdufa dates clinical trial results and ipos,https://www.benzinga.com/general/biotech/18/09/12351792/the-week-ahead-in-biotech-sept-16-22-conferences-pdufa-dates-clinical,Shanthi Rexaline,2018-09-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707580,pacira shares look expensive stifel says in bearish initiation,https://www.benzinga.com/analyst-ratings/analyst-color/18/09/12357022/pacira-shares-look-expensive-stifel-says-in-bearish-ini,Shanthi Rexaline,2018-09-14 00:00:00,JNJ,1,0,0,1,0,0,0,0,0,0.648
707581,i still believe jnj will drop gern imetelstat i guess we wait for later this month to see if im right or wrong nothing today changes my bearish view if anything not focusing on imetelstat today is a negativestats adam feuerstein tweets,https://www.benzinga.com/news/18/09/12350732/i-still-believe-jnj-will-drop-gern-imetelstat-i-guess-we-wait-for-later-this-mon,Benzinga_Newsdesk,2018-09-13 00:00:00,JNJ,1,2,0,1,0,0,0,0,0,0.18155
707582,stat news adam feuerstein retweets that johnson and johnson looking at imetelstat data right now no decision made yet,https://www.benzinga.com/general/biotech/18/09/12350707/stat-news-adam-feuerstein-retweets-that-johnson-and-johnson-looking-a,Benzinga Newsdesk,2018-09-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
707583,johnson and johnson holding investor conference call on its pharma business today,https://www.benzinga.com/general/biotech/18/09/12347688/johnson-and-johnson-holding-investor-conference-call-on-its-pharma-bu,Hal Lindon,2018-09-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707584,jjs janssen reports tremfya improves longterm patientreported outcomes in patients with moderate to severe plaque psoriasis,https://www.benzinga.com/news/18/09/12341745/j-js-janssen-reports-tremfya-improves-long-term-patient-reported-outcomes-in-pat,luke@benzinga.com,2018-09-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5258
707585,premarket prep opening nyse imbalance update alibaba k shares to sell general electric k to sell taiwan semiconductor k to sell att k to buy home depot k to buy johnson johnson k to sell,https://www.benzinga.com/news/18/09/12335232/premarket-prep-opening-nyse-imbalance-update-alibaba-109k-shares-to-sell-general,luke@benzinga.com,2018-09-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707586,the week ahead apples special event mobile world congress us inflation data on deck,https://www.benzinga.com/government/18/09/12329769/the-week-ahead-apples-special-event-mobile-world-congress-us-inflation-dat,Taylor Cox,2018-09-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
707587,the week ahead in biotech conferences clinical trial results earnings and ipos,https://www.benzinga.com/general/biotech/18/09/12314714/the-week-ahead-in-biotech-conferences-clinical-trial-results-earnings,Shanthi Rexaline,2018-09-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707588,janssen submits esketamine nasal spray new drug application to us fda for treatmentresistant depression,https://www.benzinga.com/news/18/09/12298082/janssen-submits-esketamine-nasal-spray-new-drug-application-to-u-s-fda-for-treat,Benzinga_Newsdesk,2018-09-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.21405000000000002
707589,the week ahead in biotech conferences pdufa dates clinical trials and earnings,https://www.benzinga.com/general/biotech/18/09/12277472/the-week-ahead-in-biotech-conferences-pdufa-dates-clinical-trials-and,Shanthi Rexaline,2018-09-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707590,jjs janssen reports european commission approval for darzalex for treatment of newlydiagnosed patients with multiple myeloma who are transplant ineligible,https://www.benzinga.com/news/18/08/12293491/j-js-janssen-reports-european-commission-approval-for-darzalex-for-treatment-of-,luke@benzinga.com,2018-08-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707591,sympathy move portola upgraded after competitor reports sour data,https://www.benzinga.com/analyst-ratings/analyst-color/18/08/12262873/sympathy-move-portola-upgraded-after-competitor-reports,Shanthi Rexaline,2018-08-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6806
707592,abbvies rare blood cancer drug combo snags fda approval,https://www.benzinga.com/general/biotech/18/08/12262299/abbvies-rare-blood-cancer-drug-combo-snags-fda-approval,Shanthi Rexaline,2018-08-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3409
707593,stocks trading ex dividend for mon aug ,https://www.benzinga.com/news/18/08/12262688/stocks-trading-ex-dividend-for-mon-aug-27-2018,luke@benzinga.com,2018-08-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707594,fda approves johnson johnson and abbvies imbruvica plus rituximab as first chemotherapyfree combo treatment in adults with waldenstroms macroglobulinemia,https://www.benzinga.com/news/18/08/12261611/abbvie-announces-fda-approval-of-imbruvica-plus-rituximab-as-first-chemotherapy-,Benzinga_Newsdesk,2018-08-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
707595,whats going on with geron,https://www.benzinga.com/general/biotech/18/08/12258143/whats-going-on-with-geron,Wayne Duggan,2018-08-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707596,geron shares fall modestly as jj spokesperson suggests recent job posting mentioning imetelstat is not related to an expected decision for a licensing deal and includes responsibilities for a variety of disease areas,https://www.benzinga.com/news/18/08/12257966/geron-shares-fall-modestly-3-7-as-j-j-spokesperson-suggests-recent-job-posting-m,luke@benzinga.com,2018-08-24 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.74695
707597,hearing jj spokesperson has issued response related to recent job posting says posting not related to expected decision on licensing deal,https://www.benzinga.com/news/18/08/12257959/hearing-j-j-spokesperson-has-issued-response-related-to-recent-job-posting-says-,luke@benzinga.com,2018-08-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,0,0.625
707598,stocks that will be trading ex dividend mon aug ,https://www.benzinga.com/news/18/08/12257203/stocks-that-will-be-trading-ex-dividend-mon-aug-27-2018,luke@benzinga.com,2018-08-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707599,geron shares remain elevated up with some attributing upside to johnson johnson job posting for a strategic pricing manager for imbruvica imetelstat drugs its partnered on with abbvie and geron respectively,https://www.benzinga.com/general/biotech/18/08/12257073/geron-shares-remain-elevated-up-28-3-with-some-attributing-upside-to-,Benzinga Newsdesk,2018-08-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707600,gern trading on a jnj job posting that mentions imetelstat yes its that ridiculous summer fridaysstats adam feuerstein tweets,https://www.benzinga.com/news/18/08/12256862/gern-trading-30-on-a-jnj-job-posting-that-mentions-imetelstat-yes-its-that-ridic,Benzinga_Newsdesk,2018-08-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5258
707601,jj shares tick lower as hearing judge in talcum powder case reached unfavorable for co verdict,https://www.benzinga.com/news/18/08/12244731/j-j-shares-ticker-lower-as-hearing-judge-in-talcum-powder-case-reached-unfavorab,luke@benzinga.com,2018-08-22 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.7294
707602, execs talk business models at cannabis capital conference,https://www.benzinga.com/markets/cannabis/18/08/12226368/5-execs-talk-business-models-at-cannabis-capital-conference,Jayson Derrick,2018-08-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707603,barrons picks and pans att starbucks state street verizon and more,https://www.benzinga.com/media/18/08/12228227/barrons-picks-and-pans-at-t-starbucks-state-street-verizon-and-more,Nelson Hem,2018-08-19 00:00:00,JNJ,1,2,0,0,0,0,1,1,1,0.5
707604,johnson johnson option alert aug calls sweep near the ask vs oi ref,https://www.benzinga.com/markets/options/18/08/12218609/johnson-johnson-option-alert-aug-31-132-calls-sweep-34-near-the-ask-7,Charles Gross,2018-08-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
707605,jjs janssen reports submission of us eu regulatory applications seeking approval for darzalex splitdosing regimen,https://www.benzinga.com/news/18/08/12163193/j-js-janssen-reports-submission-of-us-eu-regulatory-applications-seeking-approva,Benzinga Newsdesk,2018-08-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707606,daabon strikes deal with avicanna becoming the largest agro company to enter the cannabis industry,https://www.benzinga.com/news/18/08/12132958/daabon-strikes-deal-with-avicanna-becoming-the-largest-agro-company-to-enter-the,Javier Hasse,2018-08-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3194
707607,price action in several major healthcare names mixed stocks appear largely unaffected following latetues ny times article justice dept investigating claims that drug companies funded terrorism in iraq,https://www.benzinga.com/news/18/08/12118387/price-action-in-several-major-healthcare-names-mixed-stocks-appear-largely-unaff,Benzinga Newsdesk,2018-08-01 00:00:00,JNJ,1,1,1,1,1,1,1,0,1,0.352
707608,johnson johnson wins a m defense contract,https://www.benzinga.com/news/18/07/12097002/johnson-johnson-wins-a-227m-defense-contract,Benzinga Newsdesk,2018-07-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.81845
707609,what it takes to be a dividend king,https://www.benzinga.com/news/18/07/12084608/what-it-takes-to-be-a-dividend-king,Ben Reynolds - SureDividend.com,2018-07-26 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707610,janssen presents switch data for new hiv treatment symtuza and second study supporting its use in a rapid initiation scenario at aids ,https://www.benzinga.com/news/18/07/12062236/janssen-presents-switch-data-for-new-hiv-1-treatment-symtuza-and-second-study-su,Charles Gross,2018-07-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
707611,benzingas daily biotech pulse novartis earnings jjs hiv combo clears fda hurdle cara to offer shares,https://www.benzinga.com/general/biotech/18/07/12035427/benzingas-daily-biotech-pulse-novartis-earnings-j-js-hiv-cocktail-cle,Shanthi Rexaline,2018-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6806
707612,jj reports fda approval of symtuza for treatment of hiv infection,https://www.benzinga.com/news/18/07/12034226/j-j-reports-fda-approval-of-symtuza-for-treatment-of-hiv-1-infection,Benzinga Newsdesk,2018-07-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.81245
707613,hearing johnson johnson nears sale of sylvant to eusa pharma,https://www.benzinga.com/news/18/07/12032321/hearing-johnson-johnson-nears-sale-of-sylvant-to-eusa-pharma,Benzinga_Newsdesk,2018-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707614,benzingas daily biotech pulse bellicum cfo resigns roches trial meets endpoints avid bioservices turns to black in q,https://www.benzinga.com/general/biotech/18/07/12028028/benzingas-daily-biotech-pulse-bellicum-cfo-resigns-roches-trial-meets,Shanthi Rexaline,2018-07-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.4871
707615,a peek into the markets us stock futures edge lower ahead of goldman sachs earnings,https://www.benzinga.com/news/18/07/12028684/a-peek-into-the-markets-us-stock-futures-edge-lower-ahead-of-goldman-sachs-earni,Lisa Levin,2018-07-17 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
707616,johnson johnson sees fy of b vs b reflecting an increase in expected operational growth of sees fy adj eps vs est,https://www.benzinga.com/news/18/07/12028668/johnson-johnson-sees-fy18-of-80-5-81-3b-vs-81-47b-reflecting-an-increase-in-expe,Benzinga_Newsdesk,2018-07-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7997000000000001
707617,johnson johnson q eps beats estimate sales b beat b estimate,https://www.benzinga.com/news/earnings/18/07/12028666/johnson-johnson-q2-eps-2-10-beats-2-06-estimate-sales-20-83b-beat-20-37,Benzinga_Newsdesk,2018-07-17 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707618, stocks to watch for july ,https://www.benzinga.com/news/earnings/18/07/12028236/8-stocks-to-watch-for-july-17-2018,Lisa Levin,2018-07-17 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707619,earnings scheduled for july ,https://www.benzinga.com/news/earnings/18/07/12028179/earnings-scheduled-for-july-17-2018,Lisa Levin,2018-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707620,johnson johnson q earnings preview,https://www.benzinga.com/news/earnings-previews/18/07/12025487/earnings-outlook-for-johnson-johnson,Benzinga Newsdesk,2018-07-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707621,the week ahead netflix earnings comiccon ipo thursday and more,https://www.benzinga.com/news/earnings/18/07/12025615/the-week-ahead-netflix-earnings-comic-con-ipo-thursday-and-more,Taylor Cox,2018-07-16 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707622,jjs janssen pharma reports phase credence trial of invokana stopped early for positive efficacy findings,https://www.benzinga.com/news/18/07/12026450/j-js-janssen-pharma-reports-phase-3-credence-trial-of-invokana-stopped-early-for,Benzinga Newsdesk,2018-07-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.70095
707623,upcoming earnings netflix to report monday subscriber growth a focus,https://www.benzinga.com/news/earnings/18/07/12024489/upcoming-earnings-netflix-to-report-monday-subscriber-growth-a-focus,JJ Kinahan,2018-07-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
707624,earnings preview healthcare giant johnson johnson set to report tuesday morning,https://www.benzinga.com/news/earnings/18/07/12024093/earnings-preview-healthcare-giant-johnson-johnson-set-to-report-tuesday,JJ Kinahan,2018-07-16 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.5
707625,back to banks more financial results in ahead of powell testimony later this week,https://www.benzinga.com/news/earnings/18/07/12023964/back-to-banks-more-financial-results-in-ahead-of-powell-testimony-later,JJ Kinahan,2018-07-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707626,round two of bank earnings coming up with bank of america goldman sachs and morgan stanley,https://www.benzinga.com/news/earnings/18/07/12023635/round-two-of-bank-earnings-coming-up-with-bank-of-america-goldman-sachs,JJ Kinahan,2018-07-16 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
707627,premarket prep opening nyse imbalance update exxonmobil k shares to sell pfizer k to sell merck k to sell cocacola k to sell johnson johnson k to sell ford k to sell kroger k to sell,https://www.benzinga.com/news/18/07/12023300/premarket-prep-opening-nyse-imbalance-update-exxonmobil-55k-shares-to-sell-pfize,Benzinga Newsdesk,2018-07-16 00:00:00,JNJ,1,2,0,0,0,0,1,1,0,0.648
707628,jury returns b verdict against johnson johnson in asbestoslaced talcum case,https://www.benzinga.com/news/18/07/12017380/jury-returns-4-7b-verdict-against-johnson-johnson-in-asbestos-laced-talcum-case,Elizabeth Balboa,2018-07-13 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.57655
707629,premarket prep opening nyse imbalance update att k shares to sell bank of america k to buy jnj k to sell alibaba k to buy,https://www.benzinga.com/news/18/07/12017280/premarket-prep-opening-nyse-imbalance-update-at-t-167k-shares-to-sell-bank-of-am,Benzinga Newsdesk,2018-07-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707630,the market in minutes atttime warner appeal johnson johnson lawsuit theresa may and more,https://www.benzinga.com/news/18/07/12016916/the-market-in-5-minutes-at-t-time-warner-appeal-johnson-johnson-lawsuit-theresa-,Benzinga Newdesk,2018-07-13 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.38685
707631, stocks moving in fridays midday session,https://www.benzinga.com/news/18/07/12016835/24-stocks-moving-in-fridays-mid-day-session,Lisa Levin,2018-07-13 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707632,jj says deeply disappointed in verdict of st louis court unfair process,https://www.benzinga.com/news/18/07/12015672/j-j-says-deeply-disappointed-in-verdict-of-st-louis-court-unfair-process,Benzinga Newdesk,2018-07-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.21915
707633,jj ordered to pay b in punitive damages in talc cancer case,https://www.benzinga.com/news/18/07/12015520/j-j-ordered-to-pay-4-14b-in-punitive-damages-in-talc-cancer-case,Benzinga Newdesk,2018-07-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.0625
707634,courtroom video shows jj ordered to pay m in compensatory damages in missouri trial which claimed asbestos in talc caused cancer in women,https://www.benzinga.com/news/18/07/12014577/courtroom-video-shows-j-j-ordered-to-pay-550m-in-compensatory-damages-in-missour,Benzinga Newsdesk,2018-07-12 00:00:00,JNJ,1,1,0,1,1,1,1,0,1,0.11414999999999997
707635,bank earnings jpmorgan wells fargo and citigroup are slated to report friday morning,https://www.benzinga.com/news/earnings/18/07/12013550/bank-earnings-jpmorgan-wells-fargo-and-citigroup-are-slated-to-report-f,JJ Kinahan,2018-07-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707636,goldman sachs swaps perrigo johnson johnson ratings,https://www.benzinga.com/analyst-ratings/analyst-color/18/07/12011854/goldman-sachs-swaps-perrigo-johnson-johnson-ratings,Elizabeth Balboa,2018-07-12 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
707637,benzingas top upgrades downgrades for july ,https://www.benzinga.com/analyst-ratings/upgrades/18/07/12011566/benzingas-top-upgrades-downgrades-for-july-12-2018,Lisa Levin,2018-07-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
707638,goldman sachs upgrades johnson johnson to neutral,https://www.benzinga.com/news/18/07/12010751/goldman-sachs-upgrades-johnson-johnson-to-neutral,Benzinga Newsdesk,2018-07-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707639,benzingas daily biotech pulse pfizer to defer price hikes iderabiocryst merger falls through arqule to offer shares,https://www.benzinga.com/general/biotech/18/07/12003194/benzingas-daily-biotech-pulse-pfizer-to-defer-price-hikes-idera-biocr,Shanthi Rexaline,2018-07-11 00:00:00,JNJ,1,2,0,1,0,1,1,0,1,0.5
707640,johnson johnson option alert aug puts sweep near the bid vs oi earnings before open ref,https://www.benzinga.com/markets/options/18/07/12001396/johnson-johnson-option-alert-aug-17-120-puts-sweep-29-near-the-bid-93,Benzinga Newdesk,2018-07-10 00:00:00,JNJ,1,0,1,1,0,0,1,0,0,0.648
707641,health care sector outlook checking in ahead of q earnings reports,https://www.benzinga.com/news/earnings/18/07/11994014/health-care-sector-outlook-checking-in-ahead-of-q2-earnings-reports,JJ Kinahan,2018-07-09 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.74695
707642,a look at biotech in and the biggest catalysts coming up in the second half of the year,https://www.benzinga.com/general/biotech/18/07/11955951/a-look-at-biotech-in-2018-and-the-biggest-catalysts-coming-up-in-the-,Shanthi Rexaline,2018-07-05 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707643,johnson johnson option alert jul calls sweep near the ask vs oi earnings before open ref,https://www.benzinga.com/markets/options/18/07/11981055/johnson-johnson-option-alert-jul-13-125-calls-sweep-28-near-the-ask-5,Benzinga Newdesk,2018-07-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
707644,the success of xlrn luspatercept is bad for gern and another reason for jnj to sever the imetelstat relationship in qstats adam feuerstein tweets,https://www.benzinga.com/news/fda/18/06/11957687/the-success-of-xlrn-luspatercept-is-bad-for-gern-and-another-reason-for-jnj-,Benzinga Newsdesk,2018-06-29 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5258
707645,benzingas top upgrades downgrades for june ,https://www.benzinga.com/analyst-ratings/upgrades/18/06/11942702/benzingas-top-upgrades-downgrades-for-june-27-2018,Lisa Levin,2018-06-27 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
707646,bernstein initiates coverage on johnson johnson with market perform rating announces price target,https://www.benzinga.com/news/18/06/11941045/bernstein-initiates-coverage-on-johnson-johnson-with-market-perform-rating-annou,Benzinga Newsdesk,2018-06-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707647,janssen pharmaceutical signs license agreement with saladax biomedical,https://www.benzinga.com/news/contracts/18/06/11935777/janssen-pharmaceutical-signs-license-agreement-with-saladax-biomedical,Benzinga Newsdesk,2018-06-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707648,abbvie announces snda for ibrutinib accepted for review by fda,https://www.benzinga.com/general/biotech/18/06/11927664/abbvie-announces-snda-for-ibrutinib-accepted-for-review-by-fda,Benzinga Newsdesk,2018-06-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6366
707649,a look back at whats happened to each sector through the first half of part ,https://www.benzinga.com/real-estate/reit/18/06/11902103/a-look-back-at-whats-happened-to-each-sector-through-the-first-half-,Chris Dier-Scalise,2018-06-19 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.5
707650,gern wants jnj to continue a drug development partnership but new data weaken its casestats adam feuerstein tweets,https://www.benzinga.com/news/18/06/11894824/gern-wants-jnj-to-continue-a-drug-development-partnership-but-new-data-weaken-it,Benzinga Newsdesk,2018-06-18 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.21405000000000002
707651,johnson johnson announces fda approval of idesign refractive studio for lasik treatment,https://www.benzinga.com/news/18/06/11892980/johnson-johnson-announces-fda-approval-of-idesign-refractive-studio-for-lasik-tr,luke@benzinga.com,2018-06-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707652,jjs janssen reports xarelto associated with significantly reduced hospital time decreased costs with lowrisk pulmonary embolism,https://www.benzinga.com/news/18/06/11879388/j-js-janssen-reports-xarelto-associated-with-significantly-reduced-hospital-time,Benzinga Newsdesk,2018-06-14 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.5
707653,johnson johnson announces acceptance of binding offer from platinum equity to acquire lifescan inc for approximately b,https://www.benzinga.com/news/18/06/11868674/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-ac,Benzinga Newsdesk,2018-06-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7294
707654,vivus reports has met closing conditions for purchase of us canadian rights to pancreaze capsules for treatment of epi from jjs janssen pharma for m,https://www.benzinga.com/news/18/06/11857951/vivus-reports-has-met-closing-conditions-for-purchase-of-us-canadian-rights-to-p,Benzinga Newsdesk,2018-06-11 00:00:00,JNJ,1,0,1,1,1,1,1,0,1,0.5
707655,benzingas daily biotech pulse johnson johnson to dispose sterilization products business mixed results from protesostasis cystic fibrosis study,https://www.benzinga.com/general/biotech/18/06/11843330/benzingas-daily-biotech-pulse-johnson-johnson-to-dispose-sterilizatio,Shanthi Rexaline,2018-06-07 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707656,fortive reports binding offer to buy advanced sterilization products business from jj for b in cash,https://www.benzinga.com/news/18/06/11841608/fortive-reports-binding-offer-to-buy-advanced-sterilization-products-business-fr,Benzinga Newsdesk,2018-06-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7294
707657,jj shares ticker slightly higher over last few mins hearing jim cramer mentioned stockco positively on cnbc,https://www.benzinga.com/news/18/06/11823722/j-j-shares-ticker-slightly-higher-over-last-few-mins-hearing-jim-cramer-mentione,Benzinga Newsdesk,2018-06-04 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.8825000000000001
707658,janssen says phase study shows esketamine nasal spray plus oral antidepressant delayed time to relapse in patients with treatmentresistant depression,https://www.benzinga.com/news/18/05/11807249/janssen-says-phase-3-study-shows-esketamine-nasal-spray-plus-oral-antidepressant,Eddie Staley,2018-05-31 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.15960000000000002
707659,jjs janssen pharma earlier reported initiation of phase b development program evaluating jnj cart cells for treatment of multiple myeloma,https://www.benzinga.com/news/fda/18/05/11796957/j-js-janssen-pharma-earlier-reported-initiation-of-phase-1b2-development-pro,Paul Quintaro,2018-05-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707660,stocks that made new week lows today include patterson companies philip morris coty and johnson johnson,https://www.benzinga.com/trading-ideas/technicals/18/05/11789093/stocks-that-made-new-52-week-lows-today-include-patterson-co,Benzinga Newsdesk,2018-05-29 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.39885
707661,pot stocks etfs top news and data from the cannabis industry this week,https://www.benzinga.com/general/biotech/18/05/11782496/pot-stocks-etfs-top-news-and-data-from-the-cannabis-industry-this-wee,Javier Hasse,2018-05-27 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.60115
707662,barrons picks and pans best ceos altice usa micron technology and more,https://www.benzinga.com/media/18/05/11783846/barrons-picks-and-pans-best-ceos-altice-usa-micron-technology-and-more,Nelson Hem,2018-05-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
707663,novartis gets approval for remicade biosimilar in europe,https://www.benzinga.com/general/biotech/18/05/11774178/novartis-gets-approval-for-remicade-biosimilar-in-europe,Zacks,2018-05-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707664,an etf play for quality stocks at a fair price,https://www.benzinga.com/markets/18/05/11768647/an-etf-play-for-quality-stocks-at-a-fair-price,ETF Professor,2018-05-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
707665,the week ahead in biotech pdufa dates ipos and more,https://www.benzinga.com/analyst-ratings/analyst-color/18/05/11734653/the-week-ahead-in-biotech-pdufa-dates-ipos-and-more,Shanthi Rexaline,2018-05-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707666,janssen announces european commission approval of juluca,https://www.benzinga.com/news/18/05/11747211/janssen-announces-european-commission-approval-of-juluca,Benzinga Newsdesk,2018-05-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
707667, dow companies with aboveaverage salaries,https://www.benzinga.com/general/education/18/05/11728469/12-dow-30-companies-with-above-average-salaries,Elizabeth Balboa,2018-05-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707668,how to get quality in the core,https://www.benzinga.com/trading-ideas/long-ideas/18/05/11729692/how-to-get-quality-in-the-core,ETF Professor,2018-05-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707669,jim cramer shares his thoughts on johnson johnson nike and more,https://www.benzinga.com/media/18/05/11730859/jim-cramer-shares-his-thoughts-on-johnson-johnson-nike-and-more,Craig Jones,2018-05-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.648
707670,analyst morphosys is wellpositioned to continue success with antibody discovery platforms,https://www.benzinga.com/analyst-ratings/analyst-color/18/05/11704053/analyst-morphosys-is-well-positioned-to-continue-succes,Shanthi Rexaline,2018-05-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7859499999999999
707671,benzingas daily biotech pulse valeant earnings lipocines fda watch invivo cfo departure,https://www.benzinga.com/general/biotech/18/05/11662745/benzingas-daily-biotech-pulse-valeant-earnings-lipocines-fda-watch-in,Shanthi Rexaline,2018-05-08 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707672,jim cramer advises his viewers on prestige brands cvs health and more,https://www.benzinga.com/media/18/05/11661978/jim-cramer-advises-his-viewers-on-prestige-brands-cvs-health-and-more,Craig Jones,2018-05-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707673,janssen pharmaceuticals announces new phase data show esketamine nasal spray demonstrated rapid improvements in depressive symptoms in patients with treatmentresistant depression,https://www.benzinga.com/news/18/05/11653385/janssen-pharmaceuticals-announces-new-phase-3-data-show-esketamine-nasal-spray-d,Charles Gross,2018-05-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.19379999999999997
707674,stocks that made new week lows today include colgatepalmolive philip morris regeneron corning hanesbrands bed bath beyond pepsi cocacola paccar johnson johnson mallinckrodt cbs dish network goodyear tire chubb hershey and att,https://www.benzinga.com/trading-ideas/technicals/18/05/11638938/stocks-that-made-new-52-week-lows-today-include-colgate-palm,Hal Lindon,2018-05-03 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.39885
707675,hc reports benevir biopharm to be purchased by jjs janssen biotech for up to b,https://www.benzinga.com/news/m-a/18/05/11624953/hc2-reports-benevir-biopharm-to-be-purchased-by-j-js-janssen-biotech-for-up-,Paul Quintaro,2018-05-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707676,attention biotech investors mark your calendar for these may pdufa action dates,https://www.benzinga.com/general/biotech/18/05/11600569/attention-biotech-investors-mark-your-calendar-for-these-may-pdufa-ac,Shanthi Rexaline,2018-05-01 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707677,vivus acquires pancreaze from jannsen for m,https://www.benzinga.com/news/18/05/11613545/vivus-acquires-pancreaze-from-jannsen-for-135m,Charles Gross,2018-05-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707678,johnson johnson raises qtr dividend from to share,https://www.benzinga.com/trading-ideas/dividends/18/04/11584152/johnson-johnson-raises-qtr-dividend-from-0-84-to-0-90share,Eddie Staley,2018-04-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
707679,credit suisse maintains outperform on johnson johnson lowers price target to ,https://www.benzinga.com/news/18/04/11549787/credit-suisse-maintains-outperform-on-johnson-johnson-lowers-price-target-to-151,Vick Meyer,2018-04-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6366
707680,an incredible signal experts weigh in on positive fda panel vote for gw pharmas epidiolex,https://www.benzinga.com/general/biotech/18/04/11546455/an-incredible-signal-4-experts-weigh-in-on-positive-fda-panel-vote-fo,Javier Hasse,2018-04-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707681,big bank season rolls on as morgan stanley easily beats expectations,https://www.benzinga.com/news/earnings/18/04/11536535/big-bank-season-rolls-on-as-morgan-stanley-easily-beats-expectations,JJ Kinahan,2018-04-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.67
707682,stifel nicolaus maintains hold on johnson johnson lowers price target to ,https://www.benzinga.com/news/18/04/11534888/stifel-nicolaus-maintains-hold-on-johnson-johnson-lowers-price-target-to-135-00,Vick Meyer,2018-04-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.436
707683,a peek into the markets us stock futures surge goldman sachs earnings in focus,https://www.benzinga.com/news/18/04/11527372/a-peek-into-the-markets-us-stock-futures-surge-goldman-sachs-earnings-in-focus,Lisa Levin,2018-04-17 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
707684,johnson johnson reaffirms fy adj eps guidance raises fy sales guidance from bb to bb vs b est,https://www.benzinga.com/news/18/04/11527196/johnson-johnson-reaffirms-fy-2018-adj-eps-guidance-raises-fy-2018-sales-guidance,Paul Quintaro,2018-04-17 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707685,johnson johnson reports q adj eps beats est sales b beats b est,https://www.benzinga.com/news/earnings/18/04/11527187/johnson-johnson-reports-q1-adj-eps-2-06-beats-2-01-est-sales-20-0b-beat,Paul Quintaro,2018-04-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707686, stocks to watch for april ,https://www.benzinga.com/news/earnings/18/04/11526757/12-stocks-to-watch-for-april-17-2018,Lisa Levin,2018-04-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707687,earnings scheduled for april ,https://www.benzinga.com/news/earnings/18/04/11526726/earnings-scheduled-for-april-17-2018,Lisa Levin,2018-04-17 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707688,bristolmyers announces collaboration with johnson johnsons janssen to develop and commercialize nextgen cardiovascular therapy,https://www.benzinga.com/general/biotech/18/04/11524879/bristol-myers-announces-collaboration-with-johnson-johnsons-janssen-t,Hal Lindon,2018-04-16 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
707689,upcoming earnings johnson johnson and ibm are scheduled to report this week,https://www.benzinga.com/news/earnings/18/04/11523342/upcoming-earnings-johnson-johnson-and-ibm-are-scheduled-to-report-this-,JJ Kinahan,2018-04-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707690,the week ahead netflix earnings big bank results fda actions abound,https://www.benzinga.com/news/18/04/11522872/the-week-ahead-netflix-earnings-big-bank-results-fda-actions-abound,Taylor Cox,2018-04-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707691,earnings parade continues this week after missile attacks with banks netflix on way,https://www.benzinga.com/news/18/04/11521968/earnings-parade-continues-this-week-after-missile-attacks-with-banks-netflix-on-,JJ Kinahan,2018-04-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.2798
707692,netflix earnings preview international subscriber growth in focus,https://www.benzinga.com/news/earnings/18/04/11521657/netflix-earnings-preview-international-subscriber-growth-in-focus,JJ Kinahan,2018-04-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
707693,benzingas top analyst calls from april ,https://www.benzinga.com/analyst-ratings/analyst-color/18/04/11516373/benzingas-top-analyst-calls-from-april-13-2018,Bill Haddad,2018-04-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
707694,next weeks round of bank earnings includes bank of america goldman sachs and morgan stanley,https://www.benzinga.com/news/earnings/18/04/11516609/next-weeks-round-of-bank-earnings-includes-bank-of-america-goldman-sach,JJ Kinahan,2018-04-13 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707695,chardan assembly biosciences hep b antiviral data positive but undifferentiated from competitor johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/18/04/11515042/chardan-assembly-biosciences-hep-b-antiviral-data-posit,Shanthi Rexaline,2018-04-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
707696,upcoming earnings big banks jp morgan wells fargo and citigroup to kick off q season,https://www.benzinga.com/news/earnings/18/04/11510004/upcoming-earnings-big-banks-jp-morgan-wells-fargo-and-citigroup-to-kick,JJ Kinahan,2018-04-12 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.71075
707697,update jjs janssen says canagliflozin reduced urinary albumin to creatinine ratio,https://www.benzinga.com/news/18/04/11508524/update-j-js-janssen-says-canagliflozin-reduced-urinary-albumin-to-creatinine-rat,Paul Quintaro,2018-04-12 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.55135
707698,jjs janssen pharma says invokana showed significant renal protective benefits in patients with type diabetes,https://www.benzinga.com/news/fda/18/04/11508522/j-js-janssen-pharma-says-invokana-showed-significant-renal-protective-benefi,Paul Quintaro,2018-04-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.76335
707699,courtroom video shows jj imerys subsidiary ordered to pay m in punitive damages in new jersey case blaming talc for mesothelioma,https://www.benzinga.com/news/18/04/11505053/courtroom-video-shows-j-j-imerys-subsidiary-ordered-to-pay-80m-in-punitive-damag,luke@benzinga.com,2018-04-11 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.0842
707700,fda cleared acuvue oasys contact lenses with transitions light intelligent tech to johnson johnson,https://www.benzinga.com/news/fda/18/04/11497744/fda-cleared-acuvue-oasys-contact-lenses-with-transitions-light-intelligent-t,Eddie Staley,2018-04-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.76335
707701,morgan stanley maintains equalweight on johnson johnson lowers price target to ,https://www.benzinga.com/news/18/04/11496591/morgan-stanley-maintains-equal-weight-on-johnson-johnson-lowers-price-target-to-,Vick Meyer,2018-04-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
707702,pot stocks etfs top news and data from the cannabis industry this week,https://www.benzinga.com/general/biotech/18/04/11485740/pot-stocks-etfs-top-news-and-data-from-the-cannabis-industry-this-wee,Javier Hasse,2018-04-06 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.60115
707703,dws quantifies quality in a new etf,https://www.benzinga.com/trading-ideas/long-ideas/18/04/11480618/dws-quantifies-quality-in-a-new-etf,ETF Professor,2018-04-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707704,smoking is just one way to use marijuana an introduction to vaporizers edibles oils tinctures dabs and other cannabis products,https://www.benzinga.com/general/biotech/18/03/11035855/smoking-is-just-one-way-to-use-marijuana-an-introduction-to-vaporizer,Javier Hasse,2018-03-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707705,icymi gamestop omeros congress impacts biotechs,https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11407046/icymi-gamestop-omeros-congress-impacts-biotechs,Taylor Cox,2018-03-23 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707706,biotech winners and losers from congress latest funding bill,https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11404092/biotech-winners-and-losers-from-congress-latest-funding,Wayne Duggan,2018-03-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4614
707707,johnson johnson cfo dominic caruso to retire,https://www.benzinga.com/news/management/18/03/11392885/johnson-johnson-cfo-dominic-caruso-to-retire,Hal Lindon,2018-03-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707708,checking in on the healthcare sector ahead of q earnings season,https://www.benzinga.com/general/biotech/18/03/11390687/checking-in-on-the-healthcare-sector-ahead-of-q1-earnings-season,JJ Kinahan,2018-03-20 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707709,johnson johnson gets b offer for lifescan diabetes device unit,https://www.benzinga.com/news/18/03/11382978/johnson-johnson-gets-2-1b-offer-for-lifescan-diabetes-device-unit,Zacks,2018-03-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707710,a dividend alternative to broad market exposure,https://www.benzinga.com/trading-ideas/long-ideas/18/03/11385417/a-dividend-alternative-to-broad-market-exposure,ETF Professor,2018-03-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707711,johnson johnson receives takeover offer for its lifescan business to platinum equity for b,https://www.benzinga.com/news/18/03/11373300/johnson-johnson-receives-takeover-offer-for-its-lifescan-business-to-platinum-eq,Paul Quintaro,2018-03-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707712,jj macleods in talks for licence deal of tuberculosis drug bedaquiline economic times,https://www.benzinga.com/news/18/03/11348883/j-j-macleods-in-talks-for-licence-deal-of-tuberculosis-drug-bedaquiline-economic,Charles Gross,2018-03-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
707713,jannsen announces invokana significantly reduces risk of heart failurerelated outcomes in type diabetes patients at risk for or with a history of cardiovascular disease,https://www.benzinga.com/news/18/03/11340273/jannsen-announces-invokana-significantly-reduces-risk-of-heart-failure-related-o,Charles Gross,2018-03-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.25305
707714,johnson johnson and bayer announce judges order sets xarelto product liability lawsuits for separate jury trials,https://www.benzinga.com/news/legal/18/03/11331730/johnson-johnson-and-bayer-announce-judges-order-sets-1-200-xarelto-product,Hal Lindon,2018-03-08 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.32999999999999996
707715,zosano pharma is the latest low float stock to make a huge move,https://www.benzinga.com/news/18/03/11330268/zosano-pharma-is-the-latest-low-float-stock-to-make-a-huge-move,Wayne Duggan,2018-03-08 00:00:00,JNJ,1,2,1,1,1,1,1,0,1,0.5258
707716,height casts odds that congress rolls back pharma discounts,https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11320275/height-casts-65-odds-that-congress-rolls-back-pharma-di,Elizabeth Balboa,2018-03-07 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707717,analyst insulet on track for profitability in ,https://www.benzinga.com/analyst-ratings/analyst-color/18/03/11312920/analyst-insulet-on-track-for-profitability-in-2018,Elizabeth Balboa,2018-03-06 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.6366
707718,medtechs longterm prospects outweigh nearterm risks,https://www.benzinga.com/general/biotech/18/03/11284481/medtechs-long-term-prospects-outweigh-near-term-risks,Zacks,2018-03-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5129
707719,jim cramer advises his viewers on johnson johnson nokia and more,https://www.benzinga.com/media/18/03/11284408/jim-cramer-advises-his-viewers-on-johnson-johnson-nokia-and-more,Craig Jones,2018-03-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707720,citigroup maintains neutral on johnson johnson lowers price target to ,https://www.benzinga.com/news/18/02/11266811/citigroup-maintains-neutral-on-johnson-johnson-lowers-price-target-to-146-00,Vick Meyer,2018-02-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
707721,aldeyra therapeutics announces collaborative agreement with johnson johnson innovation to advance novel immunemodulating drugs for systemic inflammatory diseases,https://www.benzinga.com/news/contracts/18/02/11265664/aldeyra-therapeutics-announces-collaborative-agreement-with-johnson-jo,Eddie Staley,2018-02-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8982
707722,sierra oncology and janssen sign supply agreement for prostate cancer study,https://www.benzinga.com/news/18/02/11265425/sierra-oncology-and-janssen-sign-supply-agreement-for-prostate-cancer-study,Paul Quintaro,2018-02-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.352
707723,premarket prep opening nyse imbalance update bank of america k shares to sell johnson johnson k shares to buy general electric k shares to sell hpq k shares to buy,https://www.benzinga.com/pre-market-outlook/18/02/11241685/premarket-prep-opening-nyse-imbalance-update-bank-of-america-379k-,Paul Quintaro,2018-02-22 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.88915
707724,form filing late tuesday showed johnson johnson chief scientific officer paulus stoffels sold k shares at ,https://www.benzinga.com/news/insider-trades/18/02/11234895/form-4-filing-late-tuesday-showed-johnson-johnson-chief-scientifi,Hal Lindon,2018-02-21 00:00:00,JNJ,1,2,0,0,1,0,1,1,1,0.648
707725,quantifying quality with an ishares etf,https://www.benzinga.com/analyst-ratings/analyst-color/18/02/11221436/quantifying-quality-with-an-ishares-etf,ETF Professor,2018-02-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707726,jjs janssen wins health canada approval for new zytiga indication for treatment of newlydiagnosed metastatic prostate cancer,https://www.benzinga.com/news/fda/18/02/11207868/j-js-janssen-wins-health-canada-approval-for-new-zytiga-indication-for-treat,Paul Quintaro,2018-02-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.67
707727,jj shares unaffected as fda says erleada by cos janssen pharma approved,https://www.benzinga.com/news/fda/18/02/11201059/j-j-shares-unaffected-as-fda-says-erleada-by-co-s-janssen-pharma-approved,Paul Quintaro,2018-02-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8592
707728,cramer looks at the dows biggest losers,https://www.benzinga.com/media/jim-cramer/18/02/11196687/cramer-looks-at-the-dows-biggest-losers,Jayson Derrick,2018-02-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.23665000000000003
707729,janssen submits marketing authorisation application to ema for apalutamide to treat patients with highrisk nonmetastatic castrationresistant prostate cancer,https://www.benzinga.com/news/18/02/11164833/janssen-submits-marketing-authorisation-application-to-ema-for-apalutamide-to-tr,Charles Gross,2018-02-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.29905000000000004
707730, biotech stocks with clinical trial outcomes in february,https://www.benzinga.com/general/biotech/18/02/11155160/19-biotech-stocks-with-clinical-trial-outcomes-in-february,Shanthi Rexaline,2018-02-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707731,the alzheimers drug pipeline high failure rates in research on an increasingly common disease,https://www.benzinga.com/general/biotech/18/02/11011808/the-alzheimers-drug-pipeline-high-failure-rates-in-research-on-an-inc,Shanthi Rexaline,2018-02-08 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.24469999999999997
707732,theravance biopharma reports entered global collaboration with jjs janssen for td in inflammatory intestinal diseases,https://www.benzinga.com/news/18/02/11147799/theravance-biopharma-reports-entered-global-collaboration-with-j-js-janssen-for-,Paul Quintaro,2018-02-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707733,jj shares fall quickly rebound from lows but still down for session traders circulate mesotheliomanet article johnson johnson mesothelioma trial likely to expose company documents,https://www.benzinga.com/news/18/02/11134089/j-j-shares-fall-3-5-quickly-rebound-from-lows-but-still-down-2-5-for-session-tra,Paul Quintaro,2018-02-05 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.4742
707734,jim cramer weighs in on johnson johnson stmicroelectronics and more,https://www.benzinga.com/media/cnbc/18/02/11114646/jim-cramer-weighs-in-on-johnson-johnson-stmicroelectronics-and-more,Craig Jones,2018-02-01 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707735, dividend growth stocks to watch in ,https://www.benzinga.com/trading-ideas/dividends/18/01/11081631/11-dividend-growth-stocks-to-watch-in-2018,Wayne Duggan,2018-01-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
707736,protagonist therapeutics poised for upside stifel says,https://www.benzinga.com/analyst-ratings/analyst-color/18/01/11093084/protagonist-therapeutics-poised-for-upside-stifel-says,Elizabeth Balboa,2018-01-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
707737,pfe lly mrk write up scripts for q,https://www.benzinga.com/news/earnings/18/01/11094446/pfe-lly-mrk-write-up-scripts-for-q4,JJ Kinahan,2018-01-29 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.5
707738,why gw pharmas epidiolex results could shape the future of cannabisbased therapeutics,https://www.benzinga.com/analyst-ratings/analyst-color/18/01/11082287/why-gw-pharmas-epidiolex-results-could-shape-the-future,Javier Hasse,2018-01-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707739,jj no longer candidate for purchase of pfizers consumer unit glaxosmithkline reckitt benickser working with banks to make a bid,https://www.benzinga.com/news/18/01/11079437/j-j-no-longer-candidate-for-purchase-of-pfizers-consumer-unit-glaxosmithkline-re,Paul Quintaro,2018-01-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4742
707740,midafternoon market update crude oil up resmed shares rise on earnings beat,https://www.benzinga.com/news/18/01/11067895/mid-afternoon-market-update-crude-oil-up-1-4-resmed-shares-rise-on-earnings-beat,Lisa Levin,2018-01-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3194
707741,midday market update netflix climbs following q results insmed shares plummet,https://www.benzinga.com/news/18/01/11066835/mid-day-market-update-netflix-climbs-following-q4-results-insmed-shares-plummet,Lisa Levin,2018-01-23 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.648
707742,biotech ma off to a strong start in more deals to follow,https://www.benzinga.com/general/biotech/18/01/11064912/biotech-m-a-off-to-a-strong-start-in-2018-more-deals-to-follow,Zacks,2018-01-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7553000000000001
707743,jj shares unaffected amid word us appeals court invalidated co patent on remicade ruling prevents co from challenging pfizers launch of cheaper version of remicade,https://www.benzinga.com/news/18/01/11066285/j-j-shares-unaffected-amid-word-us-appeals-court-invalidated-co-patent-on-remica,Paul Quintaro,2018-01-23 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.81245
707744,midmorning market update markets mixed johnson johnson beats q views,https://www.benzinga.com/news/18/01/11066062/mid-morning-market-update-markets-mixed-johnson-johnson-beats-q4-views,Lisa Levin,2018-01-23 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
707745,johnson johnson shares down earlier co reported q beat announced fy guidance sees adj eps vs est sales bb vs b est,https://www.benzinga.com/news/guidance/18/01/11066055/johnson-johnson-shares-down-2-02-earlier-co-reported-q4-beat-announced-,Hal Lindon,2018-01-23 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.648
707746,johnson johnson on conf call says b of overseas cash will come back immediately,https://www.benzinga.com/news/18/01/11065837/johnson-johnson-on-conf-call-says-12b-of-overseas-cash-will-come-back-immediatel,Hal Lindon,2018-01-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707747,benzinga pros stocks to watch today,https://www.benzinga.com/news/18/01/11065598/benzinga-pros-5-stocks-to-watch-today,Jayson Derrick,2018-01-23 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707748,a peek into the markets us stock futures mostly higher ahead of earnings,https://www.benzinga.com/news/18/01/11064513/a-peek-into-the-markets-u-s-stock-futures-mostly-higher-ahead-of-earnings,Lisa Levin,2018-01-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707749,johnson johnson reports q adj eps vs est sales b vs b est,https://www.benzinga.com/news/earnings/18/01/11064314/johnson-johnson-reports-q4-adj-eps-1-74-vs-1-72-est-sales-20-20b-vs-20-,Paul Quintaro,2018-01-23 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707750,earnings scheduled for january ,https://www.benzinga.com/news/earnings/18/01/11063883/earnings-scheduled-for-january-23-2018,Lisa Levin,2018-01-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707751, stocks to watch for january ,https://www.benzinga.com/news/earnings/18/01/11063879/10-stocks-to-watch-for-january-23-2018,Lisa Levin,2018-01-23 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707752,a cure for the typical healthcare trade,https://www.benzinga.com/general/biotech/18/01/11005413/a-cure-for-the-typical-healthcare-trade,ETF Professor,2018-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707753,the week ahead ipos earnings and fda actions provide catalysts,https://www.benzinga.com/general/biotech/18/01/11061451/the-week-ahead-ipos-earnings-and-fda-actions-provide-catalysts,Taylor Cox,2018-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707754,earnings preview johnson johnson and procter gamble take the stage tomorrow morning,https://www.benzinga.com/news/earnings/18/01/11060630/earnings-preview-johnson-johnson-and-procter-gamble-take-the-stage-tomo,JJ Kinahan,2018-01-22 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707755,upcoming earnings verizon to report q results tomorrow morning,https://www.benzinga.com/news/earnings/18/01/11060248/upcoming-earnings-verizon-to-report-q4-results-tomorrow-morning,JJ Kinahan,2018-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707756,washington shutdown takes center stage but market impact only slight so far,https://www.benzinga.com/news/earnings/18/01/11059872/washington-shutdown-takes-center-stage-but-market-impact-only-slight-so,JJ Kinahan,2018-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707757,will johnson johnsons pharma segment pull up its q earnings,https://www.benzinga.com/general/biotech/18/01/11053061/will-johnson-johnsons-pharma-segment-pull-up-its-q4-earnings,Zacks,2018-01-19 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
707758,upcoming netflix earnings subscriber growth and price hikes in focus,https://www.benzinga.com/news/earnings/18/01/11053150/upcoming-netflix-earnings-subscriber-growth-and-price-hikes-in-focus,JJ Kinahan,2018-01-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
707759,intel johnson johnson ups fast money picks for january ,https://www.benzinga.com/media/cnbc/18/01/11044530/intel-johnson-johnson-ups-fast-money-picks-for-january-18,Craig Jones,2018-01-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707760,btg says previous guidance on zytiga royalties is unchanged despite us administrative court decision to invalidate patent reuters,https://www.benzinga.com/news/18/01/11044817/btg-says-previous-guidance-on-zytiga-royalties-is-unchanged-despite-u-s-administ,Charles Gross,2018-01-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707761,update jj says we believe the patent is valid and will continue to vigorously defend it,https://www.benzinga.com/news/18/01/11043560/update-j-j-says-we-believe-the-438-patent-is-valid-and-will-continue-to-vigorous,Paul Quintaro,2018-01-17 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.6806
707762,jj issues response following zytiga ipr strongly disagreeare evaluating our options with respect to a request for rehearing andor appeal,https://www.benzinga.com/news/legal/18/01/11043539/j-j-issues-response-following-zytiga-ipr-strongly-disagree-are-evaluating-,Paul Quintaro,2018-01-17 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.86755
707763,update traders attributing move lower in jj shares to news from indonesian source suggesting zytiga received a negative ipr decision,https://www.benzinga.com/news/18/01/11042019/update-traders-attributing-move-lower-in-j-j-shares-to-news-from-indonesian-sour,Paul Quintaro,2018-01-17 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.29905000000000004
707764,jj shares down over last min stock down for session,https://www.benzinga.com/movers/18/01/11042015/j-j-shares-down-2-over-last-min-stock-down-0-6-for-session,Paul Quintaro,2018-01-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.74695
707765,earnings preview ibm to report on thursday strategic imperatives in focus,https://www.benzinga.com/news/earnings/18/01/11041644/earnings-preview-ibm-to-report-on-thursday-strategic-imperatives-in-foc,JJ Kinahan,2018-01-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707766,chinese bidders looking at jnj diabetes business in deal that could be valued at b reuters,https://www.benzinga.com/news/18/01/11038363/chinese-bidders-looking-at-jnj-diabetes-business-in-deal-that-could-be-valued-at,Charles Gross,2018-01-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
707767,dow earnings analysts expect goldman sachs revenue decline,https://www.benzinga.com/analyst-ratings/analyst-color/18/01/11028632/dow-earnings-analysts-expect-goldman-sachs-revenue-decl,Nelson Hem,2018-01-16 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.5
707768,upcoming earnings bank of america goldman sachs and morgan stanley to report this week,https://www.benzinga.com/news/18/01/11034572/upcoming-earnings-bank-of-america-goldman-sachs-and-morgan-stanley-to-report-thi,JJ Kinahan,2018-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707769,putting on the brakes rally takes breather as bond yields hit month high,https://www.benzinga.com/news/18/01/11014489/putting-on-the-brakes-rally-takes-breather-as-bond-yields-hit-10-month-high,JJ Kinahan,2018-01-10 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707770, tailwinds driving raymond james insulet bull case,https://www.benzinga.com/analyst-ratings/analyst-color/18/01/11001540/4-tailwinds-driving-raymond-james-insulet-bull-case,Shanthi Rexaline,2018-01-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707771,the bomb cyclone portfolio winners and losers,https://www.benzinga.com/news/18/01/10994604/the-bomb-cyclone-portfolio-winners-and-losers,Elizabeth Balboa,2018-01-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.22885
707772,benzingas top upgrades downgrades for january ,https://www.benzinga.com/analyst-ratings/upgrades/18/01/10972481/benzingas-top-upgrades-downgrades-for-january-2-2018,Lisa Levin,2018-01-02 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
707773,the market in minutes oils strong open cohens comeback and a look back at s best and worst stocks,https://www.benzinga.com/news/18/01/10971815/the-market-in-5-minutes-oils-strong-open-cohens-comeback-and-a-look-back-at-2017,Benzinga Newsdesk,2018-01-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.76335
707774,syros announces clinical supply agreement with janssen to evaluate sy its firstinclass selective rarα agonist,https://www.benzinga.com/news/18/01/10972034/syros-announces-clinical-supply-agreement-with-janssen-to-evaluate-sy-1425-its-f,Paul Quintaro,2018-01-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707775,jp morgan downgrades johnson johnson to neutral,https://www.benzinga.com/news/18/01/10971457/jp-morgan-downgrades-johnson-johnson-to-neutral,Eddie Staley,2018-01-02 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.60115
707776,the companies that led s biotech rally,https://www.benzinga.com/general/biotech/17/12/10927494/the-companies-that-led-2017s-biotech-rally,Shanthi Rexaline,2017-12-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707777,vetr upgrades johnson johnson as the stock tests resistance,https://www.benzinga.com/analyst-ratings/upgrades/17/12/10948245/vetr-upgrades-johnson-johnson-as-the-stock-tests-resistance,Chris Dier-Scalise,2017-12-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707778,jjs janssen says jj reaffirmed fy adj eps outlook of vs est,https://www.benzinga.com/news/guidance/17/12/10948620/j-js-janssen-says-j-j-reaffirmed-fy17-adj-eps-outlook-of-7-25-7-30-vs-7,Paul Quintaro,2017-12-21 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.625
707779,jjs janssen reports global collaboration license deal with units of genscript will make upfront payment of m,https://www.benzinga.com/news/17/12/10948611/j-js-janssen-reports-global-collaboration-license-deal-with-units-of-genscript-w,Paul Quintaro,2017-12-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707780,earlier chicago tribune report detailed illinois counties suing drug cos over opioid abuses shares of cos mentioned seem largely unaffected teva abt jnj endp ,https://www.benzinga.com/general/biotech/17/12/10947028/earlier-chicago-tribune-report-detailed-5-illinois-counties-suing-dru,Hal Lindon,2017-12-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.22885
707781,fda grants priority review for johnson johnsons janssen nda for apalutamide pdufa target date april ,https://www.benzinga.com/general/biotech/17/12/10944775/fda-grants-priority-review-for-johnson-johnsons-janssen-nda-for-apalu,Hal Lindon,2017-12-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
707782, biotech pipeline areas to keep an eye on in ,https://www.benzinga.com/general/biotech/17/12/10939349/3-biotech-pipeline-areas-to-keep-an-eye-on-in-2018,Zacks,2017-12-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707783,ash highlights gilead novartis juno bluebird bio and more,https://www.benzinga.com/analyst-ratings/analyst-color/17/12/10909727/ash-2017-highlights-gilead-novartis-juno-bluebird-bio-a,Shanthi Rexaline,2017-12-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707784,a trendy new etf from pacer,https://www.benzinga.com/trading-ideas/long-ideas/17/12/10906161/a-trendy-new-etf-from-pacer,ETF Professor,2017-12-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707785, stocks in focus as biotech ma hopes for rise,https://www.benzinga.com/general/biotech/17/12/10897424/3-stocks-in-focus-as-biotech-m-a-hopes-for-2018-rise,Zacks,2017-12-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
707786,bayer johnson johnson reportedly ordered by philadelphia jury to pay m in xarelto lawsuit,https://www.benzinga.com/news/17/12/10873983/bayer-johnson-johnson-reportedly-ordered-by-philadelphia-jury-to-pay-29m-in-xare,Hal Lindon,2017-12-05 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.3409
707787,reminder tuesday is estimated fda pdufa date for johnson johnson for rilpivirine and in partnership with glaxosmithkline for dolutegravir and novo nordisk for semaglutide,https://www.benzinga.com/general/biotech/17/12/10868230/reminder-tuesday-is-estimated-fda-pdufa-date-for-johnson-johnson-for-,Hal Lindon,2017-12-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707788,eli lillys taltz gets approval for label expansion in us,https://www.benzinga.com/general/biotech/17/12/10866077/eli-lillys-taltz-gets-approval-for-label-expansion-in-us,Zacks,2017-12-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707789,the week ahead for december the biggest catalysts conferences and investor events,https://www.benzinga.com/news/17/12/10866623/the-week-ahead-for-december-4-the-biggest-catalysts-conferences-and-investor-eve,Taylor Cox,2017-12-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707790,glaxosmithkline begins phase iii study on injection to prevent hiv,https://www.benzinga.com/general/biotech/17/12/10858495/glaxosmithkline-begins-phase-iii-study-on-injection-to-prevent-hiv,Zacks,2017-12-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5129
707791,missouri judge upholds million talc verdict awarded to virgina women who claims decades of daily use of johnson johnsons talcum powder caused her ovarian cancer jurisdiction established by new evidence in ovarian cancer claim,https://www.benzinga.com/news/17/11/10853463/missouri-judge-upholds-110-million-talc-verdict-awarded-to-virgina-women-who-cla,Eddie Staley,2017-11-30 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.12104999999999999
707792,a lazarus act for this pharma etf,https://www.benzinga.com/trading-ideas/long-ideas/17/11/10794742/a-lazarus-act-for-this-pharma-etf,ETF Professor,2017-11-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707793,endpoint news cofounder john carroll tweets jj spokesperson says telegraph story about axing jlabs in uk is completely unfounded asking for a retraction jnj,https://www.benzinga.com/news/17/11/10839616/endpoint-news-co-founder-john-carroll-tweets-j-j-spokesperson-says-telegraph-sto,Eddie Staley,2017-11-28 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
707794,stocks going ex dividend the fifth week of november,https://www.benzinga.com/news/17/11/10822302/stocks-going-ex-dividend-the-fifth-week-of-november,Fred Fuld,2017-11-22 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707795,jjs janssen submits fda application for expansion of indication for darzalex combo therapy for patients with newlydiagnosed multiple myeloma who are transplant ineligible,https://www.benzinga.com/news/fda/17/11/10818384/j-js-janssen-submits-fda-application-for-expansion-of-indication-for-darzale,Paul Quintaro,2017-11-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707796,johnson johnsons janssen gets european commission approval to broaden marketing authorization for zytiga,https://www.benzinga.com/news/17/11/10810481/johnson-johnsons-janssen-gets-european-commission-approval-to-broaden-marketing-,Hal Lindon,2017-11-20 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7383500000000001
707797,pr confirms earlier johnson johnson legal headline federal jury returns million verdict in defective hip implants case depuy orthopaedics found liable for metalonmetal implant failures,https://www.benzinga.com/news/legal/17/11/10799735/pr-confirms-earlier-johnson-johnson-legal-headline-federal-jury-returns-24,Eddie Staley,2017-11-16 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.20705
707798,johnson johnson wins trial in lawsuit claiming asbestos in talc products caused cancer,https://www.benzinga.com/news/legal/17/11/10799265/johnson-johnson-wins-trial-in-lawsuit-claiming-asbestos-in-talc-products-c,Eddie Staley,2017-11-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.30910000000000004
707799,watching jj shares amid report jury has returned m verdict against co unit depuy related to defective hip implant suit,https://www.benzinga.com/news/17/11/10799074/watching-j-j-shares-amid-report-jury-has-returned-247m-verdict-against-co-unit-d,Paul Quintaro,2017-11-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.61315
707800,pharma etfs down post q earnings,https://www.benzinga.com/general/biotech/17/11/10757139/pharma-etfs-down-post-q3-earnings,Zacks,2017-11-09 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707801,jjs janssen rd reports stelara showed positive results in treatment of systemic lupus erythematosus in phase trial,https://www.benzinga.com/news/fda/17/11/10727934/j-js-janssen-r-d-reports-stelara-showed-positive-results-in-treatment-of-sys,Paul Quintaro,2017-11-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707802,a dividend etf for november and beyond,https://www.benzinga.com/analyst-ratings/analyst-color/17/11/10269576/a-dividend-etf-for-november-and-beyond,ETF Professor,2017-11-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707803,update halozyme will receive m milestone payment from jjs janssen following dosing of rd patient in phase trial,https://www.benzinga.com/news/fda/17/10/10254998/update-halozyme-will-receive-15m-milestone-payment-from-j-js-janssen-followi,Paul Quintaro,2017-10-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707804,how surgeons are responding to transenterixs senhance following fda approval,https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10247774/how-surgeons-are-responding-to-transenterixs-senhance-f,Elizabeth Balboa,2017-10-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
707805,johnson johnsons janssen gets fda approval for the mg dose of xarelto,https://www.benzinga.com/news/17/10/10247019/johnson-johnsons-janssen-gets-fda-approval-for-the-10mg-dose-of-xarelto,Paul Quintaro,2017-10-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707806,janssen reports imbruvica as first approved treatment for chronic graftversushost disease granted by health canada priority review,https://www.benzinga.com/news/fda/17/10/10246705/janssen-reports-imbruvica-as-first-approved-treatment-for-chronic-graft-vers,Paul Quintaro,2017-10-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.79295
707807,reminder johnson johnson has pdufa date expected for xarelto oct ,https://www.benzinga.com/general/biotech/17/10/10244490/reminder-johnson-johnson-has-pdufa-date-expected-for-xarelto-oct-28,Hal Lindon,2017-10-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707808,vetr upgrades johnson johnson following postearnings dip,https://www.benzinga.com/analyst-ratings/upgrades/17/10/10228516/vetr-upgrades-johnson-johnson-following-post-earnings-dip,Chris Dier-Scalise,2017-10-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707809,jjs janssen reports darunavirbased single tablet regimen showed effective viral suppression in hiv patients,https://www.benzinga.com/news/fda/17/10/10223447/j-js-janssen-reports-darunavir-based-single-tablet-regimen-showed-effective-,Paul Quintaro,2017-10-25 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7383500000000001
707810,this weeks most and least crowded trades,https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10216619/this-weeks-most-and-least-crowded-trades,Shanthi Rexaline,2017-10-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707811, biggest price target changes for monday,https://www.benzinga.com/analyst-ratings/price-target/17/10/10211136/5-biggest-price-target-changes-for-monday,Lisa Levin,2017-10-23 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707812,the week ahead earnings season starts in earnest,https://www.benzinga.com/news/17/10/10210048/the-week-ahead-earnings-season-starts-in-earnest,Brent Slava,2017-10-23 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.7553000000000001
707813,this factor etf could be ready to shine,https://www.benzinga.com/trading-ideas/long-ideas/17/10/10208783/this-factor-etf-could-be-ready-to-shine,ETF Professor,2017-10-23 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.6806
707814,jjs janssen reports received fda approvals for simponi aria for treatment of adults with active psoriatic arthritis active ankylosing spondyilitis,https://www.benzinga.com/news/fda/17/10/10207609/j-js-janssen-reports-received-2-fda-approvals-for-simponi-aria-for-treatment,Paul Quintaro,2017-10-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.82985
707815,white house shenanigans represent a buying opportunity cramer,https://www.benzinga.com/media/cnbc/17/10/10198951/white-house-shenanigans-represent-a-buying-opportunity-cramer,Jayson Derrick,2017-10-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
707816,johnson johnson to acquire software company surgical process institute terms not disclosed,https://www.benzinga.com/news/m-a/17/10/10197867/johnson-johnson-to-acquire-software-company-surgical-process-institute-terms,Paul Quintaro,2017-10-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707817,benzingas option alert recap from october ,https://www.benzinga.com/news/17/10/10196539/benzingas-option-alert-recap-from-october-18,Javier Hasse,2017-10-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
707818,cramer breaks down cheap stocks that crushed earnings,https://www.benzinga.com/news/earnings/17/10/10194039/cramer-breaks-down-3-cheap-stocks-that-crushed-earnings,Jayson Derrick,2017-10-18 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.28925
707819, biggest price target changes for wednesday,https://www.benzinga.com/analyst-ratings/price-target/17/10/10193763/5-biggest-price-target-changes-for-wednesday,Lisa Levin,2017-10-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707820,jj option alert jan puts sweep at the bid vs oi ref,https://www.benzinga.com/markets/options/17/10/10193756/j-j-option-alert-jan-2019-140-puts-sweep-27-at-the-bid-658-9-504-vs-3,Charles Gross,2017-10-18 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.74695
707821,premarket imbalance update ibm k shares to buy alibaba k to buy cocacola k to sell twitter k to sell square k to buy att k to buy pfizer k to sell ford k to sell jj k to sell,https://www.benzinga.com/news/17/10/10193189/pre-market-imbalance-update-ibm-219k-shares-to-buy-alibaba-133k-to-buy-coca-cola,Paul Quintaro,2017-10-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
707822,johnson johnson makes new alltime high by a wide margin,https://www.benzinga.com/trading-ideas/technicals/17/10/10187961/johnson-johnson-makes-new-all-time-high-by-a-wide-margin,Joel Elconin,2017-10-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707823,hearing court papers show missouri appeals court has overturned m verdict against jj related to talc case,https://www.benzinga.com/news/17/10/10187437/hearing-court-papers-show-missouri-appeals-court-has-overturned-72m-verdict-agai,Paul Quintaro,2017-10-17 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.6909
707824,can the dow pass another milestone financials feed frenzy but might it be enough,https://www.benzinga.com/news/earnings/17/10/10186876/can-the-dow-pass-another-milestone-financials-feed-frenzy-but-might-it-,JJ Kinahan,2017-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.41725
707825,a peek into the markets us stock futures flat goldman sachs earnings in focus,https://www.benzinga.com/news/17/10/10185057/a-peek-into-the-markets-u-s-stock-futures-flat-goldman-sachs-earnings-in-focus,Lisa Levin,2017-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707826,johnson johnson discontinues its study of talacotuzumab in patients with acute myeloid leukemia,https://www.benzinga.com/news/17/10/10184835/johnson-johnson-discontinues-its-study-of-talacotuzumab-in-patients-with-acute-m,Paul Quintaro,2017-10-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707827,johnson johnson says it will not pursue approvals of sirukumab for rheumatoid arhritis,https://www.benzinga.com/news/17/10/10184823/johnson-johnson-says-it-will-not-pursue-approvals-of-sirukumab-for-rheumatoid-ar,Paul Quintaro,2017-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707828,johnson johnson sees fy eps from sales bb from bb,https://www.benzinga.com/news/guidance/17/10/10184820/johnson-johnson-sees-fy-2017-eps-7-25-7-30-from-7-12-7-22-sales-76-1b-7,Paul Quintaro,2017-10-17 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707829,johnson johnson raises guidance,https://www.benzinga.com/news/guidance/17/10/10184812/johnson-johnson-raises-guidance,Paul Quintaro,2017-10-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707830,johnson johnson q eps vs est sales b vs b est,https://www.benzinga.com/news/earnings/17/10/10184811/johnson-johnson-q3-eps-1-90-vs-1-80-est-sales-19-7b-vs-19-3m-est,Paul Quintaro,2017-10-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707831, stocks to watch for october ,https://www.benzinga.com/news/earnings/17/10/10184487/10-stocks-to-watch-for-october-17-2017,Lisa Levin,2017-10-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707832,earnings scheduled for october ,https://www.benzinga.com/news/earnings/17/10/10184445/earnings-scheduled-for-october-17-2017,Lisa Levin,2017-10-17 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707833, mostleast crowded trades of week ended oct ,https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10182611/10-mostleast-crowded-trades-of-week-ended-oct-13,Shanthi Rexaline,2017-10-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707834,cerveau technologies reports research collaboration with janssen pharmaceuticals for use of fmk,https://www.benzinga.com/news/contracts/17/10/10182843/cerveau-technologies-reports-research-collaboration-with-janssen-pharm,Paul Quintaro,2017-10-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707835,the week ahead earnings earnings and more earnings,https://www.benzinga.com/news/17/10/10180071/the-week-ahead-earnings-earnings-and-more-earnings,Taylor Cox,2017-10-16 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.5
707836, biggest price target changes for monday,https://www.benzinga.com/analyst-ratings/price-target/17/10/10181382/5-biggest-price-target-changes-for-monday,Lisa Levin,2017-10-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707837,pharma stock roundup pfizer mulls options for consumer healthcare eli lillys pipeline setback,https://www.benzinga.com/general/biotech/17/10/10175753/pharma-stock-roundup-pfizer-mulls-options-for-consumer-healthcare-eli,Zacks,2017-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707838,reminder johnson johnson has pdufa date for stelara over the weekend oct th,https://www.benzinga.com/general/biotech/17/10/10176811/reminder-johnson-johnson-has-pdufa-date-for-stelara-over-the-weekend-,Hal Lindon,2017-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707839,jnj and ibm report q earnings early next week what might be in store,https://www.benzinga.com/news/earnings/17/10/10176675/jnj-and-ibm-report-q3-earnings-early-next-week-what-might-be-in-store,JJ Kinahan,2017-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707840,janssencilag intl chmp issues positive opinion on zytiga to include earlier stage prostate patients,https://www.benzinga.com/news/17/10/10175471/janssen-cilag-intl-chmp-issues-positive-opinion-on-zytiga-to-include-earlier-sta,Paul Quintaro,2017-10-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
707841,premarket imbalance update verizon k shares to sell jj k to sell,https://www.benzinga.com/news/17/10/10171090/pre-market-imbalance-update-verizon-60k-shares-to-sell-j-j-42k-to-sell,Paul Quintaro,2017-10-12 00:00:00,JNJ,1,2,0,1,0,0,1,1,0,0.74695
707842, of the most crowded trades and of the least crowded,https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10165815/10-of-the-most-crowded-trades-and-10-of-the-least-crowd,Shanthi Rexaline,2017-10-11 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707843,why jefferies upgraded johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10167854/why-jefferies-upgraded-johnson-johnson,Craig Jones,2017-10-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707844,jjs janssen earlier reported submission of nda for arn to treat men with nonmetastatic castrationresistant prostate cancer,https://www.benzinga.com/news/17/10/10165605/j-js-janssen-earlier-reported-submission-of-nda-for-arn-509-to-treat-men-with-no,Paul Quintaro,2017-10-11 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.29905000000000004
707845,benzingas top upgrades downgrades for october ,https://www.benzinga.com/analyst-ratings/upgrades/17/10/10165603/benzingas-top-upgrades-downgrades-for-october-11-2017,Lisa Levin,2017-10-11 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
707846,the market in minutes alibabas expansion ubers warning,https://www.benzinga.com/news/17/10/10165127/the-market-in-5-minutes-alibabas-expansion-ubers-warning,Benzinga News Desk,2017-10-11 00:00:00,JNJ,1,0,0,1,0,0,0,0,1,0.32999999999999996
707847,a peek into the markets us stock futures edge lower ahead of fed minutes,https://www.benzinga.com/news/17/10/10164730/a-peek-into-the-markets-u-s-stock-futures-edge-lower-ahead-of-fed-minutes,Lisa Levin,2017-10-11 00:00:00,JNJ,0,1,0,1,1,0,0,0,0,0.352
707848,jefferies upgrades johnson johnson to buy,https://www.benzinga.com/news/17/10/10164460/jefferies-upgrades-johnson-johnson-to-buy,Paul Quintaro,2017-10-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707849,jefferies upgrades jj to buy from hold raises pt to from ,https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10164204/jefferies-upgrades-j-j-to-buy-from-hold-raises-pt-to-15,Charles Gross,2017-10-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707850,benzingas top upgrades downgrades for october ,https://www.benzinga.com/analyst-ratings/upgrades/17/10/10155372/benzingas-top-upgrades-downgrades-for-october-9-2017,Lisa Levin,2017-10-09 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
707851,wells fargo upgrades johnson johnson to outperform,https://www.benzinga.com/news/17/10/10155110/wells-fargo-upgrades-johnson-johnson-to-outperform,Paul Quintaro,2017-10-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
707852,heaps of healthy health care etfs,https://www.benzinga.com/general/biotech/17/10/10093347/heaps-of-healthy-health-care-etfs,ETF Professor,2017-10-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.8548
707853,jj diabetes care cos animas announces intention to discontinue manufacturing sale of vibe onetouch ping insulin pumps close operations exit insulin pump business,https://www.benzinga.com/news/17/10/10144238/j-j-diabetes-care-cos-animas-announces-intention-to-discontinue-manufacturing-sa,Paul Quintaro,2017-10-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.81845
707854,morgan stanley catches flack for colgatepalmolive upgrade,https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10125511/morgan-stanley-catches-flack-for-colgate-palmolive-upgr,Shanthi Rexaline,2017-10-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707855,jjs janssen reports submission of snda seeking new indication for invokana to reduce risk of major adverse cardiovascular events based on landmark canvas program,https://www.benzinga.com/news/fda/17/10/10124552/j-js-janssen-reports-submission-of-snda-seeking-new-indication-for-invokana-,Paul Quintaro,2017-10-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.24469999999999997
707856,janssen submits snda to fda seeking new indication for invokana to reduce risk of major adverse cardiovascular events based on landmark canvas programs,https://www.benzinga.com/news/fda/17/10/10124541/janssen-submits-snda-to-fda-seeking-new-indication-for-invokana-to-reduce-ri,Paul Quintaro,2017-10-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.24469999999999997
707857,attention biotech investors heres your pdufa primer for october,https://www.benzinga.com/general/biotech/17/09/10102546/attention-biotech-investors-heres-your-pdufa-primer-for-october,Shanthi Rexaline,2017-09-28 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
707858,ai summit in san francisco concludes today attendees include morgan stanley johnson johnson bank of america ibm nvidia microsoft amazon and footlocker,https://www.benzinga.com/news/17/09/10113098/a-i-summit-in-san-francisco-concludes-today-attendees-include-morgan-stanley-joh,Hal Lindon,2017-09-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.58895
707859,jim cramer weighs in on johnson johnson ford and more,https://www.benzinga.com/media/cnbc/17/09/10111588/jim-cramer-weighs-in-on-johnson-johnson-ford-and-more,Craig Jones,2017-09-28 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707860,ftc says it requires divestiture of medical device product lines as condition of integra acquiring johnson johnsons codman neuro division,https://www.benzinga.com/news/17/09/10108116/ftc-says-it-requires-divestiture-of-5-medical-device-product-lines-as-condition-,Paul Quintaro,2017-09-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707861,bloomberg earlier reported apple samsung roche holding will participate in fda pilot program for digital health software,https://www.benzinga.com/news/17/09/10103526/bloomberg-earlier-reported-apple-samsung-roche-holding-will-participate-in-fda-p,Hal Lindon,2017-09-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707862,cramers guide to profit from market rotations,https://www.benzinga.com/analyst-ratings/analyst-color/17/09/10069482/cramers-guide-to-profit-from-market-rotations,Jayson Derrick,2017-09-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
707863,a venerable vanguard dividend etf,https://www.benzinga.com/trading-ideas/long-ideas/17/09/10083632/a-venerable-vanguard-dividend-etf,ETF Professor,2017-09-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707864,johnson johnson downgraded on hefty valuation compared to peers,https://www.benzinga.com/analyst-ratings/analyst-color/17/09/10080961/johnson-johnson-downgraded-on-hefty-valuation-compared-,Jayson Derrick,2017-09-20 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
707865,goldman sachs downgrades johnson johnson to sell,https://www.benzinga.com/news/17/09/10079867/goldman-sachs-downgrades-johnson-johnson-to-sell,Paul Quintaro,2017-09-20 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
707866,johnson johnson shares down premarket,https://www.benzinga.com/movers/17/09/10079653/johnson-johnson-shares-down-1-64-premarket,Paul Quintaro,2017-09-20 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.648
707867,update ny ag schneiderman served subpoenas to endo intl jjs janssen pharma teva allergan,https://www.benzinga.com/news/17/09/10075681/update-ny-ag-schneiderman-served-subpoenas-to-endo-intl-j-js-janssen-pharma-teva,Paul Quintaro,2017-09-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707868,janssens guselkumab drug for the treatment of plaque psoriasis recommended by the eu medicines agency for approval,https://www.benzinga.com/news/17/09/10062106/janssens-guselkumab-drug-for-the-treatment-of-plaque-psoriasis-recommended-by-th,Paul Quintaro,2017-09-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7997000000000001
707869,johnson johnsons janssen announces submission of snda to fda for zytiga,https://www.benzinga.com/general/biotech/17/09/10059933/johnson-johnsons-janssen-announces-submission-of-snda-to-fda-for-zyti,Hal Lindon,2017-09-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707870,a hidden gem among dividend etfs,https://www.benzinga.com/trading-ideas/long-ideas/17/09/10042516/a-hidden-gem-among-dividend-etfs,ETF Professor,2017-09-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707871,wall streets ma chatter from september western digitaltoshiba pilgrims pridemoy park gigamon and more,https://www.benzinga.com/news/17/09/10044022/wall-streets-m-a-chatter-from-september-11-western-digital-toshiba-pilgrims-prid,Charles Gross,2017-09-12 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707872,your easy guide to credit suisses new top stocks list,https://www.benzinga.com/analyst-ratings/analyst-color/17/09/10033590/your-easy-guide-to-credit-suisses-new-top-stocks-list,Wayne Duggan,2017-09-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8714999999999999
707873,janssen terminates worldwide collaboration for hepatitis c with achillion pharmaceuticals,https://www.benzinga.com/news/17/09/10037692/janssen-terminates-worldwide-collaboration-for-hepatitis-c-with-achillion-pharma,Charles Gross,2017-09-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707874,what pharmaceuticals spend on lobbying to influence trump,https://www.benzinga.com/general/biotech/17/09/10008324/what-pharmaceuticals-spend-on-lobbying-to-influence-trump,Elizabeth Balboa,2017-09-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4614
707875,new mexico said to be suing johnson johnson endo teva allergan others over their role in opioid drug epidemic,https://www.benzinga.com/news/legal/17/09/10029519/new-mexico-said-to-be-suing-johnson-johnson-endo-teva-allergan-others-over,Hal Lindon,2017-09-07 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.3634
707876,this drug an alternative to marijuana and ketamine could treat suicidal depression and ptsd,https://www.benzinga.com/general/biotech/17/09/10008568/this-drug-an-alternative-to-marijuana-and-ketamine-could-treat-suicid,Javier Hasse,2017-09-07 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.12104999999999999
707877,attention biotech investors september ushers in another slew of pdufa catalysts,https://www.benzinga.com/general/biotech/17/09/9991436/attention-biotech-investors-september-ushers-in-another-slew-of-pdufa-,Shanthi Rexaline,2017-09-01 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707878,macrogenics reports termination of duvortuxizumab collab license deal with jjs janssen,https://www.benzinga.com/news/17/08/10004522/macrogenics-reports-termination-of-duvortuxizumab-collab-license-deal-with-j-js-,Paul Quintaro,2017-08-31 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707879,johnson johnson management meetings leave ubs reiterating stock as a top pick,https://www.benzinga.com/analyst-ratings/analyst-color/17/08/10002313/johnson-johnson-management-meetings-leave-ubs-reiterati,Brett Hershman,2017-08-31 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.57655
707880,protagonist therapeutics announces receipt of m upfront payment from jnjs jansse license deal for ptg,https://www.benzinga.com/general/biotech/17/08/9973889/protagonist-therapeutics-announces-receipt-of-50m-upfront-payment-from,Hal Lindon,2017-08-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707881,playing the us pharma space buy portola hold corvus sell teva,https://www.benzinga.com/analyst-ratings/analyst-color/17/08/9972796/playing-the-us-pharma-space-buy-portola-hold-corvus-sell,Shanthi Rexaline,2017-08-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
707882,explaining a crowded trade and the top cramped plays right now,https://www.benzinga.com/analyst-ratings/analyst-color/17/08/9962244/explaining-a-crowded-trade-and-the-top-10-cramped-plays-,Jayson Derrick,2017-08-23 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.71075
707883,premarket imbalance update sprint k shares to buy square k to buy ge k to buy snap k to buy cocacola k shares to sell alibaba k to buy jj k to sell,https://www.benzinga.com/news/17/08/9960192/pre-market-imbalance-update-sprint-223k-shares-to-buy-square-139k-to-buy-ge-90k-t,Paul Quintaro,2017-08-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.82985
707884,jury awards woman million on allegation johnson johnson talcum powder gave her cancer,https://www.benzinga.com/general/biotech/17/08/9959966/jury-awards-woman-417-million-on-allegation-johnson-johnson-talcum-pow,Mark Fritz,2017-08-22 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.32999999999999996
707885,premarket prep host dennis dick tweets notable opening imbalances snap k ge k pfe k jnj k baba k,https://www.benzinga.com/news/17/08/9955258/premarket-prep-host-dennis-dick-tweets-notable-opening-imbalances-snap-354k-ge-26,Paul Quintaro,2017-08-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.24469999999999997
707886,meg tirrell tweets jnj says presidents more recent comments changed our decision to participate in the white house manufacturing advisory council,https://www.benzinga.com/news/17/08/9940534/meg-tirrell-tweets-jnj-says-presidents-more-recent-comments-changed-our-decision-,Paul Quintaro,2017-08-16 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707887,genmab ceo says its moving forward aggressively together with janssen on subcutaneous formulation of daratumumab,https://www.benzinga.com/news/17/08/9903497/genmab-ceo-says-its-moving-forward-aggressively-together-with-janssen-on-subcutan,Paul Quintaro,2017-08-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3409
707888,every generation has its drug how people are dealing with opioids the new old thing,https://www.benzinga.com/general/biotech/17/08/9884817/every-generation-has-its-drug-how-people-are-dealing-with-opioids-the-,Mark Fritz,2017-08-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707889,wall streets ma chatter from august acadia pharma united technologiesrockwell collins united therapeutics,https://www.benzinga.com/news/17/08/9886011/wall-streets-m-a-chatter-from-august-4-7-acadia-pharma-united-technologies-rockwe,Charles Gross,2017-08-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8404
707890,hearing fda panel has said safety profile of jjs sirukumab not adequate to support approval,https://www.benzinga.com/news/17/08/9865640/hearing-fda-panel-has-said-safety-profile-of-j-js-sirukumab-not-adequate-to-suppo,Paul Quintaro,2017-08-02 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.72725
707891,key fda events to watch out for in august ,https://www.benzinga.com/general/biotech/17/08/9854177/key-fda-events-to-watch-out-for-in-august-2017,Zacks,2017-08-01 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
707892,august pdufa dates biotech investors stay tuned to a month of plenty,https://www.benzinga.com/general/biotech/17/08/9824945/august-pdufa-dates-biotech-investors-stay-tuned-to-a-month-of-plenty,Shanthi Rexaline,2017-08-01 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707893,johnson johnson granted orphan drug desiganation for bedaquiline,https://www.benzinga.com/news/17/07/9846900/johnson-johnson-granted-orphan-drug-desiganation-for-bedaquiline,Paul Quintaro,2017-07-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
707894,on wisconsin university wins half billion in iphone patent suit another sign schools are research cash cows,https://www.benzinga.com/general/biotech/17/07/9832748/on-wisconsin-university-wins-half-billion-in-iphone-patent-suit-anothe,Mark Fritz,2017-07-27 00:00:00,JNJ,1,0,0,0,1,0,1,0,1,0.7859499999999999
707895,samsung amazon everyone is getting into pharmaceuticals,https://www.benzinga.com/general/biotech/17/07/9827012/samsung-amazon-everyone-is-getting-into-pharmaceuticals,Elizabeth Balboa,2017-07-27 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.58895
707896,wall streets ma chatter from july biomarin sigma designs colgatepalmolive markelstate national,https://www.benzinga.com/news/17/07/9830627/wall-streets-m-a-chatter-from-july-26-biomarin-sigma-designs-colgate-palmolive-ma,Charles Gross,2017-07-27 00:00:00,JNJ,1,2,1,1,1,0,1,0,1,0.5
707897,meet avicanna the first marijuana company to be accepted into johnson johnson innovation jlabs toronto,https://www.benzinga.com/general/biotech/17/07/9811029/meet-avicanna-the-first-marijuana-company-to-be-accepted-into-johnson-,Javier Hasse,2017-07-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
707898, benefits etf investing may add to your portfolio,https://www.benzinga.com/etfs/broad-u-s-equity-etfs/17/07/9818004/4-benefits-etf-investing-may-add-to-your-portfolio,Spencer Israel,2017-07-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707899, ways to trade this weeks healthcare earnings,https://www.benzinga.com/news/earnings/17/07/9776865/2-ways-to-trade-this-weeks-healthcare-earnings,ETF Professor,2017-07-24 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.5
707900,jnj announces encouraging firstinhuman clinical data for investigational hiv preventive vaccine,https://www.benzinga.com/news/17/07/9809482/jnj-announces-encouraging-first-in-human-clinical-data-for-investigational-hiv-pr,Charles Gross,2017-07-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.76335
707901, months in trump has filled only out of more than envoy posts mostly with cronies,https://www.benzinga.com/news/17/07/9801201/6-months-in-trump-has-filled-only-27-out-of-more-the-200-envoy-posts-mostly-with-,Mark Fritz,2017-07-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707902,dow earnings score card from the past week ibm visa goldman and more,https://www.benzinga.com/news/earnings/17/07/9804019/dow-30-earnings-score-card-from-the-past-week-ibm-visa-goldman-and-more,Shanthi Rexaline,2017-07-22 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707903,johnson johnson shares might break lower before they break out,https://www.benzinga.com/analyst-ratings/analyst-color/17/07/9805436/johnson-johnson-shares-might-break-lower-before-they-bre,Ezra Schwarzbaum,2017-07-21 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.5
707904,atlantic equities downgrades johnson johnson to underweight,https://www.benzinga.com/news/17/07/9805101/atlantic-equities-downgrades-johnson-johnson-to-underweight,Paul Quintaro,2017-07-21 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707905,btig research downgrades johnson johnson to sell,https://www.benzinga.com/news/17/07/9804899/btig-research-downgrades-johnson-johnson-to-sell,Paul Quintaro,2017-07-21 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707906,johnson johnson shares strong since actelion acquisition but potential for upside remains,https://www.benzinga.com/analyst-ratings/analyst-color/17/07/9800730/johnson-johnson-shares-strong-since-actelion-acquisition,Wayne Duggan,2017-07-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7059
707907,the market in minutes,https://www.benzinga.com/news/17/07/9799754/the-market-in-5-minutes,Benzinga News Desk,2017-07-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707908,credit suisse reinstates outperform on johnson johnson announces price target,https://www.benzinga.com/news/17/07/9799047/credit-suisse-reinstates-outperform-on-johnson-johnson-announces-148-00-price-tar,Paul Quintaro,2017-07-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707909,caution still the watchword but stocks hit record highs as earnings mostly strong,https://www.benzinga.com/news/earnings/17/07/9794199/caution-still-the-watchword-but-stocks-hit-record-highs-as-earnings-most,JJ Kinahan,2017-07-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8326
707910,finding a way banks beat expectations despite struggles as earnings go into high gear,https://www.benzinga.com/news/earnings/17/07/9789100/finding-a-way-banks-beat-expectations-despite-struggles-as-earnings-go-i,JJ Kinahan,2017-07-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.63775
707911,a peek into the markets us stock futures mostly flat ahead of goldman sachs earnings,https://www.benzinga.com/news/earnings/17/07/9787411/a-peek-into-the-markets-u-s-stock-futures-mostly-flat-ahead-of-goldman-s,Lisa Levin,2017-07-18 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
707912,johnson johnson sees fy eps from vs est see sales bb from bb vs b est,https://www.benzinga.com/news/guidance/17/07/9787227/johnson-johnson-sees-fy-2017-eps-7-12-7-22-from-7-00-7-15-vs-7-10-est-se,Paul Quintaro,2017-07-18 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707913,johnson johnson raises fy guidance,https://www.benzinga.com/news/guidance/17/07/9787223/johnson-johnson-raises-fy-2017-guidance,Paul Quintaro,2017-07-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707914,johnson johnson q eps vs est sales b vs b est,https://www.benzinga.com/news/earnings/17/07/9787222/johnson-johnson-q2-eps-1-83-vs-1-80-est-sales-18-84b-vs-18-95b-est,Paul Quintaro,2017-07-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707915, stocks to watch for july ,https://www.benzinga.com/news/earnings/17/07/9786890/10-stocks-to-watch-for-july-18-2017,Lisa Levin,2017-07-18 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707916,earnings scheduled for july ,https://www.benzinga.com/news/earnings/17/07/9786832/earnings-scheduled-for-july-18-2017,Lisa Levin,2017-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707917,earnings roundup jnj ibm and lmt report q results tomorrow,https://www.benzinga.com/news/earnings/17/07/9784975/earnings-roundup-jnj-ibm-and-lmt-report-q2-results-tomorrow,JJ Kinahan,2017-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707918,earnings preview financial giants bac gs and ms report q results this week,https://www.benzinga.com/news/earnings/17/07/9784835/earnings-preview-financial-giants-bac-gs-and-ms-report-q2-results-this-w,JJ Kinahan,2017-07-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707919, sellranked drug stocks to avoid ahead of q earnings,https://www.benzinga.com/general/biotech/17/07/9783420/4-sell-ranked-drug-stocks-to-avoid-ahead-of-q2-earnings,Zacks,2017-07-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.352
707920,fdas day extension for medical device defects not likely obstructive to public health,https://www.benzinga.com/news/17/07/9774919/fdas-60-day-extension-for-medical-device-defects-not-likely-obstructive-to-public,Elizabeth Balboa,2017-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.29905000000000004
707921,jj announces fda approval for janssens plaque psoriasis treatment tremfya,https://www.benzinga.com/news/fda/17/07/9775755/j-j-announces-fda-approval-for-janssens-plaque-psoriasis-treatment-tremfya,Paul Quintaro,2017-07-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.81245
707922,jj to commence pharma q earnings season whats up,https://www.benzinga.com/general/biotech/17/07/9768254/j-j-to-commence-pharma-q2-earnings-season-whats-up,Zacks,2017-07-12 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.625
707923,the royaltyamassing strategy of royalty pharma,https://www.benzinga.com/general/biotech/17/07/9757779/the-royalty-amassing-strategy-of-royalty-pharma,Elizabeth Balboa,2017-07-10 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
707924,the japanese governments pension fund made a cool billion last year,https://www.benzinga.com/news/17/07/9752972/the-japanese-governments-pension-fund-made-a-cool-70-billion-last-year,Jayson Derrick,2017-07-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
707925,focusing on an alternative to sp etfs,https://www.benzinga.com/analyst-ratings/analyst-color/17/07/9742463/focusing-on-an-alternative-to-s-p-500-etfs,ETF Professor,2017-07-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707926,premarket imbalance update sprint k shares to buy ge k shares to sell twitter k to sell cocacola k to sell pg k to buy citi k to buy bofa k to buy wells fargo k to buy jj k to sell,https://www.benzinga.com/news/17/07/9745473/pre-market-imbalance-update-sprint-84k-shares-to-buy-ge-80k-shares-to-sell-twitte,Paul Quintaro,2017-07-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8753
707927, biggest price target changes for wednesday,https://www.benzinga.com/analyst-ratings/price-target/17/07/9739342/5-biggest-price-target-changes-for-wednesday,Lisa Levin,2017-07-05 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707928,how to interpret big oils support for a carbon tax,https://www.benzinga.com/17/06/9665256/how-to-interpret-big-oils-support-for-a-carbon-tax,Zacks,2017-06-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
707929,janssen says fda accepted for priority review a snda for xarelto,https://www.benzinga.com/news/fda/17/06/9663802/janssen-says-fda-accepted-for-priority-review-a-snda-for-xarelto,Paul Quintaro,2017-06-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6366
707930,attention to details neos adhd portfolio,https://www.benzinga.com/general/biotech/17/06/9634178/attention-to-details-neos-adhd-portfolio,Shanthi Rexaline,2017-06-26 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707931,a new etf for low vol etfs,https://www.benzinga.com/trading-ideas/long-ideas/17/06/9645222/a-new-etf-for-low-vol-etfs,ETF Professor,2017-06-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.3634
707932,benzinga pmp host dennis dick tweets a few large imbalances this morning ge k jnj k f k bac k wfc k jpm k,https://www.benzinga.com/news/17/06/9646678/benzinga-pmp-host-dennis-dick-tweets-a-few-large-imbalances-this-morning-ge-825k-,Paul Quintaro,2017-06-23 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.24469999999999997
707933,dow stock roundup boeing bags big orders at paris air show walmart to buy bonobos,https://www.benzinga.com/17/06/9647209/dow-30-stock-roundup-boeing-bags-big-orders-at-paris-air-show-wal-mart-to-buy-bonobos,Zacks,2017-06-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707934,healthcare etf iyh hits new week high,https://www.benzinga.com/17/06/9646888/healthcare-etf-iyh-hits-new-52-week-high,Zacks,2017-06-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707935,healthcare etf iyh hits new week high,https://www.benzinga.com/17/06/9646889/healthcare-etf-iyh-hits-new-52-week-high,Zacks,2017-06-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707936,if colgates looking to sell itself would berkshire be looking to buy,https://www.benzinga.com/analyst-ratings/analyst-color/17/06/9643726/if-colgates-looking-to-sell-itself-would-berkshire-be-lo,Taylor Cox,2017-06-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707937,wall streets ma chatter from june staplessycamore partners diageocasamigos bristolmyers acadia pharma,https://www.benzinga.com/news/17/06/9640369/wall-streets-m-a-chatter-from-june-21-staples-sycamore-partners-diageo-casamigos-,Charles Gross,2017-06-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707938,fitch sees fastest global growth in years etfs to buy,https://www.benzinga.com/17/06/9637417/fitch-sees-fastest-global-growth-in-10-years-etfs-to-buy,Zacks,2017-06-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707939,shires shpg adhd drug mydayis receives approval in us,https://www.benzinga.com/17/06/9636766/shires-shpg-adhd-drug-mydayis-receives-approval-in-us,Zacks,2017-06-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707940,nonhorrible bosses meet the best ceos of ,https://www.benzinga.com/news/17/06/9629768/non-horrible-bosses-meet-the-best-ceos-of-2017,Javier Hasse,2017-06-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
707941,how to uncover institutional buying,https://www.benzinga.com/17/06/9633794/how-to-uncover-institutional-buying,Zacks,2017-06-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707942,abbvie abbv stock hits week high more room to run,https://www.benzinga.com/17/06/9625199/abbvie-abbv-stock-hits-52-week-high-more-room-to-run,Zacks,2017-06-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707943,fda reports approval of jjs janssens darzalex in combo with pomalidomide dexamethasone for patients with multiple myeloma,https://www.benzinga.com/news/fda/17/06/9620388/fda-reports-approval-of-j-js-janssens-darzalex-in-combo-with-pomalidomide-dex,Paul Quintaro,2017-06-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
707944,pharma stock roundup jj lilly present data merck keytruda study enrolment paused,https://www.benzinga.com/17/06/9618359/pharma-stock-roundup-j-j-lilly-present-data-merck-keytruda-study-enrolment-paused,Zacks,2017-06-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
707945,jnj completes acquisition of actelion,https://www.benzinga.com/news/earnings/17/06/9617424/jnj-completes-acquisition-of-actelion,Charles Gross,2017-06-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707946,johnson johnsons janssen present phase data on sirukumab says longterm efficacy is encouraging,https://www.benzinga.com/general/biotech/17/06/9608261/johnson-johnsons-janssen-present-phase-3-data-on-sirukumab-says-long-t,Hal Lindon,2017-06-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.76335
707947,cramer ms stock quietly hit alltime highs thanks to weak us dollar,https://www.benzinga.com/media/jim-cramer/17/06/9607071/cramer-3ms-stock-quietly-hit-all-time-highs-thanks-to-weak-us-dollar,Jayson Derrick,2017-06-14 00:00:00,JNJ,1,0,0,0,0,0,0,0,0,0.5
707948,amgens multiple myeloma drug receives nice recommendation,https://www.benzinga.com/17/06/9601767/amgens-multiple-myeloma-drug-receives-nice-recommendation,Zacks,2017-06-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
707949,update tesaro says janssen anticipates reopening enrollment for galahad trial soon k,https://www.benzinga.com/news/17/06/9593624/update-tesaro-says-janssen-anticipates-re-opening-enrollment-for-galahad-trial-so,Charles Gross,2017-06-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707950,tesaro says on june janssen updated clinicaltrialsgov website to reflect janssen had placed temporary enrollment hold in galahad trial says galahad trial not on clinical hold temporary enrollment hold not due to safety concerns,https://www.benzinga.com/news/17/06/9593617/tesaro-says-on-june-janssen-updated-clinicaltrials-gov-website-to-reflect-janssen,Charles Gross,2017-06-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.33740000000000003
707951,janssen and tesaro galahad trial puts patient enrollment on temporary hold,https://www.benzinga.com/news/17/06/9593616/janssen-and-tesaro-galahad-trial-puts-patient-enrollment-on-temporary-hold,Paul Quintaro,2017-06-12 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.5
707952,johnson johnson tesaro niraparib trial enrollment suspension not related to safety,https://www.benzinga.com/news/17/06/9589686/johnson-johnson-tesaro-niraparib-trial-enrollment-suspension-not-related-to-safet,Elizabeth Balboa,2017-06-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.33740000000000003
707953,tesaro volatile after johnson johnson suspends enrollment in prostate cancer trial,https://www.benzinga.com/trading-ideas/technicals/17/06/9589650/tesaro-volatile-after-johnson-johnson-suspends-enrollment-in-,Joel Elconin,2017-06-09 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.17015000000000002
707954,jnj spokesperson says our team put a temporarily hold on enrollment so we could assess the enrolled currently patients against the protocol criteria we need to make sure we dont overenroll some patient types and underenroll others,https://www.benzinga.com/news/17/06/9589614/jnj-spokesperson-says-our-team-put-a-temporarily-hold-on-enrollment-so-we-could-a,Hal Lindon,2017-06-09 00:00:00,JNJ,1,2,1,1,0,1,1,0,0,0.6591
707955,johnson johnson spokesperson tells benzinga tesaros niraparib study enrollment is on temporary hold and we anticipate reopening enrollment soon the hold is not related to safety,https://www.benzinga.com/news/17/06/9589601/johnson-johnson-spokesperson-tells-benzinga-tesaros-niraparib-study-enrollment-is,Hal Lindon,2017-06-09 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.33740000000000003
707956,johnson johnson acquisition of actelion is approved by the eu,https://www.benzinga.com/news/17/06/9587855/johnson-johnson-acquisition-of-actelion-is-approved-by-the-eu,Paul Quintaro,2017-06-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
707957,world bank foresees year high global growth etfs to buy,https://www.benzinga.com/17/06/9578819/world-bank-foresees-7-year-high-global-growth-etfs-to-buy,Zacks,2017-06-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
707958,barrons picks and pans att express scripts accenture and more,https://www.benzinga.com/media/barrons/17/06/9560787/barrons-picks-and-pans-at-t-express-scripts-accenture-and-more,Nelson Hem,2017-06-04 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707959,trial results show johnson johnsons zytiga lowers death risk by in newly diagnosed advanced prostate cancer asco,https://www.benzinga.com/news/17/06/9560786/trial-results-show-johnson-johnsons-zytiga-lowers-death-risk-by-38-in-newly-diagn,Charles Gross,2017-06-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.064
707960,states are firing back at opioid drug producers,https://www.benzinga.com/analyst-ratings/analyst-color/17/06/9550004/states-are-firing-back-at-opioid-drug-producers,Wayne Duggan,2017-06-01 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.32999999999999996
707961,shares of johnons johnson teva pharma endo intl and allergan all higher today despite news state of ohio has sued these companies for alleged role in opioid epidemic,https://www.benzinga.com/news/17/05/9543998/shares-of-johnons-johnson-teva-pharma-endo-intl-and-allergan-all-higher-today-des,Hal Lindon,2017-05-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
707962,protagonist therapeutics spikes to high of following announcement of worldwide agreement with janssen,https://www.benzinga.com/news/17/05/9534813/protagonist-therapeutics-spikes-to-high-of-14-85-following-announcement-of-worldw,Charles Gross,2017-05-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
707963,tracking the busy june pdufa calendar,https://www.benzinga.com/general/biotech/17/05/9503323/tracking-the-busy-june-pdufa-calendar,Shanthi Rexaline,2017-05-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707964,protagonist therapeutics enters into worldwide agreement with janssen to codevelop and commercialize ptg protagonist to gets m upfront payment,https://www.benzinga.com/news/17/05/9533737/protagonist-therapeutics-enters-into-worldwide-agreement-with-janssen-to-co-devel,Paul Quintaro,2017-05-30 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.74695
707965, most likely suitors for colgatepalmolive in jefferies view,https://www.benzinga.com/analyst-ratings/analyst-color/17/05/9486914/3-most-likely-suitors-for-colgate-palmolive-in-jefferies,Wayne Duggan,2017-05-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707966,premarket imbalance update ge k shares to sell twitter k to sell general mills k to sell jj k to sell morgan stanley k to sell,https://www.benzinga.com/news/17/05/9479236/pre-market-imbalance-update-ge-179k-shares-to-sell-twitter-167k-to-sell-general-m,Paul Quintaro,2017-05-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.74695
707967,johnson johnson holding pharmaceutical business review today,https://www.benzinga.com/news/events/17/05/9479165/johnson-johnson-holding-pharmaceutical-business-review-today,Hal Lindon,2017-05-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707968,johnson johnson says expecting to launch or file for regulatory approval for new products from to and line extensions of existing products,https://www.benzinga.com/news/17/05/9478247/johnson-johnson-says-expecting-to-launch-or-file-for-regulatory-approval-for-10-n,Paul Quintaro,2017-05-17 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7383500000000001
707969,johnson johnsons sales slump has played itself out could reaccelerate this year,https://www.benzinga.com/analyst-ratings/analyst-color/17/05/9463188/johnson-johnsons-sales-slump-has-played-itself-out-could,Jayson Derrick,2017-05-15 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.67
707970,benzingas top upgrades downgrades for may ,https://www.benzinga.com/analyst-ratings/upgrades/17/05/9462267/benzingas-top-upgrades-downgrades-for-may-15-2017,Lisa Levin,2017-05-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
707971,jp morgan upgrades johnson johnson to overweight,https://www.benzinga.com/news/17/05/9460030/jp-morgan-upgrades-johnson-johnson-to-overweight,Paul Quintaro,2017-05-15 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.41105
707972,top picks for the rest of courtesy of ubs,https://www.benzinga.com/analyst-ratings/analyst-color/17/05/9455016/top-picks-for-the-rest-of-2017-courtesy-of-ubs,Jayson Derrick,2017-05-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7553000000000001
707973,apple is the worlds biggest dividend payer,https://www.benzinga.com/media/cnbc/17/05/9392828/apple-is-the-worlds-biggest-dividend-payer,Jayson Derrick,2017-05-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707974,exclusive capricor ceo talks exondys competition,https://www.benzinga.com/general/biotech/17/05/9384883/exclusive-capricor-ceo-talks-exondys-competition,Elizabeth Balboa,2017-05-03 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5640000000000001
707975,weed vs opioids nontraditional and traditional biotech take on wall street but whos winning,https://www.benzinga.com/general/biotech/17/04/9351363/weed-vs-opioids-nontraditional-and-traditional-biotech-take-on-wall-st,Javier Hasse,2017-04-30 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.8404
707976,johnson johnson increases qtr dividend from share to share,https://www.benzinga.com/trading-ideas/dividends/17/04/9357468/johnson-johnson-increases-qtr-dividend-from-0-80share-to-0-84s,Hal Lindon,2017-04-27 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.76335
707977,companies holding shareholder meetings today include akorn astrazeneca hca holdings johnson johnson lockheed martin,https://www.benzinga.com/news/events/17/04/9355891/companies-holding-shareholder-meetings-today-include-akorn-astrazeneca-hca,Hal Lindon,2017-04-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707978,janssen holding announces of actelion shares tendered,https://www.benzinga.com/news/17/04/9354153/janssen-holding-announces-92-51-of-actelion-shares-tendered,Charles Gross,2017-04-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
707979,earnings caterpillar lockheed martin and eli lilly report tomorrow,https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9336445/earnings-caterpillar-lockheed-martin-and-eli-lilly-repor,The Ticker Tape,2017-04-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
707980,how family office manager julio gonzalez is helping keep jobs in the us using tax engineering,https://www.benzinga.com/personal-finance/financial-advisors/17/04/9330734/how-family-office-manager-julio-gonzalez-is-helpin,Javier Hasse,2017-04-24 00:00:00,JNJ,1,2,1,1,1,1,1,0,1,0.648
707981,jim cramer gives his opinion on johnson johnson and ppg industries,https://www.benzinga.com/media/cnbc/17/04/9332789/jim-cramer-gives-his-opinion-on-johnson-johnson-and-ppg-industries,Craig Jones,2017-04-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707982,what would a billion nih cut look like devastation,https://www.benzinga.com/news/17/04/9308625/what-would-a-5-8-billion-nih-cut-look-like-devastation,Elizabeth Balboa,2017-04-20 00:00:00,JNJ,1,2,0,1,0,0,0,0,0,0.32999999999999996
707983,the lucky beneficiaries of tax day,https://www.benzinga.com/news/17/04/9314695/the-lucky-beneficiaries-of-tax-day,Elizabeth Balboa,2017-04-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.8404
707984,jmp calls alteryx a compelling investment sees upside,https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9311759/jmp-calls-alteryx-a-compelling-investment-sees-23-upside,Shanthi Rexaline,2017-04-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.61315
707985,johnson johnson pummeled after mixed q report,https://www.benzinga.com/trading-ideas/technicals/17/04/9311720/johnson-johnson-pummeled-after-mixed-q1-report,Joel Elconin,2017-04-18 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
707986,meg tirrell tweets jnj says its seeing higher discounting on drugs for favorable coverage increased rx assistance discounts hit q results by m per jpm,https://www.benzinga.com/news/fda/17/04/9310432/meg-tirrell-tweets-jnj-says-its-seeing-higher-discounting-on-drugs-for-favora,Hal Lindon,2017-04-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.81845
707987,a peek into the markets us stock futures mostly lower ahead of earnings,https://www.benzinga.com/news/earnings/17/04/9309837/a-peek-into-the-markets-u-s-stock-futures-mostly-lower-ahead-of-earnings,Lisa Levin,2017-04-18 00:00:00,JNJ,0,1,0,1,1,0,0,0,0,0.352
707988,johnson johnson sees fy eps to vs est,https://www.benzinga.com/news/guidance/17/04/9309513/johnson-johnson-sees-fy-2017-eps-7-00-to-7-15-vs-7-05-est,Paul Quintaro,2017-04-18 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
707989,johnson johnson q eps vs est sales b vs b est,https://www.benzinga.com/news/earnings/17/04/9309512/johnson-johnson-q1-eps-1-83-vs-1-77-est-sales-17-8b-vs-18-0b-est,Paul Quintaro,2017-04-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707990, stocks to watch for april ,https://www.benzinga.com/news/earnings/17/04/9309113/10-stocks-to-watch-for-april-18-2017,Lisa Levin,2017-04-18 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
707991,earnings scheduled for april ,https://www.benzinga.com/news/earnings/17/04/9309091/earnings-scheduled-for-april-18-2017,Lisa Levin,2017-04-18 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
707992,earnings another financial roundup with bac gs and ms,https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9306716/earnings-another-financial-roundup-with-bac-gs-and-ms,The Ticker Tape,2017-04-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
707993,johnson johnsons janssen data from phase studies supported new approval darzalex in canada,https://www.benzinga.com/news/fda/17/04/9304689/johnson-johnsons-janssen-data-from-2-phase-3-studies-supported-new-approval-d,Hal Lindon,2017-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.82985
707994,united airlines should learn from how these companies handled pr disasters,https://www.benzinga.com/general/travel/17/04/9303315/united-airlines-should-learn-from-how-these-6-companies-handled-pr-disa,Wayne Duggan,2017-04-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.39885
707995,healthcare sector earnings making a comeback in q ,https://www.benzinga.com/analyst-ratings/analyst-color/17/04/9293543/healthcare-sector-earnings-making-a-comeback-in-q1-2017,The Ticker Tape,2017-04-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
707996,from conf call geron says jansen has right to terminate agreement at any time for any reason,https://www.benzinga.com/news/17/04/9281304/from-conf-call-geron-says-jansen-has-right-to-terminate-agreement-at-any-time-for,Charles Gross,2017-04-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
707997,adam feuerstein tweets jnj reluctance to commit to imetelstat disclosed in last sentence of gern pr is most important point,https://www.benzinga.com/news/17/04/9281043/adam-feuerstein-tweets-jnj-reluctance-to-commit-to-imetelstat-disclosed-in-last-s,Paul Quintaro,2017-04-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6472
707998,there is value to be had with the right healthcare etfs,https://www.benzinga.com/general/biotech/17/04/9260682/there-is-value-to-be-had-with-the-right-healthcare-etfs,ETF Professor,2017-04-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.67
707999, advertisers boycott youtube advertising and it wont mean more than a dip in googles top line,https://www.benzinga.com/tech/17/04/9228381/50-advertisers-boycott-youtube-advertising-and-it-wont-mean-more-than-a-1-dip-in-,Shanthi Rexaline,2017-04-01 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.436
708000,premarket imbalance update att k shares to buy salesforce k to sell bofa k to buy cvs k to sell twitter k to sell jj k to sell walmart k to sell,https://www.benzinga.com/news/17/03/9241804/pre-market-imbalance-update-at-t-90k-shares-to-buy-salesforce-70k-to-sell-bofa-64,Paul Quintaro,2017-03-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
708001,jnj subsidiary janssen declares tender offer for actelion successful,https://www.benzinga.com/news/17/03/9240388/jnj-subsidiary-janssen-declares-tender-offer-for-actelion-successful,Charles Gross,2017-03-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.79295
708002,heres every major corporation thats pulled ads from youtube,https://www.benzinga.com/news/17/03/9217402/heres-every-major-corporation-thats-pulled-ads-from-youtube,Jayson Derrick,2017-03-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708003,watch these huge put purchases in monday trade,https://www.benzinga.com/markets/options/17/03/9216577/watch-these-5-huge-put-purchases-in-monday-trade,Lisa Levin,2017-03-27 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.6591
708004,benzingas option alert recap from march ,https://www.benzinga.com/news/17/03/9214891/benzingas-option-alert-recap-from-march-24,Javier Hasse,2017-03-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708005,option alert jnj may put bid ref,https://www.benzinga.com/markets/options/17/03/9213649/option-alert-jnj-may-120-put-2800-bid-0-90-ref-125-79,Charles Gross,2017-03-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708006,youtubes ad controversy not going away yet will it prove to be temporary,https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9213094/youtubes-ad-controversy-not-going-away-yet-will-it-prove,Shanthi Rexaline,2017-03-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708007,johnson johnson unit mentor spokeswoman tells benzinga we fully support the fdas efforts to gather additional data and study biaalcl in patients with breast implants will continue to work to understand associated risks and causes,https://www.benzinga.com/news/17/03/9212602/johnson-johnson-unit-mentor-spokeswoman-tells-benzinga-we-fully-support-the-fdas-,Paul Quintaro,2017-03-24 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.61235
708008,american express johnson johnson square vale fast money picks for march ,https://www.benzinga.com/media/cnbc/17/03/9211383/american-express-johnson-johnson-square-vale-fast-money-picks-for-march-24,Craig Jones,2017-03-24 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708009,allergan continues educational strategy amid fdas report linking breast implants to rare cancer,https://www.benzinga.com/news/17/03/9202028/allergan-continues-educational-strategy-amid-fdas-report-linking-breast-implants-,Elizabeth Balboa,2017-03-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.17015000000000002
708010,premarket prep host dennis dick tweets bac m c k ms k wfc k nke k baba k twtr k jnj k ge k f k,https://www.benzinga.com/news/17/03/9201739/premarket-prep-host-dennis-dick-tweets-bac-1-2m-c-179k-ms-82k-wfc-48k-nke-113k-ba,Paul Quintaro,2017-03-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.24469999999999997
708011,fda links breast implants to a rare form of cancer,https://www.benzinga.com/news/17/03/9199575/fda-links-breast-implants-to-a-rare-form-of-cancer,Elizabeth Balboa,2017-03-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.17015000000000002
708012,watch for weakness in sientra johnson johnson and allergan nbc news reports that fda says breast implants can cause a rare form of cancer that may have killed at least people,https://www.benzinga.com/news/fda/17/03/9199365/watch-for-weakness-in-sientra-johnson-johnson-and-allergan-nbc-news-reports-t,Paul Quintaro,2017-03-21 00:00:00,JNJ,1,1,1,1,0,0,1,1,0,0.043200000000000016
708013,that was fast healthcare etf races to new highs,https://www.benzinga.com/trading-ideas/long-ideas/17/03/9177808/that-was-fast-healthcare-etf-races-to-new-highs,ETF Professor,2017-03-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708014,barclays global healthcare conference begins today presenters include johnson johnson alnylam axovant paraxel gilead bluebird bio envision healthcare tenet healthcare,https://www.benzinga.com/news/events/17/03/9168192/barclays-global-healthcare-conference-begins-today-presenters-include-john,Hal Lindon,2017-03-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708015,how the ultrawealthy are helping advance health and life sciences,https://www.benzinga.com/general/biotech/17/03/9154421/how-the-ultra-wealthy-are-helping-advance-health-and-life-sciences,Javier Hasse,2017-03-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708016,jim cramer advises his viewers on johnson johnson corecivic urban outfitters and realty income,https://www.benzinga.com/media/cnbc/17/03/9156576/jim-cramer-advises-his-viewers-on-johnson-johnson-corecivic-urban-outfitter,Craig Jones,2017-03-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708017,fast money picks for march ,https://www.benzinga.com/media/cnbc/17/03/9144287/fast-money-picks-for-march-8,Craig Jones,2017-03-08 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708018,concerns from valeants k billion of asset sales is now a mirage,https://www.benzinga.com/analyst-ratings/analyst-color/17/03/9138331/concerns-from-valeants-10-k-8-billion-of-asset-sales-is-,Jim Swanson,2017-03-07 00:00:00,JNJ,1,1,0,1,1,0,1,1,1,0.6806
708019,benzinga premarket prep host dennis dick tweets notable opening imbalances xrx k bac k pfe k crm k pep k jnj k pg k,https://www.benzinga.com/news/17/03/9132976/benzinga-premarket-prep-host-dennis-dick-tweets-notable-opening-imbalances-xrx-46,Paul Quintaro,2017-03-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.24469999999999997
708020,jjs janssen reports results from second phase study of guselkumab vs humira for treatment of moderatetosevere plaque psoriasis show significant efficacy superiority,https://www.benzinga.com/news/fda/17/03/9125635/j-js-janssen-reports-results-from-second-phase-3-study-of-guselkumab-vs-humir,Paul Quintaro,2017-03-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708021,johnson johnson in k filing says janssen pharma subsidiary received civil investigative demand from doj related to allegations concerning sales marketing practices of olysio,https://www.benzinga.com/news/legal/17/02/9102881/johnson-johnson-in-10-k-filing-says-janssen-pharma-subsidiary-received-civi,Hal Lindon,2017-02-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.436
708022,jj reports expected charge of bb related to medical devices unit restructuring,https://www.benzinga.com/news/17/02/9102880/j-j-reports-expected-charge-of-2b-2-4b-related-to-medical-devices-unit-restructur,Hal Lindon,2017-02-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
708023,johnson johnson received subpoena from massachusetts seeking records related to payments to any c charitable organizations that provide assistance to medicare patients,https://www.benzinga.com/news/legal/17/02/9102876/johnson-johnson-received-subpoena-from-massachusetts-seeking-records-relate,Hal Lindon,2017-02-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.70095
708024,how trumps tax policy could affect large companies like apple,https://www.benzinga.com/17/02/9100578/how-trumps-tax-policy-could-affect-large-companies-like-apple,Brent Douglas,2017-02-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.6806
708025,dan nathans bearish johnson johnson trade,https://www.benzinga.com/media/cnbc/17/02/9097135/dan-nathans-bearish-johnson-johnson-trade,Craig Jones,2017-02-26 00:00:00,JNJ,1,2,0,1,0,0,0,0,0,0.5
708026,hearing johnson and johnson searching for medical device partnerships at rbc conf,https://www.benzinga.com/news/17/02/9087430/hearing-johnson-and-johnson-searching-for-medical-device-partnerships-at-rbc-conf,Paul Quintaro,2017-02-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708027,rbc capital markets healthcare conference concludes today presenters include spark therapeutics johnson johnson hca holdings ocular therapeutix valeant agile therapeutics,https://www.benzinga.com/news/events/17/02/9086157/rbc-capital-markets-healthcare-conference-concludes-today-presenters-inclu,Hal Lindon,2017-02-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
708028, companies with the best corporate reputations,https://www.benzinga.com/top-stories/17/02/9081686/10-companies-with-the-best-corporate-reputations,Jayson Derrick,2017-02-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
708029,icahn takes bristolmyers stake with ma in mind who could be the acquirer,https://www.benzinga.com/general/biotech/17/02/9076742/icahn-takes-bristol-myers-stake-with-m-a-in-mind-who-could-be-the-acqu,Elizabeth Balboa,2017-02-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708030,exclusive following up akebia johnson johnsons research and license agreement,https://www.benzinga.com/general/biotech/17/02/9061564/exclusive-following-up-akebia-johnson-johnsons-research-and-license-ag,Elizabeth Balboa,2017-02-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
708031,jj medical devices ethicon reports deal to buy torax medical no terms disclosed,https://www.benzinga.com/news/m-a/17/02/9065559/j-j-medical-devices-ethicon-reports-deal-to-buy-torax-medical-no-terms-disclo,Paul Quintaro,2017-02-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4742
708032,wall streets ma chatter from february ,https://www.benzinga.com/news/17/02/9064279/wall-streets-m-a-chatter-from-february-16,Charles Gross,2017-02-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708033,swiss takeover commission says jj offer for actelion meets legal requirements,https://www.benzinga.com/news/17/02/9057861/swiss-takeover-commission-says-j-j-offer-for-actelion-meets-legal-requirements,Charles Gross,2017-02-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6806
708034,jj publishes prospectus for actelion tender offer,https://www.benzinga.com/news/17/02/9057799/j-j-publishes-prospectus-for-actelion-tender-offer,Charles Gross,2017-02-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708035,a peek into the markets us stock futures mostly higher ahead of economic data yellen speech,https://www.benzinga.com/news/earnings/17/02/9051697/a-peek-into-the-markets-u-s-stock-futures-mostly-higher-ahead-of-economi,Lisa Levin,2017-02-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708036,integra acquires codman neurosurgery business from johnson johnson for b cash,https://www.benzinga.com/news/17/02/9051480/integra-acquires-codman-neurosurgery-business-from-johnson-johnson-for-1-045b-cas,Paul Quintaro,2017-02-15 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708037,acadia shares up over last min as hearing dealreporter suggesting jj could approach co,https://www.benzinga.com/news/rumors/17/02/9046173/acadia-shares-up-0-80-over-last-min-as-hearing-dealreporter-suggesting-j-j,Paul Quintaro,2017-02-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708038,johnson johnsons janssen pharmaceuticals enters agreement to give investigational new drug file for stresscopin to renova therapeutics,https://www.benzinga.com/news/17/02/8998500/johnson-johnsons-janssen-pharmaceuticals-enters-agreement-to-give-investigational,Hal Lindon,2017-02-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708039,donald trump calls johnson johnson a good company,https://www.benzinga.com/general/politics/17/01/8971434/donald-trump-calls-johnson-johnson-a-good-company,Paul Quintaro,2017-01-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
708040,a ceo whos who of trumps manufacturing council,https://www.benzinga.com/news/17/01/8959545/a-ceo-whos-who-of-trumps-manufacturing-council,Dustin Blitchok,2017-01-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708041,missouri supreme court denies request to delay johnson johnson talcproduct cancer allegation trials,https://www.benzinga.com/news/17/01/8953121/missouri-supreme-court-denies-request-to-delay-johnson-johnson-talc-product-cance,Hal Lindon,2017-01-26 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.1452
708042,benzingas top upgrades downgrades for january ,https://www.benzinga.com/analyst-ratings/upgrades/17/01/8950639/benzingas-top-upgrades-downgrades-for-january-26-2017,Lisa Levin,2017-01-26 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
708043,the market in minutes earnings trump and dowk,https://www.benzinga.com/news/17/01/8949746/the-market-in-5-minutes-earnings-trump-and-dow20k,Benzinga News Desk,2017-01-26 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708044,a peek into the markets us stock futures up ahead of earnings,https://www.benzinga.com/news/earnings/17/01/8949642/a-peek-into-the-markets-u-s-stock-futures-up-ahead-of-earnings,Lisa Levin,2017-01-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708045,wells fargo downgrades johnson johnson to market perform,https://www.benzinga.com/news/17/01/8949387/wells-fargo-downgrades-johnson-johnson-to-market-perform,Paul Quintaro,2017-01-26 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.625
708046,jnj to acquire actelion for share in cash actelion to spin out drug discovery operations and earlystage clinical development assets,https://www.benzinga.com/news/17/01/8948971/jnj-to-acquire-actelion-for-280share-in-cash-actelion-to-spin-out-drug-discovery-,Charles Gross,2017-01-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
708047,dow ks hottest stocks where are they now,https://www.benzinga.com/general/topics/17/01/8946256/dow-10ks-hottest-stocks-where-are-they-now,Shanthi Rexaline,2017-01-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708048,trump helps send markets to new highs with keystone pipeline order,https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8944960/trump-helps-send-markets-to-new-highs-with-keystone-pipe,The Ticker Tape,2017-01-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
708049,q earnings thus far a reality check for the trump rally,https://www.benzinga.com/news/earnings/17/01/8940510/q4-earnings-thus-far-a-reality-check-for-the-trump-rally,Manikandan Raman,2017-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708050,q realtime call brief,https://www.benzinga.com/node/8940350,Scout Finance,2017-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708051,johnson johnson takes a hit after mixed q report,https://www.benzinga.com/trading-ideas/technicals/17/01/8939250/johnson-johnson-takes-a-hit-after-mixed-q4-report,Joel Elconin,2017-01-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708052,stocks could remain rangebound until trump policy details become clearer,https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8938770/stocks-could-remain-range-bound-until-trump-policy-detai,The Ticker Tape,2017-01-24 00:00:00,JNJ,1,2,0,0,0,0,1,1,1,0.5
708053,johnson and johnson says to expect new product launches by with b in sales potential,https://www.benzinga.com/news/17/01/8938063/johnson-and-johnson-says-to-expect-10-new-product-launches-by-2019-with-1b-in-sal,Paul Quintaro,2017-01-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708054,the market in minutes alibaba beats verizon disappoints,https://www.benzinga.com/news/17/01/8937466/the-market-in-5-minutes-alibaba-beats-verizon-disappoints,Benzinga News Desk,2017-01-24 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.30910000000000004
708055,a peek into the markets us stock futures flat ahead of earnings reports,https://www.benzinga.com/news/earnings/17/01/8937393/a-peek-into-the-markets-u-s-stock-futures-flat-ahead-of-earnings-reports,Lisa Levin,2017-01-24 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708056,johnson johnson says evaluating strategic options for diabetes care companies,https://www.benzinga.com/news/17/01/8937166/johnson-johnson-says-evaluating-strategic-options-for-diabetes-care-companies,Paul Quintaro,2017-01-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708057,johnson johnson sees fy eps to vs est,https://www.benzinga.com/news/17/01/8937165/johnson-johnson-sees-fy-eps-6-93-to-7-08-vs-7-11-est,Paul Quintaro,2017-01-24 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708058,johnson johnson q eps vs est revenue b vs b est,https://www.benzinga.com/news/earnings/17/01/8937164/johnson-johnson-q4-eps-1-58-vs-1-56-est-revenue-18-1b-vs-18-3b-est,Paul Quintaro,2017-01-24 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708059, stocks you should be watching today,https://www.benzinga.com/news/earnings/17/01/8936926/12-stocks-you-should-be-watching-today,Lisa Levin,2017-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708060,earnings scheduled for january ,https://www.benzinga.com/news/earnings/17/01/8936864/earnings-scheduled-for-january-24-2017,Lisa Levin,2017-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708061,jj chair ceo alex gorsky offers statement following manufacturer meeting with trump,https://www.benzinga.com/news/17/01/8935585/j-j-chair-ceo-alex-gorsky-offers-statement-following-manufacturer-meeting-with-tr,Paul Quintaro,2017-01-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708062,earnings last call for yahoo johnson johnson alibaba also release this week,https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8933780/earnings-last-call-for-yahoo-johson-johnson-alibaba-also,The Ticker Tape,2017-01-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708063,reutersbiz tweets breaking executives from whirlpool under armour tesla lockheed martin johnson johnson and more attend trump meeting on manufacturing,https://www.benzinga.com/news/17/01/8932852/reutersbiz-tweets-breaking-executives-from-whirlpool-under-armour-tesla-lockheed-,Paul Quintaro,2017-01-23 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708064,execs from tesla jj lockheed under armour whirlpool attend trump meeting with key us manufacturers,https://www.benzinga.com/news/17/01/8932779/execs-from-tesla-j-j-lockheed-under-armour-whirlpool-attend-trump-meeting-with-ke,Paul Quintaro,2017-01-23 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.625
708065,dow earnings high hopes for chevron johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8931326/dow-earnings-high-hopes-for-chevron-johnson-johnson,Nelson Hem,2017-01-23 00:00:00,JNJ,1,0,1,0,0,0,1,1,1,0.71075
708066,health canada wants warning stickers on prescription painkillers reuters,https://www.benzinga.com/news/17/01/8931669/health-canada-wants-warning-stickers-on-prescription-painkillers-reuters,Charles Gross,2017-01-23 00:00:00,JNJ,1,2,0,1,0,0,0,0,0,0.32999999999999996
708067,inauguration day trump speech in focus as new president prepares to take office,https://www.benzinga.com/analyst-ratings/analyst-color/17/01/8928038/inauguration-day-trump-speech-in-focus-as-new-president-,The Ticker Tape,2017-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708068,johnson and johnson unit ethicon acquires megadyne medical products terms not disclosed,https://www.benzinga.com/news/m-a/17/01/8927470/johnson-and-johnson-unit-ethicon-acquires-megadyne-medical-products-terms-not,Paul Quintaro,2017-01-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708069,does luxottica now have a monopoly on the eyeglass space,https://www.benzinga.com/news/17/01/8912654/does-luxottica-now-have-a-monopoly-on-the-eyeglass-space,Wayne Duggan,2017-01-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708070,quality dividends on the cheap with this etf,https://www.benzinga.com/trading-ideas/long-ideas/17/01/8909548/quality-dividends-on-the-cheap-with-this-etf,ETF Professor,2017-01-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708071,johnson johnson deal with actelion said to be valued at share,https://www.benzinga.com/news/rumors/17/01/8900832/johnson-johnson-deal-with-actelion-said-to-be-valued-at-250-260share,Hal Lindon,2017-01-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81245
708072,jj and actelion said to reach tentative agreement on price,https://www.benzinga.com/news/m-a/17/01/8896727/j-j-and-actelion-said-to-reach-tentative-agreement-on-price,Paul Quintaro,2017-01-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8243
708073,the fentanyl abuse epidemic,https://www.benzinga.com/general/biotech/17/01/8879640/the-fentanyl-abuse-epidemic,Javier Hasse,2017-01-10 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.18155
708074,jp morgan healthcare conf begins today presenters include insulet teladoc incyte johnson johnson acadia healthcare teva pharmaceuticals,https://www.benzinga.com/news/17/01/8883019/jp-morgan-healthcare-conf-begins-today-presenters-include-insulet-teladoc-incyte-,Hal Lindon,2017-01-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708075,jj actelion discuss deal with swiss takeover board tagesanzeiger,https://www.benzinga.com/news/17/01/8876773/j-j-actelion-discuss-deal-with-swiss-takeover-board-tages-anzeiger,Charles Gross,2017-01-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708076,execs giving ces keynote speeches could create volatility for shareholders,https://www.benzinga.com/news/17/01/8873798/execs-giving-ces-keynote-speeches-could-create-volatility-for-shareholders,Shanthi Rexaline,2017-01-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.77115
708077,a peek into the markets us stock futures rise on final trading day of ,https://www.benzinga.com/news/16/12/8852644/a-peek-into-the-markets-u-s-stock-futures-rise-on-final-trading-day-of-2016,Lisa Levin,2016-12-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708078,wall streets ma chatter from december ,https://www.benzinga.com/news/16/12/8852587/wall-streets-m-a-chatter-from-december-29,Charles Gross,2016-12-30 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708079,hearing jj is negotiating placing actelions rd assets into a separate co,https://www.benzinga.com/news/rumors/16/12/8849752/hearing-j-j-is-negotiating-placing-actelions-r-d-assets-into-a-separate-co,Paul Quintaro,2016-12-29 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.70095
708080,update achillion receives m milestone payment from jjs janssen research development,https://www.benzinga.com/news/16/12/8845285/update-achillion-receives-15m-milestone-payment-from-j-js-janssen-research-develo,Paul Quintaro,2016-12-28 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708081,achillion reports clinical milestone for advancement of jnj in phase b development for chronic hpv,https://www.benzinga.com/news/16/12/8845284/achillion-reports-clinical-milestone-for-advancement-of-jnj-4178-in-phase-2b-deve,Paul Quintaro,2016-12-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708082,the market in minutes gdp jobless claims and micron,https://www.benzinga.com/news/16/12/8834500/the-market-in-5-minutes-gdp-jobless-claims-and-micron,Benzinga News Desk,2016-12-22 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.5
708083,wall streets ma chatter from december ,https://www.benzinga.com/news/16/12/8834384/wall-streets-m-a-chatter-from-december-21,Charles Gross,2016-12-22 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708084,johnson johnson confirms exclusive negotiations with actelion in press release,https://www.benzinga.com/news/16/12/8831468/johnson-johnson-confirms-exclusive-negotiations-with-actelion-in-press-release,Hal Lindon,2016-12-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
708085,actelion and johnson johnson enter into exclusive discussion,https://www.benzinga.com/news/16/12/8831449/actelion-and-johnson-johnson-enter-into-exclusive-discussion,Paul Quintaro,2016-12-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
708086,jjs janssen announces submission of two fda applications for approval of simponi aria for treatment of active psoriatic arthritis active ankylosing spondyllitis,https://www.benzinga.com/news/fda/16/12/8828426/j-js-janssen-announces-submission-of-two-fda-applications-for-approval-of-sim,Paul Quintaro,2016-12-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.9088
708087,janssen sciences ireland uc announces positive results from first phase iii studies of investigational twodrug hiv treatment regimen,https://www.benzinga.com/news/16/12/8824039/janssen-sciences-ireland-uc-announces-positive-results-from-first-phase-iii-studi,Charles Gross,2016-12-19 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7787
708088,jefferies global pharma outlook,https://www.benzinga.com/analyst-ratings/analyst-color/16/12/8820515/jefferies-2017-global-pharma-outlook,Jim Swanson,2016-12-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708089,janssen submits application seeking fda approval of stelara for treatment of adolescents with moderatetosevere plaque psoriasis,https://www.benzinga.com/news/16/12/8814611/janssen-submits-application-seeking-fda-approval-of-stelara-for-treatment-of-adol,Paul Quintaro,2016-12-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
708090,wall streets ma chatter from december ,https://www.benzinga.com/news/16/12/8809083/wall-streets-m-a-chatter-from-december-14,Charles Gross,2016-12-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708091,watch these huge call purchases in thursday trade,https://www.benzinga.com/markets/options/16/12/8808724/watch-these-7-huge-call-purchases-in-thursday-trade,Lisa Levin,2016-12-15 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.6591
708092,who else might johnson johnson seek to acquire with actelion now out of its crosshairs,https://www.benzinga.com/general/biotech/16/12/8806280/who-else-might-johnson-johnson-seek-to-acquire-with-actelion-now-out-o,Wayne Duggan,2016-12-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708093,option alert jnj dec calls sweep ask traded vs oi earnings before open ref,https://www.benzinga.com/markets/options/16/12/8805118/option-alert-jnj-dec16-119-calls-sweep-1482-ask-0-12-1482-traded-vs-23,Charles Gross,2016-12-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708094,the market in minutes all eyes on the fed,https://www.benzinga.com/news/16/12/8804339/the-market-in-5-minutes-all-eyes-on-the-fed,Benzinga News Desk,2016-12-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708095,wall streets ma chatter from december ,https://www.benzinga.com/news/16/12/8804125/wall-streets-m-a-chatter-from-december-13,Charles Gross,2016-12-14 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708096,actelion confirms jj has withdrawn from discussions with actelion says engaged in discussions with another party,https://www.benzinga.com/news/16/12/8803479/actelion-confirms-j-j-has-withdrawn-from-discussions-with-actelion-says-engaged-i,Charles Gross,2016-12-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.8753
708097,jnj confirms it ended discussions with actelion,https://www.benzinga.com/news/16/12/8803431/jnj-confirms-it-ended-discussions-with-actelion,Charles Gross,2016-12-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708098,vetr calls for a hold on johnson johnson amid sector competition,https://www.benzinga.com/general/biotech/16/12/8797737/vetr-calls-for-a-hold-on-johnson-johnson-amid-sector-competition,Chris Dier-Scalise,2016-12-12 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708099,barrons picks and pans goodyear johnson johnson and more,https://www.benzinga.com/media/barrons/16/12/8794322/barrons-picks-and-pans-goodyear-johnson-johnson-and-more,Nelson Hem,2016-12-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708100,facebook google make glassdoors list of top places to work,https://www.benzinga.com/news/16/12/8781356/facebook-google-make-glassdoors-list-of-top-50-places-to-work,Jayson Derrick,2016-12-07 00:00:00,JNJ,1,2,1,1,1,1,1,0,1,0.60115
708101,pfizer jj other big pharma names dip lower just after the open,https://www.benzinga.com/movers/16/12/8780747/pfizer-j-j-other-big-pharma-names-dip-lower-just-after-the-open,Paul Quintaro,2016-12-07 00:00:00,JNJ,0,1,0,1,1,0,0,0,0,0.4742
708102,karyopharm therapeutics top execs talk recent results in multiple myeloma and acute myeloid leukemia,https://www.benzinga.com/general/biotech/16/12/8777292/karyopharm-therapeutics-top-execs-talk-recent-results-in-multiple-myel,Javier Hasse,2016-12-06 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.60115
708103,the market in minutes lower oil prices higher apple watch sales,https://www.benzinga.com/news/16/12/8774443/the-market-in-5-minutes-lower-oil-prices-higher-apple-watch-sales,Benzinga News Desk,2016-12-06 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708104,actelion large shareholder would back johnson johnson acquisition takeover for sfr or higher according to reuters,https://www.benzinga.com/news/16/12/8774353/actelion-large-shareholder-would-back-johnson-johnson-acquisition-takeover-for-24,Paul Quintaro,2016-12-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708105,sanofi said to explore actelion counterbid to johnson johnson,https://www.benzinga.com/news/16/12/8772378/sanofi-said-to-explore-actelion-counterbid-to-johnson-johnson,Paul Quintaro,2016-12-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708106,johnson johnson shares trading down premarket on b verdict on faulty pinnacle hip implants from its depuy orthopedics unit,https://www.benzinga.com/news/legal/16/12/8763827/johnson-johnson-shares-trading-down-0-3-pre-market-on-1b-verdict-on-faulty-,Paul Quintaro,2016-12-02 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5640000000000001
708107,achillion says dosing of phase b study initiated by janssen,https://www.benzinga.com/news/16/11/8752104/achillion-says-dosing-of-phase-2b-study-initiated-by-janssen,Paul Quintaro,2016-11-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708108,barclays downgrades biopharma stocks upgrades pfizer and alexion,https://www.benzinga.com/analyst-ratings/analyst-color/16/11/8747281/barclays-downgrades-5-biopharma-stocks-upgrades-pfizer-a,Jim Swanson,2016-11-29 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708109,jj said to raise actelion takeover offer as talks advance,https://www.benzinga.com/news/16/11/8747922/j-j-said-to-raise-actelion-takeover-offer-as-talks-advance,Paul Quintaro,2016-11-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708110, biggest price target changes for tuesday,https://www.benzinga.com/analyst-ratings/price-target/16/11/8747858/7-biggest-price-target-changes-for-tuesday,Lisa Levin,2016-11-29 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
708111,benzingas top downgrades,https://www.benzinga.com/analyst-ratings/downgrades/16/11/8747657/benzingas-top-downgrades,Lisa Levin,2016-11-29 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
708112,jim cramer shares his thoughts on johnson johnson anheuser busch and starbucks,https://www.benzinga.com/media/cnbc/16/11/8745950/jim-cramer-shares-his-thoughts-on-johnson-johnson-anheuser-busch-and-starbu,Craig Jones,2016-11-29 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.648
708113,barclays downgrades johnson johnson to equalweight,https://www.benzinga.com/news/16/11/8746339/barclays-downgrades-johnson-johnson-to-equal-weight,Paul Quintaro,2016-11-29 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
708114,financial times reporting actelion weighs complicated deal to combine with part of jj,https://www.benzinga.com/news/16/11/8743649/financial-times-reporting-actelion-weighs-complicated-deal-to-combine-with-part-o,Paul Quintaro,2016-11-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708115,the market in minutes castro trump and oil in focus,https://www.benzinga.com/news/16/11/8741250/the-market-in-5-minutes-castro-trump-and-oil-in-focus,Benzinga News Desk,2016-11-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708116,wall streets ma chatter from november ,https://www.benzinga.com/news/16/11/8741149/wall-streets-m-a-chatter-from-november-25-27,Charles Gross,2016-11-28 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.5
708117,johnson johnson press release confirms prelim discussions with actelion pharma regarding to potential acquisition,https://www.benzinga.com/news/16/11/8739479/johnson-johnson-press-release-confirms-prelim-discussions-with-actelion-pharma-re,Hal Lindon,2016-11-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708118,actelion issues press release confirming co has been approached by jj related to possible transaction,https://www.benzinga.com/news/16/11/8739298/actelion-issues-press-release-confirming-co-has-been-approached-by-j-j-related-to,Paul Quintaro,2016-11-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708119,the market in minutes black friday closes shortened trading week,https://www.benzinga.com/news/16/11/8738744/the-market-in-5-minutes-black-friday-closes-shortened-trading-week,Benzinga News Desk,2016-11-25 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708120,johnson johnson said to approach actelion regarding potential takeover bloomberg,https://www.benzinga.com/news/16/11/8738595/johnson-johnson-said-to-approach-actelion-regarding-potential-takeover-bloomberg,Charles Gross,2016-11-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708121,technical alert johnson johnson lower for third day in a row,https://www.benzinga.com/trading-ideas/technicals/16/11/8729235/technical-alert-johnson-johnson-lower-for-third-day-in-a-row,Eddie Staley,2016-11-22 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.5
708122,johnson johnson opens slightly lower jnjs janssen reported fda approval of darzalex yesterday,https://www.benzinga.com/general/biotech/16/11/8729052/johnson-johnson-opens-slightly-lower-jnjs-janssen-reported-fda-approva,Hal Lindon,2016-11-22 00:00:00,JNJ,0,0,0,1,0,0,0,0,0,0.6472
708123,janssen submits application to fda seeking guselkumab approval for treatment of plaque psoriasis,https://www.benzinga.com/news/16/11/8712430/janssen-submits-application-to-fda-seeking-guselkumab-approval-for-treatment-of-p,Paul Quintaro,2016-11-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
708124,update janssen reports safety observations through weeks for guselkumab show of patients experienced adverse events vs of placebo,https://www.benzinga.com/news/16/11/8700395/update-janssen-reports-safety-observations-through-24-weeks-for-guselkumab-show-3,Paul Quintaro,2016-11-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5386
708125,janssen reports guselkumab phase results in psoriatic arthritis follow positive phase study in plaque psoriasis serious adverse events were reported safety observations,https://www.benzinga.com/news/16/11/8700387/janssen-reports-guselkumab-phase-2-results-in-psoriatic-arthritis-follow-positive,Paul Quintaro,2016-11-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7787
708126,f from paulson co shows new stakes in ebay hp enterprises infblox carmike increased stake in facebook boston scientific reduced stake in jj liquidated stakes in emc be aerospace,https://www.benzinga.com/news/16/11/8698043/13f-from-paulson-co-shows-new-stakes-in-ebay-hp-enterprises-infblox-carmike-incre,Paul Quintaro,2016-11-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
708127,johnson and johnson new phase data shows simponi aria significantly improved signs symptoms in patients with ankylosing spondylitis,https://www.benzinga.com/news/16/11/8690399/johnson-and-johnson-new-phase-3-data-shows-simponi-aria-significantly-improved-si,Paul Quintaro,2016-11-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
708128, of the most successful veterans turned ceos,https://www.benzinga.com/news/16/11/8667308/9-of-the-most-successful-veterans-turned-ceos,Manikandan Raman,2016-11-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.812
708129,janssen reports clinical trial partnership and supply agreement with amgen to evaluate daratumumab in combination with carfilzomib,https://www.benzinga.com/news/16/11/8678873/janssen-reports-clinical-trial-partnership-and-supply-agreement-with-amgen-to-eva,Paul Quintaro,2016-11-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708130,update bayer says statements published in handelsblatt are misleading reuters,https://www.benzinga.com/news/16/11/8670941/update-bayer-says-statements-published-in-handelsblatt-are-misleading-reuters,Charles Gross,2016-11-09 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.29905000000000004
708131,handlelsblatt reports test equipment used in pivotal trial of bayers xarelto was defective,https://www.benzinga.com/news/16/11/8670938/handlelsblatt-reports-test-equipment-used-in-pivotal-trial-of-bayers-xarelto-was-,Charles Gross,2016-11-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2798
708132,in latest johnson johnson q company reported a patient death in janssens imbbark and imerge with adverse events associated with gerons imetelstat,https://www.benzinga.com/news/16/11/8652944/in-latest-johnson-johnson-10-q-company-reported-a-patient-death-in-janssens-imbba,Paul Quintaro,2016-11-04 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.12469999999999998
708133,are the drugs working pfizer updates financials and disease therapy performances,https://www.benzinga.com/general/biotech/16/10/8624782/are-the-drugs-working-pfizer-updates-financials-and-disease-therapy-pe,The Ticker Tape,2016-10-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708134,can you guess this chart,https://www.benzinga.com/general/16/10/8616650/can-you-guess-this-chart,Benzinga News Desk,2016-10-28 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708135,jury awards m in johnson johnson cancer suit,https://www.benzinga.com/news/16/10/8616063/jury-awards-70m-in-johnson-johnson-cancer-suit,Charles Gross,2016-10-28 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.32999999999999996
708136,goldman says these healthcare stocks are immune to the election,https://www.benzinga.com/analyst-ratings/analyst-color/16/10/8591798/goldman-says-these-25-healthcare-stocks-are-immune-to-th,Wayne Duggan,2016-10-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708137,fed speakers and beige book bank earnings rising crude take center stage,https://www.benzinga.com/news/earnings/16/10/8578682/fed-speakers-and-beige-book-bank-earnings-rising-crude-take-center-stage,The Ticker Tape,2016-10-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.21405000000000002
708138,johnson johnsons robust pipeline supports its aboveaverage valuation,https://www.benzinga.com/analyst-ratings/analyst-color/16/10/8577908/johnson-johnsons-robust-pipeline-supports-its-above-aver,Shanthi Rexaline,2016-10-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7997000000000001
708139,technical alert johnson johnson craters after q report,https://www.benzinga.com/trading-ideas/technicals/16/10/8574164/technical-alert-johnson-johnson-craters-after-q3-report,Eddie Staley,2016-10-18 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
708140,earnings roll on with goldman netflix results giving market a lift,https://www.benzinga.com/analyst-ratings/analyst-color/16/10/8573582/earnings-roll-on-with-goldman-netflix-results-giving-mar,The Ticker Tape,2016-10-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.67
708141,the market in minutes netflix dominates goldman sachs keeps banks flowing,https://www.benzinga.com/news/16/10/8571600/the-market-in-5-minutes-netflix-dominates-goldman-sachs-keeps-banks-flowing,Benzinga News Desk,2016-10-18 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5258
708142,a peek into the markets us stock futures surge goldman sachs earnings in focus,https://www.benzinga.com/news/earnings/16/10/8571727/a-peek-into-the-markets-u-s-stock-futures-surge-goldman-sachs-earnings-i,Monica Gerson,2016-10-18 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
708143,johnson johnson delivers another earnings beat,https://www.benzinga.com/news/earnings/16/10/8571597/johnson-johnson-delivers-another-earnings-beat,R. Chandrasekaran,2016-10-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708144,johnson johnson sees fy eps to vs est revenue b to b vs b est,https://www.benzinga.com/news/earnings/16/10/8571460/johnson-johnson-sees-fy-eps-6-68-to-6-73-vs-6-69-est-revenue-71-5b-to-72,Paul Quintaro,2016-10-18 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
708145,johnson johnson q eps vs est revenue b vs b est,https://www.benzinga.com/news/earnings/16/10/8571449/johnson-johnson-q3-eps-1-68-vs-1-65-est-revenue-17-8b-vs-17-7b-est,Paul Quintaro,2016-10-18 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708146, stocks to watch for october ,https://www.benzinga.com/news/earnings/16/10/8571205/10-stocks-to-watch-for-october-18-2016,Monica Gerson,2016-10-18 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708147,earnings scheduled for october ,https://www.benzinga.com/news/earnings/16/10/8571111/earnings-scheduled-for-october-18-2016,Monica Gerson,2016-10-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708148,technical alert johnson johnson finds support,https://www.benzinga.com/trading-ideas/technicals/16/10/8568980/technical-alert-johnson-johnson-finds-support,Eddie Staley,2016-10-17 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7997000000000001
708149,earnings whos at bat next netflix ibm and more,https://www.benzinga.com/news/earnings/16/10/8568511/earnings-whos-at-bat-next-netflix-ibm-and-more,The Ticker Tape,2016-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708150,plenty to chew on as heart of earnings season approaches fed speakers on prowl,https://www.benzinga.com/analyst-ratings/analyst-color/16/10/8567594/plenty-to-chew-on-as-heart-of-earnings-season-approaches,The Ticker Tape,2016-10-17 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708151,kevin kellys johnson johnson trade,https://www.benzinga.com/markets/options/16/10/8552690/kevin-kellys-johnson-johnson-trade,Craig Jones,2016-10-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708152,can you guess this chart,https://www.benzinga.com/general/16/10/8548507/can-you-guess-this-chart,Benzinga News Desk,2016-10-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708153,jj warns diabetic patients that insulin pump is vulnerable to hacking reuters,https://www.benzinga.com/news/16/10/8524746/j-j-warns-diabetic-patients-that-insulin-pump-is-vulnerable-to-hacking-reuters,Charles Gross,2016-10-04 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.4614
708154,heres everything you need to know about blue chip stocks,https://www.benzinga.com/general/education/16/09/8506377/heres-everything-you-need-to-know-about-blue-chip-stocks,Nicole Dugan - DriveWealth,2016-09-28 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708155,vtv therapeutics shares initiated with buy rating target,https://www.benzinga.com/analyst-ratings/analyst-color/16/09/8494801/vtv-therapeutics-shares-initiated-with-buy-rating-13-tar,Manikandan Raman,2016-09-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708156,jjs janssen reports fda approval of stelara for treatment of adults with moderately to severely active crohns disease,https://www.benzinga.com/news/16/09/8494504/j-js-janssen-reports-fda-approval-of-stelara-for-treatment-of-adults-with-moderat,Paul Quintaro,2016-09-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
708157,first trust gets smart with new sector etfs,https://www.benzinga.com/trading-ideas/long-ideas/16/09/8493047/first-trust-gets-smart-with-new-sector-etfs,ETF Professor,2016-09-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8592
708158,the market in minutes no interest rate hikeyet,https://www.benzinga.com/news/16/09/8485248/the-market-in-5-minutes-no-interest-rate-hike-yet,Benzinga News Desk,2016-09-22 00:00:00,JNJ,1,2,0,0,1,0,1,1,1,0.60115
708159,can you guess this chart,https://www.benzinga.com/general/16/09/8485249/can-you-guess-this-chart,Benzinga News Desk,2016-09-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708160,shares of johnson johnson volatile traders attribute action to negative comments from favus research,https://www.benzinga.com/analyst-ratings/analyst-color/16/09/8481584/shares-of-johnson-johnson-volatile-traders-attribute-act,Paul Quintaro,2016-09-21 00:00:00,JNJ,1,1,1,1,0,1,1,0,0,0.3194
708161,credit suisse can clearly see why johnson johnson acquired abbotts optics division,https://www.benzinga.com/analyst-ratings/analyst-color/16/09/8471769/credit-suisse-can-clearly-see-why-johnson-johnson-acquir,Jim Swanson,2016-09-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8243
708162,alere shares up over last few mins as traders seemingly responding to jj abbott deal,https://www.benzinga.com/news/16/09/8466994/alere-shares-up-0-60-over-last-few-mins-as-traders-seemingly-responding-to-j-j-ab,Paul Quintaro,2016-09-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708163,update abbott labs says net impact of jj transaction will not effect abbotts targeted eps in ,https://www.benzinga.com/news/16/09/8466990/update-abbott-labs-says-net-impact-of-j-j-transaction-will-not-effect-abbotts-tar,Hal Lindon,2016-09-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708164,johnson johnson to acquire abbott medical optics for b cash,https://www.benzinga.com/news/16/09/8466983/johnson-johnson-to-acquire-abbott-medical-optics-for-4-325b-cash,Paul Quintaro,2016-09-16 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708165,hearing johnson johnson nearing deal to buy abbotts eyesurgery equipment unit,https://www.benzinga.com/node/8466460,Paul Quintaro,2016-09-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708166,bz note jj shares appear rangebound over the last hour trading between and ,https://www.benzinga.com/trading-ideas/technicals/16/09/8466139/bz-note-j-j-shares-appear-rangebound-over-the-last-hour-tradi,Paul Quintaro,2016-09-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.7787
708167,jj shares up over last min upside attributing to unconfirmed chatter of bill ackman stake,https://www.benzinga.com/news/16/09/8466134/j-j-shares-up-0-13-over-last-min-upside-attributing-to-unconfirmed-chatter-of-bil,Paul Quintaro,2016-09-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
708168,jjs janssen says following positive chmp opinion on ustekinumab final decision from ec expected later in ,https://www.benzinga.com/news/16/09/8465583/j-js-janssen-says-following-positive-chmp-opinion-on-ustekinumab-final-decision-f,Paul Quintaro,2016-09-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7787
708169,the market in minutes apple helps lead stocks higher,https://www.benzinga.com/news/16/09/8461169/the-market-in-5-minutes-apple-helps-lead-stocks-higher,Benzinga News Desk,2016-09-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
708170,can you guess this chart,https://www.benzinga.com/general/16/09/8461126/can-you-guess-this-chart,Spencer Israel,2016-09-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708171,jj reports who will review cos ebola vaccine regiment for eual,https://www.benzinga.com/news/16/09/8448301/j-j-reports-who-will-review-co-s-ebola-vaccine-regiment-for-eual,Paul Quintaro,2016-09-12 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.625
708172,geron following update on imetelstat,https://www.benzinga.com/news/16/09/8445273/geron-13-64-3-25-following-update-on-imetelstat,Charles Gross,2016-09-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708173,reads for the weedkend marijuana roadside testing pregnancy and depression,https://www.benzinga.com/general/biotech/16/09/8443672/reads-for-the-weed-kend-marijuana-roadside-testing-pregnancy-and-depre,Javier Hasse,2016-09-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.21405000000000002
708174,achillion pharma reports svr reported in janssens phase a trial evaluating triple combination of odalasvir al and simeprevir for genotype treatmentnaive hcv,https://www.benzinga.com/news/16/09/8440210/achillion-pharma-reports-100-svr-reported-in-janssens-phase-2a-trial-evaluating-t,Paul Quintaro,2016-09-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708175,how does amazons meteoric rise compare to those of its megacap peers,https://www.benzinga.com/general/education/16/09/8436713/how-does-amazons-meteoric-rise-compare-to-those-of-its-mega-cap-peer,Wayne Duggan,2016-09-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4871
708176,another election year view on healthcare etfs,https://www.benzinga.com/general/biotech/16/09/8434271/another-election-year-view-on-healthcare-etfs,ETF Professor,2016-09-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708177,fda orders stores to cleanse their shelves of ineffective hand soaps,https://www.benzinga.com/news/16/09/8425331/fda-orders-stores-to-cleanse-their-shelves-of-ineffective-hand-soaps,Jayson Derrick,2016-09-06 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.70095
708178,out with the old in with the new state agencies seem to prefer marijuana over opioids,https://www.benzinga.com/general/biotech/16/09/8421637/out-with-the-old-in-with-the-new-state-agencies-seem-to-prefer-marijua,Javier Hasse,2016-09-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708179,johnson johnson gets patent for ortho regenerate technologies,https://www.benzinga.com/news/16/09/8415594/johnson-johnson-gets-patent-for-ortho-regenerate-technologies,Paul Quintaro,2016-09-01 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708180,premarket prep host dennis dick tweets notable opening imbalance notable opening imbalances bac m abx k ge k jnj k veev k f k ms k c k,https://www.benzinga.com/news/16/08/8410223/pre-market-prep-host-dennis-dick-tweets-notable-opening-imbalance-notable-opening,Paul Quintaro,2016-08-31 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.24469999999999997
708181,option alert jnj fri puts wkly ask traded vs oi earnings ref,https://www.benzinga.com/news/16/08/8388312/option-alert-jnj-fri-826-119-puts-wkly-2000-ask-0-55-2398-traded-vs-1999-oi-earni,Charles Gross,2016-08-24 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.648
708182,write a prescription for more pharma ma with this etf,https://www.benzinga.com/general/biotech/16/08/8385130/write-a-prescription-for-more-pharma-m-a-with-this-etf,ETF Professor,2016-08-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708183,janssen submit european application to expand darzalex use reuters,https://www.benzinga.com/news/16/08/8381440/janssen-submit-european-application-to-expand-darzalex-use-reuters,Paul Quintaro,2016-08-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
708184,goldman sachs talks pfizers acquisition deal of medivation,https://www.benzinga.com/analyst-ratings/analyst-color/16/08/8377001/is-pfizer-finalizing-deal-to-acquire-medivation-for-14-b,Jim Swanson,2016-08-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708185,geron shares seen rangebound on lack of major data until late ,https://www.benzinga.com/analyst-ratings/analyst-color/16/08/8372822/geron-shares-seen-range-bound-on-lack-of-major-data-unti,Manikandan Raman,2016-08-19 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.4871
708186, notable stocks trading exdividend friday august ,https://www.benzinga.com/news/16/08/8370243/10-notable-stocks-trading-ex-dividend-friday-august-19,Lisa Levin,2016-08-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708187,deutsche takes a look at johnson johnsons patent woes,https://www.benzinga.com/analyst-ratings/analyst-color/16/08/8369913/deutsche-takes-a-look-at-johnson-johnsons-patent-woes,Manikandan Raman,2016-08-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.2798
708188,recent patent ruling a positive for pfizer,https://www.benzinga.com/analyst-ratings/analyst-color/16/08/8369231/recent-patent-ruling-a-positive-for-pfizer,Jayson Derrick,2016-08-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708189,johnson johnson reaffirms sales guidance for fy of not including possibility of a biosimilar launch on or after oct th ,https://www.benzinga.com/news/16/08/8363964/johnson-johnson-reaffirms-sales-guidance-for-fy16-of-3-4-not-including-possibilit,Paul Quintaro,2016-08-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708190,johnson johnson says janssen continuing appeal process in proceedings related to patent before uspto,https://www.benzinga.com/news/16/08/8363962/johnson-johnson-says-janssen-continuing-appeal-process-in-proceedings-related-to-,Paul Quintaro,2016-08-17 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.5
708191,jnj spikes to high of on volume,https://www.benzinga.com/news/16/08/8363891/jnj-spikes-to-high-of-121-19-on-volume,Charles Gross,2016-08-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708192,jjs janssen rd unit says esketamine receives breakthrough therapy designation from fda related to major depressive disorder with imminent risk for suicide,https://www.benzinga.com/news/16/08/8357386/j-js-janssen-r-d-unit-says-esketamine-receives-breakthrough-therapy-designation-f,Paul Quintaro,2016-08-16 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.051049999999999984
708193,biogen cancels out of citigroup conference following weeks of rumors,https://www.benzinga.com/news/16/08/8340086/biogen-cancels-out-of-citigroup-conference-following-weeks-of-rumors,Nicholas Donato,2016-08-11 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.38685
708194,canadas plan to fight opioid addiction might hurt its weakest patients,https://www.benzinga.com/news/16/08/8320639/canadas-plan-to-fight-opioid-addiction-might-hurt-its-weakest-patients,Javier Hasse,2016-08-08 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.07405
708195,biogen shares unaffected amid dealreporter report suggesting pfizer jj could also be looking at co,https://www.benzinga.com/news/16/08/8319616/biogen-shares-unaffected-amid-dealreporter-report-suggesting-pfizer-j-j-could-als,Paul Quintaro,2016-08-08 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.74695
708196,deutsche downgrades ligand as riskreward becomes challenging,https://www.benzinga.com/analyst-ratings/analyst-color/16/08/8313807/deutsche-downgrades-ligand-as-riskreward-becomes-challen,Manikandan Raman,2016-08-05 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.57655
708197,another jobs report bonanza big july job gains lend support to stock market,https://www.benzinga.com/news/16/08/8313148/another-jobs-report-bonanza-big-july-job-gains-lend-support-to-stock-market,The Ticker Tape,2016-08-05 00:00:00,JNJ,1,0,0,1,0,0,1,0,0,0.81245
708198, things the market is focused on this week,https://www.benzinga.com/analyst-ratings/analyst-color/16/07/8252128/3-things-the-market-is-focused-on-this-week,Jayson Derrick,2016-07-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708199,johnson johnson subsidiary acclarent to pay m to settle false claims act allegations,https://www.benzinga.com/news/16/07/8247764/johnson-johnson-subsidiary-acclarent-to-pay-18m-to-settle-false-claims-act-allega,Paul Quintaro,2016-07-22 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.44865
708200,opioid addiction what to do when a loved one is hooked according to science,https://www.benzinga.com/general/biotech/16/07/8239867/opioid-addiction-what-to-do-when-a-loved-one-is-hooked-according-to-sc,Javier Hasse,2016-07-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7997000000000001
708201,argus boosts price target on johnson johnson following strong quarter,https://www.benzinga.com/analyst-ratings/analyst-color/16/07/8237391/argus-boosts-price-target-on-johnson-johnson-following-s,Jim Swanson,2016-07-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8404
708202,option alert jnj sep calls ask traded vs oi ref,https://www.benzinga.com/news/16/07/8237307/option-alert-jnj-sep16-130-calls-2500-ask-0-41-2556-traded-vs-1057-oi-125-51-ref,Charles Gross,2016-07-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708203, biggest price target changes for wednesday,https://www.benzinga.com/analyst-ratings/price-target/16/07/8237036/7-biggest-price-target-changes-for-wednesday,Monica Gerson,2016-07-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708204,the market in minutes microsoft beat disney downgrade and donald trump,https://www.benzinga.com/news/16/07/8236474/the-market-in-5-minutes-microsoft-beat-disney-downgrade-and-donald-trump,Benzinga News Desk,2016-07-20 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5
708205,benzingas top upgrades,https://www.benzinga.com/analyst-ratings/upgrades/16/07/8236717/benzingas-top-upgrades,Monica Gerson,2016-07-20 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.60115
708206,argus research upgrades johnson johnson to buy raises pt to ,https://www.benzinga.com/news/16/07/8236107/argus-research-upgrades-johnson-johnson-to-buy-raises-pt-to-145-00,Paul Quintaro,2016-07-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708207,earnings hals tie to oil prices could set stage for quarterly loss,https://www.benzinga.com/news/earnings/16/07/8232890/earnings-hals-tie-to-oil-prices-could-set-stage-for-quarterly-loss,The Ticker Tape,2016-07-19 00:00:00,JNJ,0,1,0,1,1,1,1,0,1,0.3409
708208,stocks hitting week highs,https://www.benzinga.com/news/16/07/8232146/stocks-hitting-52-week-highs,Lisa Levin,2016-07-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708209,the market in minutes netflix earnings disappoint goldman sachs has big beat,https://www.benzinga.com/news/earnings/16/07/8231017/the-market-in-5-minutes-netflix-earnings-disappoint-goldman-sachs-has-bi,Benzinga News Desk,2016-07-19 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.29905000000000004
708210, stocks moving in tuesdays premarket session,https://www.benzinga.com/news/16/07/8231323/12-stocks-moving-in-tuesdays-pre-market-session,Monica Gerson,2016-07-19 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708211,a peek into the markets us stock futures down ahead of earnings,https://www.benzinga.com/news/earnings/16/07/8231057/a-peek-into-the-markets-u-s-stock-futures-down-ahead-of-earnings,Monica Gerson,2016-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708212,investors cheer johnson johnsons q results,https://www.benzinga.com/news/earnings/16/07/8230988/investors-cheer-johnson-johnsons-q2-results,R. Chandrasekaran,2016-07-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7553000000000001
708213,ionis pharma reports licensing of first oral antisense drug acting locally in gt tract to jjs janssen,https://www.benzinga.com/news/16/07/8230842/ionis-pharma-reports-licensing-of-first-oral-antisense-drug-acting-locally-in-gt-,Paul Quintaro,2016-07-19 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.6366
708214,johnson johnson q eps vs est revenue b vs b est,https://www.benzinga.com/news/earnings/16/07/8230682/johnson-johnson-q2-eps-1-74-vs-1-68-est-revenue-18-5b-vs-18-0b-est,Paul Quintaro,2016-07-19 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708215,keep an eye on these stocks for july ,https://www.benzinga.com/news/earnings/16/07/8230345/keep-an-eye-on-these-12-stocks-for-july-19-2016,Monica Gerson,2016-07-19 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708216,earnings scheduled for july ,https://www.benzinga.com/news/earnings/16/07/8230259/earnings-scheduled-for-july-19-2016,Monica Gerson,2016-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708217,johnson johnson dividend offers yield,https://www.benzinga.com/news/16/07/8228684/johnson-johnson-dividend-offers-2-6-yield,R. Chandrasekaran,2016-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708218,can nflx grow its subscriber base,https://www.benzinga.com/news/earnings/16/07/8227738/can-nflx-grow-its-subscriber-base,The Ticker Tape,2016-07-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708219,bank earnings keep coming in new week but economic data flow to slow,https://www.benzinga.com/news/earnings/16/07/8227462/bank-earnings-keep-coming-in-new-week-but-economic-data-flow-to-slow,The Ticker Tape,2016-07-18 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708220,the market in minutes earnings season is upon us,https://www.benzinga.com/news/16/07/8226304/the-market-in-5-minutes-earnings-season-is-upon-us,Benzinga News Desk,2016-07-18 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708221,a shark of an etf in the dividend etf tank,https://www.benzinga.com/trading-ideas/long-ideas/16/07/8225467/a-shark-of-an-etf-in-the-dividend-etf-tank,ETF Professor,2016-07-18 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.5
708222,benzingas weekend ma chatter,https://www.benzinga.com/news/16/07/8225492/benzingas-weekend-m-a-chatter,Charles Gross,2016-07-17 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708223,amazon moves cloud service focus from startups like lyft to big enterprises like netflix and capital one,https://www.benzinga.com/analyst-ratings/analyst-color/16/07/8218752/amazon-moves-cloud-service-focus-from-startups-like-lyft,Davit Kirakosyan,2016-07-14 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.8453999999999999
708224,amazons cloud services could add billion to revenue says pacific crest,https://www.benzinga.com/analyst-ratings/analyst-color/16/07/8217495/amazons-cloud-services-could-add-1-billion-to-revenue-sa,Andrew Efimoff,2016-07-14 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.4871
708225,update ciz will receive two board members from johnson johnson,https://www.benzinga.com/news/16/07/8204663/update-ci-z-will-receive-two-board-members-from-johnson-johnson,Paul Quintaro,2016-07-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708226,update a johnson johnson subsidiary will buy a stake in ciz becoming nd largest shareholder,https://www.benzinga.com/news/16/07/8204655/update-a-johnson-johnson-subsidiary-will-buy-a-19-9-stake-in-ci-z-becoming-2nd-la,Paul Quintaro,2016-07-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708227,johnson johnson to buy stake in japanese cosmetics maker,https://www.benzinga.com/news/16/07/8204653/johnson-johnson-to-buy-20-stake-in-japanese-cosmetics-maker,Paul Quintaro,2016-07-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708228,barclays morning research summary commodities comcast and healthcare in focus,https://www.benzinga.com/analyst-ratings/analyst-color/16/07/8198974/barclays-morning-research-summary-commodities-comcast-an,Manikandan Raman,2016-07-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708229,achillion shares rally following jmps upgrade to market outperform,https://www.benzinga.com/analyst-ratings/analyst-color/16/07/8194136/achillion-shares-rally-following-jmps-upgrade-to-market-,Jim Swanson,2016-07-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
708230,be aware of these key technical levels as you trade today,https://www.benzinga.com/analyst-ratings/analyst-color/16/07/8188683/be-aware-of-these-key-technical-levels-as-you-trade-toda,Spencer Israel,2016-07-06 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708231,johnson johnson subsidiary depuy orthopaedics says patients suffering from companys pinnacle metalonmetal hip implants will be heard in september,https://www.benzinga.com/news/16/07/8189416/johnson-johnson-subsidiary-depuy-orthopaedics-says-patients-suffering-from-compan,Paul Quintaro,2016-07-06 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.26165
708232,no tears in johnson johnson,https://www.benzinga.com/trading-ideas/technicals/16/06/8155518/no-tears-in-johnson-johnson,Joel Elconin,2016-06-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.26165
708233,invega trinza approved by health canada for schizophrenia,https://www.benzinga.com/news/16/06/8153353/invega-trinza-approved-by-health-canada-for-schizophrenia,Paul Quintaro,2016-06-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
708234,baird says buy cooper companies at current levels,https://www.benzinga.com/analyst-ratings/analyst-color/16/06/8149190/baird-says-buy-cooper-companies-at-current-levels,Monica Gerson,2016-06-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708235,gilead sciences get european commission grant for marketing authorization of its single tablet regimen odefsey,https://www.benzinga.com/general/biotech/16/06/8145164/gilead-sciences-get-european-commission-grant-for-marketing-authorizat,R. Chandrasekaran,2016-06-23 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.6806
708236,european commission grants marketing authorization for gileads single tablet regimen odefsey for the treatment of hiv,https://www.benzinga.com/news/16/06/8143694/european-commission-grants-marketing-authorization-for-gileads-single-tablet-regi,Paul Quintaro,2016-06-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.61315
708237,technology forces advertisers to get creative,https://www.benzinga.com/general/education/16/06/8140915/technology-forces-advertisers-to-get-creative,Wayne Duggan,2016-06-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
708238,sp index futures trading higher,https://www.benzinga.com/markets/futures/16/06/8140206/s-p-500-index-futures-trading-higher,Joel Elconin,2016-06-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708239,a peek into the markets us stock futures edge higher ahead of yellen speech,https://www.benzinga.com/news/earnings/16/06/8139029/a-peek-into-the-markets-u-s-stock-futures-edge-higher-ahead-of-yellen-sp,Monica Gerson,2016-06-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708240,johnson johnson names joseph wolk as vp of investor relations in place of louise mehrotra,https://www.benzinga.com/news/16/06/8138902/johnson-johnson-names-joseph-wolk-as-vp-of-investor-relations-in-place-of-louise-,R. Chandrasekaran,2016-06-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708241,arbutus biopharma taken off of chardans sell list,https://www.benzinga.com/analyst-ratings/analyst-color/16/06/8118472/arbutus-biopharma-taken-off-of-chardans-sell-list,Manikandan Raman,2016-06-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708242, pharmaceutical price target raises from jefferies,https://www.benzinga.com/analyst-ratings/analyst-color/16/06/8110291/5-pharmaceutical-price-target-raises-from-jefferies,Andrew Efimoff,2016-06-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708243,february earnings update,https://www.benzinga.com/news/earnings/16/06/8109073/november-9-earnings-update,The Ticker Tape,2016-06-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708244,janssen announces eprex demonstrates effectiveness as treatment for anaemia in patients with low or intermediate risk myelodysplastic syndromes at eha,https://www.benzinga.com/news/16/06/8101342/janssen-announces-eprex-demonstrates-effectiveness-as-treatment-for-anaemia-in-pa,Charles Gross,2016-06-11 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.25305
708245,johnson johnsons janssen rd reports phase pollux trial shows daratumumab achieved reduction in risk of disease progression or death compared to lenalidomide and dexamethasone alone,https://www.benzinga.com/news/16/06/8097097/johnson-johnsons-janssen-r-d-reports-phase-3-pollux-trial-shows-daratumumab-achie,Paul Quintaro,2016-06-10 00:00:00,JNJ,1,0,0,1,0,0,1,0,1,0.10470000000000002
708246,sp index futures trading lower,https://www.benzinga.com/markets/futures/16/06/8093192/s-p-500-index-futures-trading-lower,Joel Elconin,2016-06-09 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708247, key takeaways from asco,https://www.benzinga.com/analyst-ratings/analyst-color/16/06/8076107/4-key-takeaways-from-asco,Javier Hasse,2016-06-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708248,johnson johnson continues winning streak makes another new alltime high,https://www.benzinga.com/trading-ideas/technicals/16/06/8074631/johnson-johnson-continues-winning-streak-makes-another-new-al,Joel Elconin,2016-06-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.76335
708249,sp index futures trading higher,https://www.benzinga.com/markets/futures/16/06/8073636/s-p-500-index-futures-trading-higher,Joel Elconin,2016-06-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708250,amyris premarket co announced collaboration with jj on biosynthetic drug discovery,https://www.benzinga.com/news/16/06/8072976/amyris-22-premarket-0-65-co-announced-collaboration-with-j-j-on-biosynthetic-drug,Charles Gross,2016-06-06 00:00:00,JNJ,1,0,1,0,1,0,1,1,1,0.625
708251,sp index futures trading lower in choppy session,https://www.benzinga.com/markets/futures/16/06/8061921/s-p-500-index-futures-trading-lower-in-choppy-session,Joel Elconin,2016-06-02 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
708252,the market in minutes draghi iphones and warriors,https://www.benzinga.com/news/16/06/8060812/the-market-in-5-minutes-draghi-iphones-and-warriors,Benzinga News Desk,2016-06-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708253,johnson johnson announces acquisition of vogue international for b cash,https://www.benzinga.com/news/16/06/8060233/johnson-johnson-announces-acquisition-of-vogue-international-for-3-3b-cash,Paul Quintaro,2016-06-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708254,janssen pharmaceutica nv idylla ebola virus triage test granted emergency use authorization by fda reuters,https://www.benzinga.com/news/16/06/8053743/janssen-pharmaceutica-nv-idylla-ebola-virus-triage-test-granted-emergency-use-aut,Charles Gross,2016-06-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.42345
708255,the market in minutes national send a nude day,https://www.benzinga.com/news/16/05/8011960/the-market-in-5-minutes-national-send-a-nude-day,Benzinga News Desk,2016-05-20 00:00:00,JNJ,1,2,0,1,1,0,1,0,1,0.5
708256,benzingas top initiations,https://www.benzinga.com/analyst-ratings/initiation/16/05/8012172/benzingas-top-initiations,Monica Gerson,2016-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708257,standpoint research initiates coverage on johnson johnson at sell,https://www.benzinga.com/news/16/05/8011671/standpoint-research-initiates-coverage-on-johnson-johnson-at-sell,Eddie Staley,2016-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708258,one analysts top takeaways from johnson johnsons analyst day,https://www.benzinga.com/analyst-ratings/analyst-color/16/05/8010309/one-analysts-top-5-takeaways-from-johnson-johnsons-analy,Amy Weingarden,2016-05-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.60115
708259, reasons arrowhead pharma is a hepatitis b leader,https://www.benzinga.com/analyst-ratings/analyst-color/16/05/8007493/5-reasons-arrowhead-pharma-is-a-hepatitis-b-leader,Jim Swanson,2016-05-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708260,johnson johnson aligns with hp to create personalized healthcare solutions,https://www.benzinga.com/news/16/05/7995003/johnson-johnson-aligns-with-hp-to-create-personalized-healthcare-solutions,R. Chandrasekaran,2016-05-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
708261,johnson johnson hp partner on d printing technologies to reduce costs and improve healthcare,https://www.benzinga.com/news/16/05/7994461/johnson-johnson-hp-partner-on-3d-printing-technologies-to-reduce-costs-and-improv,Paul Quintaro,2016-05-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
708262,an etf that takes investors to dividend growth,https://www.benzinga.com/trading-ideas/long-ideas/16/05/7984143/an-etf-that-takes-investors-to-dividend-growth,ETF Professor,2016-05-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708263,benzingas top downgrades,https://www.benzinga.com/analyst-ratings/downgrades/16/05/7978550/benzingas-top-downgrades,Monica Gerson,2016-05-13 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
708264,what to expect this f season and which hedge funds to watch,https://www.benzinga.com/general/hedge-funds/16/05/7967794/what-to-expect-this-13f-season-and-which-hedge-funds-to-watch,Javier Hasse,2016-05-13 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708265,btig downgrades johnson johnson admits buy thesis had some hits misses,https://www.benzinga.com/analyst-ratings/analyst-color/16/05/7976532/btig-downgrades-johnson-johnson-admits-buy-thesis-had-so,Garrett Cook,2016-05-13 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5386
708266,btig research downgrades johnson johnson to neutral,https://www.benzinga.com/news/16/05/7976425/btig-research-downgrades-johnson-johnson-to-neutral,Eddie Staley,2016-05-12 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708267,jefferies updates price targets in global pharma sees rich catalyst environment ahead,https://www.benzinga.com/analyst-ratings/analyst-color/16/05/7966287/jefferies-updates-price-targets-in-global-pharma-sees-ri,Wayne Duggan,2016-05-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708268,the market in minutes dont stop me now,https://www.benzinga.com/news/16/05/7965189/the-market-in-5-minutes-dont-stop-me-now,Benzinga News Desk,2016-05-11 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.61175
708269,a trusted dividend etf,https://www.benzinga.com/trading-ideas/long-ideas/16/05/7955965/a-trusted-dividend-etf,ETF Professor,2016-05-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
708270,jjs janssen pharma unit reports received cid in mar related to contractual relationships with pharmacy benefit managers,https://www.benzinga.com/news/16/05/7957211/j-js-janssen-pharma-unit-reports-received-cid-in-mar-related-to-contractual-relat,Paul Quintaro,2016-05-10 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7294
708271,sp index futures turn lower,https://www.benzinga.com/markets/futures/16/05/7938402/s-p-500-index-futures-turn-lower,Joel Elconin,2016-05-05 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.352
708272,johnson johnson loses another court case over claims its talcum powder causes cancer,https://www.benzinga.com/news/16/05/7920407/johnson-johnson-loses-another-court-case-over-claims-its-talcum-powder-causes-can,Jayson Derrick,2016-05-03 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.11414999999999997
708273,geoinvesting says anavex life sciences stock has a book value of just ,https://www.benzinga.com/news/16/05/7914112/geoinvesting-says-anavex-life-sciences-stock-has-a-book-value-of-just-0-36,Jayson Derrick,2016-05-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.67
708274,jpmorgan doesnt see a competing bid for st jude medical downgrades to neutral,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7906520/jpmorgan-doesnt-see-a-competing-bid-for-st-jude-medical-,Jim Swanson,2016-04-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708275,johnson johnson boosts dividend by ,https://www.benzinga.com/news/16/04/7899520/johnson-johnson-boosts-dividend-by-6-7,R. Chandrasekaran,2016-04-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
708276,biotech boom may continue through earnings season,https://www.benzinga.com/general/biotech/16/04/7899411/biotech-boom-may-continue-through-earnings-season,Motif Investing,2016-04-28 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5
708277,johnson johnson raises dividend from to ,https://www.benzinga.com/news/16/04/7898592/johnson-johnson-raises-dividend-6-7-from-0-75-to-0-80,Charles Gross,2016-04-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708278, put spread strategies for the next week mcdonalds johnson johnson and nvidia,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7891930/3-put-spread-strategies-for-the-next-week-mcdonalds-john,Wayne Duggan,2016-04-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708279,whats weighing on markets aapl tech stocks,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7891382/whats-weighing-on-markets-aapl-tech-stocks,The Ticker Tape,2016-04-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708280,johnson johnson consumer inc to acquire neostrata company inc terms not disclosed,https://www.benzinga.com/news/16/04/7886553/johnson-johnson-consumer-inc-to-acquire-neostrata-company-inc-terms-not-disclosed,Paul Quintaro,2016-04-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708281,the heart of major pharma q earnings season eli lilly abbvie bristolmyers,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7878887/the-heart-of-major-pharma-q1-earnings-season-eli-lilly-a,Wayne Duggan,2016-04-25 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708282,cramer what to know about perrigo,https://www.benzinga.com/general/biotech/16/04/7873356/cramer-what-to-know-about-perrigo,Manikandan Raman,2016-04-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708283,johnson johnson makes new alltime high,https://www.benzinga.com/trading-ideas/technicals/16/04/7862215/johnson-johnson-makes-new-all-time-high,Joel Elconin,2016-04-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708284,argus research maintains buy on johnson johnson raises pt to ,https://www.benzinga.com/news/16/04/7860812/argus-research-maintains-buy-on-johnson-johnson-raises-pt-to-130-00,Eddie Staley,2016-04-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708285,buy bank of america sell jpmorgan fast money picks for april ,https://www.benzinga.com/media/cnbc/16/04/7859980/buy-bank-of-america-sell-jpmorgan-fast-money-picks-for-april-20,Craig Jones,2016-04-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708286,goldman sachs maintains neutral on johnson johnson raises pt to ,https://www.benzinga.com/news/16/04/7860401/goldman-sachs-maintains-neutral-on-johnson-johnson-raises-pt-to-114-00,Eddie Staley,2016-04-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708287,barclays maintains overweight on johnson johnson raises pt to ,https://www.benzinga.com/news/16/04/7860399/barclays-maintains-overweight-on-johnson-johnson-raises-pt-to-120-00,Eddie Staley,2016-04-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.3194
708288,all eyes on markets theyre reaching for fresh highs,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7856498/all-eyes-on-markets-theyre-reaching-for-fresh-highs,The Ticker Tape,2016-04-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
708289,johnson johnson q adjusted eps tops estimations boosts full year outlook,https://www.benzinga.com/news/earnings/16/04/7855128/johnson-johnson-q1-adjusted-eps-tops-estimations-boosts-full-year-outloo,R. Chandrasekaran,2016-04-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.8404
708290,johnson johnson sees fy eps to vs est revenue b to b vs b est,https://www.benzinga.com/news/16/04/7854931/johnson-johnson-sees-fy-2016-eps-6-53-to-6-68-vs-6-54-est-revenue-71-2b-to-71-9b-,Paul Quintaro,2016-04-19 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
708291,johnson johnson q eps vs est revenue b vs b est,https://www.benzinga.com/news/earnings/16/04/7854924/johnson-johnson-q1-eps-1-68-vs-1-65-est-revenue-17-5b-vs-17-5b-est,Paul Quintaro,2016-04-19 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708292,disney twitter and more fast money picks for april ,https://www.benzinga.com/media/cnbc/16/04/7854157/disney-twitter-and-more-fast-money-picks-for-april-19,Craig Jones,2016-04-19 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708293,keep an eye on these stocks for april ,https://www.benzinga.com/news/earnings/16/04/7854585/keep-an-eye-on-these-10-stocks-for-april-19-2016,Monica Gerson,2016-04-19 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708294,earnings scheduled for april ,https://www.benzinga.com/news/earnings/16/04/7854492/earnings-scheduled-for-april-19-2016,Monica Gerson,2016-04-19 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708295,cost efficiency and quality with this dividend etf,https://www.benzinga.com/trading-ideas/long-ideas/16/04/7849141/cost-efficiency-and-quality-with-this-dividend-etf,ETF Professor,2016-04-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6806
708296,flextronics hires john carlson as president for flex medical solutions,https://www.benzinga.com/news/16/04/7852215/flextronics-hires-john-carlson-as-president-for-flex-medical-solutions,R. Chandrasekaran,2016-04-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.58895
708297,earnings ibm nflx gs and jnj join the earnings parade,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7851635/earnings-ibm-nflx-gs-and-jnj-join-the-earnings-parade,The Ticker Tape,2016-04-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.648
708298,notable imbalances before fridays open telecom pair trade health care stocks in focus,https://www.benzinga.com/news/16/04/7845033/notable-imbalances-before-fridays-open-telecom-pair-trade-health-care-stocks-in-f,Jayson Derrick,2016-04-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.74695
708299,johnson johnson approaches alltime high,https://www.benzinga.com/markets/futures/16/04/7841508/johnson-johnson-approaches-all-time-high,Joel Elconin,2016-04-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708300,new tax inversions rules threats to healthcare etfs,https://www.benzinga.com/etfs/sector-etfs/16/04/7810319/new-tax-inversions-rules-threats-to-healthcare-etfs,Zacks,2016-04-06 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.28925
708301,pph may be home to hedge fund hotels but this etf can endure,https://www.benzinga.com/general/biotech/16/04/7807835/pph-may-be-home-to-hedge-fund-hotels-but-this-etf-can-endure,ETF Professor,2016-04-06 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708302,socgen picks new favorites in big pharma,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7810497/socgen-picks-new-favorites-in-big-pharma,Manikandan Raman,2016-04-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
708303, options trades goldman is watching with catalysts coming,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7810122/3-options-trades-goldman-is-watching-with-catalysts-comi,Jim Swanson,2016-04-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708304,societe generale initiates coverage on johnson johnson at hold,https://www.benzinga.com/news/16/04/7810188/societe-generale-initiates-coverage-on-johnson-johnson-at-hold,Eddie Staley,2016-04-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708305,pfizer receives fda approval for cheaper version of johnson johnsons top drug remicade,https://www.benzinga.com/news/16/04/7809844/pfizer-receives-fda-approval-for-cheaper-version-of-johnson-johnsons-top-drug-rem,Jayson Derrick,2016-04-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7997000000000001
708306,goldman offers options trades for upcoming catalyst in amg jnj lpla,https://www.benzinga.com/analyst-ratings/analyst-color/16/04/7808404/goldman-offers-3-options-trades-for-upcoming-catalyst-in,Paul Quintaro,2016-04-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708307,johnson johnson launches new global public health strategy,https://www.benzinga.com/news/16/04/7808023/johnson-johnson-launches-new-global-public-health-strategy,Charles Gross,2016-04-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708308,fda approved inflectra infliximabdyyb for multiple indications shares of jnj maker of remicade sell off on news,https://www.benzinga.com/news/16/04/7805606/fda-approved-inflectra-infliximab-dyyb-for-multiple-indications-shares-of-jnj-mak,Charles Gross,2016-04-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.8062
708309,inflectra biosimilar to johnson and johnsons remicade approved by fda shares fell to after hours before trading up back at share,https://www.benzinga.com/news/16/04/7805598/inflectra-biosimilar-to-johnson-and-johnsons-remicade-approved-by-fda-shares-fell,Hal Lindon,2016-04-05 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.86755
708310,sp index futures trading lower,https://www.benzinga.com/trading-ideas/technicals/16/04/7803382/s-p-500-index-futures-trading-lower,Joel Elconin,2016-04-05 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708311,genmab announces patent infringement suit against co janssen in us related to darzalex,https://www.benzinga.com/news/16/04/7797598/genmab-announces-patent-infringement-suit-against-co-janssen-in-us-related-to-dar,Paul Quintaro,2016-04-04 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.26165
708312,morphosys sues janssen biotech and genmab for patent infringement,https://www.benzinga.com/news/16/04/7796792/morphosys-sues-janssen-biotech-and-genmab-for-patent-infringement,Charles Gross,2016-04-04 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.26165
708313,make a house call with a familiar healthcare etf,https://www.benzinga.com/general/biotech/16/04/7794107/make-a-house-call-with-a-familiar-healthcare-etf,ETF Professor,2016-04-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708314,eu medicines agency recommends approval of jnj genmab ass daratumimab,https://www.benzinga.com/news/16/04/7789743/eu-medicines-agency-recommends-approval-of-jnj-genmab-ass-daratumimab,Paul Quintaro,2016-04-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5640000000000001
708315,correction janssen announces discontinuation of fulranumab phase development program in osteoarthritis pain,https://www.benzinga.com/news/16/03/7785841/correction-janssen-announces-discontinuation-of-fulranumab-phase-3-development-pr,Paul Quintaro,2016-03-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.24469999999999997
708316,janssen announces discontinuation of fulranumab phase development program in osteoarthritis pain,https://www.benzinga.com/news/16/03/7785811/johnson-johnson-announces-discontinuation-of-fulranumab-phase-3-development-progr,Paul Quintaro,2016-03-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.24469999999999997
708317,johnson johnson approaches alltime high,https://www.benzinga.com/trading-ideas/technicals/16/03/7751434/johnson-johnson-approaches-all-time-high,Joel Elconin,2016-03-23 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708318,update janssen research development llc signs clinical trial collaboration with roche group memeber genentech,https://www.benzinga.com/news/16/03/7740336/update-janssen-research-development-llc-signs-clinical-trial-collaboration-with-r,Paul Quintaro,2016-03-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708319,janssen announces initiation of studies evaluating daratumumab atezolizumab in multiple myeloma solid tumor,https://www.benzinga.com/news/16/03/7740333/janssen-announces-initiation-of-2-studies-evaluating-daratumumab-atezolizumab-in-,Paul Quintaro,2016-03-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.375
708320,johnson johnson phase data shows treatment w stelara induced clinical response and clinical remission,https://www.benzinga.com/news/16/03/7732826/johnson-johnson-phase-3-data-shows-treatment-w-stelara-induced-clinical-response-,Paul Quintaro,2016-03-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708321,jj unit says to appeal jury verdicts in ultamet metalonmetal hip trial dj,https://www.benzinga.com/news/16/03/7729659/j-j-unit-says-to-appeal-jury-verdicts-in-ultamet-metal-on-metal-hip-trial-dj,Charles Gross,2016-03-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6591
708322,dallas jury awards nearly million against jj unit in bellwether hip implant trial,https://www.benzinga.com/news/16/03/7729238/dallas-jury-awards-nearly-500-million-against-j-j-unit-in-bellwether-hip-implant-,Hal Lindon,2016-03-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.8062
708323,option alert jnj mar puts sweep ask traded vs oi earnings before open ref,https://www.benzinga.com/news/16/03/7728998/option-alert-jnj-mar16-106-puts-sweep-1000-ask-0-18-1525-traded-vs-2546-oi-earnin,Charles Gross,2016-03-17 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.648
708324,benzingas top upgrades,https://www.benzinga.com/analyst-ratings/upgrades/16/03/7704829/benzingas-top-upgrades,Monica Gerson,2016-03-14 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.60115
708325,goldman upgrades johnson johnson removes from americas sell list,https://www.benzinga.com/analyst-ratings/analyst-color/16/03/7704491/goldman-upgrades-johnson-johnson-removes-from-americas-s,Monica Gerson,2016-03-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708326,goldman sachs says jj conglomerate structure has caused shareholder value to be trapped goldman continues to advocate for a breakup of co to maximize value,https://www.benzinga.com/analyst-ratings/analyst-color/16/03/7703707/goldman-sachs-says-j-j-conglomerate-structure-has-caused,Paul Quintaro,2016-03-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.67
708327,goldman sachs upgrades johnson johnson to neutral raises pt to ,https://www.benzinga.com/news/16/03/7703695/goldman-sachs-upgrades-johnson-johnson-to-neutral-raises-pt-to-112-00,Eddie Staley,2016-03-14 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708328,the market in minutes tuesday march ,https://www.benzinga.com/analyst-ratings/analyst-color/16/03/7627914/the-market-in-5-minutes-tuesday-march-8-2016,Benzinga News Desk,2016-03-08 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708329,sumoftheparts analysis suggests jj stock price of ,https://www.benzinga.com/analyst-ratings/analyst-color/16/03/7625309/sum-of-the-parts-analysis-suggests-j-j-stock-price-of-12,Monica Gerson,2016-03-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708330,the other sector etf player,https://www.benzinga.com/trading-ideas/long-ideas/16/03/7177621/the-other-sector-etf-player,ETF Professor,2016-03-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708331,a winning dividend etf idea for march,https://www.benzinga.com/trading-ideas/long-ideas/16/03/6792276/a-winning-dividend-etf-idea-for-march,ETF Professor,2016-03-03 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.76335
708332,pg reports divestiture of hipoglos brand to jj consumer no terms disclosed,https://www.benzinga.com/news/16/03/6780468/p-g-reports-divestiture-of-hipoglos-brand-to-j-j-consumer-no-terms-disclosed,Paul Quintaro,2016-03-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4742
708333,galapagos shares premarket co announced transparency notification from jnj on tuesday,https://www.benzinga.com/news/16/03/6778921/galapagos-shares-0-58-premarket-43-37-co-announced-transparency-notification-from,Charles Gross,2016-03-02 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.648
708334,watch pharma names following fda issuance of new mandatory clinical study for bayers essure requires product labeling including box warnings and patient decision checklist,https://www.benzinga.com/news/16/02/6754078/watch-pharma-names-following-fda-issuance-of-new-mandatory-clinical-study-for-bay,Paul Quintaro,2016-02-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.38685
708335,cramer says he likes bargain stores its all about value,https://www.benzinga.com/analyst-ratings/analyst-color/16/02/6703120/cramer-says-he-likes-bargain-stores-its-all-about-value,Javier Hasse,2016-02-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8592
708336,option alert jnj fri calls wkly ask traded vs oi earnings ref,https://www.benzinga.com/markets/options/16/02/6696467/option-alert-jnj-fri-34-106-calls-wkly-4000-ask-0-86-4024-traded-vs-86,Charles Gross,2016-02-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708337,love this low volatility dividend etf,https://www.benzinga.com/trading-ideas/long-ideas/16/02/6658023/love-this-low-volatility-dividend-etf,ETF Professor,2016-02-25 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.7383500000000001
708338,jj selling m galapagos sharesbbg,https://www.benzinga.com/news/16/02/6498866/j-j-selling-2-5m-galapagos-shares-bbg,Hal Lindon,2016-02-22 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.625
708339,should johnson johnson break up,https://www.benzinga.com/analyst-ratings/analyst-color/16/02/6493770/should-johnson-johnson-break-up,Jim Swanson,2016-02-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708340,morgan stanley says johnson johnson could possibly operate better if broken up cautions breakup unlikely to resonate with investors,https://www.benzinga.com/analyst-ratings/analyst-color/16/02/6490370/morgan-stanley-says-johnson-johnson-could-possibly-opera,Paul Quintaro,2016-02-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.4742
708341,new dividend etf proves to be a worthy hideout,https://www.benzinga.com/trading-ideas/long-ideas/16/02/6373535/new-dividend-etf-proves-to-be-a-worthy-hideout,ETF Professor,2016-02-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
708342,sp index futures treading water,https://www.benzinga.com/markets/futures/16/02/6387317/s-p-500-index-futures-treading-water,Joel Elconin,2016-02-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708343,everything you might have missed this f season part ,https://www.benzinga.com/trading-ideas/long-ideas/16/02/6358353/everything-you-might-have-missed-this-13f-season-part-2,Javier Hasse,2016-02-17 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.352
708344,the stocks that moved the sp dow and nasdaq yesterday,https://www.benzinga.com/top-stories/16/02/6261301/the-stocks-that-moved-the-s-p-dow-and-nasdaq-yesterday,Javier Hasse,2016-02-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708345,the generic drug battle,https://www.benzinga.com/general/biotech/16/02/6238597/the-generic-drug-battle,Laura Brodbeck,2016-02-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
708346,fda panel has backed approval of celltrions biosimilar version of jjs remicade,https://www.benzinga.com/news/16/02/6237160/fda-panel-has-backed-approval-of-celltrions-biosimilar-version-of-j-js-remicade,Paul Quintaro,2016-02-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708347,icahn gilead ge lead top insider trades of the week,https://www.benzinga.com/news/16/02/6226582/icahn-gilead-ge-lead-top-insider-trades-of-the-week,TipRanks,2016-02-09 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.60115
708348,how to invest in an aging world with the live long prosper etf,https://www.benzinga.com/trading-ideas/long-ideas/16/02/6227065/how-to-invest-in-an-aging-world-with-the-live-long-prosper-et,Wayne Duggan,2016-02-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708349,sp index futures sharply lower,https://www.benzinga.com/trading-ideas/technicals/16/02/6226798/s-p-500-index-futures-sharply-lower,Joel Elconin,2016-02-08 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
708350,a checkup on a big healthcare etf,https://www.benzinga.com/analyst-ratings/analyst-color/16/02/6218736/a-checkup-on-a-big-healthcare-etf,ETF Professor,2016-02-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708351,how to build a defensive portfolio,https://www.benzinga.com/general/education/16/02/6216146/how-to-build-a-defensive-portfolio,Motif Investing,2016-02-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5129
708352,bull market bear market or just a trading range,https://www.benzinga.com/trading-ideas/long-ideas/16/02/6187759/bull-market-bear-market-or-just-a-trading-range,Joel Elconin,2016-02-01 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708353,warm up with this low volatility etf,https://www.benzinga.com/analyst-ratings/analyst-color/16/02/6191502/warm-up-with-this-low-volatility-etf,ETF Professor,2016-02-01 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.43915
708354,benzingas ma chatter for thursday january ,https://www.benzinga.com/news/16/01/6184545/benzingas-m-a-chatter-for-thursday-january-28-2015,Charles Gross,2016-01-28 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708355, biotech traders pick their favorite stocks for ,https://www.benzinga.com/general/biotech/16/01/6183291/7-biotech-traders-pick-their-favorite-stocks-for-2016,ClosingBell,2016-01-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7294
708356,large johnson johnson shareholder just revealed major concerns,https://www.benzinga.com/analyst-ratings/analyst-color/16/01/6181405/large-johnson-johnson-shareholder-just-revealed-8-major-,Jayson Derrick,2016-01-28 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
708357,stocks to play in a zika virus pandemic,https://www.benzinga.com/general/biotech/16/01/6180568/stocks-to-play-in-a-zika-virus-pandemic,Wayne Duggan,2016-01-28 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.67
708358,trxc bidding war ramping up according to report jnjgoogl both focused on trxc according to moneymorning report,https://www.benzinga.com/news/16/01/6180710/trxc-bidding-war-ramping-up-according-to-report-jnjgoogl-both-focused-on-trxc-acc,Paul Quintaro,2016-01-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3409
708359,hearing unconfirmed market chatter of potential jnj deal to acquire glaxosmithkline,https://www.benzinga.com/news/16/01/6180049/hearing-unconfirmed-market-chatter-of-potential-jnj-deal-to-acquire-glaxosmithkli,Charles Gross,2016-01-28 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.436
708360,artisan partners urges jj to adopt new publiclydisclosed financial targets for medical devices consumer businesses,https://www.benzinga.com/news/16/01/6179268/artisan-partners-urges-j-j-to-adopt-new-publicly-disclosed-financial-targets-for-,Charles Gross,2016-01-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
708361,update artisan partners global values daniel okeefe sends letter to jj board,https://www.benzinga.com/news/16/01/6179252/update-artisan-partners-global-values-daniel-okeefe-sends-letter-to-j-j-board,Paul Quintaro,2016-01-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
708362,artisan partners global values daniel okeefe sends letter to jj board,https://www.benzinga.com/news/16/01/6179242/artisan-partners-global-values-daniel-okeefe-sends-letter-to-j-j-board,Paul Quintaro,2016-01-28 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.7859499999999999
708363,update ft article citing a source speculates on turnaround catalyst for jnjs recent poor performance,https://www.benzinga.com/news/16/01/6175525/update-ft-article-citing-a-source-speculates-on-turnaround-catalyst-for-jnjs-rece,Paul Quintaro,2016-01-27 00:00:00,JNJ,1,1,0,1,1,0,1,1,1,0.26165
708364,johnson johnson shares steadily gain over past min reports shareholders pushing activists for shake up,https://www.benzinga.com/news/16/01/6175520/johnson-johnson-shares-steadily-gain-over-past-20-min-reports-shareholders-pushin,Paul Quintaro,2016-01-27 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7997000000000001
708365,johnson johnson continues to rally,https://www.benzinga.com/trading-ideas/technicals/16/01/6174794/johnson-johnson-continues-to-rally,Joel Elconin,2016-01-27 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708366,sp index futures lower,https://www.benzinga.com/trading-ideas/technicals/16/01/6174722/s-p-500-index-futures-lower,Joel Elconin,2016-01-27 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708367,earnings recap for january ,https://www.benzinga.com/news/earnings/16/01/6172292/earnings-recap-for-january-26,Javier Hasse,2016-01-26 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708368,sp index futures sharply higher,https://www.benzinga.com/trading-ideas/technicals/16/01/6171578/s-p-500-index-futures-sharply-higher,Joel Elconin,2016-01-26 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708369,no shortage of stock drivers oil swivels fed meets apple reports,https://www.benzinga.com/news/earnings/16/01/6170766/no-shortage-of-stock-drivers-oil-swivels-fed-meets-apple-reports,The Ticker Tape,2016-01-26 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.25305
708370,johnson and johnson sees fy eps to vs est revenue b to b vs b est,https://www.benzinga.com/news/16/01/6169296/johnson-and-johnson-sees-fy-eps-6-43-to-6-58-vs-6-38-est-revenue-70-8b-to-71-5b-v,Paul Quintaro,2016-01-26 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
708371,johnson and johnson q eps vs est revenue b vs b est,https://www.benzinga.com/news/earnings/16/01/6169287/johnson-and-johnson-q4-eps-1-44-vs-1-42-est-revenue-17-8b-vs-17-9b-est,Paul Quintaro,2016-01-26 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708372, stocks you should be watching today,https://www.benzinga.com/news/earnings/16/01/6169016/7-stocks-you-should-be-watching-today,Monica Gerson,2016-01-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708373,earnings scheduled for january ,https://www.benzinga.com/news/earnings/16/01/6169008/earnings-scheduled-for-january-26-2016,Monica Gerson,2016-01-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708374,jnj kicks off health care earningswhat about deals buybacks,https://www.benzinga.com/news/earnings/16/01/6166994/jnj-kicks-off-health-care-earnings-what-about-deals-buybacks,The Ticker Tape,2016-01-25 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.74695
708375,us big pharma what to watch for in q results,https://www.benzinga.com/analyst-ratings/analyst-color/16/01/6166545/us-big-pharma-what-to-watch-for-in-q4-results,Wayne Duggan,2016-01-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708376,johnson johnson details billion cost saving initiative for its medical devices segment will deliver more value to customers,https://www.benzinga.com/news/16/01/6152911/johnson-johnson-details-1-billion-cost-saving-initiative-for-its-medical-devices-,Jayson Derrick,2016-01-19 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.70025
708377,najarian brothers see unusual activity in johnson johnson and cisco systems inc,https://www.benzinga.com/media/cnbc/16/01/6153026/najarian-brothers-see-unusual-activity-in-johnson-johnson-and-cisco-systems,Craig Jones,2016-01-19 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708378,johnson johnson restructures medical devices unit sees nearly billion in annual cost savings,https://www.benzinga.com/news/16/01/6152368/johnson-johnson-restructures-medical-devices-unit-sees-nearly-1-billion-in-annual,Jennifer Lynn,2016-01-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708379,update jj reaffirms fy adj eps outlook of vs est sales bb vs b est,https://www.benzinga.com/news/16/01/6150955/update-j-j-reaffirms-fy15-adj-eps-outlook-of-6-15-6-20-vs-6-18-est-sales-70b-71b-,Paul Quintaro,2016-01-19 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.625
708380,update jj restructuring related to medical devices unit consumer medical devices vision care diabetes care units will not be impacted by restructuring,https://www.benzinga.com/news/16/01/6150953/update-j-j-restructuring-related-to-medical-devices-unit-consumer-medical-devices,Paul Quintaro,2016-01-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,0,0.9277500000000001
708381,jj shares indicated higher co announced restructuring with projected annualized pretax cost savings mb sees bb charge affirms fy outlook,https://www.benzinga.com/news/16/01/6150952/j-j-shares-indicated-1-25-higher-co-announced-restructuring-with-projected-annual,Paul Quintaro,2016-01-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.74695
708382,dividend aristocrats etf joins the billion club,https://www.benzinga.com/trading-ideas/long-ideas/16/01/6145260/dividend-aristocrats-etf-joins-the-1-billion-club,ETF Professor,2016-01-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708383,write a prescription for this healthcare etf,https://www.benzinga.com/general/biotech/16/01/6145257/write-a-prescription-for-this-healthcare-etf,ETF Professor,2016-01-15 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708384, different ways to play the bear market from traders,https://www.benzinga.com/analyst-ratings/analyst-color/16/01/6144087/11-different-ways-to-play-the-bear-market-from-11-trader,Jake Mann,2016-01-14 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.67
708385,how will dividend stocks perform this year,https://www.benzinga.com/trading-ideas/long-ideas/16/01/6142191/how-will-dividend-stocks-perform-this-year,Laura Brodbeck,2016-01-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708386,jjs janssen reports health canada has approved stelara for treatment of chronic moderatetosevere plaque psoriasis in adolescents,https://www.benzinga.com/news/16/01/6138609/j-js-janssen-reports-health-canada-has-approved-stelara-for-treatment-of-chronic-,Paul Quintaro,2016-01-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
708387,chemdiv achieves development milestone in drug recovery collaboration with janssen,https://www.benzinga.com/news/16/01/6132864/chemdiv-achieves-development-milestone-in-drug-recovery-collaboration-with-jansse,Paul Quintaro,2016-01-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708388,for this low vol etf its not all about sector selection,https://www.benzinga.com/trading-ideas/long-ideas/16/01/6126497/for-this-low-vol-etf-its-not-all-about-sector-selection,ETF Professor,2016-01-08 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.3634
708389,sino biopharmaceutical says chia taitianqing pharmaceutical entered into exclusive license agreement with janssen pharmaceuticals under johnson johnson reuters,https://www.benzinga.com/news/16/01/6126816/sino-biopharmaceutical-says-chia-tai-tianqing-pharmaceutical-entered-into-exclusi,Charles Gross,2016-01-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7859499999999999
708390,johnson and johnson along with janssen agree to develop and commercialize hbv treatments with chia tai,https://www.benzinga.com/news/16/01/6123354/johnson-and-johnson-along-with-janssen-agree-to-develop-and-commercialize-hbv-tre,Hal Lindon,2016-01-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6806
708391,apple is the second cheapest megacap on a free cash flow basis,https://www.benzinga.com/general/education/16/01/6121364/apple-is-the-second-cheapest-mega-cap-on-a-free-cash-flow-basis,Jake Mann,2016-01-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7553000000000001
708392,the two best sector spdr etfs for january,https://www.benzinga.com/trading-ideas/long-ideas/16/01/6088089/the-two-best-sector-spdr-etfs-for-january,ETF Professor,2016-01-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
708393,a sound etf idea for ,https://www.benzinga.com/trading-ideas/long-ideas/15/12/6078556/a-sound-etf-idea-for-2016,ETF Professor,2015-12-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708394,hearing kentucky attorney general announcing settlement related to purdue pharma jjs janssen case related to oxycontin risperdal,https://www.benzinga.com/news/15/12/6072198/hearing-kentucky-attorney-general-announcing-settlement-related-to-purdue-pharma-,Paul Quintaro,2015-12-23 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.5
708395,not all of clintons policies are bad for pharmaceuticals,https://www.benzinga.com/general/biotech/15/12/6070719/not-all-of-clintons-policies-are-bad-for-pharmaceuticals,Laura Brodbeck,2015-12-23 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.22885
708396,peering through the fog to find the best sectors into year end,https://www.benzinga.com/trading-ideas/long-ideas/15/12/6071250/peering-through-the-fog-to-find-the-best-sectors-into-year-en,Greg Harmon,2015-12-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
708397,intrexon to partner with johnson johnson for type diabetes innovative therapies,https://www.benzinga.com/news/15/12/6067712/intrexon-to-partner-with-johnson-johnson-for-type-2-diabetes-innovative-therapies,Hal Lindon,2015-12-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
708398,medivir announces development of al terminated by janssen following completion of phase i clinical studies,https://www.benzinga.com/news/15/12/6063989/medivir-announces-development-of-al-704-terminated-by-janssen-following-completio,Charles Gross,2015-12-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708399,dan nathan reduces risk on his utilities spdr etf trade,https://www.benzinga.com/media/cnbc/15/12/6063224/dan-nathan-reduces-risk-on-his-utilities-spdr-etf-trade,Craig Jones,2015-12-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.3634
708400,credit suisse offers us largecap pharma outlook,https://www.benzinga.com/analyst-ratings/analyst-color/15/12/6061487/credit-suisse-offers-2016-u-s-large-cap-pharma-outlook,Jayson Derrick,2015-12-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708401,atlantic equities initiates coverage on johnson johnson at neutral announces pt,https://www.benzinga.com/news/15/12/6060410/atlantic-equities-initiates-coverage-on-johnson-johnson-at-neutral-announces-95-0,Paul Quintaro,2015-12-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708402,janney lists top bond surrogate stocks by sector identified by beta dividend yield and forward pe,https://www.benzinga.com/analyst-ratings/analyst-color/15/12/6054408/janney-lists-top-bond-surrogate-stocks-by-sector-identif,Eddie Staley,2015-12-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708403,jj reports formation of verb surgical,https://www.benzinga.com/news/15/12/6036948/j-j-reports-formation-of-verb-surgical,Paul Quintaro,2015-12-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.625
708404,jjs janssen issues release showing imbruvica resonate data demonstrated significant improvements in progressionfree overall survival vs chlorambucil,https://www.benzinga.com/news/15/12/6029897/j-js-janssen-issues-release-showing-imbruvica-resonate-2-data-demonstrated-signif,Paul Quintaro,2015-12-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
708405,sp index futures under pressure,https://www.benzinga.com/trading-ideas/technicals/15/12/6026701/s-p-500-index-futures-under-pressure,Joel Elconin,2015-12-07 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.352
708406,carter worth and mike khouws johnson johnson trade,https://www.benzinga.com/media/cnbc/15/12/6024613/carter-worth-and-mike-khouws-johnson-johnson-trade,Craig Jones,2015-12-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
708407,barclays biopharmaceuticals blueprint for ,https://www.benzinga.com/analyst-ratings/analyst-color/15/12/6011335/barclays-biopharmaceuticals-blueprint-for-2016,Jayson Derrick,2015-12-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708408,benzingas top upgrades,https://www.benzinga.com/analyst-ratings/upgrades/15/12/6011813/benzingas-top-upgrades,Lisa Levin,2015-12-01 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.60115
708409,jjs steady cash flow is key barclays upgrades to overweight,https://www.benzinga.com/analyst-ratings/analyst-color/15/12/6011561/j-js-steady-cash-flow-is-key-barclays-upgrades-to-overwe,Jim Swanson,2015-12-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3194
708410,us stock futures signal higher start on wall street,https://www.benzinga.com/news/15/12/6011104/us-stock-futures-signal-higher-start-on-wall-street,Monica Gerson,2015-12-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708411,barclays upgrades johnson johnson to overweight raises pt to ,https://www.benzinga.com/news/15/12/6010830/barclays-upgrades-johnson-johnson-to-overweight-raises-pt-to-115-00,Charles Gross,2015-12-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.3194
708412,a look at investment firms favorite stocks in q,https://www.benzinga.com/analyst-ratings/analyst-color/15/11/5995729/a-look-at-investment-firms-favorite-stocks-in-q3,Javier Hasse,2015-11-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7294
708413, value stocks for investors worried about risk,https://www.benzinga.com/trading-ideas/long-ideas/15/11/5979988/8-value-stocks-for-investors-worried-about-risk,Laura Brodbeck,2015-11-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.38685
708414,hanmi pharmaceuticals signs an exclusive license agreement with janssen to develop treatment for diabetes obesity,https://www.benzinga.com/news/15/11/5968289/hanmi-pharmaceuticals-signs-an-exclusive-license-agreement-with-janssen-to-develo,Charles Gross,2015-11-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7859499999999999
708415,goldmans first etf is off to a stellar start,https://www.benzinga.com/trading-ideas/long-ideas/15/11/5965762/goldmans-first-etf-is-off-to-a-stellar-start,ETF Professor,2015-11-06 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5
708416,johnson amp johnson to acquire novira therapeutics financial terms not dislcosed,https://www.benzinga.com/news/15/11/5960971/johnson-amp-johnson-to-acquire-novira-therapeutics-financial-terms-not-dislcosed,Charles Gross,2015-11-04 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708417,sp index futures unchanged,https://www.benzinga.com/markets/futures/15/11/5960755/s-p-500-index-futures-unchanged,Joel Elconin,2015-11-04 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708418,johnson johnson moves up,https://www.benzinga.com/trading-ideas/technicals/15/10/5950880/johnson-johnson-moves-up,Joel Elconin,2015-10-29 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.5
708419,aduro biotech announces received upfront m milestone payment from jjs janssen for acceptance of ind app for adu in lung cancer,https://www.benzinga.com/news/15/10/5949793/aduro-biotech-announces-received-up-front-30m-milestone-payment-from-j-js-janssen,Paul Quintaro,2015-10-29 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.32999999999999996
708420,genmab announces m milestone payment in duobody platform collaboration with janssen,https://www.benzinga.com/news/15/10/5941433/genmab-announces-3m-milestone-payment-in-duobody-platform-collaboration-with-jans,Charles Gross,2015-10-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708421,some new multifactor etfs look appealing,https://www.benzinga.com/analyst-ratings/analyst-color/15/10/5933309/some-new-multi-factor-etfs-look-appealing,ETF Professor,2015-10-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708422,counting on quality with etfs,https://www.benzinga.com/trading-ideas/long-ideas/15/10/5922372/counting-on-quality-with-etfs,ETF Professor,2015-10-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708423,jjs janssen reports rd segment showed uniti study meet primary endpoint major secondary endpoints showed clinical remission significantly higher than placebo,https://www.benzinga.com/news/15/10/5923247/j-js-janssen-reports-r-d-segment-showed-uniti-2-study-meet-primary-endpoint-major,Paul Quintaro,2015-10-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708424,hearing jjs stelara for crohns disease showed clinical response statistically higher remission for candidate than placebo,https://www.benzinga.com/news/15/10/5923174/hearing-j-js-stelara-for-crohns-disease-showed-clinical-response-statistically-hi,Paul Quintaro,2015-10-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708425,achillion announces janssen initiated phase a study to evaluate combination of al ach and simeprevir for treatment of genotype chronic hcv,https://www.benzinga.com/news/15/10/5919336/achillion-announces-janssen-initiated-phase-2a-study-to-evaluate-combination-of-a,Charles Gross,2015-10-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708426,jjs janssen reports collaboration deal with novera for acceleration of development of promising small molecule drug candidates for hematological cancers,https://www.benzinga.com/news/15/10/5911685/j-js-janssen-reports-collaboration-deal-with-novera-for-acceleration-of-developme,Paul Quintaro,2015-10-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
708427,engene announces strategic collaboration with johnson johnson innovation to develop novel gene delivery products for inflammatory bowel disease,https://www.benzinga.com/news/15/10/5911684/engene-announces-strategic-collaboration-with-johnson-johnson-innovation-to-devel,Paul Quintaro,2015-10-14 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7997000000000001
708428,midafternoon market update ryder system declines on lowered forecast newbridge bancorp shares spike higher,https://www.benzinga.com/news/earnings/15/10/5909575/mid-afternoon-market-update-ryder-system-declines-on-lowered-forecast-ne,Lisa Levin,2015-10-13 00:00:00,JNJ,1,1,1,1,0,1,0,1,1,0.58895
708429,johnson johnson sales fall what the street is saying now,https://www.benzinga.com/analyst-ratings/analyst-color/15/10/5908947/johnson-johnson-sales-fall-what-the-street-is-saying-now,Wayne Duggan,2015-10-13 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.5
708430,midday market update wausau paper jumps on acquisition news aixtron shares slide,https://www.benzinga.com/news/earnings/15/10/5909056/mid-day-market-update-wausau-paper-jumps-on-acquisition-news-aixtron-sha,Lisa Levin,2015-10-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
708431,midmorning market update markets down johnson johnson posts mixed q results,https://www.benzinga.com/news/earnings/15/10/5908509/mid-morning-market-update-markets-down-johnson-johnson-posts-mixed-q3-re,Lisa Levin,2015-10-13 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
708432,johnson johnson posts upbeat q earnings but sales drop,https://www.benzinga.com/news/earnings/15/10/5907635/johnson-johnson-posts-upbeat-q3-earnings-but-sales-drop,Monica Gerson,2015-10-13 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.30405
708433,johnson johnson reports q adj eps vs est ,https://www.benzinga.com/news/earnings/15/10/5907448/johnson-johnson-reports-q3-adj-eps-1-49-vs-est-1-45,Paul Quintaro,2015-10-13 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708434,jj raises fy eps to vs est,https://www.benzinga.com/news/15/10/5907423/j-j-raises-fy15-eps-to-6-15-6-20-vs-6-16-est,Paul Quintaro,2015-10-13 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.625
708435,us stock futures down jpmorgan earnings in focus,https://www.benzinga.com/news/15/10/5907418/us-stock-futures-down-jpmorgan-earnings-in-focus,Monica Gerson,2015-10-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708436,jj reports q eps sales b vs b est,https://www.benzinga.com/news/earnings/15/10/5907409/j-j-reports-q3-eps-1-20-vs-1-45-est-sales-17-1b-vs-17-5b-est,Paul Quintaro,2015-10-13 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.625
708437,jnj announces b share buyback program,https://www.benzinga.com/news/15/10/5907190/jnj-announces-10b-share-buyback-program,Charles Gross,2015-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708438,jj announces b buyback plan,https://www.benzinga.com/news/15/10/5907187/j-j-announces-10b-buyback-plan,Paul Quintaro,2015-10-13 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.625
708439, stocks you should be watching today,https://www.benzinga.com/news/earnings/15/10/5906940/7-stocks-you-should-be-watching-today,Monica Gerson,2015-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708440,earnings scheduled for october ,https://www.benzinga.com/news/earnings/15/10/5906848/earnings-scheduled-for-october-13-2015,Monica Gerson,2015-10-13 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708441,johnson johnson is first of big pharma earnings reports will price debate dominate,https://www.benzinga.com/general/biotech/15/10/5905520/johnson-johnson-is-first-of-big-pharma-earnings-reports-will-price-deb,The Ticker Tape,2015-10-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.436
708442,johnson amp johnson announces start of safety and immunogenicity clinical trial of ebola vaccine regimen in sierra leone,https://www.benzinga.com/news/15/10/5900915/johnson-amp-johnson-announces-start-of-safety-and-immunogenicity-clinical-trial-o,Charles Gross,2015-10-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
708443,benzingas ma chatter for wednesday october ,https://www.benzinga.com/news/15/10/5896361/benzingas-m-a-chatter-for-wednesday-october-7-2015,Charles Gross,2015-10-07 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708444,singapore ministry of health convenes independent review committee on report of cluster of acute cases of hepatitis c among kidney patients reuters,https://www.benzinga.com/news/15/10/5890622/singapore-ministry-of-health-convenes-independent-review-committee-on-report-of-c,Charles Gross,2015-10-06 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708445,earnings outlook is street already positioned for same story of global woes oil stain,https://www.benzinga.com/trading-ideas/previews/15/10/5888065/earnings-outlook-is-street-already-positioned-for-same-story-of,TD Ameritrade,2015-10-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2798
708446,energy weakness skews earnings view can the rest of corporate america deliver,https://www.benzinga.com/trading-ideas/previews/15/10/5887982/energy-weakness-skews-earnings-view-can-the-rest-of-corporate-a,The Ticker Tape,2015-10-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,0,0.41105
708447,genmab reaches m milestone payment in duobody platform collaboration with janssen,https://www.benzinga.com/news/15/10/5887255/genmab-reaches-3m-milestone-payment-in-duobody-platform-collaboration-with-jansse,Charles Gross,2015-10-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5258
708448,benzingas top upgrades,https://www.benzinga.com/analyst-ratings/upgrades/15/09/5872446/benzingas-top-upgrades,Lisa Levin,2015-09-29 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.60115
708449,johnson johnson collaborates with ubivac to develop and test a oral cancer vaccine to be tested in preclinical trials,https://www.benzinga.com/news/15/09/5872347/johnson-johnson-collaborates-with-ubivac-to-develop-and-test-a-oral-cancer-vaccin,Paul Quintaro,2015-09-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.17015000000000002
708450,johnson johnson seen as safe haven by these experts,https://www.benzinga.com/analyst-ratings/analyst-color/15/09/5872079/johnson-johnson-seen-as-safe-haven-by-these-experts,Jim Swanson,2015-09-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
708451,deutsche bank upgrades johnson johnson to buy,https://www.benzinga.com/news/15/09/5871535/deutsche-bank-upgrades-johnson-johnson-to-buy,Paul Quintaro,2015-09-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708452,patients to benefit from latest tech trends,https://www.benzinga.com/news/15/09/5867784/patients-to-benefit-from-latest-tech-trends,Laura Brodbeck,2015-09-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7294
708453,jjs consumer unit reports closing of divestiture of splenda brand,https://www.benzinga.com/news/15/09/5866552/j-js-consumer-unit-reports-closing-of-divestiture-of-splenda-brand,Paul Quintaro,2015-09-25 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708454, us stocks likely to hike their dividends,https://www.benzinga.com/trading-ideas/dividends/15/09/5865641/5-u-s-stocks-likely-to-hike-their-dividends,SmallCapPower,2015-09-25 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708455,genmab announces chmp grants accelerated assessment for daratumumab for double refractory multiple myeloma,https://www.benzinga.com/news/15/09/5864775/genmab-announces-chmp-grants-accelerated-assessment-for-daratumumab-for-double-re,Charles Gross,2015-09-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.61315
708456,ubs initiates coverage on johnson johnson at buy,https://www.benzinga.com/news/15/09/5856240/ubs-initiates-coverage-on-johnson-johnson-at-buy,Paul Quintaro,2015-09-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708457,make the world a better place withstock picks,https://www.benzinga.com/trading-ideas/long-ideas/15/09/5850361/make-the-world-a-better-place-with-stock-picks,Motif Investing,2015-09-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
708458,bearish on bucks try this etf,https://www.benzinga.com/trading-ideas/long-ideas/15/09/5848919/bearish-on-bucks-try-this-etf,ETF Professor,2015-09-18 00:00:00,JNJ,1,2,0,1,0,0,0,0,0,0.5
708459,sp index futures trading higher,https://www.benzinga.com/general/movers-shakers/15/09/5824866/s-p-500-index-futures-trading-higher,Joel Elconin,2015-09-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708460,mkm partners would sell these healthcare stocks on weaker relative trends,https://www.benzinga.com/analyst-ratings/analyst-color/15/09/5819760/mkm-partners-would-sell-these-healthcare-stocks-on-weake,Hal Lindon,2015-09-08 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.2798
708461,sp index retreats from highs,https://www.benzinga.com/markets/futures/15/09/5810491/s-p-500-index-retreats-from-highs,Joel Elconin,2015-09-02 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708462,its not shopping its market research talking investing trends with td ameritrades nicole sherrod,https://www.benzinga.com/be-your-own-boss/15/09/5799678/its-not-shopping-its-market-research-talking-investing-trends-with-td,Rebecca Sheppard,2015-09-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708463,benzingas ma chatter for tuesday august ,https://www.benzinga.com/news/15/08/5791256/benzingas-m-a-chatter-for-tuesday-august-25-2015,Charles Gross,2015-08-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708464,heartland food products group reports definitive deal to buy jj consumers splenda brand no terms disclosed,https://www.benzinga.com/news/15/08/5790256/heartland-food-products-group-reports-definitive-deal-to-buy-j-j-consumers-splend,Paul Quintaro,2015-08-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.4742
708465,heartland food products to acquire splenda brand from johnson johnson consumer inc,https://www.benzinga.com/news/15/08/5790255/heartland-food-products-to-acquire-splenda-brand-from-johnson-johnson-consumer-in,Charles Gross,2015-08-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708466,fast money traders give their opinion on what to buy in this selloff,https://www.benzinga.com/media/cnbc/15/08/5785257/fast-money-traders-give-their-opinion-on-what-to-buy-in-this-sell-off,Craig Jones,2015-08-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708467,option alert jnj sep call sweep contracts ask now ,https://www.benzinga.com/markets/options/15/08/5784168/option-alert-jnj-sep-25-98-call-sweep-1209-contracts-ask-1-47,Charles Gross,2015-08-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708468,f recap the most popular and unpopular stocks of q,https://www.benzinga.com/trading-ideas/long-ideas/15/08/5775100/13f-recap-the-most-popular-and-unpopular-stocks-of-q2,Javier Hasse,2015-08-19 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7377
708469,sp index futures trading lower,https://www.benzinga.com/trading-ideas/technicals/15/08/5774054/s-p-500-index-futures-trading-lower,Joel Elconin,2015-08-18 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708470,when size matters consider these etfs,https://www.benzinga.com/trading-ideas/long-ideas/15/08/5762049/when-size-matters-consider-these-etfs,ETF Professor,2015-08-13 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5129
708471,johnson johnson cashes out of aquinox pharmaceuticals parabolic rally,https://www.benzinga.com/trading-ideas/technicals/15/08/5760452/johnson-johnson-cashes-out-of-aquinox-pharmaceuticals-parabol,Joel Elconin,2015-08-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708472,johnson johnson sells shares of aquinox pharmaceuticals share form ,https://www.benzinga.com/news/15/08/5760314/johnson-johnson-sells-1-514-821-shares-of-aquinox-pharmaceuticals-22-41share-form,Charles Gross,2015-08-12 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.76335
708473,heres which it stocks benefit from healthcare ma,https://www.benzinga.com/analyst-ratings/analyst-color/15/08/5751903/heres-which-it-stocks-benefit-from-healthcare-m-a,Wayne Duggan,2015-08-10 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.7294
708474, dividend growth stocks to buy today for your retirement portfolio,https://www.benzinga.com/trading-ideas/long-ideas/15/08/5748490/20-dividend-growth-stocks-to-buy-today-for-your-retirement-po,Chuck Carnevale,2015-08-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708475, us mega caps with less than insider ownership,https://www.benzinga.com/trading-ideas/long-ideas/15/08/5732900/5-u-s-mega-caps-with-less-than-0-1-insider-ownership,SmallCapPower,2015-08-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708476,achillion announces janssen initiated phase i study to evaluate effect of simeprevir and odalasvir on al pharmacokinetics,https://www.benzinga.com/news/15/08/5727124/achillion-announces-janssen-initiated-phase-i-study-to-evaluate-effect-of-simepre,Charles Gross,2015-08-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708477,sp index futures trading higher,https://www.benzinga.com/markets/futures/15/07/5714780/s-p-500-index-futures-trading-higher,Joel Elconin,2015-07-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708478,etfs for the next pharma takeover candidates,https://www.benzinga.com/trading-ideas/long-ideas/15/07/5710517/etfs-for-the-next-pharma-takeover-candidates,ETF Professor,2015-07-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708479,johnson johnson q earnings top expectations,https://www.benzinga.com/news/earnings/15/07/5669756/johnson-johnson-q2-earnings-top-expectations,Monica Gerson,2015-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708480,update johnson johnson q medical devices sales b cardiovascular sales m orthopaedics sales b,https://www.benzinga.com/news/earnings/15/07/5669545/update-johnson-johnson-2q-medical-devices-sales-6-36b-cardiovascular-sal,Eddie Staley,2015-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708481,jj raises fy adj eps vs est,https://www.benzinga.com/news/15/07/5669542/j-j-raises-fy15-adj-eps-6-10-6-20-vs-6-14-est,Paul Quintaro,2015-07-14 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.625
708482,johnson johnson reports q eps vs est rev b vs est b,https://www.benzinga.com/news/earnings/15/07/5669538/johnson-johnson-reports-q2-eps-1-71-vs-est-1-67-rev-17-8b-vs-est-17-57b,Hal Lindon,2015-07-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708483,earning economic calendar for tuesday july ,https://www.benzinga.com/news/earnings/15/07/5669106/earning-economic-calendar-for-tuesday-july-14-2015,Charles Gross,2015-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708484,earnings scheduled for july ,https://www.benzinga.com/news/earnings/15/07/5669029/earnings-scheduled-for-july-14-2015,Monica Gerson,2015-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708485, stocks you should be watching today,https://www.benzinga.com/news/earnings/15/07/5668999/7-stocks-you-should-be-watching-today,Monica Gerson,2015-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708486,from jpmorgan to johnson johnson options activity surrounds this weeks earnings,https://www.benzinga.com/analyst-ratings/analyst-color/15/07/5668316/from-jpmorgan-to-johnson-johnson-options-activity-surrou,Javier Hasse,2015-07-13 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708487,can johnson johnson deliver its best quarter ever despite fx headwinds,https://www.benzinga.com/analyst-ratings/analyst-color/15/07/5667566/can-johnson-johnson-deliver-its-best-quarter-ever-despit,Javier Hasse,2015-07-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.81845
708488,strong dollar not so good for johnson johnson earnings,https://www.benzinga.com/general/health-care/15/07/5664205/strong-dollar-not-so-good-for-johnson-johnson-earnings,The Ticker Tape,2015-07-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.53495
708489,td ameritrade clients are buying apple twitter selling facebook aol,https://www.benzinga.com/general/education/15/07/5653326/td-ameritrade-clients-are-buying-apple-twitter-selling-facebook-aol,Wayne Duggan,2015-07-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708490,jj reports passive stake in achillion pharmaceuticals as of july ,https://www.benzinga.com/news/15/07/5651736/j-j-reports-15-6-passive-stake-in-achillion-pharmaceuticals-as-of-july-1-2015,Charles Gross,2015-07-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
708491,sp index futures trading higher,https://www.benzinga.com/markets/futures/15/06/5628538/s-p-500-index-futures-trading-higher,Joel Elconin,2015-06-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708492,a gay friendly portfolio includes apple microsoft disneyand it beats the market,https://www.benzinga.com/trading-ideas/long-ideas/15/06/5588389/a-gay-friendly-portfolio-includes-apple-microsoft-disney-and-,Javier Hasse,2015-06-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708493,sp index futures trading lower in volatile session,https://www.benzinga.com/general/movers-shakers/15/06/5594797/s-p-500-index-futures-trading-lower-in-volatile-session,Joel Elconin,2015-06-15 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
708494,sp index futures trading higher,https://www.benzinga.com/trading-ideas/technicals/15/06/5587626/s-p-500-index-futures-trading-higher,Joel Elconin,2015-06-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708495,analyst cardinal health buying spree to boost fy eps,https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5580354/analyst-cardinal-health-buying-spree-to-boost-fy17-eps,John Seward,2015-06-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
708496,this technology could disrupt us pharma stocks credit suisse says,https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5576612/this-technology-could-disrupt-u-s-pharma-stocks-credit-s,John Seward,2015-06-08 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6909
708497,sp index futures trading lower in choppy session,https://www.benzinga.com/markets/futures/15/06/5575945/s-p-500-index-futures-trading-lower-in-choppy-session,Joel Elconin,2015-06-08 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
708498,sp index futures trading lower in volatile session,https://www.benzinga.com/markets/futures/15/06/5572243/s-p-500-index-futures-trading-lower-in-volatile-session,Joel Elconin,2015-06-05 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
708499,jmp securities boosts halozyme price target on longterm value,https://www.benzinga.com/analyst-ratings/analyst-color/15/06/5568745/jmp-securities-boosts-halozyme-price-target-on-long-term,Monica Gerson,2015-06-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8548
708500,jjs janssen rd llc reported data from phase multicenter study sar showed significant improvement in pfs with trabectedin vs dacarbazine,https://www.benzinga.com/news/15/06/5558239/j-js-janssen-r-d-llc-reported-data-from-phase-3-multicenter-study-sar3007-showed-,Paul Quintaro,2015-06-01 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.79295
708501,healthcare yen and oil etfs to watch this week,https://www.benzinga.com/etfs/sector-etfs/15/05/5554473/healthcare-yen-and-oil-etfs-to-watch-this-week,David Fabian,2015-05-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708502,phase iii helios study results show imbruvica combination therapy significantly increased progressionfree survival in previouslytreated chronic lymphocytic leukemiasmall lymphocytic lymphoma patients,https://www.benzinga.com/news/15/05/5554048/phase-iii-helios-study-results-show-imbruvica-combination-therapy-significantly-i,Charles Gross,2015-05-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6366
708503, positive negative for johnson johnson stock,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5551489/1-positive-1-negative-for-johnson-johnson-stock,Zoheb Sait,2015-05-29 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.4871
708504,jj reports acceptance of binding offer from cordis,https://www.benzinga.com/news/15/05/5547243/j-j-reports-acceptance-of-binding-offer-from-cordis,Paul Quintaro,2015-05-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8062
708505,update jj removed the device from the market last year,https://www.benzinga.com/news/15/05/5544717/update-j-j-removed-the-device-from-the-market-last-year,Charles Gross,2015-05-27 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.625
708506,fbi said to be investigating jnj surgical device tied to cancer in women dj,https://www.benzinga.com/news/15/05/5544714/fbi-said-to-be-investigating-jnj-surgical-device-tied-to-cancer-in-women-dj,Charles Gross,2015-05-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.17015000000000002
708507,sp index futures trading lower in quiet session,https://www.benzinga.com/markets/futures/15/05/5535424/s-p-500-index-futures-trading-lower-in-quiet-session,Joel Elconin,2015-05-22 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
708508,chmp gave six recommendations on extensions of therapeutic indication for janssens simponi and stelara pharmacyclics imbruvica eisais fycompa biomarins kuvan novos xultophy,https://www.benzinga.com/news/15/05/5534431/chmp-gave-six-recommendations-on-extensions-of-therapeutic-indication-for-janssen,Paul Quintaro,2015-05-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708509,sp index futures trading higher,https://www.benzinga.com/markets/futures/15/05/5531917/s-p-500-index-futures-trading-higher,Joel Elconin,2015-05-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708510,raymond james johnson johnson has innovation,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5531071/raymond-james-johnson-johnson-has-innovation,Jim Swanson,2015-05-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708511,what does the johnson johnsonachillion deal mean for hcv competitors,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5529079/what-does-the-johnson-johnsonachillion-deal-mean-for-hcv,Wayne Duggan,2015-05-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708512,the most popular stocks held by different generations of investors,https://www.benzinga.com/general/education/15/05/5528087/the-most-popular-stocks-held-by-4-different-generations-of-investors,Wayne Duggan,2015-05-21 00:00:00,JNJ,1,2,0,0,1,1,1,1,1,0.7377
708513,novo sells license on autoimmune disease to janssen,https://www.benzinga.com/news/15/05/5527368/novo-sells-license-on-autoimmune-disease-to-janssen,Paul Quintaro,2015-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708514,morning market losers,https://www.benzinga.com/news/15/05/5527271/morning-market-losers,Lisa Levin,2015-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.23665000000000003
708515,jmp says stepping to the sidelines on achillion,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5526800/jmp-says-stepping-to-the-sidelines-on-achillion,Jim Swanson,2015-05-20 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708516,benzingas top premarket losers,https://www.benzinga.com/news/15/05/5526713/benzingas-top-premarket-losers,Monica Gerson,2015-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
708517,jj announces pharma unit will continue driving aboveindustry growth with plans to file more than new products by ,https://www.benzinga.com/news/15/05/5526399/j-j-announces-pharma-unit-will-continue-driving-above-industry-growth-with-plans-,Paul Quintaro,2015-05-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708518,achillion pharmaceuticals shares fall premarket following announcement of hep c collaboration with janssen,https://www.benzinga.com/news/15/05/5526113/achillion-pharmaceuticals-shares-fall-2-premarket-following-announcement-of-hep-c,Charles Gross,2015-05-20 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.648
708519,update achillion janssen deal includes m investment for m newly issued unregistered shares of achillion at share,https://www.benzinga.com/news/15/05/5524692/update-achillion-janssen-deal-includes-225m-investment-for-18-4m-newly-issued-unr,Paul Quintaro,2015-05-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,0,0.76335
708520,update achillion janssen collab includes up to b in potential development regulatory sales milestone payments separate equity investment,https://www.benzinga.com/news/15/05/5524681/update-achillion-janssen-collab-includes-up-to-1-1b-in-potential-development-regu,Paul Quintaro,2015-05-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708521,achillion announces collaboration for hep c with jjs janssen pharma,https://www.benzinga.com/news/15/05/5524659/achillion-announces-collaboration-for-hep-c-with-j-js-janssen-pharma,Paul Quintaro,2015-05-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708522,from achillion events page posts link for co janssen discussion for hcv collab webcast,https://www.benzinga.com/news/15/05/5524648/from-achillion-events-page-posts-link-for-co-janssen-discussion-for-hcv-collab-we,Paul Quintaro,2015-05-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708523,jjs janssen pharma reports fda approval of invega trinza for treatment of schizophrenia,https://www.benzinga.com/news/15/05/5522171/j-js-janssen-pharma-reports-fda-approval-of-invega-trinza-for-treatment-of-schizo,Paul Quintaro,2015-05-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
708524,jjs janssen reports data demonstrates adults with type diabetes achieved blood glucose treatment goals with use of invokana,https://www.benzinga.com/news/15/05/5518623/j-js-janssen-reports-data-demonstrates-adults-with-type-2-diabetes-achieved-blood,Paul Quintaro,2015-05-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708525,option alert jnj may call contract trade above ask now ,https://www.benzinga.com/news/15/05/5516075/option-alert-jnj-may-29-103-call-1291-contract-trade-above-ask-0-45,Charles Gross,2015-05-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708526,the fdas authority challenged by mallinckrodt,https://www.benzinga.com/news/15/05/5514009/the-fdas-authority-challenged-by-mallinckrodt,Laura Brodbeck,2015-05-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4871
708527,these charts explain why johnson johnson should be approached tactically,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5512389/these-charts-explain-why-johnson-johnson-should-be-appro,Javier Hasse,2015-05-15 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708528,morgan stanley has cautious optimism on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5514436/morgan-stanley-has-cautious-optimism-on-johnson-johnson,Monica Gerson,2015-05-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7383500000000001
708529,what current buyback levels mean for the bull market,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5511229/what-current-buyback-levels-mean-for-the-bull-market,Wayne Duggan,2015-05-14 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.5
708530,bavarian nordic announces presentation of preliminary phase results for ebola primeboost vaccine regimen of mvabn filo and janssens advac,https://www.benzinga.com/news/15/05/5503251/bavarian-nordic-announces-presentation-of-preliminary-phase-1-results-for-ebola-p,Charles Gross,2015-05-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708531,ipo outlook galapagos offers new hope for cf and ra sufferers,https://www.benzinga.com/general/biotech/15/05/5501534/ipo-outlook-galapagos-offers-new-hope-for-cf-and-ra-sufferers,Charles Enser,2015-05-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.436
708532,bavarian nordic receives m loan from the european investment bank to help co develop ebola vaccine reuters,https://www.benzinga.com/news/15/05/5502235/bavarian-nordic-receives-50m-loan-from-the-european-investment-bank-to-help-co-de,Charles Gross,2015-05-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
708533,jjs janssen pharma announces fda issued crl to snda for expanded labe on invega sustenna,https://www.benzinga.com/news/15/05/5499644/j-js-janssen-pharma-announces-fda-issued-crl-to-snda-for-expanded-labe-on-invega-,Paul Quintaro,2015-05-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708534,traders heres what youre doing wrong and how to fix it,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5494564/traders-heres-what-youre-doing-wrong-and-how-to-fix-it,Wayne Duggan,2015-05-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.26165
708535, hot or not ipos scheduled to debut this week,https://www.benzinga.com/news/15/05/5496756/9-hot-or-not-ipos-scheduled-to-debut-this-week,Mark Meadows,2015-05-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708536,countdown to the best public reputations company,https://www.benzinga.com/general/education/15/05/5485825/countdown-to-the-best-public-reputations-company,Wayne Duggan,2015-05-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
708537,johnson johnson nyu school of medicine partner to evaluate compassionate use of investigational medicines,https://www.benzinga.com/news/15/05/5486228/johnson-johnson-nyu-school-of-medicine-partner-to-evaluate-compassionate-use-of-i,Charles Gross,2015-05-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
708538,credit suisse we prefer pfizer bristol over pharma peers,https://www.benzinga.com/analyst-ratings/analyst-color/15/05/5476290/credit-suisse-we-prefer-pfizer-bristol-over-pharma-peers,Mark Meadows,2015-05-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708539,jj announces further pto action realted to remicade office maintained rejection of patent patent remains valid,https://www.benzinga.com/news/15/04/5458379/j-j-announces-further-pto-action-realted-to-remicade-office-maintained-rejection-,Paul Quintaro,2015-04-29 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.3194
708540,technician breaks down johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/15/04/5426362/technician-breaks-down-johnson-johnson,Javier Hasse,2015-04-23 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708541,jj raises qtr dividend from to share,https://www.benzinga.com/news/15/04/5436872/j-j-raises-qtr-dividend-from-0-70-to-0-75share,Paul Quintaro,2015-04-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708542,jjs janssen reports svr rates with twelve weeks of treatment with alloral oncedaily regimen of simeprevir plus sofosbuvir,https://www.benzinga.com/news/15/04/5436339/j-js-janssen-reports-svr12-rates-with-twelve-weeks-of-treatment-with-all-oral-onc,Paul Quintaro,2015-04-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708543,bank of america sees big divestitures upcoming for johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/15/04/5411625/bank-of-america-sees-big-divestitures-upcoming-for-johns,John Seward,2015-04-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708544,morgan stanley shares what johnson johnson investors should focus on now,https://www.benzinga.com/analyst-ratings/analyst-color/15/04/5410066/morgan-stanley-shares-what-johnson-johnson-investors-sho,Jim Swanson,2015-04-15 00:00:00,JNJ,1,2,1,1,1,1,1,0,1,0.648
708545,what specific role will apple play in ibms watson health cloud alliance,https://www.benzinga.com/media/cnbc/15/04/5408903/what-specific-role-will-apple-play-in-ibms-watson-health-cloud-alliance,Ritesh Anan,2015-04-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.67
708546,jjs janssen highlights study published in jcp showing longacting invega sustenna effective six months longer than other oral antipsychotics,https://www.benzinga.com/news/15/04/5409822/j-js-janssen-highlights-study-published-in-jcp-showing-long-acting-invega-sustenn,Paul Quintaro,2015-04-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7383500000000001
708547,why johnson johnsons strong pharmaceutical business is a concern,https://www.benzinga.com/general/biotech/15/04/5406842/why-johnson-johnsons-strong-pharmaceutical-business-is-a-concern,Ritesh Anan,2015-04-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7553000000000001
708548,the big health data orgy happening in the cloud,https://www.benzinga.com/news/15/04/5406213/the-big-health-data-orgy-happening-in-the-cloud,Jayson Derrick,2015-04-14 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708549,us stock futures down ahead of business inventories data,https://www.benzinga.com/news/15/04/5405934/us-stock-futures-down-ahead-of-business-inventories-data,Lisa Levin,2015-04-14 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708550,from jj earnings conference call expecting fy constant currency sales bb vs b est,https://www.benzinga.com/news/15/04/5405566/from-j-j-earnings-conference-call-expecting-fy15-constant-currency-sales-75b-76b-,Paul Quintaro,2015-04-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.625
708551,johnson johnson posts upbeat q earnings but lowers fy forecast,https://www.benzinga.com/news/earnings/15/04/5405256/johnson-johnson-posts-upbeat-q1-earnings-but-lowers-fy15-forecast,Lisa Levin,2015-04-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.40495000000000003
708552,update jj cuts fy eps outlook from previously to vs est,https://www.benzinga.com/news/15/04/5405073/update-j-j-cuts-fy-eps-outlook-from-6-12-6-27-previously-to-6-04-6-19-vs-6-16-est,Paul Quintaro,2015-04-14 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.4742
708553,johnson johnson cuts outlook,https://www.benzinga.com/news/15/04/5405072/johnson-johnson-cuts-outlook,Paul Quintaro,2015-04-14 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.352
708554,johnson johnson reports q eps vs est sales b vs est b,https://www.benzinga.com/news/earnings/15/04/5405071/johnson-johnson-reports-q1-eps-1-56-vs-est-1-54-sales-17-4b-vs-est-17-31,Eddie Staley,2015-04-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708555,earnings scheduled for april ,https://www.benzinga.com/news/earnings/15/04/5404524/earnings-scheduled-for-april-14-2015,Monica Gerson,2015-04-14 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708556, stocks you should be watching today,https://www.benzinga.com/news/earnings/15/04/5404453/7-stocks-you-should-be-watching-today,Monica Gerson,2015-04-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708557,stock investors dig in for bank earnings ready for next spx test,https://www.benzinga.com/opinion/15/04/5402967/stock-investors-dig-in-for-bank-earnings-ready-for-next-spx-test,The Ticker Tape,2015-04-13 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.6806
708558,ichor medical systems announces entering into product development collaboration global license deal with jjs janssen pharma,https://www.benzinga.com/news/15/04/5401143/ichor-medical-systems-announces-entering-into-product-development-collaboration-g,Paul Quintaro,2015-04-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708559,morphosys ag to receive milestone payment for guselkumab program in psoriatic arthritis,https://www.benzinga.com/news/15/04/5400546/morphosys-ag-to-receive-milestone-payment-for-guselkumab-program-in-psoriatic-art,Charles Gross,2015-04-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708560, stocks to watch as earnings season ramps up,https://www.benzinga.com/news/earnings/15/04/5400029/13-stocks-to-watch-as-earnings-season-ramps-up,Nelson Hem,2015-04-12 00:00:00,JNJ,1,0,0,0,0,0,1,1,1,0.5
708561,sector etfs and earnings,https://www.benzinga.com/etfs/sector-etfs/15/04/5384249/sector-etfs-and-earnings,Matthew McCall,2015-04-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708562,jpmorgan cut its johnson johnson forecast before earnings but why,https://www.benzinga.com/analyst-ratings/analyst-color/15/04/5384555/jpmorgan-cut-its-johnson-johnson-forecast-before-earning,Jayson Derrick,2015-04-06 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.42969999999999997
708563,janssen pharmaceuticals inc finalizes divestiture of us license rights to nucynta tapentadol nucynta er tapentadol extendedrelease tablets and nucynta tapentadol oral solution to depomed inc for b,https://www.benzinga.com/news/15/04/5380868/janssen-pharmaceuticals-inc-finalizes-divestiture-of-u-s-license-rights-to-nucynt,Hal Lindon,2015-04-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
708564,hearing unconfirmed market chatter jnj to spinoff pharma business from medical device business,https://www.benzinga.com/news/15/04/5379549/hearing-unconfirmed-market-chatter-jnj-to-spinoff-pharma-business-from-medical-de,Charles Gross,2015-04-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
708565,hearing unconfirmed market chatter jnj branding brevangenplus products worldwide,https://www.benzinga.com/news/15/04/5376107/hearing-unconfirmed-market-chatter-jnj-brevangenplus-products-worldwide,Charles Gross,2015-04-01 00:00:00,JNJ,1,2,0,0,0,0,1,1,1,0.436
708566,jjs janssen announces fda approval for label update for zytiga to include statistically significant overall survival results in chemotherapynaive men with metastatic castrationresistant prostate cancer,https://www.benzinga.com/news/15/03/5366190/j-js-janssen-announces-fda-approval-for-label-update-for-zytiga-to-include-statis,Paul Quintaro,2015-03-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.436
708567,johnson johnson teams with google on surgery robot development,https://www.benzinga.com/news/15/03/5363016/johnson-johnson-teams-with-google-on-surgery-robot-development,John Seward,2015-03-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708568,watch shares of intuitive surgical here as bloomberg reporting jj in a deal with google related to surgical robotics terms not disclosed,https://www.benzinga.com/news/15/03/5362750/watch-shares-of-intuitive-surgical-here-as-bloomberg-reporting-j-j-in-a-deal-with,Paul Quintaro,2015-03-27 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.74695
708569,jj bausch lomb accused of price fixing antitrust suit claims contact lens makers set minimum resale prices,https://www.benzinga.com/news/15/03/5352993/j-j-bausch-lomb-accused-of-price-fixing-antitrust-suit-claims-contact-lens-makers,Paul Quintaro,2015-03-24 00:00:00,JNJ,1,1,0,0,0,0,1,0,1,0.4742
708570,benzingas ma chatter for thursday march ,https://www.benzinga.com/news/15/03/5342844/benzingas-m-a-chatter-for-thursday-march-19-2015,Charles Gross,2015-03-19 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708571,jj announces janssen purchase of xo limited,https://www.benzinga.com/news/15/03/5340200/j-j-announces-janssen-purchase-of-xo1-limited,Paul Quintaro,2015-03-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5129
708572,janssen acquires xo limited terms not disclosed,https://www.benzinga.com/news/15/03/5339661/janssen-acquires-xo1-limited-terms-not-disclosed,Charles Gross,2015-03-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.38685
708573,fda panel to discuss development of ebola vaccines in may reuters,https://www.benzinga.com/news/15/03/5336365/fda-panel-to-discuss-development-of-ebola-vaccines-in-may-reuters,Charles Gross,2015-03-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708574,preview pharmacyclics shares to resume trading at pm et,https://www.benzinga.com/news/15/03/5330146/preview-pharmacyclics-shares-to-resume-trading-at-3-30-pm-et,Charles Gross,2015-03-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.648
708575,update independent data monitoring committee unanimously recommends unblinding of imbruvica,https://www.benzinga.com/news/15/03/5330138/update-independent-data-monitoring-committee-unanimously-recommends-unblinding-of,Paul Quintaro,2015-03-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
708576,johnson and johnsons janssen unit loses appeal for m topamax verdict,https://www.benzinga.com/news/15/03/5330023/johnson-and-johnsons-janssen-unit-loses-appeal-for-11m-topamax-verdict,Paul Quintaro,2015-03-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.41105
708577,lifetime income payments or lump sum how to decide,https://www.benzinga.com/general/education/15/03/5303148/lifetime-income-payments-or-lump-sum-how-to-decide,Eric Mancini,2015-03-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708578,jjs mcneil consumer healthcare unit announces deal for resolution of us doj probe will pay m settlement enter plea for single misdemeanor violation,https://www.benzinga.com/news/15/03/5314391/j-js-mcneil-consumer-healthcare-unit-announces-deal-for-resolution-of-us-doj-prob,Paul Quintaro,2015-03-10 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.2213
708579,mcneil consumer healthcare resolves us doj investigation to pay settlement of m,https://www.benzinga.com/news/15/03/5314388/mcneil-consumer-healthcare-resolves-u-s-doj-investigation-to-pay-settlement-of-25,Charles Gross,2015-03-10 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5386
708580,jj ordered to pay m for incontinence implant,https://www.benzinga.com/news/15/03/5302869/j-j-ordered-to-pay-5-7m-for-incontinence-implant,Paul Quintaro,2015-03-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.57655
708581,johnson johnsons ethicon unit ordered to pay m from trial ver transvaginal mesh injuries reuters,https://www.benzinga.com/news/15/03/5302644/johnson-johnsons-ethicon-unit-ordered-to-pay-5-6m-from-trial-ver-transvaginal-mes,Charles Gross,2015-03-05 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.44865
708582,benzingas ma chatter for wednesday march ,https://www.benzinga.com/news/15/03/5299713/benzingas-m-a-chatter-for-wednesday-march-4-2015,Charles Gross,2015-03-04 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
708583,report pharmacyclics inc to be acquired by johnson johnson,https://www.benzinga.com/news/15/03/5299444/report-pharmacyclics-inc-to-be-acquired-by-johnson-johnson,John Seward,2015-03-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708584,update jjs purchase of pharmacyclics may be announced as soon as thursday,https://www.benzinga.com/news/15/03/5299241/update-j-js-purchase-of-pharmacyclics-may-be-announced-as-soon-as-thursday,Paul Quintaro,2015-03-04 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708585,hearing jj has agreed to purchase pharmacyclics,https://www.benzinga.com/news/15/03/5299239/hearing-j-j-has-agreed-to-purchase-pharmacyclics,Paul Quintaro,2015-03-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
708586,fast money halftime report final trade from march ,https://www.benzinga.com/media/cnbc/15/03/5299079/fast-money-halftime-report-final-trade-from-march-4,Craig Jones,2015-03-04 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708587,hearing ft reporting jj near deal to purchase pharmacyclics,https://www.benzinga.com/news/15/03/5298815/hearing-ft-reporting-j-j-near-deal-to-purchase-pharmacyclics,Paul Quintaro,2015-03-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708588,benzingas ma chatter for monday march ,https://www.benzinga.com/news/15/03/5290697/benzingas-m-a-chatter-for-monday-march-2-2015,Charles Gross,2015-03-02 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708589,merger monday lives up to name from nxp semiconductors to ebay theres at least billon in total deals,https://www.benzinga.com/news/15/03/5289035/merger-monday-lives-up-to-name-from-nxp-semiconductors-to-ebay-theres-at-least-20,Javier Hasse,2015-03-02 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708590,update johnson johnson announces binding offer from cardinal health to acquire cordis,https://www.benzinga.com/news/15/03/5287001/update-johnson-johnson-announces-binding-offer-from-cardinal-health-to-acquire-co,Eddie Staley,2015-03-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708591,johnson johnson announces binding offer from cardinal health to acquire cordis,https://www.benzinga.com/news/15/03/5287000/johnson-johnson-announces-binding-offer-from-cardinal-health-to-acquire-cordis,Eddie Staley,2015-03-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708592,who says independent advisory body to decide no earlier than august on recommendation of widespread ebola vaccinations,https://www.benzinga.com/news/15/02/5281889/who-says-independent-advisory-body-to-decide-no-earlier-than-august-on-recommenda,Charles Gross,2015-02-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.352
708593,jj announces formation of new health and wellness platform aimed at transforming health care delivery improve the patient experience,https://www.benzinga.com/news/15/02/5277505/j-j-announces-formation-of-new-health-and-wellness-platform-aimed-at-transforming,Paul Quintaro,2015-02-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.9375
708594,benzingas ma chatter for wednesday february ,https://www.benzinga.com/news/15/02/5275276/benzingas-m-a-chatter-for-wednesday-february-25-2015,Charles Gross,2015-02-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708595,deutsche bank on pharmacyclics we do not see much upside,https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5275221/deutsche-bank-on-pharmacyclics-we-do-not-see-much-upside,Monica Gerson,2015-02-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708596,bloomberg reporting jnj loses bid to get south carolina risperdal verdict tossed,https://www.benzinga.com/news/15/02/5274404/bloomberg-reporting-jnj-loses-bid-to-get-south-carolina-risperdal-verdict-tossed,Paul Quintaro,2015-02-25 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.41105
708597,ontario institute for cancer research extends collaboration with janssen on developing clinical trials for prostate cancer,https://www.benzinga.com/news/15/02/5273263/ontario-institute-for-cancer-research-extends-collaboration-with-janssen-on-devel,Charles Gross,2015-02-25 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.07405
708598,johnson johnson to pay m for failing to properly warn about risperdal risks,https://www.benzinga.com/news/15/02/5270087/johnson-johnson-to-pay-2-5m-for-failing-to-properly-warn-about-risperdal-risks,Paul Quintaro,2015-02-24 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.13245
708599,jnj shares spike higher afterhours,https://www.benzinga.com/news/15/02/5265948/jnj-shares-spike-higher-after-hours,Charles Gross,2015-02-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
708600, companies that could be negatively impacted by johnson johnson sale of cordis,https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5265098/3-companies-that-could-be-negatively-impacted-by-johnson,Kevin Riley,2015-02-23 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708601,morgan stanley analyst sees higher net for cardinal health in johnson johnson deal,https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5264723/morgan-stanley-analyst-sees-higher-net-for-cardinal-heal,John Seward,2015-02-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708602,jj has agreed to pay additional m related to deal in asr hip settlement case,https://www.benzinga.com/news/15/02/5263352/j-j-has-agreed-to-pay-additional-420m-related-to-deal-in-asr-hip-settlement-case,Paul Quintaro,2015-02-23 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.70095
708603,cardnial health potential buyer for jjs cordis unit bloomberg,https://www.benzinga.com/news/15/02/5262830/cardnial-health-potential-buyer-for-j-js-cordis-unit-bloomberg,Charles Gross,2015-02-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708604,jefferies names abbvie as top pharmaceutical pick offers alternative choices,https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5260700/jefferies-names-abbvie-as-top-pharmaceutical-pick-offers,Jayson Derrick,2015-02-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.60115
708605, stocks institutional investors loved last quarter,https://www.benzinga.com/trading-ideas/long-ideas/15/02/5257085/10-stocks-institutional-investors-loved-last-quarter,Javier Hasse,2015-02-20 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.7997000000000001
708606,sterne agee to investors caution boston scientific priced to perfection,https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5259718/sterne-agee-to-investors-caution-boston-scientific-price,Mark Meadows,2015-02-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
708607,boston scientific closes up ,https://www.benzinga.com/news/15/02/5252947/boston-scientific-closes-up-12,John Seward,2015-02-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708608,option alert jnj mar call contract trade above ask now ,https://www.benzinga.com/markets/options/15/02/5252641/option-alert-jnj-mar-105-call-3698-contract-trade-above-ask-0-19,Charles Gross,2015-02-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708609,boston scientific soars after settling dispute with johnson johnson,https://www.benzinga.com/news/15/02/5252461/boston-scientific-soars-11-after-settling-dispute-with-johnson-johnson,Kevin Riley,2015-02-18 00:00:00,JNJ,1,1,1,0,0,1,1,1,1,0.29905000000000004
708610,midday market update angies list jumps on upbeat earnings medassets shares tumble,https://www.benzinga.com/news/earnings/15/02/5252091/mid-day-market-update-angies-list-jumps-on-upbeat-earnings-medassets-sha,Garrett Cook,2015-02-18 00:00:00,JNJ,1,0,0,1,1,0,1,1,1,0.648
708611,sterne agree weighs in on boston scientificjohnson johnson litigation settlement,https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5250823/sterne-agree-weighs-in-on-boston-scientific-johnson-john,Javier Hasse,2015-02-18 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.58895
708612,stocks hitting week highs,https://www.benzinga.com/news/15/02/5251372/stocks-hitting-52-week-highs,Lisa Levin,2015-02-18 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708613,morning market gainers,https://www.benzinga.com/news/15/02/5251137/morning-market-gainers,Lisa Levin,2015-02-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708614,benzingas top premarket gainers,https://www.benzinga.com/news/15/02/5250517/benzingas-top-premarket-gainers,Monica Gerson,2015-02-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708615,fast money halftime report final trade from february ,https://www.benzinga.com/media/cnbc/15/02/5248901/fast-money-halftime-report-final-trade-from-february-17,Craig Jones,2015-02-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708616,boston scientific shares rise afterhours on jnj settlement news,https://www.benzinga.com/news/15/02/5248840/boston-scientific-shares-rise-12-after-hours-on-jnj-settlement-news,Charles Gross,2015-02-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
708617,boston scientific reports deal with jj for resolution of guidant litigation will make m in payments sees pretax charge m,https://www.benzinga.com/news/15/02/5248286/boston-scientific-reports-deal-with-j-j-for-resolution-of-guidant-litigation-will,Paul Quintaro,2015-02-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5258
708618, stocks going exdividend this week and trading idea,https://www.benzinga.com/trading-ideas/dividends/15/02/5233165/8-stocks-going-ex-dividend-this-week-and-1-trading-idea,Fred Fuld,2015-02-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708619,american firms in china feel antiforeign sentiment rising in the wake of qualcomm settlement,https://www.benzinga.com/news/15/02/5234373/american-firms-in-china-feel-anti-foreign-sentiment-rising-in-the-wake-of-qualcom,Laura Brodbeck,2015-02-13 00:00:00,JNJ,1,1,0,0,0,0,1,1,1,0.5
708620,bill ackman thinks valeant is incredibly disciplined and says hed own mcdonalds if g capital was in charge,https://www.benzinga.com/trading-ideas/long-ideas/15/02/5240155/bill-ackman-thinks-valeant-is-incredibly-disciplined-and-says,Ritesh Anan,2015-02-13 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.5
708621,johnson johnson faces pressure from us patent office,https://www.benzinga.com/analyst-ratings/analyst-color/15/02/5240525/johnson-johnson-faces-pressure-from-u-s-patent-office,Anthony Sanfilippo,2015-02-13 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.352
708622,itc to acquire jnjs savlon shower to shower brands business standard,https://www.benzinga.com/news/15/02/5239787/itc-to-acquire-jnjs-savlon-shower-to-shower-brands-business-standard,Charles Gross,2015-02-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708623,jj announces pto action related to remicade co has days to respond,https://www.benzinga.com/news/15/02/5237796/j-j-announces-pto-action-related-to-remicade-company-has-60-days-to-respond,Hal Lindon,2015-02-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
708624,johnson johnson under selling pressure,https://www.benzinga.com/general/movers-shakers/15/02/5237169/johnson-johnson-under-selling-pressure,Joel Elconin,2015-02-12 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.352
708625,jj shares plunge below level few mins ahead of bloomberg headline suggesting cos remicade patent claims have been given final patent office rejection,https://www.benzinga.com/news/15/02/5237198/j-j-shares-plunge-below-100-level-few-mins-ahead-of-bloomberg-headline-suggesting,Paul Quintaro,2015-02-12 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.4614
708626,jnj shares selling off,https://www.benzinga.com/news/15/02/5237064/jnj-shares-selling-off,Charles Gross,2015-02-12 00:00:00,JNJ,1,1,0,1,1,0,1,1,1,0.648
708627,hearing unconfirmed market chatter jnj has hired goldman sachs to explore breakup into cos,https://www.benzinga.com/news/15/02/5227754/hearing-unconfirmed-market-chatter-jnj-has-hired-goldman-sachs-to-explore-breakup,Charles Gross,2015-02-10 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.436
708628,jj reports passive stake in aquinox pharmaceuticals as of december ,https://www.benzinga.com/news/15/02/5218086/j-j-reports-15-1-passive-stake-in-aquinox-pharmaceuticals-as-of-december-31,Charles Gross,2015-02-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
708629,us fda grants priority review for yondelis,https://www.benzinga.com/news/15/02/5205992/u-s-fda-grants-priority-review-for-yondelis,Paul Quintaro,2015-02-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
708630,jj sarcoma drug yondelis gets fda priority review,https://www.benzinga.com/news/15/02/5203940/j-j-sarcoma-drug-yondelis-gets-fda-priority-review,Charles Gross,2015-02-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
708631,etf spotlight dividend aristocrat index,https://www.benzinga.com/etfs/broad-u-s-equity-etfs/15/01/5192636/etf-spotlight-dividend-aristocrat-index,David Fabian,2015-01-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708632,premarket prep technical update johnson johnson lower,https://www.benzinga.com/general/movers-shakers/15/01/5192480/premarket-prep-technical-update-johnson-johnson-lower,Hal Lindon,2015-01-29 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.352
708633,whos aylward says running out of cash needed to fight ebola needs m months best case for virus to stop reuters,https://www.benzinga.com/news/15/01/5172831/whos-aylward-says-running-out-of-cash-needed-to-fight-ebola-needs-260m-4-5-months,Charles Gross,2015-01-23 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.55135
708634,morgan stanley analyst sees fy trough for johnson johnson pharma growth,https://www.benzinga.com/analyst-ratings/analyst-color/15/01/5169927/morgan-stanley-analyst-sees-fy15-trough-for-johnson-john,John Seward,2015-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708635,why minerva neurosciences is trading higher,https://www.benzinga.com/news/15/01/5166824/why-minerva-neurosciences-is-trading-higher,Kyle Dennis,2015-01-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708636,ecb easing could strengthen headwinds for us firms,https://www.benzinga.com/news/15/01/5163346/ecb-easing-could-strengthen-headwinds-for-u-s-firms,Laura Brodbeck,2015-01-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7553000000000001
708637,uns david nabarro cites need for b to fight ebola reuters,https://www.benzinga.com/news/15/01/5164881/uns-david-nabarro-cites-need-for-1b-to-fight-ebola-reuters,Charles Gross,2015-01-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.30910000000000004
708638,morgan stanley sees balance sheet pipeline as more critical for johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/15/01/5163840/morgan-stanley-sees-balance-sheet-pipeline-as-more-criti,Dwight Einhorn,2015-01-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.30979999999999996
708639,cnbcs stock pops drops from january ,https://www.benzinga.com/media/cnbc/15/01/5162722/cnbcs-stock-pops-drops-from-january-20,Craig Jones,2015-01-20 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708640, companies capturing social media attention on tuesday morning,https://www.benzinga.com/trading-ideas/previews/15/01/5160338/4-companies-capturing-social-media-attention-on-tuesday-morning,Garrett Cook,2015-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708641,morning market losers,https://www.benzinga.com/news/15/01/5160361/morning-market-losers,Lisa Levin,2015-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.23665000000000003
708642,from conf call jj cfo says expects better growth outlook for medical devices consumer products for vs ,https://www.benzinga.com/news/earnings/15/01/5160331/from-conf-call-j-j-cfo-says-expects-better-growth-outlook-for-medical-de,Charles Gross,2015-01-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.87895
708643,update johnson johnson posts upbeat q earnings,https://www.benzinga.com/news/earnings/15/01/5159769/update-johnson-johnson-posts-upbeat-q4-earnings,Monica Gerson,2015-01-20 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
708644,benzingas top premarket losers,https://www.benzinga.com/news/15/01/5159627/benzingas-top-premarket-losers,Monica Gerson,2015-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
708645,earning economic calendar for tuesday january ,https://www.benzinga.com/news/earnings/15/01/5158725/earning-economic-calendar-for-tuesday-january-20-2015,Charles Gross,2015-01-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708646,woman who worked with ebola patients taken off united airlines flight monday in newark after showing ebola signs being tested at hackensack university medical center,https://www.benzinga.com/news/15/01/5158668/woman-who-worked-with-ebola-patients-taken-off-united-airlines-flight-monday-in-n,Charles Gross,2015-01-20 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.71075
708647,earnings scheduled for january ,https://www.benzinga.com/news/earnings/15/01/5158666/earnings-scheduled-for-january-20-2015,Monica Gerson,2015-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708648, stocks you should be watching today,https://www.benzinga.com/news/earnings/15/01/5158621/7-stocks-you-should-be-watching-today,Monica Gerson,2015-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708649,midafternoon market update precision castparts slides after weak q outlook schlumberger shares spike higher,https://www.benzinga.com/news/15/01/5155217/mid-afternoon-market-update-precision-castparts-slides-after-weak-q3-outlook-schl,Garrett Cook,2015-01-16 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.41105
708650,nih director says study of experimental ebola drug zmapp could start next month in west africa dj,https://www.benzinga.com/news/15/01/5155103/nih-director-says-study-of-experimental-ebola-drug-zmapp-could-start-next-month-i,Charles Gross,2015-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708651,midday market update us stocks rise suntrust shares surge on upbeat earnings,https://www.benzinga.com/news/earnings/15/01/5154921/mid-day-market-update-u-s-stocks-rise-suntrust-shares-surge-on-upbeat-ea,Garrett Cook,2015-01-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
708652,benzingas volume movers,https://www.benzinga.com/news/15/01/5154397/benzingas-volume-movers,Lisa Levin,2015-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708653,knuckman on johnson johnson and ford surprise movers,https://www.benzinga.com/media/cnbc/15/01/5152010/knuckman-on-johnson-johnson-and-ford-surprise-movers,Ritesh Anan,2015-01-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.6366
708654,stocks hitting week highs,https://www.benzinga.com/news/15/01/5154285/stocks-hitting-52-week-highs,Lisa Levin,2015-01-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708655,morning market gainers,https://www.benzinga.com/news/15/01/5154086/morning-market-gainers,Lisa Levin,2015-01-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708656,depomed surges following nucynta acquisition from janssen pharmaceuticals,https://www.benzinga.com/news/15/01/5153774/depomed-surges-8-following-nucynta-acquisition-from-janssen-pharmaceuticals,Kevin Riley,2015-01-16 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
708657,benzingas top premarket gainers,https://www.benzinga.com/news/15/01/5153636/benzingas-top-premarket-gainers,Monica Gerson,2015-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708658,us stock futures slip ahead of goldman sachs earnings,https://www.benzinga.com/news/15/01/5153375/us-stock-futures-slip-ahead-of-goldman-sachs-earnings,Monica Gerson,2015-01-16 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
708659,update jj announces formation of ebola vaccine development consortia imi to award consortia grants totaling m,https://www.benzinga.com/news/15/01/5153311/update-j-j-announces-formation-of-ebola-vaccine-development-consortia-imi-to-awar,Charles Gross,2015-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8753
708660,johnson johnson announces formation of ebola vaccine development consortia,https://www.benzinga.com/news/15/01/5153301/johnson-johnson-announces-formation-of-ebola-vaccine-development-consortia,Charles Gross,2015-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708661,a pair trade with eli lilly and johnson johnson goldman just explained why its a solid idea,https://www.benzinga.com/analyst-ratings/analyst-color/15/01/5151534/here-is-goldman-sachs-potential-pair-trade-for-2-drug-gi,Javier Hasse,2015-01-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.57655
708662,depomed to acquire rights to nucynta franchise for billion,https://www.benzinga.com/news/15/01/5152042/depomed-to-acquire-rights-to-nucynta-franchise-for-1-05-billion,Kevin Riley,2015-01-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708663,depomed shares resume trading now up ,https://www.benzinga.com/news/15/01/5152035/depomed-shares-resume-trading-now-up-15,Charles Gross,2015-01-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708664,preview depomed to resume trading at pm et,https://www.benzinga.com/news/15/01/5152002/preview-depomed-to-resume-trading-at-4-30-pm-et,Charles Gross,2015-01-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708665,premarket prep technical update johnson johnson lower,https://www.benzinga.com/general/movers-shakers/15/01/5151293/premarket-prep-technical-update-johnson-johnson-lower,Hal Lindon,2015-01-15 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.352
708666,goldman sachs downgrades johnson johnson to sell maintains pt,https://www.benzinga.com/news/15/01/5149582/goldman-sachs-downgrades-johnson-johnson-to-sell-maintains-97-00-pt,Paul Quintaro,2015-01-15 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
708667,wall streets wheelings and dealings,https://www.benzinga.com/news/15/01/5137620/wall-streets-wheelings-and-dealings,Laura Brodbeck,2015-01-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708668,jjs janssen johnson johnson innovation report license deal with vedanta related to microbiome pharma candidate for inflammatory bowel disease,https://www.benzinga.com/news/15/01/5141795/j-js-janssen-johnson-johnson-innovation-report-license-deal-with-vedanta-related-,Paul Quintaro,2015-01-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6909
708669,bloomberg reporting johnson johnson ac immune enter alzheimers disease vaccines pact,https://www.benzinga.com/news/15/01/5139744/bloomberg-reporting-johnson-johnson-ac-immune-enter-alzheimers-disease-vaccines-p,Paul Quintaro,2015-01-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708670,jnj ceo intends b in operational savings over next years,https://www.benzinga.com/news/15/01/5139423/jnj-ceo-intends-1b-in-operational-savings-over-next-3-years,Paul Quintaro,2015-01-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708671,johnson johnson webcast presentation begins,https://www.benzinga.com/news/15/01/5139416/johnson-johnson-webcast-presentation-begins,Paul Quintaro,2015-01-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708672,what investors should expect from portola pharmaceuticals upcoming data readouts,https://www.benzinga.com/trading-ideas/long-ideas/15/01/5132106/what-investors-should-expect-from-portola-pharmaceuticals-upc,Kyle Dennis,2015-01-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708673,premarket prep technical update johnson johnson higher,https://www.benzinga.com/general/movers-shakers/15/01/5131928/premarket-prep-technical-update-johnson-johnson-higher,Hal Lindon,2015-01-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708674, sectors that could survive a correction,https://www.benzinga.com/trading-ideas/long-ideas/15/01/5122145/3-sectors-that-could-survive-a-correction,Laura Brodbeck,2015-01-07 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708675,healthcare sector survives europes slide,https://www.benzinga.com/news/15/01/5121956/healthcare-sector-survives-europes-slide,Laura Brodbeck,2015-01-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708676,jj reports commencement of phase trial of ebola virus vaccine regimen,https://www.benzinga.com/news/15/01/5122165/j-j-reports-commencement-of-phase-1-trial-of-ebola-virus-vaccine-regimen,Paul Quintaro,2015-01-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708677,johnson amp johnson announces commencement of phase clinical trial of ebola vaccine regimen,https://www.benzinga.com/news/15/01/5121235/johnson-amp-johnson-announces-commencement-of-phase-1-clinical-trial-of-ebola-vac,Charles Gross,2015-01-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708678,isis pharmaceuticals shares rise premarket following announcement of deal with jnj,https://www.benzinga.com/news/15/01/5118332/isis-pharmaceuticals-shares-rise-4-5-premarket-following-announcement-of-deal-wit,Charles Gross,2015-01-05 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.648
708679,isis pharmaceuticals announces collaboration with janssen on rnatargeted therapeutics for autoimmune diseases in the gi tract,https://www.benzinga.com/news/15/01/5117899/isis-pharmaceuticals-announces-collaboration-with-janssen-on-rna-targeted-therape,Charles Gross,2015-01-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708680,gilead reports amended deals with jjs janssen to develop prezistabased singletablet regimen for treatment of people living with hiv,https://www.benzinga.com/news/14/12/5108317/gilead-reports-amended-deals-with-j-js-janssen-to-develop-prezista-based-single-t,Paul Quintaro,2014-12-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708681,premarket prep technical update johnson johnson higher,https://www.benzinga.com/general/movers-shakers/14/12/5106671/premarket-prep-technical-update-johnson-johnson-higher,Hal Lindon,2014-12-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708682,premarket prep technical update johnson johnson higher,https://www.benzinga.com/general/movers-shakers/14/12/5105318/premarket-prep-technical-update-johnson-johnson-higher,Hal Lindon,2014-12-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708683,macrogenics enters collaboration license agreement with janssen to develop mgd for multiple bcell malignancies macrogenics to receive m upfront license fee m equity investment by jnj,https://www.benzinga.com/news/14/12/5098801/macrogenics-enters-collaboration-license-agreement-with-janssen-to-develop-mgd011,Charles Gross,2014-12-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708684,analysts see no sweeter deal for volcano,https://www.benzinga.com/analyst-ratings/analyst-color/14/12/5088702/analysts-see-no-sweeter-deal-for-volcano,John Seward,2014-12-17 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.352
708685,update geron says initial payment of m due,https://www.benzinga.com/news/14/12/5083111/update-geron-says-initial-payment-of-35m-due,Paul Quintaro,2014-12-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708686,geron reports early hsr clearance for global strategic collaboration with jjs janssen,https://www.benzinga.com/news/14/12/5083110/geron-reports-early-hsr-clearance-for-global-strategic-collaboration-with-j-js-ja,Paul Quintaro,2014-12-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708687,janssen research announces presentation of data at sabcs from the phase epoane study,https://www.benzinga.com/news/14/12/5077528/janssen-research-announces-presentation-of-data-at-sabcs-from-the-phase-3-epo-ane,Paul Quintaro,2014-12-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708688,market mixed amid plan to spend million on ebola vaccines,https://www.benzinga.com/news/14/12/5074907/market-mixed-amid-plan-to-spend-300-million-on-ebola-vaccines,John Seward,2014-12-11 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
708689,premarket prep technical update johnson johnson lower,https://www.benzinga.com/general/movers-shakers/14/12/5071302/premarket-prep-technical-update-johnson-johnson-lower,Hal Lindon,2014-12-10 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.352
708690,premarket prep technical update johnson johnson lower,https://www.benzinga.com/general/movers-shakers/14/12/5067995/premarket-prep-technical-update-johnson-johnson-lower,Hal Lindon,2014-12-09 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.352
708691,jjs janssen reports imbruvica shows sustained progressionfree survival in patients with highrisk chronic lymphocytic leukemia with genetic mutation,https://www.benzinga.com/news/14/12/5066450/j-js-janssen-reports-imbruvica-shows-sustained-progression-free-survival-in-patie,Paul Quintaro,2014-12-09 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708692,new etf for environmentalists,https://www.benzinga.com/etfs/specialty-etfs/14/12/5058072/new-etf-for-environmentalists,Matthew McCall,2014-12-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708693,markets marginally lower ahead of fridays jobs report,https://www.benzinga.com/news/14/12/5058987/markets-marginally-lower-ahead-of-fridays-jobs-report,Jayson Derrick,2014-12-04 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.386
708694,markets inch higher following encouraging beige book commentary,https://www.benzinga.com/news/14/12/5055374/markets-inch-higher-following-encouraging-beige-book-commentary,Jayson Derrick,2014-12-03 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.76335
708695,report johnson johnson may put splenda on block,https://www.benzinga.com/news/14/12/5054271/report-johnson-johnson-may-put-splenda-on-block,John Seward,2014-12-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2798
708696,reuters reports johnson johnson hired goldman sachs to explore sale of splenda according to sources,https://www.benzinga.com/news/14/12/5053860/reuters-reports-johnson-johnson-hired-goldman-sachs-to-explore-sale-of-splenda-ac,Charles Gross,2014-12-03 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708697,top stocks in the drug manufacturersmajor industry with the highest operating margin,https://www.benzinga.com/trading-ideas/14/12/5048823/top-4-stocks-in-the-drug-manufacturers-major-industry-with-the-highest-o,Monica Gerson,2014-12-02 00:00:00,JNJ,1,0,0,0,0,0,1,1,0,0.60115
708698,sp stocks with most active options today pwr xel nsc bsx lltc jnj,https://www.benzinga.com/markets/options/14/12/5047317/s-p-500-stocks-with-most-active-options-today-pwr-xel-nsc-bsx-lltc-jnj,Hal Lindon,2014-12-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7288
708699,correction fda says jnjs hysterectomy device shouldnt be used by most women,https://www.benzinga.com/news/14/11/5033518/correction-fda-says-jnjs-hysterectomy-device-shouldnt-be-used-by-most-women,Paul Quintaro,2014-11-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708700,fda says jnjs hysterectomy device shouldnt be used by most women,https://www.benzinga.com/news/14/11/5033468/fda-says-jnjs-hysterectomy-device-shouldnt-be-used-by-most-women,Paul Quintaro,2014-11-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708701,riding the bull market with these momentum etfs,https://www.benzinga.com/trading-ideas/long-ideas/14/11/5023072/riding-the-bull-market-with-these-2-momentum-etfs,Matthew McCall,2014-11-20 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708702,jjs janssen reports submission of nda for threemo paliperidone palmitate to treat schizophrenia,https://www.benzinga.com/news/14/11/5022396/j-js-janssen-reports-submission-of-nda-for-three-mo-paliperidone-palmitate-to-tre,Paul Quintaro,2014-11-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.70095
708703,what johnson johnsons chart watchers need to know,https://www.benzinga.com/trading-ideas/long-ideas/14/11/5002510/what-johnson-johnsons-chart-watchers-need-to-know,James Mecir,2014-11-12 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.5
708704,jim cramer weighs in on johnson johnson and toyota motor,https://www.benzinga.com/media/cnbc/14/11/4998002/jim-cramer-weighs-in-on-johnson-johnson-and-toyota-motor,Craig Jones,2014-11-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708705,premarket primer monday november nuclear talks enter second day,https://www.benzinga.com/news/earnings/14/11/4994301/premarket-primer-monday-november-10-nuclear-talks-enter-second-day,Laura Brodbeck,2014-11-10 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708706,johnson johnson ceo says seeks acquisitions in china wsj,https://www.benzinga.com/news/14/11/4994330/johnson-johnson-ceo-says-seeks-acquisitions-in-china-wsj,Charles Gross,2014-11-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708707,premarket prep technical update johnson johnson lower,https://www.benzinga.com/general/movers-shakers/14/11/4992584/premarket-prep-technical-update-johnson-johnson-lower,Hal Lindon,2014-11-07 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.352
708708,premarket prep technical update facebook trading higher,https://www.benzinga.com/general/movers-shakers/14/11/4992565/premarket-prep-technical-update-facebook-trading-higher,Hal Lindon,2014-11-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708709,reuters reports group of scientists proposes us health officials find ebola treatment in survivors antibodies reuters,https://www.benzinga.com/news/14/11/4991920/reuters-reports-group-of-scientists-proposes-us-health-officials-find-ebola-treat,Charles Gross,2014-11-07 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708710,premarket prep technical update johnson johnson makes new all time high and retreats,https://www.benzinga.com/general/movers-shakers/14/11/4984588/premarket-prep-technical-update-johnson-johnson-makes-new-all-t,Hal Lindon,2014-11-05 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708711,which megacaps arent paying taxes,https://www.benzinga.com/general/topics/14/11/4983192/which-mega-caps-arent-paying-taxes,Ophir Gottlieb,2014-11-05 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708712,ebola vaccine contenders,https://www.benzinga.com/news/14/10/4963210/ebola-vaccine-contenders,Jim Probasco,2014-10-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708713,update gtcr announces devicor medical products to be acquired by danaher corporations leica biosystems,https://www.benzinga.com/news/14/10/4956985/update-gtcr-announces-devicor-medical-products-to-be-acquired-by-danaher-corporat,Charles Gross,2014-10-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708714,who says ebola death toll rises to from cases in eight countries through october ,https://www.benzinga.com/news/14/10/4952079/who-says-ebola-death-toll-rises-to-4-922-from-10-141-cases-in-eight-countries-thr,Charles Gross,2014-10-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.20029999999999998
708715,report malis first ebola case a year old girl has died according to health official reuters,https://www.benzinga.com/news/14/10/4951414/report-malis-first-ebola-case-a-2-year-old-girl-has-died-according-to-health-offi,Charles Gross,2014-10-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.2213
708716,ebola related stocks move off lows on report of potential new ebola case in houston tx,https://www.benzinga.com/news/14/10/4951353/ebola-related-stocks-move-off-lows-on-report-of-potential-new-ebola-case-in-houst,Charles Gross,2014-10-24 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.58895
708717,cdc spokesperson says a number of options for returnees from africa are on the table changes to policy likely,https://www.benzinga.com/news/14/10/4951339/cdc-spokesperson-says-a-number-of-options-for-returnees-from-africa-are-on-the-ta,Charles Gross,2014-10-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5386
708718,nih says did not administer experimental drugs to nina pham while she was in maryland hospital,https://www.benzinga.com/news/14/10/4950899/nih-says-did-not-administer-experimental-drugs-to-nina-pham-while-she-was-in-mary,Charles Gross,2014-10-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708719,dallas nurse nina pham declared virus free being discharged dj,https://www.benzinga.com/news/14/10/4950642/dallas-nurse-nina-pham-declared-virus-free-being-discharged-dj,Charles Gross,2014-10-24 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7553000000000001
708720,update who expects first data on efficacy of ebola vaccines by april ,https://www.benzinga.com/news/14/10/4950188/update-who-expects-first-data-on-efficacy-of-ebola-vaccines-by-april-2015,Charles Gross,2014-10-24 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708721,who says at least five more experimental ebola vaccines scheduled to begin clinical trials soon says k does of vaccine should be ready in h reuters,https://www.benzinga.com/news/14/10/4950118/who-says-at-least-five-more-experimental-ebola-vaccines-scheduled-to-begin-clinic,Charles Gross,2014-10-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6806
708722,procter gamble co shares lower following management change,https://www.benzinga.com/news/14/10/4948022/procter-gamble-co-shares-lower-following-management-change,Alex Furno,2014-10-23 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.5
708723,genmab to receive m milestone payment for daratumumab collaboration with janssen,https://www.benzinga.com/news/14/10/4947996/genmab-to-receive-10m-milestone-payment-for-daratumumab-collaboration-with-jansse,Charles Gross,2014-10-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708724,drug etfs attractive buys on pullback,https://www.benzinga.com/etfs/sector-etfs/14/10/4936002/drug-etfs-attractive-buys-on-pullback,Matthew McCall,2014-10-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
708725,markets reverse early morning gains following canadian shooting,https://www.benzinga.com/news/earnings/14/10/4944959/markets-reverse-early-morning-gains-following-canadian-shooting,Jayson Derrick,2014-10-22 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.67
708726,premarket primer wednesday october johnson johnson develops ebola vaccine,https://www.benzinga.com/news/earnings/14/10/4941979/premarket-primer-wednesday-october-22-johnson-johnson-develops-ebola-vac,Laura Brodbeck,2014-10-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708727,johnson amp johnson commits up to m to speed ebola vaccine development,https://www.benzinga.com/news/14/10/4941998/johnson-amp-johnson-commits-up-to-200m-to-speed-ebola-vaccine-development,Charles Gross,2014-10-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5129
708728,jjs janssen announces imbruvica snda submitted to fda for waldenstroms macroglobulinemia,https://www.benzinga.com/news/14/10/4934676/j-js-janssen-announces-imbruvica-snda-submitted-to-fda-for-waldenstroms-macroglob,Paul Quintaro,2014-10-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708729,benzinga weekly preview earnings season is in full swing,https://www.benzinga.com/news/earnings/14/10/4931957/benzinga-weekly-preview-earnings-season-is-in-full-swing,Laura Brodbeck,2014-10-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708730,sometimes you need to close your eyes and buy,https://www.benzinga.com/general/movers-shakers/14/10/4932216/sometimes-you-need-to-close-your-eyes-and-buy,Joel Elconin,2014-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708731,premarket primer thursday october this years spending season could be muted,https://www.benzinga.com/news/earnings/14/10/4926957/premarket-primer-thursday-october-16-this-years-spending-season-could-be,Laura Brodbeck,2014-10-16 00:00:00,JNJ,1,2,0,0,0,0,1,1,0,0.5
708732,barclays johnson johnsons q could be high water mark,https://www.benzinga.com/analyst-ratings/analyst-color/14/10/4925944/barclays-johnson-johnsons-q3-could-be-high-water-mark,John Seward,2014-10-15 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708733,update bank of america reiterates on johnson johnson on likely eps headwinds,https://www.benzinga.com/analyst-ratings/analyst-color/14/10/4923215/update-bank-of-america-reiterates-on-johnson-johnson-on-,Dwight Einhorn,2014-10-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708734,markets unable to hold on to gains as oil continues to plunge,https://www.benzinga.com/news/earnings/14/10/4921776/markets-unable-to-hold-on-to-gains-as-oil-continues-to-plunge,Jayson Derrick,2014-10-14 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.67
708735,johnson johnson conference call highlights,https://www.benzinga.com/news/earnings/14/10/4921402/johnson-johnson-conference-call-highlights,Shazir Mucklai,2014-10-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708736,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/general/movers-shakers/14/10/4921367/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-10-14 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708737,deutsche bank says gilead sciences stock reaction is overdone,https://www.benzinga.com/analyst-ratings/analyst-color/14/10/4921188/deutsche-bank-says-gilead-sciences-stock-reaction-is-ove,Kevin Riley,2014-10-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708738,deutsche bank just out with midday defense on gilead weakness on irish tax jnj comments is overdone,https://www.benzinga.com/analyst-ratings/analyst-color/14/10/4920737/deutsche-bank-just-out-with-mid-day-defense-on-gilead-we,Paul Quintaro,2014-10-14 00:00:00,JNJ,1,1,0,0,0,0,1,1,0,0.3409
708739,update johnson johnson posts betterthanexpected q earnings lifts fullyear forecast,https://www.benzinga.com/news/earnings/14/10/4919986/update-johnson-johnson-posts-better-than-expected-q3-earnings-lifts-full,Monica Gerson,2014-10-14 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708740,from jj earnings conference call expecting fy operating sales growth on a constant currency basis ,https://www.benzinga.com/news/14/10/4919897/from-j-j-earnings-conference-call-expecting-fy14-operating-sales-growth-on-a-cons,Paul Quintaro,2014-10-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708741,jj worldwide pharama sales growth yoy,https://www.benzinga.com/news/earnings/14/10/4919472/j-j-worldwide-pharama-sales-growth-yoy,Eddie Staley,2014-10-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708742,johnson johnson q orthopaedics sales b,https://www.benzinga.com/news/earnings/14/10/4919446/johnson-johnson-3q-orthopaedics-sales-2-34b,Eddie Staley,2014-10-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708743,johnson johnson q risperdalconsta sales m,https://www.benzinga.com/news/earnings/14/10/4919445/johnson-johnson-3q-risperdalconsta-sales-284m,Eddie Staley,2014-10-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708744,johnson johnson q worldwide pharmaceutical sales b,https://www.benzinga.com/news/earnings/14/10/4919439/johnson-johnson-3q-worldwide-pharmaceutical-sales-8-31b,Eddie Staley,2014-10-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708745,johnson johnson q worldwide consumer sales b,https://www.benzinga.com/news/earnings/14/10/4919438/johnson-johnson-3q-worldwide-consumer-sales-3-59b,Eddie Staley,2014-10-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708746,johnson johnson sees fy eps vs est,https://www.benzinga.com/news/14/10/4919437/johnson-johnson-sees-fy2014-eps-5-92-5-97-vs-5-93-est,Paul Quintaro,2014-10-14 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708747,johnson johnson reports q eps of vs est revenue of b vs b est raising guidance,https://www.benzinga.com/news/earnings/14/10/4919434/johnson-johnson-reports-q3-eps-of-1-50-vs-1-43-est-revenue-of-18-50b-vs-,Eddie Staley,2014-10-14 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708748,earnings scheduled for october ,https://www.benzinga.com/news/earnings/14/10/4918962/earnings-scheduled-for-october-14-2014,Monica Gerson,2014-10-14 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708749,stocks to watch for october ,https://www.benzinga.com/news/earnings/14/10/4918866/stocks-to-watch-for-october-14-2014,Monica Gerson,2014-10-14 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708750,jjs alios biopharma reports presented positive results of antirsv nucleoside analog al,https://www.benzinga.com/news/14/10/4916736/j-js-alios-biopharma-reports-presented-positive-results-of-anti-rsv-nucleoside-an,Paul Quintaro,2014-10-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708751,bristolmyers pharmacyclics janssen report clinical collaboration of evaluate opdivo imbruvica in nhl,https://www.benzinga.com/news/14/10/4916508/bristol-myers-pharmacyclics-janssen-report-clinical-collaboration-of-evaluate-opd,Paul Quintaro,2014-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708752,bavarian nordics shares rise in copenhagen on ceo comments its mva technology can be used to improve ebola vaccines from jnj gsk create biodefense business,https://www.benzinga.com/news/14/10/4916135/bavarian-nordics-shares-rise-8-in-copenhagen-on-ceo-comments-its-mva-technology-c,Charles Gross,2014-10-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.86755
708753,earnings expectations for the week of october the crunch is on,https://www.benzinga.com/news/earnings/14/10/4915706/earnings-expectations-for-the-week-of-october-13-the-crunch-is-on,Nelson Hem,2014-10-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708754,janssen presents data from hepatitis c in european israeli patients at viral hepatitis congress,https://www.benzinga.com/news/14/10/4913202/janssen-presents-data-from-hepatitis-c-in-european-israeli-patients-at-viral-hepa,Charles Gross,2014-10-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708755,premarket prep technical update johnson johnson trading sharply lower,https://www.benzinga.com/general/movers-shakers/14/10/4911987/premarket-prep-technical-update-johnson-johnson-trading-sharply,Hal Lindon,2014-10-09 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.352
708756,strike while the iron is hot stryker syk,https://www.benzinga.com/14/10/4908603/strike-while-the-iron-is-hot-stryker-syk,David Trainer,2014-10-08 00:00:00,JNJ,1,2,0,1,1,0,1,0,1,0.436
708757,premarket primer wednesday october imf cuts global growth prospects puts a damper on wall street,https://www.benzinga.com/news/earnings/14/10/4906293/premarket-primer-wednesday-october-8-imf-cuts-global-growth-prospects-pu,Laura Brodbeck,2014-10-08 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.6909
708758,premarket primer friday october jp morgan suffers largest cyberattack against a financial institution,https://www.benzinga.com/news/earnings/14/10/4896467/premarket-primer-friday-october-3-jp-morgan-suffers-largest-cyberattack-,Laura Brodbeck,2014-10-03 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.3409
708759,markets little changed ahead of fridays jobs report,https://www.benzinga.com/news/earnings/14/10/4895753/markets-little-changed-ahead-of-fridays-jobs-report,Jayson Derrick,2014-10-02 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708760,benzingas top initiations,https://www.benzinga.com/analyst-ratings/initiation/14/10/4894202/benzingas-top-initiations,Lisa Levin,2014-10-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708761,guggenheim securities initiates johnson johnson at neutral,https://www.benzinga.com/analyst-ratings/initiation/14/10/4894136/guggenheim-securities-initiates-johnson-johnson-at-neutral,Monica Gerson,2014-10-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708762,guggenheim securities initiates coverage on johnson johnson at neutral announces pt,https://www.benzinga.com/news/14/10/4893393/guggenheim-securities-initiates-coverage-on-johnson-johnson-at-neutral-announces-,Paul Quintaro,2014-10-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708763,johnson johnson falls on bernstein downgrade,https://www.benzinga.com/analyst-ratings/downgrades/14/10/4892020/johnson-johnson-falls-on-bernstein-downgrade,Kevin Riley,2014-10-01 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
708764,benzingas top downgrades,https://www.benzinga.com/analyst-ratings/downgrades/14/10/4890315/benzingas-top-downgrades,Lisa Levin,2014-10-01 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
708765,bernstein downgrades johnson johnson to market perform shares drop,https://www.benzinga.com/analyst-ratings/downgrades/14/10/4890060/bernstein-downgrades-johnson-johnson-to-market-perform-shar,Monica Gerson,2014-10-01 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.5129
708766,bernstein downgrades johnson johnson to market perform,https://www.benzinga.com/news/14/10/4889592/bernstein-downgrades-johnson-johnson-to-market-perform,Paul Quintaro,2014-10-01 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
708767,achillion pharmaceuticals inc less attractive amid johnson johnsonalios biopharma deal,https://www.benzinga.com/analyst-ratings/analyst-color/14/09/4887152/achillion-pharmaceuticals-inc-less-attractive-amid-johns,Mike Butler,2014-09-30 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6916
708768,jj announces deal to buy alios biopharma for b in cash,https://www.benzinga.com/news/14/09/4885901/j-j-announces-deal-to-buy-alios-biopharma-for-1-75b-in-cash,Paul Quintaro,2014-09-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708769,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/general/movers-shakers/14/09/4883681/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-09-29 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708770,jjs janssen says zytiga plus prednisone shows statistically significant overall survival in men with advanced prostate cancer prior to chemotherapy,https://www.benzinga.com/news/14/09/4881589/j-js-janssen-says-zytiga-plus-prednisone-shows-statistically-significant-overall-,Paul Quintaro,2014-09-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.30910000000000004
708771,premarket primer thursday september us airstrikes do little to stem isis advances,https://www.benzinga.com/news/earnings/14/09/4875274/premarket-primer-thursday-september-25-us-airstrikes-do-little-to-stem-i,Laura Brodbeck,2014-09-25 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
708772,jjs janssen reports research demonstrated association between connect injection centers increased adherence to healthcare providerordered janssen longacting treatment for schizophrenia,https://www.benzinga.com/news/14/09/4874445/j-js-janssen-reports-research-demonstrated-association-between-connect-injection-,Paul Quintaro,2014-09-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6366
708773,premarket prep technical update johnson johnson approaches all time high,https://www.benzinga.com/general/movers-shakers/14/09/4873504/premarket-prep-technical-update-johnson-johnson-approaches-all-,Hal Lindon,2014-09-24 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708774,premarket prep technical update johnson johnson makes new alltime high,https://www.benzinga.com/general/movers-shakers/14/09/4863665/premarket-prep-technical-update-johnson-johnson-makes-new-all-t,Hal Lindon,2014-09-19 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708775,stocks hitting week highs,https://www.benzinga.com/news/14/09/4862774/stocks-hitting-52-week-highs,Lisa Levin,2014-09-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708776,new active etf for all risk environments,https://www.benzinga.com/etfs/specialty-etfs/14/09/4843925/new-active-etf-for-all-risk-environments,Matthew McCall,2014-09-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.57655
708777,premarket prep technical update johnson johnson trading higher,https://www.benzinga.com/general/movers-shakers/14/09/4854208/premarket-prep-technical-update-johnson-johnson-trading-higher,Hal Lindon,2014-09-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708778, companies investing in stem cell research,https://www.benzinga.com/general/health-care/14/09/4843794/3-companies-investing-in-stem-cell-research,Craig Adeyanju,2014-09-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708779,janssen jj innovation announce establishment of research collaboration with university of toronto,https://www.benzinga.com/news/14/09/4831326/janssen-j-j-innovation-announce-establishment-of-research-collaboration-with-univ,Paul Quintaro,2014-09-08 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7787
708780,jury finds jjs incontinence sling caused womans injuries co ordered to pay m bloomberg,https://www.benzinga.com/news/14/09/4829147/jury-finds-j-js-incontinence-sling-caused-womans-injuries-co-ordered-to-pay-3-25m,Paul Quintaro,2014-09-05 00:00:00,JNJ,1,1,0,1,0,1,1,1,1,0.44865
708781,who says available supply of ebola drugs will be used in the field,https://www.benzinga.com/news/14/09/4829125/who-says-available-supply-of-ebola-drugs-will-be-used-in-the-field,Paul Quintaro,2014-09-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708782,who says two promising ebola vaccines identified safety results from clinical trials may be available in nov paving way for use,https://www.benzinga.com/news/14/09/4829079/who-says-two-promising-ebola-vaccines-identified-safety-results-from-clinical-tri,Charles Gross,2014-09-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.83525
708783,johnson johnson metal hip might lead to poisoning facing suits,https://www.benzinga.com/news/14/09/4827269/johnson-johnson-metal-hip-might-lead-to-poisoning-facing-6-000-suits,Paul Quintaro,2014-09-04 00:00:00,JNJ,1,1,1,0,0,1,1,1,1,0.20705
708784,us stock futures gain adp jobless claims data in focus,https://www.benzinga.com/news/14/09/4824936/us-stock-futures-gain-adp-jobless-claims-data-in-focus,Monica Gerson,2014-09-04 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.76335
708785,johnson amp johnson to fasttrack development of ebola vaccine,https://www.benzinga.com/news/14/09/4824511/johnson-amp-johnson-to-fast-track-development-of-ebola-vaccine,Charles Gross,2014-09-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708786,morgan stanley sees johnson johnson taking rx estimates higher,https://www.benzinga.com/analyst-ratings/analyst-color/14/09/4818136/morgan-stanley-sees-johnson-johnson-taking-rx-estimates-,Dwight Einhorn,2014-09-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708787,bank of america remains optimistic on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/14/08/4813855/bank-of-america-remains-optimistic-on-cordis,Dwight Einhorn,2014-08-29 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.6591
708788,morgan stanley sees more focused device strategy continue for johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/14/08/4813749/morgan-stanley-sees-more-focused-device-strategy-continu,Dwight Einhorn,2014-08-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71955
708789,wsj reporting jj looking for buyers for cordis unit deal could be for up to b,https://www.benzinga.com/news/14/08/4812589/wsj-reporting-j-j-looking-for-buyers-for-cordis-unit-deal-could-be-for-up-to-2b,Paul Quintaro,2014-08-28 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.625
708790,the companies teaming up for a new tool to fight cancer,https://www.benzinga.com/news/14/08/4800621/the-4-companies-teaming-up-for-a-new-tool-to-fight-cancer,Mark Morelli,2014-08-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.10470000000000002
708791,vivus announces purchase of topiramaterelated patents from jjs janssen pharma will dismiss suit against vivus,https://www.benzinga.com/news/14/08/4800708/vivus-announces-purchase-of-topiramate-related-patents-from-j-js-janssen-pharma-w,Paul Quintaro,2014-08-25 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708792,premarket primer friday august draghi yellen set to speak at jackson hole,https://www.benzinga.com/news/earnings/14/08/4797888/premarket-primer-friday-august-22-draghi-yellen-set-to-speak-at-jackson-,Laura Brodbeck,2014-08-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708793,illumina announces strategic partnerships with astrazeneca janssen sanofi,https://www.benzinga.com/news/14/08/4794791/illumina-announces-strategic-partnerships-with-astrazeneca-janssen-sanofi,Charles Gross,2014-08-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708794,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/general/movers-shakers/14/08/4784292/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-08-15 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708795,earnings season is the right prescription for health care etfs,https://www.benzinga.com/etfs/sector-etfs/14/08/4775391/earnings-season-is-the-right-prescription-for-health-care-etfs,David Fabian,2014-08-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
708796,genmab announces jannsen to start new phase iii study of daratumumab in front line multiple myeloma,https://www.benzinga.com/news/14/08/4770760/genmab-announces-jannsen-to-start-new-phase-iii-study-of-daratumumab-in-front-lin,Charles Gross,2014-08-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708797, companies that should benefit from the new initiative in africa,https://www.benzinga.com/trading-ideas/long-ideas/14/08/4762837/3-companies-that-should-benefit-from-the-new-initiative-in-af,Jonathan Yates,2014-08-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7294
708798,premarket primer thursday august russia set to release a list of banned goods,https://www.benzinga.com/news/earnings/14/08/4763230/premarket-primer-thursday-august-7-russia-set-to-release-a-list-of-banne,Laura Brodbeck,2014-08-07 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.2706
708799,premarket prep technical update johnson johnson trading higher,https://www.benzinga.com/general/movers-shakers/14/08/4761479/premarket-prep-technical-update-johnson-johnson-trading-higher,Hal Lindon,2014-08-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708800,unique d startups and the public companies that should buy them,https://www.benzinga.com/news/14/08/4747505/unique-3d-startups-and-the-public-companies-that-should-buy-them,Jim Probasco,2014-08-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708801,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/general/movers-shakers/14/07/4747155/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-07-31 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708802,ibm announces alex gorsky ceo of johnson johnson joining board peter voser will also join board,https://www.benzinga.com/news/14/07/4739206/ibm-announces-alex-gorsky-ceo-of-johnson-johnson-joining-board-peter-voser-will-a,Hal Lindon,2014-07-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
708803,fda expands approved use labeling of imbruvica for chronic lymphocytic leukemia,https://www.benzinga.com/news/14/07/4734310/fda-expands-approved-use-of-imbruvica-for-chronic-lymphocytic-leukemia,Charles Gross,2014-07-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708804,phase cosmos study results published in the lancet demonstrate efficacy and safety of janssens oncedaily simeprevir in all oral week combination with sofosbuvir for genotype chronic hepatitis c,https://www.benzinga.com/news/14/07/4732820/phase-2-cosmos-study-results-published-in-the-lancet-demonstrate-efficacy-and-saf,Charles Gross,2014-07-28 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
708805,eu medicines agency recommends johnson johnson pharmacyclics leukaemia drug ibrutinib,https://www.benzinga.com/news/14/07/4729994/eu-medicines-agency-recommends-johnson-johnson-pharmacyclics-leukaemia-drug-ibrut,Charles Gross,2014-07-25 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.61315
708806,ytd biggest buyback companies trailing sp in stock appreciation,https://www.benzinga.com/analyst-ratings/analyst-color/14/07/4728482/ytd-biggest-buyback-companies-trailing-s-p-in-stock-appr,John Seward,2014-07-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.7553000000000001
708807,organovo up premarket in research pact with johnson johnson unit,https://www.benzinga.com/news/14/07/4727188/organovo-up-19-premarket-in-research-pact-with-johnson-johnson-unit,John Seward,2014-07-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708808,organovo holdings enters agreement with janssen rd to evaluate use of d bioprinted tissue in drug discovery setting,https://www.benzinga.com/news/14/07/4726730/organovo-holdings-enters-agreement-with-janssen-r-d-to-evaluate-use-of-3d-bio-pri,Charles Gross,2014-07-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708809,the mostrespected corporate brands,https://www.benzinga.com/analyst-ratings/analyst-color/14/07/4717294/the-10-most-respected-corporate-brands,Brianna Valleskey,2014-07-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708810,stocks to watch for july ,https://www.benzinga.com/news/earnings/14/07/4718251/stocks-to-watch-for-july-22-2014,Monica Gerson,2014-07-22 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708811,jj announces b buyback plan,https://www.benzinga.com/news/14/07/4717341/j-j-announces-5b-buyback-plan,Paul Quintaro,2014-07-21 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.625
708812,why has wall street punished johnson johnson for its earnings beat,https://www.benzinga.com/general/movers-shakers/14/07/4713206/why-has-wall-street-punished-johnson-johnson-for-its-earnings-b,Joel Elconin,2014-07-18 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.2706
708813,premarket primer friday july tension between russia and the west at an all time high,https://www.benzinga.com/news/earnings/14/07/4712118/premarket-primer-friday-july-18-tension-between-russia-and-the-west-at-a,Laura Brodbeck,2014-07-18 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.3409
708814,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/general/movers-shakers/14/07/4710773/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-07-17 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708815,alzheimers rates falling but pharmas search for a cure yields no results,https://www.benzinga.com/news/14/07/4707388/alzheimers-rates-falling-but-pharmas-search-for-a-cure-yields-no-results,Bruce Kennedy,2014-07-17 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.26165
708816,shares of minerva neurosciences moving higher following g filing from jj showing stake in co,https://www.benzinga.com/news/14/07/4710094/shares-of-minerva-neurosciences-moving-higher-following-13g-filing-from-j-j-showi,Paul Quintaro,2014-07-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708817,earnings continue driving markets higher,https://www.benzinga.com/news/earnings/14/07/4707647/earnings-continue-driving-markets-higher,Jayson Derrick,2014-07-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708818,which matters more janet yellen or earnings economic data,https://www.benzinga.com/economics/14/07/4707055/which-matters-more-janet-yellen-or-earnings-economic-data,Dave Moenning,2014-07-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5129
708819,morgan stanley sees meaningful headwind for johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/14/07/4706057/morgan-stanley-sees-meaningful-15-headwind-for-johnson-j,Dwight Einhorn,2014-07-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6591
708820,premarket primer wednesday july yellen hints at sooner than expected rate hike,https://www.benzinga.com/news/earnings/14/07/4705236/premarket-primer-wednesday-july-16-yellen-hints-at-sooner-than-expected-,Laura Brodbeck,2014-07-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708821,markets mixed nasdaq lower as yellen suggests valuations are stretched,https://www.benzinga.com/news/earnings/14/07/4704184/markets-mixed-nasdaq-lower-as-yellen-suggests-valuations-are-stretched,Jayson Derrick,2014-07-15 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.352
708822,goldman sachs jpmorgan chase report strong earnings retail numbers fall below estimates,https://www.benzinga.com/news/earnings/14/07/4703939/goldman-sachs-jpmorgan-chase-report-strong-earnings-retail-numbers-fall-,Garrett Cook,2014-07-15 00:00:00,JNJ,0,1,0,1,0,0,0,1,0,0.7553000000000001
708823,us stocks sink jpmorgan shares surge on upbeat earnings,https://www.benzinga.com/news/earnings/14/07/4703569/u-s-stocks-sink-jpmorgan-shares-surge-on-upbeat-earnings,Garrett Cook,2014-07-15 00:00:00,JNJ,1,0,0,1,0,1,1,1,1,0.648
708824,markets rise goldman sachs profit beats estimates,https://www.benzinga.com/news/earnings/14/07/4703011/markets-rise-goldman-sachs-profit-beats-estimates,Garrett Cook,2014-07-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7202
708825,from jj call sees sales bb vs b est,https://www.benzinga.com/news/14/07/4702731/from-j-j-call-sees-sales-74-50b-75-30b-vs-74-91b-est,Paul Quintaro,2014-07-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.625
708826,johnson johnson goldman sachs pushing these etfs upward,https://www.benzinga.com/etfs/sector-etfs/14/07/4702114/johnson-johnson-goldman-sachs-pushing-these-etfs-upward,Matthew McCall,2014-07-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708827,update johnson johnson posts upbeat q earnings lifts outlook,https://www.benzinga.com/news/earnings/14/07/4702084/update-johnson-johnson-posts-upbeat-q2-earnings-lifts-outlook,Monica Gerson,2014-07-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708828,update jj q sales breakdown,https://www.benzinga.com/news/earnings/14/07/4701948/update-j-j-q2-sales-breakdown,Paul Quintaro,2014-07-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.625
708829,update johnson johnson raises fy eps guidance from to vs est,https://www.benzinga.com/news/14/07/4701931/update-johnson-johnson-raises-fy2014-eps-guidance-from-5-80-5-90-to-5-85-5-92-vs-,Paul Quintaro,2014-07-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708830,johnson johnson reports q eps of vs est revenue of b vs b est raises outlook,https://www.benzinga.com/news/earnings/14/07/4701923/johnson-johnson-reports-q2-eps-of-1-66-vs-1-54-est-revenue-of-19-50b-vs-,Paul Quintaro,2014-07-15 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708831,us stock futures mostly higher ahead of goldman sachs earnings,https://www.benzinga.com/news/14/07/4701903/us-stock-futures-mostly-higher-ahead-of-goldman-sachs-earnings,Monica Gerson,2014-07-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708832,premarket primer tuesday july citigroup settles mortgage probe,https://www.benzinga.com/news/earnings/14/07/4701059/premarket-primer-tuesday-july-15-citigroup-settles-mortgage-probe,Laura Brodbeck,2014-07-15 00:00:00,JNJ,1,2,0,1,0,1,1,1,0,0.5
708833,earnings scheduled for july ,https://www.benzinga.com/news/earnings/14/07/4701475/earnings-scheduled-for-july-15-2014,Monica Gerson,2014-07-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708834,stocks to watch for july ,https://www.benzinga.com/news/earnings/14/07/4701433/stocks-to-watch-for-july-15-2014,Monica Gerson,2014-07-15 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708835,dow sets new intraday high citigroup impresses with earnings,https://www.benzinga.com/analyst-ratings/analyst-color/14/07/4700510/dow-sets-new-intraday-high-citigroup-impresses-with-earn,Jayson Derrick,2014-07-14 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7383500000000001
708836,jjs janssen pharma announces seeking expanded label for oncemonthly invega sustenna,https://www.benzinga.com/news/14/07/4698831/j-js-janssen-pharma-announces-seeking-expanded-label-for-once-monthly-invega-sust,Paul Quintaro,2014-07-14 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
708837,earnings expectations for the week of july big banks tech giants and more,https://www.benzinga.com/news/earnings/14/07/4697945/earnings-expectations-for-the-week-of-july-14-big-banks-tech-giants-and-,Nelson Hem,2014-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708838,benzinga weekly preview earnings season kicks into high gear,https://www.benzinga.com/news/earnings/14/07/4696664/benzinga-weekly-preview-earnings-season-kicks-into-high-gear,Laura Brodbeck,2014-07-11 00:00:00,JNJ,1,0,1,0,1,0,1,1,1,0.5
708839,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/intraday-update/14/07/4696818/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-07-11 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708840,jp morgan johnson johnsons drug segment may beat q street views,https://www.benzinga.com/analyst-ratings/analyst-color/14/07/4694638/j-p-morgan-johnson-johnsons-drug-segment-may-beat-q2-str,John Seward,2014-07-10 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.60115
708841,premarket prep technical update johnson johnson makes new alltime high,https://www.benzinga.com/general/movers-shakers/14/07/4684465/premarket-prep-technical-update-johnson-johnson-makes-new-all-t,Hal Lindon,2014-07-07 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708842,genmab announces has reached m milestone in daratumumab deal with jjs janssen,https://www.benzinga.com/news/14/07/4683905/genmab-announces-has-reached-25m-milestone-in-daratumumab-deal-with-j-js-janssen,Paul Quintaro,2014-07-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.55135
708843,premarket prep technical update johnson johnson finds resistance,https://www.benzinga.com/general/movers-shakers/14/07/4680665/premarket-prep-technical-update-johnson-johnson-finds-resistanc,Hal Lindon,2014-07-03 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708844,jj settles with state of oregon first state deal related to cos hip implants bloomberg,https://www.benzinga.com/news/14/07/4678885/j-j-settles-with-state-of-oregon-first-state-deal-related-to-co-s-hip-implants-bl,Paul Quintaro,2014-07-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
708845,markets little changed ahead of th of july break,https://www.benzinga.com/news/earnings/14/07/4678705/markets-little-changed-ahead-of-4th-of-july-break,Jayson Derrick,2014-07-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708846,barclays downgrades pharmaceutical sector,https://www.benzinga.com/analyst-ratings/analyst-color/14/07/4678189/barclays-downgrades-pharmaceutical-sector,John Seward,2014-07-02 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
708847,abbvie has lost us court bid to revive patent case against jj bloomberg,https://www.benzinga.com/news/14/07/4674824/abbvie-has-lost-us-court-bid-to-revive-patent-case-against-j-j-bloomberg,Paul Quintaro,2014-07-01 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.6366
708848,markets little changed as the quarter comes to an end,https://www.benzinga.com/news/earnings/14/06/4672019/markets-little-changed-as-the-quarter-comes-to-an-end,Jayson Derrick,2014-06-30 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
708849,johnson johnson completes divestiture of orthoclinical diagnostics to the carlyle group for b,https://www.benzinga.com/news/14/06/4672057/johnson-johnson-completes-divestiture-of-ortho-clinical-diagnostics-to-the-carlyl,Eddie Staley,2014-06-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708850,johnson and johnson submits marketing application for velcade in europe,https://www.benzinga.com/news/14/06/4666409/johnson-and-johnson-submits-marketing-application-for-velcade-in-europe,Paul Quintaro,2014-06-27 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708851,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/trading-ideas/technicals/14/06/4653715/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-06-23 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708852,premarket prep technical update johnson johnson makes new alltime high,https://www.benzinga.com/general/movers-shakers/14/06/4650045/premarket-prep-technical-update-johnson-johnson-makes-new-all-t,Hal Lindon,2014-06-20 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708853,premarket prep technical update johnson johnson trading higher,https://www.benzinga.com/general/movers-shakers/14/06/4647137/premarket-prep-technical-update-johnson-johnson-trading-higher,Hal Lindon,2014-06-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708854,advances in hiv hep c treatments could spark renewed interest in biotech stocks,https://www.benzinga.com/news/14/06/4640476/advances-in-hiv-hep-c-treatments-could-spark-renewed-interest-in-biotech-stocks,Bruce Kennedy,2014-06-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7997000000000001
708855,jjs janssen announces license deal with vertex to develop novel treatment for influenza a,https://www.benzinga.com/news/14/06/4642249/j-js-janssen-announces-license-deal-with-vertex-to-develop-novel-treatment-for-in,Paul Quintaro,2014-06-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
708856,jj offers new longterm data showing invokana reduces blood glucose also demonstrates reductions in secondary endpoints,https://www.benzinga.com/news/14/06/4636952/j-j-offers-new-long-term-data-showing-invokana-reduces-blood-glucose-also-demonst,Hal Lindon,2014-06-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
708857,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/trading-ideas/technicals/14/06/4629807/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-06-12 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708858,update viiv healthcare collaborates with janssen to investigate singletablet regimen for maintenance treatment of hiv,https://www.benzinga.com/news/14/06/4628118/update-viiv-healthcare-collaborates-with-janssen-to-investigate-single-tablet-reg,Charles Gross,2014-06-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708859,janssen collaborates with viiv healthcare to develop twodrug single tablet regimen for maintenance treatment hiv,https://www.benzinga.com/news/14/06/4628084/janssen-collaborates-with-viiv-healthcare-to-develop-two-drug-single-tablet-regim,Charles Gross,2014-06-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
708860,takeover whispers add to achillion pharmaceuticals momentum,https://www.benzinga.com/news/earnings/14/06/4626233/when-news-and-rumors-add-to-a-stocks-momentum,Joel Elconin,2014-06-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708861,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/trading-ideas/technicals/14/06/4626650/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-06-11 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708862,premarket prep technical update johnson johnson makes new alltime high,https://www.benzinga.com/after-hours-center/14/06/4623022/premarket-prep-technical-update-johnson-johnson-makes-new-all-time-,Hal Lindon,2014-06-10 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708863,hearing leering says jnj abbvie bristolmyers squibb could target achillion pharmaceuticals,https://www.benzinga.com/analyst-ratings/analyst-color/14/06/4619197/hearing-leering-says-jnj-abbvie-bristol-myers-squibb-cou,Charles Gross,2014-06-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708864,medical device companies future remains bright albeit slow penetration,https://www.benzinga.com/general/health-care/14/06/4617654/medical-device-companies-future-remains-bright-albeit-slow-penetra,Nicholas Kitonyi,2014-06-09 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
708865,premarket prep technical update johnson johnson trading lower,https://www.benzinga.com/general/movers-shakers/14/06/4615321/premarket-prep-technical-update-johnson-johnson-trading-lower,Hal Lindon,2014-06-06 00:00:00,JNJ,0,2,0,1,0,0,0,0,0,0.352
708866,premarket prep technical update johnson johnson makes new alltime high,https://www.benzinga.com/general/movers-shakers/14/06/4613060/premarket-prep-technical-update-johnson-johnson-makes-new-all-t,Hal Lindon,2014-06-05 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708867,hearing unconfirmed market chatter circulating in chat rooms of potential jnj interest in isoray,https://www.benzinga.com/news/14/06/4612557/hearing-unconfirmed-market-chatter-circulating-in-chat-rooms-of-potential-jnj-int,Charles Gross,2014-06-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6806
708868,premarket prep technical update johnson johnson makes new alltime high,https://www.benzinga.com/general/movers-shakers/14/06/4609677/premarket-prep-technical-update-johnson-johnson-makes-new-all-t,Hal Lindon,2014-06-04 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708869,asco meeting day promising results from jnjs imbruvica targeted therapy,https://www.benzinga.com/news/14/06/4606039/asco-meeting-day-2-promising-results-from-jnjs-imbruvica-targeted-therapy,Erika Janowicz,2014-06-04 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.70095
708870,premarket prep technical update johnson johnson makes new alltime high,https://www.benzinga.com/general/health-care/14/06/4606294/premarket-prep-technical-update-johnson-johnson-makes-new-all-time,Hal Lindon,2014-06-03 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708871,update jim cramer says jnj should spinoff their medical device business and merge it with smith nephew,https://www.benzinga.com/media/cnbc/14/06/4603085/update-jim-cramer-says-jnj-should-spinoff-their-medical-device-business-and,Charles Gross,2014-06-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708872,jim cramer says jnj could be a potential suitor for smith nephew,https://www.benzinga.com/media/cnbc/14/06/4603074/jim-cramer-says-jnj-could-be-a-potential-suitor-for-smith-nephew,Charles Gross,2014-06-02 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708873,is this time really going to be different a true look at current financial asset valuations pg wmt jnj,https://www.benzinga.com/markets/bonds/14/05/4597434/is-this-time-really-going-to-be-different-a-true-look-at-current-financi,Eric Mancini,2014-06-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8243
708874,premarket prep technical update johnson johnson trading higher,https://www.benzinga.com/trading-ideas/technicals/14/06/4602032/premarket-prep-technical-update-johnson-johnson-trading-highe,Hal Lindon,2014-06-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708875,jjs janssen announces data on ibrutinib resonatetm showed significant improvements in progressionfree survival overall survival in patients with cll sll,https://www.benzinga.com/news/14/06/4600595/j-js-janssen-announces-data-on-ibrutinib-resonate-tm-showed-significant-improveme,Hal Lindon,2014-06-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
708876,update pharmacyclics shares rise on positive imbruvica data presented at asco,https://www.benzinga.com/news/14/06/4600419/update-pharmacyclics-shares-rise-9-on-positive-imbruvica-data-presented-at-asco,Charles Gross,2014-06-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.85015
708877,pharmacyclics jnj announce imbruvica shows durable longterm responses for patients with cll,https://www.benzinga.com/news/14/05/4599070/pharmacyclics-jnj-announce-imbruvica-shows-durable-long-term-responses-for-patien,Charles Gross,2014-05-31 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5
708878,premarket primer wednesday may poroshenko moves to end prorussian rebellion,https://www.benzinga.com/news/earnings/14/05/4587956/premarket-primer-wednesday-may-28-poroshenko-moves-to-end-pro-russian-re,Laura Brodbeck,2014-05-28 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.436
708879,morgan stanley sees three debateworthy topics for johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/14/05/4581057/morgan-stanley-sees-three-debate-worthy-topics-for-johns,Dwight Einhorn,2014-05-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708880,jjs medical devices diagnostics announces expansion with innovative products customerfocused solutions,https://www.benzinga.com/news/14/05/4577365/j-js-medical-devices-diagnostics-announces-expansion-with-innovative-products-cus,Paul Quintaro,2014-05-22 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708881,update actavis shows co jjs janssen have amended supply deal for generic concerta,https://www.benzinga.com/news/14/05/4571610/update-actavis-shows-co-j-js-janssen-have-amended-supply-deal-for-generic-concert,Paul Quintaro,2014-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708882,form k from actavis shows co jjs janssen have amended supply deal for generic concerta,https://www.benzinga.com/news/14/05/4571609/form-8-k-from-actavis-shows-co-j-js-janssen-have-amended-supply-deal-for-generic-,Paul Quintaro,2014-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708883,dissecting dividend growth etfs,https://www.benzinga.com/etfs/broad-u-s-equity-etfs/14/05/4571098/dissecting-dividend-growth-etfs,David Fabian,2014-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
708884,jjs janssen announces withdraws application in eu for approval of ivadministered simponi,https://www.benzinga.com/news/14/05/4565715/j-js-janssen-announces-withdraws-application-in-eu-for-approval-of-iv-administere,Paul Quintaro,2014-05-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
708885,rd tax credit passed in the house faces challenges ahead,https://www.benzinga.com/general/politics/14/05/4551473/r-d-tax-credit-passed-in-the-house-faces-challenges-ahead,Spencer Schredder,2014-05-14 00:00:00,JNJ,1,1,0,0,0,0,1,0,0,0.7202
708886,google celebrates dorothy hodgkin her contributions to chemistry,https://www.benzinga.com/news/14/05/4548238/google-celebrates-dorothy-hodgkin-her-contributions-to-chemistry,Erika Janowicz,2014-05-12 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.7859499999999999
708887,benzingas weekend ma chatter,https://www.benzinga.com/news/14/05/4545067/benzingas-weekend-m-a-chatter,Charles Gross,2014-05-11 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708888,sanofi rumored not to be interested in allergan jj said to demur on cos breast implant business bloomberg,https://www.benzinga.com/news/14/05/4543685/sanofi-rumored-not-to-be-interested-in-allergan-j-j-said-to-demur-on-co-s-breast-,Paul Quintaro,2014-05-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.46675
708889,jnjs ortho caps gmbh gets favorable decision in patent dispute in federal patent court in germany reuters,https://www.benzinga.com/news/14/05/4542928/jnjs-ortho-caps-gmbh-gets-favorable-decision-in-patent-dispute-in-federal-patent-,Charles Gross,2014-05-09 00:00:00,JNJ,1,0,0,1,0,0,1,1,0,0.55135
708890,update jjs janssen submits snda for olysio,https://www.benzinga.com/news/14/05/4533423/update-j-js-janssen-submits-snda-for-olysio,Hal Lindon,2014-05-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708891,jjs janssen submits snda for olysio,https://www.benzinga.com/news/14/05/4533415/j-js-janssen-submits-snda-for-olysio,Paul Quintaro,2014-05-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708892,market wrap for may dow erases tripledigit loss all three major indices positive,https://www.benzinga.com/news/earnings/14/05/4527138/market-wrap-for-may-5-dow-erases-triple-digit-loss-all-three-major-indic,Jayson Derrick,2014-05-05 00:00:00,JNJ,0,1,1,1,1,1,1,1,1,0.6591
708893, top dow stocks with the most upside potential,https://www.benzinga.com/news/14/05/4523705/5-top-dow-stocks-with-the-most-upside-potential,Nelson Hem,2014-05-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708894,premarket technical update johnson johnson trading higher,https://www.benzinga.com/general/movers-shakers/14/05/4526567/premarket-technical-update-johnson-johnson-trading-higher,Hal Lindon,2014-05-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708895,benzingas ma chatter for tuesday april ,https://www.benzinga.com/news/14/04/4510271/benzingas-m-a-chatter-for-tuesday-april-29-2014,Charles Gross,2014-04-29 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708896,update jnj sanofi spokespersons decline comment on rumored contact from allergan,https://www.benzinga.com/news/14/04/4507770/update-jnj-sanofi-spokespersons-decline-comment-on-rumored-contact-from-allergan,Charles Gross,2014-04-29 00:00:00,JNJ,1,2,1,1,1,1,1,0,0,0.5
708897,allergan could explore sale to sanofi jj instead of valeant bloomberg,https://www.benzinga.com/news/14/04/4507528/allergan-could-explore-sale-to-sanofi-j-j-instead-of-valeant-bloomberg,Paul Quintaro,2014-04-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708898,jj reports new collaboration with stop tb partnerships global drug facility to enhance access to antitb compound,https://www.benzinga.com/news/14/04/4507143/j-j-reports-new-collaboration-with-stop-tb-partnerships-global-drug-facility-to-e,Paul Quintaro,2014-04-29 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.4742
708899, mega cap etfs for your portfolio mgc oef xlg aapl msft,https://www.benzinga.com/etfs/broad-u-s-equity-etfs/14/04/4499702/3-mega-cap-etfs-for-your-portfolio-mgc-oef-xlg-aapl-msft,Matthew McCall,2014-04-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708900,form k from jj includes proxy materials for annual shareholder meeting,https://www.benzinga.com/news/14/04/4500527/form-8-k-from-j-j-includes-proxy-materials-for-annual-shareholder-meeting,Paul Quintaro,2014-04-25 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.625
708901,jj raises qtr dividend from to share,https://www.benzinga.com/news/14/04/4495923/j-j-raises-qtr-dividend-from-0-66-to-0-70share,Paul Quintaro,2014-04-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
708902,fda approves jjs janssens sylvant for rare castlemans disease,https://www.benzinga.com/news/14/04/4493231/fda-approves-j-js-janssens-sylvant-for-rare-castlemans-disease,Paul Quintaro,2014-04-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
708903,johnson johnson crosses above ,https://www.benzinga.com/news/14/04/4484454/johnson-johnson-crosses-above-100,Charles Gross,2014-04-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708904,premarket primer thursday april violence in ukraine could deter thursdays negotiations,https://www.benzinga.com/news/earnings/14/04/4477929/premarket-primer-thursday-april-17-violence-in-ukraine-could-deter-thurs,Laura Brodbeck,2014-04-17 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.18755
708905,market wrap for april markets hold on to gains on positive yellen comments and economic data,https://www.benzinga.com/news/14/04/4476843/market-wrap-for-april-16-markets-hold-on-to-gains-an-positive-yellen-comments-and,Jayson Derrick,2014-04-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8592
708906,mylan launches first generic ortho evra patch,https://www.benzinga.com/news/14/04/4476763/mylan-launches-first-generic-ortho-evra-patch,Paul Quintaro,2014-04-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708907,update bank of america reiterates on johnson johnson following strong q performance,https://www.benzinga.com/analyst-ratings/analyst-color/14/04/4475378/update-bank-of-america-reiterates-on-johnson-johnson-fol,Dwight Einhorn,2014-04-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7553000000000001
708908,update deutsche bank reiterates on johnson johnson as defensive stock,https://www.benzinga.com/analyst-ratings/analyst-color/14/04/4475167/update-deutsche-bank-reiterates-on-johnson-johnson-as-de,Dwight Einhorn,2014-04-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5129
708909,credit suisse maintains underperform on johnson johnson raises pt to ,https://www.benzinga.com/news/14/04/4474444/credit-suisse-maintains-underperform-on-johnson-johnson-raises-pt-to-100-00,Juan Lopez,2014-04-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.6909
708910,bank of america maintains neutral on johnson johnson raises po to ,https://www.benzinga.com/news/14/04/4474441/bank-of-america-maintains-neutral-on-johnson-johnson-raises-po-to-106-00,Juan Lopez,2014-04-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2213
708911,premarket primer wednesday april chinese gdp slows but surpasses expectations,https://www.benzinga.com/news/earnings/14/04/4474192/premarket-primer-wednesday-april-16-chinese-gdp-slows-but-surpasses-expe,Laura Brodbeck,2014-04-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708912,market wrap for april who doesnt love a turnaround,https://www.benzinga.com/news/earnings/14/04/4473064/market-wrap-for-april-15-who-doesnt-love-a-turnaround,Jayson Derrick,2014-04-15 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.23920000000000002
708913,midafternoon market update markets trade in highly volatile session as talk of a pullback is widespread,https://www.benzinga.com/news/earnings/14/04/4472894/mid-afternoon-market-update-markets-trade-in-highly-volatile-session-as-,Jake L'Ecuyer,2014-04-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
708914,premarket prep technical update johnson johnson trading sharply higher,https://www.benzinga.com/general/movers-shakers/14/04/4472584/premarket-prep-technical-update-johnson-johnson-trading-sharply,Hal Lindon,2014-04-15 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708915,midday market update us stocks turn red pep boys shares drop after q results,https://www.benzinga.com/news/earnings/14/04/4472362/mid-day-market-update-us-stocks-turn-red-pep-boys-shares-drop-after-q4-r,Jake L'Ecuyer,2014-04-15 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.5129
708916,the market is not acting right,https://www.benzinga.com/trading-ideas/technicals/14/04/4472021/the-market-is-not-acting-right,Joel Elconin,2014-04-15 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
708917,midmorning market update markets gain johnson johnson profit beats street view,https://www.benzinga.com/news/earnings/14/04/4471866/mid-morning-market-update-markets-gain-johnson-johnson-profit-beats-stre,Jake L'Ecuyer,2014-04-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.8714999999999999
708918,update johnson johnson shares rise premarket on earnings beat raised guidance,https://www.benzinga.com/news/earnings/14/04/4471191/update-johnson-johnson-shares-rise-2-5-premarket-on-earnings-beat-raised,Charles Gross,2014-04-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.648
708919,update johnson johnson posts upbeat q earnings lifts fy outlook,https://www.benzinga.com/news/earnings/14/04/4471092/update-johnson-johnson-posts-upbeat-q1-earnings-lifts-fy14-outlook,Monica Gerson,2014-04-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708920,johnson johnson q xarel sales m risperdal m velcade m remicade b,https://www.benzinga.com/news/earnings/14/04/4470800/johnson-johnson-q1-xarel-sales-319m-risperdal-310m-velcade-408m-remicade,David Johnson,2014-04-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708921,johnson johnson raises fy eps guidance to ,https://www.benzinga.com/news/14/04/4470785/johnson-johnson-raises-fy2014-eps-guidance-to-5-80-5-90,Paul Quintaro,2014-04-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708922,johnson johnson reports q eps of vs est revenue of b vs b est,https://www.benzinga.com/news/earnings/14/04/4470780/johnson-johnson-reports-q1-eps-of-1-54-vs-1-48-est-revenue-of-18-12b-vs-,Paul Quintaro,2014-04-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708923,etf outlook for tuesday april ewh fcg psp hdv,https://www.benzinga.com/etfs/sector-etfs/14/04/4469693/etf-outlook-for-tuesday-april-15-2014-ewh-fcg-psp-hdv,Matthew McCall,2014-04-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708924,premarket primer tuesday april hopes for diplomacy in ukraine help settle markets,https://www.benzinga.com/news/earnings/14/04/4469944/premarket-primer-tuesday-april-15-hopes-for-diplomacy-in-ukraine-help-se,Laura Brodbeck,2014-04-15 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.83525
708925,earning economic and ipo calendar for tuesday april ,https://www.benzinga.com/news/earnings/14/04/4470471/earning-economic-and-ipo-calendar-for-tuesday-april-15-2014,Charles Gross,2014-04-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708926,earnings scheduled for april ,https://www.benzinga.com/news/earnings/14/04/4470370/earnings-scheduled-for-april-15-2014,Monica Gerson,2014-04-15 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708927,stocks to watch for april ,https://www.benzinga.com/news/earnings/14/04/4470311/stocks-to-watch-for-april-15-2014,Monica Gerson,2014-04-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708928,jefferies downgrades johnson johnson to hold maintains pt,https://www.benzinga.com/news/14/04/4467652/jefferies-downgrades-johnson-johnson-to-hold-maintains-105-00-pt,Hal Lindon,2014-04-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
708929,premarket primer monday april military action in ukraine looking more likely,https://www.benzinga.com/news/earnings/14/04/4466670/premarket-primer-monday-april-14-military-action-in-ukraine-looking-more,Laura Brodbeck,2014-04-14 00:00:00,JNJ,1,2,0,0,0,0,1,1,1,0.5
708930,earnings expectations for the week of april cocacola goldman sachs google and more,https://www.benzinga.com/news/earnings/14/04/4466476/earnings-expectations-for-the-week-of-april-14-coca-cola-goldman-sachs-g,Nelson Hem,2014-04-14 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708931,benzinga weekly preview short but action packed week ahead,https://www.benzinga.com/analyst-ratings/analyst-color/14/04/4465108/benzinga-weekly-preview-short-but-action-packed-week-ahe,Laura Brodbeck,2014-04-11 00:00:00,JNJ,0,2,1,1,1,1,0,0,0,0.5
708932,top upcoming earnings releases,https://www.benzinga.com/news/earnings/14/04/4463056/top-40-upcoming-earnings-releases,Erika Janowicz,2014-04-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
708933,premarket primer thursday april job creation will be chinas main focus,https://www.benzinga.com/news/earnings/14/04/4460302/premarket-primer-thursday-april-10-job-creation-will-be-chinas-main-focu,Laura Brodbeck,2014-04-10 00:00:00,JNJ,1,2,1,0,1,0,1,1,0,0.6366
708934,premarket primer wednesday april john kerry accuses russia of stirring trouble in ukraine,https://www.benzinga.com/news/earnings/14/04/4456765/premarket-primer-wednesday-april-9-john-kerry-accuses-russia-of-stirring,Laura Brodbeck,2014-04-09 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.18755
708935,pharmacyclics says snda for imbruvica submitted to us fda,https://www.benzinga.com/news/14/04/4453487/pharmacyclics-says-snda-for-imbruvica-submitted-to-us-fda,Paul Quintaro,2014-04-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708936,is the market still playing defense,https://www.benzinga.com/general/movers-shakers/14/04/4451137/is-the-market-still-playing-defense,Joel Elconin,2014-04-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
708937,jjs janssen submits nda for fixeddose combo tablet of darunavir with cobicistat to fda,https://www.benzinga.com/news/14/04/4435387/j-js-janssen-submits-nda-for-fixed-dose-combo-tablet-of-darunavir-with-cobicistat,Paul Quintaro,2014-04-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708938,benzingas ma chatter for monday march ,https://www.benzinga.com/news/14/03/4433896/benzingas-m-a-chatter-for-monday-march-31-2014,Charles Gross,2014-03-31 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708939,market wrap for march stocks rally as yellen confirms support for economy,https://www.benzinga.com/news/14/03/4433511/market-wrap-for-march-31-stocks-rally-as-yellen-confirms-support-for-economy,Jayson Derrick,2014-03-31 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.70095
708940,stocks hitting week highs,https://www.benzinga.com/news/14/03/4432064/stocks-hitting-52-week-highs,Lisa Levin,2014-03-31 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708941,update jj announces acceptance of binding offer from carlyle group to buy orthoclinical diagnostics for b,https://www.benzinga.com/news/14/03/4431065/update-j-j-announces-acceptance-of-binding-offer-from-carlyle-group-to-buy-ortho-,Paul Quintaro,2014-03-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8062
708942,jj announces acceptance of binding offer from carlyle group to buy orthoclinical diagnostics for b,https://www.benzinga.com/news/14/03/4431063/j-j-announces-acceptance-of-binding-offer-from-carlyle-group-to-buy-ortho-clinica,Paul Quintaro,2014-03-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8062
708943,fda okays janssens topamax for migraine prevention in adolescents,https://www.benzinga.com/news/14/03/4428812/fda-okays-janssens-topamax-for-migraine-prevention-in-adolescents,Paul Quintaro,2014-03-28 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7383500000000001
708944,fitch affirms aaa rating on jj outlook stable,https://www.benzinga.com/news/14/03/4425536/fitch-affirms-aaa-rating-on-j-j-outlook-stable,Paul Quintaro,2014-03-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
708945,etfs shrugging off the selling dhs smh igf intc,https://www.benzinga.com/etfs/sector-etfs/14/03/4421848/etfs-shrugging-off-the-selling-dhs-smh-igf-intc,Matthew McCall,2014-03-27 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.3409
708946,stocks hitting week highs,https://www.benzinga.com/news/14/03/4416955/stocks-hitting-52-week-highs,Lisa Levin,2014-03-25 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708947,google honors activist dorothy height her contributions,https://www.benzinga.com/news/14/03/4413835/google-honors-activist-dorothy-height-her-contributions,Erika Janowicz,2014-03-24 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.7553000000000001
708948,ap reporting jj b judgement overturned by arkansas supreme court,https://www.benzinga.com/news/14/03/4406364/ap-reporting-j-j-1-2b-judgement-overturned-by-arkansas-supreme-court,Paul Quintaro,2014-03-20 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.8404
708949,jjs janssen investigational treatment for schizophreniashows positive efficacy delays relapse,https://www.benzinga.com/news/14/03/4405575/j-js-janssen-investigational-treatment-for-schizophreniashows-positive-efficacy-d,Paul Quintaro,2014-03-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708950,slap the floor market playing defense,https://www.benzinga.com/trading-ideas/technicals/14/03/4389611/slap-the-floor-market-playing-defense,Joel Elconin,2014-03-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
708951,jnjs janssen receives positive recommendation on stelara from smc,https://www.benzinga.com/news/14/03/4378406/jnjs-janssen-receives-positive-recommendation-on-stelara-from-smc,Paul Quintaro,2014-03-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
708952,reckitt benckiser to acquire ky brand from mcneil ppc terms not disclosed,https://www.benzinga.com/news/14/03/4376535/reckitt-benckiser-to-acquire-k-y-brand-from-mcneil-ppc-terms-not-disclosed,Charles Gross,2014-03-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708953,cramer recommends jj for best big pharma pipeline play,https://www.benzinga.com/news/14/03/4367864/cramer-recommends-j-j-for-best-big-pharma-pipeline-play,Paul Quintaro,2014-03-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.92955
708954,jj says new data on xeplion significantly delays time to relapse,https://www.benzinga.com/news/14/03/4363011/j-j-says-new-data-on-xeplion-significantly-delays-time-to-relapse,Paul Quintaro,2014-03-04 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
708955,what companies stand to benefit from the th academy awards,https://www.benzinga.com/news/14/02/4350966/what-companies-stand-to-benefit-from-the-86th-academy-awards,Victoria Novikova,2014-02-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8592
708956,jj files automatic mixed securities shelf,https://www.benzinga.com/news/14/02/4347503/j-j-files-automatic-mixed-securities-shelf,Paul Quintaro,2014-02-26 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.74695
708957,jjs biosense webster receives fda approval for first catheer ablation therapy,https://www.benzinga.com/news/14/02/4341283/j-js-biosense-webster-receives-fda-approval-for-first-catheer-ablation-therapy,Paul Quintaro,2014-02-25 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7383500000000001
708958,jjs cordis receives ce mark for renlane renal deneveration system,https://www.benzinga.com/news/14/02/4328252/j-js-cordis-receives-ce-mark-for-renlane-renal-deneveration-system,Paul Quintaro,2014-02-21 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5
708959,ema isuses new compassionateuse programme,https://www.benzinga.com/news/14/02/4327759/ema-isuses-new-compassionate-use-programme,Paul Quintaro,2014-02-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708960,pharma etfs on the move again ihe pjp pph act frx,https://www.benzinga.com/etfs/sector-etfs/14/02/4319870/pharma-etfs-on-the-move-again-ihe-pjp-pph-act-frx,Matthew McCall,2014-02-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708961,jefferies d printers are about to burst across many fields,https://www.benzinga.com/analyst-ratings/analyst-color/14/02/4320682/jefferies-3d-printers-are-about-to-burst-across-many-fie,Jayson Derrick,2014-02-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708962,bloomberg reporting jj has persuaded judge to throw out suit related to vaginalmesh sling,https://www.benzinga.com/news/14/02/4316942/bloomberg-reporting-j-j-has-persuaded-judge-to-throw-out-suit-related-to-vaginal-,Paul Quintaro,2014-02-18 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.625
708963,market wrap for february markets end the week positive,https://www.benzinga.com/news/14/02/4311581/market-wrap-for-february-14-markets-end-the-week-positive,Jayson Derrick,2014-02-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7787
708964,update pharmacyclics announces will receive m milestone payment related to jjs imbruvica deal,https://www.benzinga.com/news/14/02/4304124/update-pharmacyclics-announces-will-receive-60m-milestone-payment-related-to-j-js,Paul Quintaro,2014-02-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708965,shares of pharmacyclics on the move higher following fda okay for imbruvica,https://www.benzinga.com/news/14/02/4304013/shares-of-pharmacyclics-on-the-move-higher-following-fda-okay-for-imbruvica,Paul Quintaro,2014-02-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7383500000000001
708966,fda issues okay for janssenmds imbruvica for chronic lymphcytic leukemia,https://www.benzinga.com/news/14/02/4303995/fda-issues-okay-for-imbruvica-for-chronic-lymphcytic-leukemia,Paul Quintaro,2014-02-12 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.61315
708967,an investors guide to hot in vitro diagnostics market,https://www.benzinga.com/markets/14/02/4303624/an-investors-guide-to-hot-in-vitro-diagnostics-market,Zack Miller,2014-02-12 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
708968,three steps to overcoming losses in a declining market,https://www.benzinga.com/markets/14/02/4288782/three-steps-to-overcoming-losses-in-a-declining-market,WilliamBriat,2014-02-06 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.29905000000000004
708969,bloomberg reporting judge in jj vaginalmesh case found co improperly destroyed documents,https://www.benzinga.com/news/14/02/4284850/bloomberg-reporting-judge-in-j-j-vaginal-mesh-case-found-co-improperly-destroyed-,Paul Quintaro,2014-02-05 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.352
708970,market wrap for january markets focus on good news,https://www.benzinga.com/news/14/01/4268577/market-wrap-for-january-30-markets-focus-on-good-news,Jayson Derrick,2014-01-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
708971,bloomberg reporting jj escapes m verdict following rejection of patent appeal,https://www.benzinga.com/news/14/01/4253855/bloomberg-reporting-j-j-escapes-482m-verdict-following-rejection-of-patent-appeal,Paul Quintaro,2014-01-27 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.44865
708972,premarket primer monday january markets open the week on edge,https://www.benzinga.com/news/earnings/14/01/4252791/premarket-primer-monday-january-27-markets-open-the-week-on-edge,Laura Brodbeck,2014-01-27 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708973,is it time to worry again,https://www.benzinga.com/etfs/broad-u-s-equity-etfs/14/01/4249596/is-it-time-to-worry-again,Dave Moenning,2014-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.2798
708974,jjs flubendazole wins fda orphan drug designation,https://www.benzinga.com/news/14/01/4250274/j-js-flubendazole-wins-fda-orphan-drug-designation,Paul Quintaro,2014-01-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7859499999999999
708975,court rules in favor of covidien in ethicon patent infringement lawsuit,https://www.benzinga.com/news/14/01/4247986/court-rules-in-favor-of-covidien-in-ethicon-patent-infringement-lawsuit,Charles Gross,2014-01-23 00:00:00,JNJ,1,2,1,0,0,0,1,1,1,0.3409
708976,morgan stanley maintains on johnson johnson as looks promising,https://www.benzinga.com/analyst-ratings/analyst-color/14/01/4242577/morgan-stanley-maintains-on-johnson-johnson-as-2014-look,David Johnson,2014-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
708977,jjs janssen announces health canada approval for stelara,https://www.benzinga.com/news/14/01/4242062/j-js-janssen-announces-health-canada-approval-for-stelara,Paul Quintaro,2014-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
708978,premarket primer wednesday january syrian peace talks kick off surrounded by doubt,https://www.benzinga.com/news/earnings/14/01/4241428/premarket-primer-wednesday-january-22-syrian-peace-talks-kick-off-surrou,Laura Brodbeck,2014-01-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.625
708979,market wrap for january dow hit by earnings sp and nasdaq end the day positive,https://www.benzinga.com/news/14/01/4240375/market-wrap-for-january-21-dow-hit-by-earnings-s-p-and-nasdaq-end-the-day-positiv,Jayson Derrick,2014-01-21 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7787
708980,johnson johnson earnings recap beats estimates by four cents,https://www.benzinga.com/analyst-ratings/analyst-color/14/01/4239668/johnson-johnson-earnings-recap-beats-estimates-by-four-c,Jayson Derrick,2014-01-21 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708981,johnson johnson shares lower after earnngs,https://www.benzinga.com/general/movers-shakers/14/01/4239790/johnson-johnson-shares-lower-after-earnngs,Hal Lindon,2014-01-21 00:00:00,JNJ,0,1,0,0,0,0,0,0,0,0.5
708982,update johnson johnson posts higher q earnings,https://www.benzinga.com/news/earnings/14/01/4239191/update-johnson-johnson-posts-higher-q4-earnings,Monica Gerson,2014-01-21 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708983,johnson johnson sees fy sales bb vs b est,https://www.benzinga.com/news/14/01/4238904/johnson-johnson-sees-fy2014-sales-73-50b-74-30b-vs-73-90b-est,Paul Quintaro,2014-01-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708984,johnson johnson sees fy eps vs est,https://www.benzinga.com/news/14/01/4238021/johnson-johnson-sees-fy2014-eps-5-75-5-85-vs-5-85-est,Paul Quintaro,2014-01-21 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
708985,johnson johnson reports q eps of vs est revenue of b vs b est,https://www.benzinga.com/news/earnings/14/01/4238017/johnson-johnson-reports-q4-eps-of-1-24-vs-1-20-est-revenue-of-18-40b-vs-,Paul Quintaro,2014-01-21 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708986,premarket primer tuesday january chinas central bank adds record amount of cash to markets,https://www.benzinga.com/news/earnings/14/01/4236731/premarket-primer-tuesday-january-21-chinas-central-bank-adds-record-amou,Laura Brodbeck,2014-01-21 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
708987,earnings scheduled for january ,https://www.benzinga.com/news/earnings/14/01/4237376/earnings-scheduled-for-january-21-2014,Monica Gerson,2014-01-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708988,stocks to watch for january ,https://www.benzinga.com/news/earnings/14/01/4237371/stocks-to-watch-for-january-21-2014,Monica Gerson,2014-01-21 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708989,economic outlook for the week of january how to trade with binary options,https://www.benzinga.com/markets/binary-options/14/01/4230779/economic-outlook-for-the-week-of-january-20-how-to-trade-with-b,Darrell Martin,2014-01-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
708990,earnings expectations for the week of january microsoft mcdonalds netflix and more,https://www.benzinga.com/news/earnings/14/01/4234379/earnings-expectations-for-the-week-of-january-20-microsoft-mcdonalds-net,Nelson Hem,2014-01-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
708991,benzinga weekly preview earnings season continues,https://www.benzinga.com/news/earnings/14/01/4230791/benzinga-weekly-preview-earnings-season-continues,Luke Jacobi,2014-01-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
708992,jjs janssen confirms fda panel votes against approval of xarelto for use in patients with acs,https://www.benzinga.com/news/14/01/4230628/j-js-janssen-confirms-fda-panel-votes-against-approval-of-xarelto-for-use-in-pati,Paul Quintaro,2014-01-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7383500000000001
708993,fda advisory panel votes jjbayers xarelto should not be approved,https://www.benzinga.com/news/14/01/4230399/fda-advisory-panel-votes-10-0-j-jbayers-xarelto-should-not-be-approved,Paul Quintaro,2014-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.33740000000000003
708994,jj announces binding offer from carlyle group to buy orthoclinical diagnostics unit for b,https://www.benzinga.com/news/14/01/4228381/j-j-announces-binding-offer-from-carlyle-group-to-buy-ortho-clinical-diagnostics-,Paul Quintaro,2014-01-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
708995,update jj could sell ortho unit to carlyle for b,https://www.benzinga.com/news/14/01/4226528/update-j-j-could-sell-ortho-unit-to-carlyle-for-4b,Paul Quintaro,2014-01-15 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.625
708996,bloomberg reporting jj could announce deal with carlyle as soon as tomorrow thursday,https://www.benzinga.com/news/14/01/4226527/bloomberg-reporting-j-j-could-announce-deal-with-carlyle-as-soon-as-tomorrow-thur,Paul Quintaro,2014-01-15 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.625
708997,wsj reporting carlyle paying b for jjs bloodtesting unit,https://www.benzinga.com/news/14/01/4226071/wsj-reporting-carlyle-paying-4-4-2b-for-j-js-blood-testing-unit,Paul Quintaro,2014-01-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
708998,carlyle paying bb for jj bloodtesting unit according to sources dj,https://www.benzinga.com/news/14/01/4225936/carlyle-paying-4b-4-2b-for-j-j-blood-testing-unit-according-to-sources-dj,Charles Gross,2014-01-15 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.625
708999,market wrap for january markets rebound on earnings season kickoff,https://www.benzinga.com/news/14/01/4223015/market-wrap-for-january-14-markets-rebound-on-earnings-season-kickoff,Jayson Derrick,2014-01-14 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5
709000,reuters reporting carlyle readying b in financing for bid for jj unit,https://www.benzinga.com/news/14/01/4219083/reuters-reporting-carlyle-readying-3-7b-in-financing-for-bid-for-j-j-unit,Paul Quintaro,2014-01-13 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.625
709001,market consolidates ahead of major earnings reports,https://www.benzinga.com/trading-ideas/technicals/14/01/4218153/market-consolidates-ahead-of-major-earnings-reports,PreMarketInfo,2014-01-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709002,barclays downgrades johnson johnson to equalweight maintains pt,https://www.benzinga.com/news/14/01/4208857/barclays-downgrades-johnson-johnson-to-equalweight-maintains-99-00-pt,Paul Quintaro,2014-01-10 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
709003,market wrap for january all eyes on tomorrows job report,https://www.benzinga.com/news/14/01/4207392/market-wrap-for-january-9-all-eyes-on-tomorrows-job-report,Jayson Derrick,2014-01-09 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709004,jefferies upgrades johnson johnson to buy raises pt to ,https://www.benzinga.com/news/14/01/4205504/jefferies-upgrades-johnson-johnson-to-buy-raises-pt-to-108-00,Paul Quintaro,2014-01-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709005,procter gamble vs johnson johnson which is the better bet,https://www.benzinga.com/news/14/01/4196597/procter-gamble-vs-johnson-johnson-which-is-the-better-bet,Tabitha Jean Naylor,2014-01-08 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7202
709006,johnson johnson off to a good start in ,https://www.benzinga.com/trading-ideas/technicals/14/01/4203132/johnson-johnson-off-to-a-good-start-in-2014,PreMarketInfo,2014-01-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
709007,market wrap for january markets reverse day slump,https://www.benzinga.com/news/14/01/4199997/market-wrap-for-january-7-markets-reverse-3-day-slump,Jayson Derrick,2014-01-07 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709008,update rbc capital markets upgrades johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/14/01/4198837/update-rbc-capital-markets-upgrades-johnson-johnson,David Johnson,2014-01-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709009,jj says idmc recommends early stopping of pharmacyclics phase study,https://www.benzinga.com/news/14/01/4198526/j-j-says-idmc-recommends-early-stopping-of-pharmacyclics-phase-3-study,Paul Quintaro,2014-01-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
709010,rbc capital upgrades johnson johnson to outperform raises pt to ,https://www.benzinga.com/news/14/01/4197618/rbc-capital-upgrades-johnson-johnson-to-outperform-raises-pt-to-104-00,Paul Quintaro,2014-01-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709011,stocks to watch for december ,https://www.benzinga.com/trading-ideas/technicals/13/12/4180867/stocks-to-watch-for-december-27-2013,António Costa,2013-12-27 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709012,hearing carlyle group favorite to acquire johnson johnsons clinical diagnostics unit sources,https://www.benzinga.com/news/13/12/4177389/hearing-carlyle-group-favorite-to-acquire-johnson-johnsons-clinical-diagnostics-u,Charles Gross,2013-12-23 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.7294
709013,ema issues positive opinion on bedaquiline,https://www.benzinga.com/news/13/12/4172224/ema-issues-positive-opinion-on-bedaquiline,Paul Quintaro,2013-12-20 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
709014,glaxosmithkline rocked by china bribery scandal,https://www.benzinga.com/trading-ideas/long-ideas/13/12/4166036/glaxosmithkline-rocked-by-china-bribery-scandal,Daniel Jennings,2013-12-19 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.2798
709015,orion signs license pact with janssen pharma for alzheimers treatment will receive upfront payment of m,https://www.benzinga.com/news/13/12/4170170/orion-signs-license-pact-with-janssen-pharma-for-alzheimers-treatment-will-receiv,Paul Quintaro,2013-12-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709016,which companies hoarded the most cash in ,https://www.benzinga.com/news/13/12/4163766/which-companies-hoarded-the-most-cash-in-2013,Charley Blaine,2013-12-18 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709017,update ema says will discuss voluntary withdrawal of janssens doribax riskbenefit balance of ariads iclusig,https://www.benzinga.com/news/13/12/4162256/update-ema-says-will-discuss-voluntary-withdrawal-of-janssens-doribax-risk-benefi,Paul Quintaro,2013-12-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5129
709018,fda issues complete response letter for canagliflozinmetformin fixeddose combination therapy for type diabetes,https://www.benzinga.com/news/13/12/4152576/fda-issues-complete-response-letter-for-canagliflozinmetformin-fixed-dose-combina,Paul Quintaro,2013-12-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709019,johnson johnson shares under pressure for second day in a row,https://www.benzinga.com/trading-ideas/technicals/13/12/4151757/johnson-johnson-shares-under-pressure-for-second-day-in-a-row,Hal Lindon,2013-12-12 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
709020,myriad genetics announces collaboration with janssen,https://www.benzinga.com/news/13/12/4138823/myriad-genetics-announces-collaboration-with-janssen,Charles Gross,2013-12-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709021,fda announces m settlement with jjs advanced sterilization products execs,https://www.benzinga.com/news/13/12/4130315/fda-announces-1-25m-settlement-with-j-js-advanced-sterilization-products-execs,Paul Quintaro,2013-12-04 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
709022,jj files for twopart note offering via bofa goldman jp morgan,https://www.benzinga.com/markets/bonds/13/12/4120623/j-j-files-for-two-part-note-offering-via-bofa-goldman-jp-morgan,Paul Quintaro,2013-12-02 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.71075
709023,jj says may pay b in medical costs related to hip settlement,https://www.benzinga.com/news/13/11/4113917/j-j-says-may-pay-1b-in-medical-costs-related-to-hip-settlement,Paul Quintaro,2013-11-27 00:00:00,JNJ,1,1,0,1,1,0,1,1,1,0.57655
709024,benzingas ma chatter for monday november ,https://www.benzinga.com/news/13/11/4108047/benzingas-m-a-chatter-for-monday-november-25-2013,Charles Gross,2013-11-25 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709025,form k from vertex pharma shows jjs janssen will make m payment related to incivo sales royalties during q,https://www.benzinga.com/news/13/11/4103843/form-8-k-from-vertex-pharma-shows-j-js-janssen-will-make-152m-payment-related-to-,Paul Quintaro,2013-11-22 00:00:00,JNJ,1,2,1,1,1,1,1,0,1,0.5
709026,reuters reporting jj has chosen two possible bidders for its diagnostics unit sale,https://www.benzinga.com/news/13/11/4100747/reuters-reporting-j-j-has-chosen-two-possible-bidders-for-its-diagnostics-unit-sa,Paul Quintaro,2013-11-21 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.625
709027,hearing carlyle group danaher blackstone group in final stage of negotiations for jjs diagnostics unit according to sources,https://www.benzinga.com/news/13/11/4100726/hearing-carlyle-group-danaher-blackstone-group-in-final-stage-of-negotiations-for,Charles Gross,2013-11-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709028,market wrap for november inflation data points to no tapering fed meeting notes points to yes tapering,https://www.benzinga.com/news/13/11/4097162/market-wrap-for-november-20-inflation-data-points-to-no-tapering-fed-meeting-note,Jayson Derrick,2013-11-20 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5640000000000001
709029,jjs janssen says galexos approved by canada priority review,https://www.benzinga.com/news/13/11/4095039/j-js-janssen-says-galexos-approved-by-canada-priority-review,Paul Quintaro,2013-11-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
709030,vertex sells incivo product royalty rights to janssen pharmaceutica for m,https://www.benzinga.com/news/13/11/4094648/vertex-sells-incivo-product-royalty-rights-to-janssen-pharmaceutica-for-152m,Charles Gross,2013-11-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709031,bloomberg reporting jj will pay b to settle first round of hip suits,https://www.benzinga.com/news/13/11/4093511/bloomberg-reporting-j-j-will-pay-2-47b-to-settle-first-round-of-hip-suits,Paul Quintaro,2013-11-19 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.57655
709032,wsj breaking news tweets johnson johnson has agreed to pay at least billion to settle hip lawsuits,https://www.benzinga.com/news/13/11/4091941/wsj-breaking-news-tweets-johnson-johnson-has-agreed-to-pay-at-least-2-5-billion-t,Paul Quintaro,2013-11-19 00:00:00,JNJ,1,0,0,1,0,0,1,1,1,0.5129
709033,top four overlooked stocks for incomeseeking investors,https://www.benzinga.com/markets/13/11/4088115/top-four-overlooked-stocks-for-income-seeking-investors,WilliamBriat,2013-11-18 00:00:00,JNJ,1,2,0,1,0,1,1,1,1,0.58895
709034,bloomberg reporting jj said set to announce asr hipimplant settlement on nov th,https://www.benzinga.com/news/13/11/4085256/bloomberg-reporting-j-j-said-set-to-announce-asr-hip-implant-settlement-on-nov-19,Paul Quintaro,2013-11-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709035,premarket primer thursday november markets primed for yellens big day,https://www.benzinga.com/news/earnings/13/11/4079389/premarket-primer-thursday-november-15-markets-primed-for-yellens-big-day,Laura Brodbeck,2013-11-14 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709036,pharmacyclics resumes trading,https://www.benzinga.com/news/13/11/4077390/pharmacyclics-resumes-trading,Charles Gross,2013-11-13 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709037,update pharmacyclics will hold pm call to discuss fda approval of imbruvica,https://www.benzinga.com/news/13/11/4077316/update-pharmacyclics-will-hold-1pm-call-to-discuss-fda-approval-of-imbruvica,Paul Quintaro,2013-11-13 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.7383500000000001
709038,pharmacyclics jjs janssen now confirming fda approval of imbruvica,https://www.benzinga.com/news/13/11/4077306/pharmacyclics-j-js-janssen-now-confirming-fda-approval-of-imbruvica,Paul Quintaro,2013-11-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
709039,pharmacyclics halted news pending,https://www.benzinga.com/news/13/11/4077254/pharmacyclics-halted-news-pending,Paul Quintaro,2013-11-13 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709040,fda approves ibrutinib for mcl,https://www.benzinga.com/news/13/11/4077253/fda-approves-ibrutinib-for-mcl,Charles Gross,2013-11-13 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.70095
709041,october job numbers a tale of two economies,https://www.benzinga.com/economics/13/11/4076871/october-job-numbers-a-tale-of-two-economies,WilliamBriat,2013-11-13 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
709042,bloomberg reporting jj said to reach b deal to settle hipimplant suits,https://www.benzinga.com/news/13/11/4073801/bloomberg-reporting-j-j-said-to-reach-4b-deal-to-settle-hip-implant-suits,Paul Quintaro,2013-11-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6366
709043,johnson johnson amazon at odds over rd party sales,https://www.benzinga.com/news/13/11/4069126/johnson-johnson-amazon-at-odds-over-3rd-party-sales,Bruce Kennedy,2013-11-11 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.76335
709044,why did institutions sell million apple shares,https://www.benzinga.com/general/hedge-funds/13/11/4068823/why-did-institutions-sell-29-million-apple-shares,investmentcontrarians,2013-11-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
709045,market wrap for november markets erase thursdays losses dow companies dominate headlines,https://www.benzinga.com/news/13/11/4066065/market-wrap-for-november-8-markets-erase-thursdays-losses-dow-companies-dominate-,Jayson Derrick,2013-11-08 00:00:00,JNJ,1,1,1,1,1,0,1,0,1,0.25305
709046,johnson jonhson unit could fetch over billion in sale,https://www.benzinga.com/news/13/11/4065688/johnson-jonhson-unit-could-fetch-over-4-billion-in-sale,Jayson Derrick,2013-11-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709047,premarket primer tuesday november fed speakers calm taper nerves,https://www.benzinga.com/news/earnings/13/11/4050953/premarket-primer-tuesday-november-5-fed-speakers-calm-taper-nerves,Laura Brodbeck,2013-11-05 00:00:00,JNJ,1,1,0,1,1,0,1,1,1,0.61315
709048,jj gilead report hcv combo shows svr rate prior null responders says medivir showed no benefit from ribavirin week regimen similar to ,https://www.benzinga.com/news/13/11/4049530/j-j-gilead-report-hcv-combo-shows-93-svr12-rate-prior-null-responders-says-medivi,Paul Quintaro,2013-11-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.71075
709049,jj said to pay more than billion in risperdal accord,https://www.benzinga.com/news/13/11/4048722/j-j-said-to-pay-more-than-2-2-billion-in-risperdal-accord,Erika Janowicz,2013-11-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.57655
709050,us doj says jj will pay b related to drug cases co has admitted to promoting risperdal for nonschizophrenic uses,https://www.benzinga.com/news/13/11/4048363/us-doj-says-j-j-will-pay-2-2b-related-to-drug-cases-co-has-admitted-to-promoting-,Paul Quintaro,2013-11-04 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.77115
709051,bloomberg reporting jjs settlement related to risperdal said to be announced today,https://www.benzinga.com/news/13/11/4048189/bloomberg-reporting-j-js-settlement-related-to-risperdal-said-to-be-announced-tod,Paul Quintaro,2013-11-04 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709052,dj reporting jj to pay b to settle marketing probes,https://www.benzinga.com/news/13/11/4048047/dj-reporting-j-j-to-pay-2b-to-settle-marketing-probes,Paul Quintaro,2013-11-04 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.57655
709053,jjs janssen must pay m related to topamax seizure case,https://www.benzinga.com/news/13/10/4036629/j-js-janssen-must-pay-4-02m-related-to-topamax-seizure-case,Paul Quintaro,2013-10-30 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.44865
709054,first trial related to jjs janssen product topamax seizure drug goes to jury today,https://www.benzinga.com/news/13/10/4036343/first-trial-related-to-j-js-janssen-product-topamax-seizure-drug-goes-to-jury-tod,Paul Quintaro,2013-10-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709055,premarket primer tuesday october fed meeting likely uneventful,https://www.benzinga.com/news/earnings/13/10/4029417/premarket-primer-tuesday-october-29-fed-meeting-likely-uneventful,Laura Brodbeck,2013-10-29 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709056,think silver top stocks catering to seniors,https://www.benzinga.com/general/travel/13/10/4024406/think-silver-top-stocks-catering-to-seniors,Tabitha Jean Naylor,2013-10-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
709057,jjs janssen reports nearly on simponi aria at two years had acr response,https://www.benzinga.com/news/13/10/4026365/j-js-janssen-reports-nearly-70-on-simponi-aria-at-two-years-had-acr-20-response,Paul Quintaro,2013-10-28 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709058,market primer wednesday october markets wobble on debt deal setback,https://www.benzinga.com/news/earnings/13/10/3994905/market-primer-wednesday-october-16-markets-wobble-on-debt-deal-setback,Laura Brodbeck,2013-10-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.3194
709059,market wrap for tuesday october earnings reports and white house progress send markets down,https://www.benzinga.com/news/earnings/13/10/3993701/market-wrap-for-tuesday-october-15th-disappointing-earnings-and-white-ho,Luke Jacobi,2013-10-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.71075
709060,premarket info recap for october earnings kick off tuesday,https://www.benzinga.com/trading-ideas/technicals/13/10/3992079/premarket-info-recap-for-october-15-2013-earnings-kick-off-tu,PreMarketInfo,2013-10-15 00:00:00,JNJ,1,2,0,0,0,0,1,1,1,0.5
709061,update johnson johnson posts higher q profit,https://www.benzinga.com/news/earnings/13/10/3991570/update-johnson-johnson-posts-higher-q3-profit,Monica Gerson,2013-10-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7202
709062,benzingas top premarket gainers,https://www.benzinga.com/news/13/10/3991498/benzingas-top-pre-market-gainers,Monica Gerson,2013-10-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
709063,update jj reported q remicade sales b zytiga sales m prezista m velcade m stelara m risperdal consta m,https://www.benzinga.com/news/earnings/13/10/3991344/update-j-j-reported-q3-remicade-sales-1-69b-zytiga-sales-464m-prezista-4,Paul Quintaro,2013-10-15 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.625
709064,johnson johnson raises fy eps guidance from to vs est,https://www.benzinga.com/news/13/10/3991322/johnson-johnson-raises-fy2013-eps-guidance-from-5-40-5-47-to-5-44-5-49-vs-5-46-es,Paul Quintaro,2013-10-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709065,johnson johnson reports q eps of vs est revenue of b vs b est raises outlook,https://www.benzinga.com/news/earnings/13/10/3991308/johnson-johnson-reports-q3-eps-of-1-36-vs-1-32-est-revenue-of-17-60b-vs-,Paul Quintaro,2013-10-15 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
709066,etf outlook for october ihe itb ewz smh,https://www.benzinga.com/etfs/sector-etfs/13/10/3989945/etf-outlook-for-october-15-2013-ihe-itb-ewz-smh,Matthew McCall,2013-10-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.3409
709067,market primer tuesday october tuesday could be deal day,https://www.benzinga.com/news/earnings/13/10/3990870/market-primer-tuesday-october-15-tuesday-could-be-deal-day,Laura Brodbeck,2013-10-15 00:00:00,JNJ,1,2,0,1,1,1,1,1,1,0.5
709068,earnings scheduled for october ,https://www.benzinga.com/news/earnings/13/10/3990720/earnings-scheduled-for-october-15-2013,Monica Gerson,2013-10-15 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709069,stocks to watch for october ,https://www.benzinga.com/news/earnings/13/10/3990704/stocks-to-watch-for-october-15-2013,Monica Gerson,2013-10-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709070,earnings expectations for the week of october financials tech and consumer goods,https://www.benzinga.com/news/earnings/13/10/3987325/earnings-expectations-for-the-week-of-october-14-financials-tech-and-con,Nelson Hem,2013-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709071,benzinga weekly preview earnings season gets into full swing,https://www.benzinga.com/news/13/10/3986038/benzinga-weekly-preview-earnings-season-gets-into-full-swing,Laura Brodbeck,2013-10-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709072,update goldman sachs upgrades johnson johnson based on solid pharma business,https://www.benzinga.com/analyst-ratings/analyst-color/13/10/3985305/update-goldman-sachs-upgrades-johnson-johnson-based-on-s,Erika Janowicz,2013-10-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.57655
709073,benzingas top upgrades,https://www.benzinga.com/analyst-ratings/upgrades/13/10/3984917/benzingas-top-upgrades,Monica Gerson,2013-10-11 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.60115
709074,us stock futures up jp morgan earnings in focus,https://www.benzinga.com/news/13/10/3984905/us-stock-futures-up-j-p-morgan-earnings-in-focus,Monica Gerson,2013-10-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.60115
709075,goldman sachs upgrades johnson johnson to neutral raises pt to ,https://www.benzinga.com/news/13/10/3984814/goldman-sachs-upgrades-johnson-johnson-to-neutral-raises-pt-to-95-00,Juan Lopez,2013-10-11 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709076,jjs janssen buys investigational nsa inhibitor from glaxo,https://www.benzinga.com/news/13/10/3974264/j-js-janssen-buys-investigational-ns5a-inhibitor-from-glaxo,Paul Quintaro,2013-10-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4614
709077,playing momentum with etfs pdp pie mtum,https://www.benzinga.com/etfs/sector-etfs/13/10/3971653/playing-momentum-with-etfs-pdp-pie-mtum,Matthew McCall,2013-10-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.60115
709078,jj says boehringer doxil dispute may cause yearlong shortage,https://www.benzinga.com/news/13/10/3957801/j-j-says-boehringer-doxil-dispute-may-cause-year-long-shortage,Paul Quintaro,2013-10-01 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.29905000000000004
709079,form k from endocyte shows janssen pharma informed co of estimated doxil supply interruption sees sufificient doxil supply to support patients on trials,https://www.benzinga.com/news/13/09/3946305/form-8-k-from-endocyte-shows-janssen-pharma-informed-co-of-estimated-doxil-supply,Paul Quintaro,2013-09-26 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5258
709080,biomarin celgene lead trend in biotech short interest brmn celg regn,https://www.benzinga.com/trading-ideas/short-ideas/13/09/3941947/biomarin-celgene-lead-trend-in-biotech-short-interest-brmn-c,Nelson Hem,2013-09-25 00:00:00,JNJ,0,2,0,1,1,0,0,0,0,0.7294
709081,write a prescription for health care etfs,https://www.benzinga.com/analyst-ratings/analyst-color/13/09/3925530/write-a-prescription-for-health-care-etfs,ETF Professor,2013-09-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.74695
709082,johnson and johnson near major resistance level,https://www.benzinga.com/trading-ideas/technicals/13/09/3924120/johnson-and-johnson-near-major-resistance-level,Hal Lindon,2013-09-18 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709083,alexion pharmacyclics buck trend in biotech short interest alxn celg pcyc,https://www.benzinga.com/trading-ideas/short-ideas/13/09/3913320/alexion-pharmacyclics-buck-trend-in-biotech-short-interest-a,Nelson Hem,2013-09-14 00:00:00,JNJ,0,2,0,1,1,0,0,0,0,0.7294
709084,some new etfs off to impressive starts,https://www.benzinga.com/analyst-ratings/analyst-color/13/09/3909229/some-new-etfs-off-to-impressive-starts,ETF Professor,2013-09-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7553000000000001
709085,duke energy vivus and others insiders have been buying,https://www.benzinga.com/news/insider-trades/13/09/3894529/duke-energy-vivus-and-others-insiders-have-been-buying,Nelson Hem,2013-09-07 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.6366
709086,ap reporting jj has recalled k bottles of infant motrin,https://www.benzinga.com/news/13/09/3893900/ap-reporting-j-j-has-recalled-200k-bottles-of-infant-motrin,Paul Quintaro,2013-09-06 00:00:00,JNJ,1,1,1,0,1,0,1,1,1,0.625
709087,dj reporting jj rumored to hold talks to sell diagnostics unit,https://www.benzinga.com/news/13/09/3893546/dj-reporting-j-j-rumored-to-hold-talks-to-sell-diagnostics-unit,Paul Quintaro,2013-09-06 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.625
709088,plenty of etfs with favorable risk traits,https://www.benzinga.com/analyst-ratings/analyst-color/13/08/3876854/plenty-of-etfs-with-favorable-risk-traits,ETF Professor,2013-08-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709089,short interest in celgene onyx continues to shrink celg onxx vrtx,https://www.benzinga.com/trading-ideas/short-ideas/13/08/3867159/short-interest-in-celgene-onyx-continues-to-shrink-celg-onxx,Nelson Hem,2013-08-27 00:00:00,JNJ,0,1,0,1,1,0,0,0,0,0.7294
709090,hearing symbols impacted by options issues ibkr ivz jll jnj jnpr joe joy jpm jwn k kbr key,https://www.benzinga.com/news/13/08/3852163/hearing-symbols-impacted-by-options-issues-ibkr-ivz-jll-jnj-jnpr-joe-joy-jpm-jwn-,Paul Quintaro,2013-08-20 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.79295
709091,jj closes purchase of aragon pharma,https://www.benzinga.com/news/13/08/3849317/j-j-closes-purchase-of-aragon-pharma,Paul Quintaro,2013-08-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709092,nordstrom joins ubs list of top dividend payers,https://www.benzinga.com/trading-ideas/long-ideas/13/08/3846341/nordstrom-joins-ubs-list-of-top-dividend-payers,Nelson Hem,2013-08-17 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.60115
709093,has johnson johnson peaked time to book profits,https://www.benzinga.com/markets/13/08/3842378/has-johnson-johnson-peaked-time-to-book-profits,BehindWallStreet,2013-08-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
709094,update berkshire hathaway shows increased stakes in american express conocophillips costco davita healthcare deere directv ge gm glaxosmithkline jj liberty media mt bank,https://www.benzinga.com/news/13/08/3840999/update-berkshire-hathaway-shows-increased-stakes-in-american-express-conocophilli,James Hunt,2013-08-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.87895
709095,how much does it cost to develop a new drug,https://www.benzinga.com/news/13/08/3837302/how-much-does-it-cost-to-develop-a-new-drug,Tim Parker,2013-08-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709096,royalty pharma partners with aisling capital and clarus ventures in recent ibrutinib royalty purchase,https://www.benzinga.com/news/13/08/3830181/royalty-pharma-partners-with-aisling-capital-and-clarus-ventures-in-recent-ibruti,James Hunt,2013-08-12 00:00:00,JNJ,1,0,0,1,1,0,1,1,1,0.5
709097,johnson and johnson wins appeal over rembrandts contact lens patent court says jnj did not infringe on patent,https://www.benzinga.com/news/13/08/3820315/johnson-and-johnson-wins-appeal-over-rembrandts-contact-lens-patent-court-says-jn,Paul Quintaro,2013-08-07 00:00:00,JNJ,1,1,1,0,1,0,1,1,1,0.7859499999999999
709098,buyback etf defies logic,https://www.benzinga.com/trading-ideas/long-ideas/13/08/3814206/buyback-etf-defies-logic,ETF Professor,2013-08-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709099,biotechnology stock wins,https://www.benzinga.com/markets/13/08/3812212/biotechnology-stock-wins,mdmconsult,2013-08-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
709100,deferred tax assets and liabilities,https://www.benzinga.com/markets/13/08/3811953/deferred-tax-assets-and-liabilities,David Trainer,2013-08-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4871
709101,is procter gamble a strategic bet,https://www.benzinga.com/markets/13/08/3811846/is-procter-gamble-a-strategic-bet,CapitalCube,2013-08-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709102,sp heaping praise for some health care etfs,https://www.benzinga.com/analyst-ratings/analyst-color/13/08/3809455/s-p-heaping-praise-for-some-health-care-etfs,ETF Professor,2013-08-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.88915
709103,three soaring but overlooked health care etfs,https://www.benzinga.com/trading-ideas/long-ideas/13/08/3809192/three-soaring-but-overlooked-health-care-etfs,ETF Professor,2013-08-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8155
709104,slideshow stocks to benefit from a repatriation deal in congress,https://www.benzinga.com/news/13/07/3795770/slideshow-8-stocks-to-benefit-from-a-repatriation-deal-in-congress,Matthew Kanterman,2013-07-30 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7294
709105,fda issues warning on jjs nizoral tablets says could cause severe liver injuries could have harmful interactions with medications,https://www.benzinga.com/news/13/07/3787305/fda-issues-warning-on-j-js-nizoral-tablets-says-could-cause-severe-liver-injuries,Paul Quintaro,2013-07-26 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.19379999999999997
709106,rookie etf offers exposure to rising em dividends,https://www.benzinga.com/trading-ideas/long-ideas/13/07/3767954/rookie-etf-offers-exposure-to-rising-em-dividends,ETF Professor,2013-07-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709107,jj agrees to pay m to settle case over drug recalls,https://www.benzinga.com/news/13/07/3761500/j-j-agrees-to-pay-22-9m-to-settle-case-over-drug-recalls,Paul Quintaro,2013-07-17 00:00:00,JNJ,1,0,0,1,0,0,1,0,1,0.67
709108,update citigroup raises pt on johnson johnson following good q results,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3760202/update-citigroup-raises-pt-on-johnson-johnson-following-,Dwight Einhorn,2013-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
709109,update deutsche bank downgrades johnson johnson on valuation,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3759469/update-deutsche-bank-downgrades-johnson-johnson-on-valua,Dwight Einhorn,2013-07-17 00:00:00,JNJ,1,1,0,0,0,0,1,1,1,0.5
709110,benzingas top downgrades,https://www.benzinga.com/analyst-ratings/downgrades/13/07/3759094/benzingas-top-downgrades,Monica Gerson,2013-07-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
709111,a peek into the market before the trading starts,https://www.benzinga.com/news/13/07/3759093/a-peek-into-the-market-before-the-trading-starts,Monica Gerson,2013-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709112,deutsche bank downgrades johnson johnson to hold raises pt to ,https://www.benzinga.com/news/13/07/3759023/deutsche-bank-downgrades-johnson-johnson-to-hold-raises-pt-to-93-00,Juan Lopez,2013-07-17 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
709113,benzinga market primer wednesday july bernanke is back,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3758906/benzinga-market-primer-wednesday-july-17-bernanke-is-bac,Matthew Kanterman,2013-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709114,eli lilly tries again with alzheimers drug as the race for a cure continues lly,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3756698/eli-lilly-tries-again-with-alzheimers-drug-as-the-race-f,Jim Probasco,2013-07-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709115,update johnson johnson posts upbeat q profit,https://www.benzinga.com/news/earnings/13/07/3755876/update-johnson-johnson-posts-upbeat-q2-profit,Lisa Levin,2013-07-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7202
709116,update johnson and johnson q eps includes gain on sale of elan stake saw negative currency impact of ,https://www.benzinga.com/news/earnings/13/07/3755408/update-johnson-and-johnson-q2-eps-includes-gain-on-sale-of-elan-stake-sa,James Hunt,2013-07-16 00:00:00,JNJ,1,1,1,1,1,0,1,1,0,0.4614
709117,johnson johnson raises fy eps guidance from to vs est,https://www.benzinga.com/news/13/07/3755404/johnson-johnson-raises-fy2013-eps-guidance-from-5-35-5-45-to-5-40-5-47-vs-5-42-es,Paul Quintaro,2013-07-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709118,johnson johnson reports q eps of vs est revenue of b vs b est raising guidance,https://www.benzinga.com/news/earnings/13/07/3755401/johnson-johnson-reports-q2-eps-of-1-48-vs-1-39-est-revenue-of-17-90b-vs-,Paul Quintaro,2013-07-16 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
709119,benzinga market primer tuesday july futures flat ahead of earnings,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3755051/benzinga-market-primer-tuesday-july-16-futures-flat-ahea,Matthew Kanterman,2013-07-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709120,us stock futures edge higher goldman sachs earnings cpi in focus,https://www.benzinga.com/news/13/07/3755106/us-stock-futures-edge-higher-goldman-sachs-earnings-cpi-in-focus,Monica Gerson,2013-07-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709121,earnings scheduled for july ,https://www.benzinga.com/news/earnings/13/07/3754960/earnings-scheduled-for-july-16-2013,Monica Gerson,2013-07-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709122,stocks to watch for july ,https://www.benzinga.com/news/earnings/13/07/3754951/stocks-to-watch-for-july-16-2013,Monica Gerson,2013-07-16 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709123,health care etfs looking healthy ahead of earnings,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3753598/health-care-etfs-looking-healthy-ahead-of-earnings,ETF Professor,2013-07-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8548
709124,earnings expectations for the week of july ,https://www.benzinga.com/news/earnings/13/07/3751008/earnings-expectations-for-the-week-of-july-15,Nelson Hem,2013-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709125,a look ahead this weeks etfs to watch,https://www.benzinga.com/news/earnings/13/07/3751059/a-look-ahead-this-weeks-etfs-to-watch,ETF Professor,2013-07-14 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709126,weekly preview earnings back with a bang,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3749619/weekly-preview-earnings-back-with-a-bang,Matthew Kanterman,2013-07-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709127,update jefferies raises pt on johnson johnson on challenges ahead,https://www.benzinga.com/analyst-ratings/analyst-color/13/07/3748677/update-jefferies-raises-pt-on-johnson-johnson-on-challen,Dwight Einhorn,2013-07-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5386
709128,jefferies maintains hold on johnson johnson raises pt to ,https://www.benzinga.com/news/13/07/3748356/jefferies-maintains-hold-on-johnson-johnson-raises-pt-to-92-00,Juan Lopez,2013-07-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709129,earnings expectations for the week of july aa jpm wfc,https://www.benzinga.com/news/earnings/13/07/3732778/earnings-expectations-for-the-week-of-july-8-aa-jpm-wfc,Nelson Hem,2013-07-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709130, healthcare stocks with the highest revenue,https://www.benzinga.com/trading-ideas/13/07/3730827/5-healthcare-stocks-with-the-highest-revenue,Lisa Levin,2013-07-05 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709131,etfs for an onyx takeover battle,https://www.benzinga.com/trading-ideas/long-ideas/13/07/3721317/etfs-for-an-onyx-takeover-battle,ETF Professor,2013-07-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709132,barrons recap worlds most respected companies,https://www.benzinga.com/media/13/06/3718839/barrons-recap-worlds-most-respected-companies,Nelson Hem,2013-06-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7627999999999999
709133,short interest in biogen idec and vertex shrinks biib celg vrtx,https://www.benzinga.com/trading-ideas/short-ideas/13/06/3708852/short-interest-in-biogen-idec-and-vertex-shrinks-biib-celg-v,Nelson Hem,2013-06-26 00:00:00,JNJ,0,2,0,1,1,0,0,0,0,0.7294
709134,abbott wins appeal in heart stent dispute with jj pfizer,https://www.benzinga.com/news/13/06/3708612/abbott-wins-appeal-in-heart-stent-dispute-with-j-j-pfizer,Paul Quintaro,2013-06-26 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7294
709135,rising year yields could crush popular dividend etfs,https://www.benzinga.com/trading-ideas/long-ideas/13/06/3697012/rising-10-year-yields-could-crush-popular-dividend-etfs,ETF Professor,2013-06-21 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.648
709136,one simple measure for investing in a volatile market,https://www.benzinga.com/markets/13/06/3685113/one-simple-measure-for-investing-in-a-volatile-market,investmentcontrarians,2013-06-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709137,benzingas ma chatter for monday june ,https://www.benzinga.com/news/13/06/3682763/benzingas-m-a-chatter-for-monday-june-17-2013,Charles Gross,2013-06-17 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
709138,market wrap for monday june stocks jump to start trading week dow rallies triple digits,https://www.benzinga.com/markets/bonds/13/06/3682497/market-wrap-for-tuesday-june-17-stocks-jump-to-start-trading-week-dow-ra,Scott Rubin,2013-06-17 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
709139,siemens to create companion diganostic test for indevelopment janssen heart failure drug,https://www.benzinga.com/news/13/06/3680695/siemens-to-create-companion-diganostic-test-for-in-development-janssen-heart-fail,Paul Quintaro,2013-06-17 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.352
709140,update johnson johnson announces definitive agreement to acquire aragon pharma for m includes contingent for possible additional payments of up to m,https://www.benzinga.com/news/13/06/3680279/update-johnson-johnson-announces-definitive-agreement-to-acquire-aragon-pharma-fo,Paul Quintaro,2013-06-17 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.74695
709141,jj announces definitive deal to buy aragon pharma to make m upfront payment,https://www.benzinga.com/news/13/06/3680268/j-j-announces-definitive-deal-to-buy-aragon-pharma-to-make-650m-upfront-payment,Paul Quintaro,2013-06-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
709142,bloomberg reporting a jj spokesperson has said the company sold m elan shares today this would be nearly entire stake,https://www.benzinga.com/news/13/06/3675290/bloomberg-reporting-a-j-j-spokesperson-has-said-the-company-sold-25-4m-elan-share,Paul Quintaro,2013-06-13 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.74695
709143,jjs janssen issues research study results for simponi in active ra,https://www.benzinga.com/news/13/06/3669229/j-js-janssen-issues-research-study-results-for-simponi-in-active-ra,Paul Quintaro,2013-06-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
709144,update jefferies lowers pt on johnson johnson following global pharma review,https://www.benzinga.com/analyst-ratings/analyst-color/13/06/3657841/update-jefferies-lowers-pt-on-johnson-johnson-following-,Dwight Einhorn,2013-06-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
709145,jefferies maintains hold on johnson johnson lowers pt to ,https://www.benzinga.com/news/13/06/3657172/jefferies-maintains-hold-on-johnson-johnson-lowers-pt-to-91-00,Juan Lopez,2013-06-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
709146,fdas opdp says has reviewed the doxil,https://www.benzinga.com/news/13/06/3655240/fdas-opdp-says-has-reviewed-the-doxil,Paul Quintaro,2013-06-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709147,jj innovation announces opening of california innovation center janssen second genome announce deal on microbiome drug discovery,https://www.benzinga.com/news/13/06/3649593/j-j-innovation-announces-opening-of-california-innovation-center-janssen-second-g,Paul Quintaro,2013-06-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.86755
709148,with bond yields so low reluctant investors are now making the move into these stocks,https://www.benzinga.com/markets/bonds/13/06/3646194/with-bond-yields-so-low-reluctant-investors-are-now-making-the-move-into,investmentcontrarians,2013-06-04 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.19255
709149,cvr energy warner chilcott and other top performers in may,https://www.benzinga.com/trading-ideas/long-ideas/13/06/3639582/cvr-energy-warner-chilcott-and-other-top-performers-in-may,Nelson Hem,2013-06-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
709150,valeant pharmaceuticals to buy bausch lomb,https://www.benzinga.com/analyst-ratings/analyst-color/13/05/3624257/valeant-pharmaceuticals-to-buy-bausch-lomb,Jim Probasco,2013-05-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709151,update jefferies raises pt on johnson johnson following sotp analysis,https://www.benzinga.com/analyst-ratings/analyst-color/13/05/3624629/update-jefferies-raises-pt-on-johnson-johnson-following-,Dwight Einhorn,2013-05-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709152,jefferies maintains hold on johnson johnson raises pt to ,https://www.benzinga.com/news/13/05/3623877/jefferies-maintains-hold-on-johnson-johnson-raises-pt-to-97-00,Juan Lopez,2013-05-28 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709153,jjs janssen poised to continue driving growth outlines potential new product filings by ,https://www.benzinga.com/news/13/05/3615114/j-js-janssen-poised-to-continue-driving-growth-outlines-10-potential-new-product-,Paul Quintaro,2013-05-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
709154,jjs janssen announces primary efficacy safety findings from phase study of simeprevir once daily,https://www.benzinga.com/news/13/05/3607088/j-js-janssen-announces-primary-efficacy-safety-findings-from-phase-3-study-of-sim,Paul Quintaro,2013-05-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
709155,how understanding the investment climate equals stock market success,https://www.benzinga.com/markets/13/05/3603738/how-understanding-the-investment-climate-equals-stock-market-success,investmentcontrarians,2013-05-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7859499999999999
709156,johnson johnson stops selling metal liners in metal on metal hip replacement product says decision stemmed from low sales bloomberg,https://www.benzinga.com/news/13/05/3597326/johnson-johnson-stops-selling-metal-liners-in-metal-on-metal-hip-replacement-prod,Paul Quintaro,2013-05-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.29905000000000004
709157,short interest in vertex rises in celgene falls,https://www.benzinga.com/trading-ideas/short-ideas/13/05/3581061/short-interest-in-vertex-rises-in-celgene-falls,Nelson Hem,2013-05-11 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709158,sp highlights biotech etfs,https://www.benzinga.com/analyst-ratings/analyst-color/13/05/3577818/s-p-highlights-biotech-etfs,ETF Professor,2013-05-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709159,dj reporting jj potential b settlement with doj help up,https://www.benzinga.com/news/13/05/3576474/dj-reporting-j-j-potential-2-2b-settlement-with-doj-help-up,Paul Quintaro,2013-05-09 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.7859499999999999
709160,stock market fakeout where is the retrenchment,https://www.benzinga.com/markets/13/05/3571415/stock-market-fake-out-where-is-the-retrenchment,pconfidential,2013-05-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709161,top nyse stocks in the drug manufacturersmajor industry with the lowest peg ratio,https://www.benzinga.com/trading-ideas/13/05/3569162/top-4-nyse-stocks-in-the-drug-manufacturers-major-industry-with-the-lowe,Monica Gerson,2013-05-08 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.39885
709162,three top performing healthcare stocks to watch,https://www.benzinga.com/trading-ideas/long-ideas/13/05/3562518/three-top-performing-healthcare-stocks-to-watch,Scott Rubin,2013-05-06 00:00:00,JNJ,1,2,1,0,1,0,1,1,1,0.60115
709163,dj reporting jj recalls all childrens tylenol in south korea recall doesnt affect us products,https://www.benzinga.com/news/13/05/3558219/dj-reporting-j-j-recalls-all-childrens-tylenol-in-south-korea-recall-doesnt-affec,Paul Quintaro,2013-05-03 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.625
709164,earnings trigger volume spike in pharma etf,https://www.benzinga.com/news/earnings/13/05/3549321/earnings-trigger-volume-spike-in-pharma-etf,ETF Professor,2013-05-01 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709165,daratumumab receives breakthrough therapy designation in double refractory multiple myeloma from us food and drug administration,https://www.benzinga.com/news/13/05/3548966/daratumumab-receives-breakthrough-therapy-designation-in-double-refractory-multip,Paul Quintaro,2013-05-01 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
709166,first manhattan responds to vivus board additions says board still needs overhaul,https://www.benzinga.com/news/13/05/3547726/first-manhattan-responds-to-vivus-board-additions-says-board-still-needs-overhaul,Paul Quintaro,2013-05-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709167,form k jj holders didnt okay holder bid related to independent chair,https://www.benzinga.com/news/13/04/3534894/form-8-k-j-j-holders-didnt-okay-holder-bid-related-to-independent-chair,Paul Quintaro,2013-04-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.54295
709168,short sellers move into celgene regeneron,https://www.benzinga.com/trading-ideas/short-ideas/13/04/3534019/short-sellers-move-into-celgene-regeneron,Nelson Hem,2013-04-26 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.5
709169,yes this etf offers dividend growth,https://www.benzinga.com/trading-ideas/long-ideas/13/04/3530295/yes-this-etf-offers-dividend-growth,ETF Professor,2013-04-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8243
709170,johnson johnson announces dividend increase of to per share,https://www.benzinga.com/news/13/04/3529840/johnson-johnson-announces-dividend-increase-of-8-2-to-0-66-per-share,Eddie Staley,2013-04-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.77115
709171,jj raises qtr dividend from to share,https://www.benzinga.com/news/13/04/3529839/j-j-raises-qtr-dividend-from-0-61-to-0-66share,Paul Quintaro,2013-04-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
709172,go beyond largecap etfs for dividends,https://www.benzinga.com/trading-ideas/long-ideas/13/04/3517042/go-beyond-large-cap-etfs-for-dividends,ETF Professor,2013-04-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709173,nonstreak dividend etfs impress,https://www.benzinga.com/trading-ideas/long-ideas/13/04/3511775/non-streak-dividend-etfs-impress,ETF Professor,2013-04-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
709174,update jefferies raises pt on johnson johnson on unimpressive q earnings but strong sentiment,https://www.benzinga.com/analyst-ratings/analyst-color/13/04/3511220/update-jefferies-raises-pt-on-johnson-johnson-on-unimpre,Dwight Einhorn,2013-04-19 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.78945
709175,jefferies maintains hold on johnson johnson raises pt to ,https://www.benzinga.com/news/13/04/3510750/jefferies-maintains-hold-on-johnson-johnson-raises-pt-to-90-00,Juan Lopez,2013-04-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709176,ishares bolsters factor etf lineup with new funds,https://www.benzinga.com/trading-ideas/long-ideas/13/04/3508970/ishares-bolsters-factor-etf-lineup-with-5-new-funds,ETF Professor,2013-04-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709177,update jjs janssen to get per elan share to record gain m in q from sale,https://www.benzinga.com/news/13/04/3508213/update-j-js-janssen-to-get-11-25-per-elan-share-to-record-gain-213m-in-q2-from-sa,Paul Quintaro,2013-04-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8404
709178,jj reports sale of m elan ads held by janssen pharma,https://www.benzinga.com/news/13/04/3508207/j-j-reports-sale-of-82m-elan-ads-held-by-janssen-pharma,Paul Quintaro,2013-04-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709179,fitch affirms jj idrs at aaaf outlook stable,https://www.benzinga.com/news/13/04/3504316/fitch-affirms-j-j-idrs-at-aaaf1-outlook-stable,Paul Quintaro,2013-04-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
709180,benzinga market primer wednesday april ,https://www.benzinga.com/markets/bonds/13/04/3503196/benzinga-market-primer-wednesday-april-17,Matthew Kanterman,2013-04-17 00:00:00,JNJ,1,2,0,1,1,1,1,1,1,0.5
709181,johnson johnson rises on healthy earnings,https://www.benzinga.com/news/earnings/13/04/3500433/johnson-johnson-rises-on-healthy-earnings,Clay Wyatt,2013-04-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.70095
709182,update johnson johnson posts drop in q profit,https://www.benzinga.com/news/earnings/13/04/3500507/update-johnson-johnson-posts-drop-in-q1-profit,Lisa Levin,2013-04-16 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.60115
709183,from jj call sees fy sales bb vs b est,https://www.benzinga.com/news/13/04/3500397/from-j-j-call-sees-fy13-sales-70-4b-71-1b-vs-71-1b-est,Paul Quintaro,2013-04-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.625
709184,johnson johnson reports q eps of vs est revenue of b vs b est,https://www.benzinga.com/news/earnings/13/04/3499822/johnson-johnson-reports-q1-eps-of-1-44-vs-1-40-est-revenue-of-17-50b-vs-,Paul Quintaro,2013-04-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709185,benzinga market primer tuesday april ,https://www.benzinga.com/markets/bonds/13/04/3499549/benzinga-market-primer-tuesday-april-16,Matthew Kanterman,2013-04-16 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709186,us stock futures signal higher start on wall street,https://www.benzinga.com/news/13/04/3499561/us-stock-futures-signal-higher-start-on-wall-street,Monica Gerson,2013-04-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709187,earnings scheduled for april ,https://www.benzinga.com/news/earnings/13/04/3499321/earnings-scheduled-for-april-16-2013,Monica Gerson,2013-04-16 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709188,stocks to watch for april ,https://www.benzinga.com/news/earnings/13/04/3499305/stocks-to-watch-for-april-16-2013,Monica Gerson,2013-04-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709189,lawyer says jj jury should award m for defective hip,https://www.benzinga.com/news/13/04/3498053/lawyer-says-j-j-jury-should-award-5m-for-defective-hip,Paul Quintaro,2013-04-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6909
709190,earnings expectations for the week of april ,https://www.benzinga.com/news/earnings/13/04/3495244/earnings-expectations-for-the-week-of-april-15,Nelson Hem,2013-04-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709191,a look ahead this weeks etfs to watch,https://www.benzinga.com/news/earnings/13/04/3495276/a-look-ahead-this-weeks-etfs-to-watch,ETF Professor,2013-04-14 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709192,weekly preview earnings season kicks into high gear,https://www.benzinga.com/analyst-ratings/analyst-color/13/04/3493939/weekly-preview-earnings-season-kicks-into-high-gear,Matthew Kanterman,2013-04-12 00:00:00,JNJ,1,0,1,0,1,0,1,1,1,0.5
709193,deutsche bank maintains buy on johnson johnson raises pt to ,https://www.benzinga.com/news/13/04/3492473/deutsche-bank-maintains-buy-on-johnson-johnson-raises-pt-to-87-00,Juan Lopez,2013-04-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709194,etf showdown a pharma fight,https://www.benzinga.com/trading-ideas/long-ideas/13/04/3491090/etf-showdown-a-pharma-fight,ETF Professor,2013-04-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709195,sp bullish on an array of dividend etfs,https://www.benzinga.com/analyst-ratings/analyst-color/13/04/3490265/s-p-bullish-on-an-array-of-dividend-etfs,ETF Professor,2013-04-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709196,short sellers move out of amgen celgene pharmacyclics,https://www.benzinga.com/trading-ideas/short-ideas/13/04/3486909/short-sellers-move-out-of-amgen-celgene-pharmacyclics,Nelson Hem,2013-04-10 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.5
709197,update jefferies raises pt on johnson johnson on attractive valuation,https://www.benzinga.com/analyst-ratings/analyst-color/13/04/3486703/update-jefferies-raises-pt-on-johnson-johnson-on-attract,Dwight Einhorn,2013-04-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7202
709198,jefferies maintains hold on johnson johnson raises pt to ,https://www.benzinga.com/news/13/04/3485537/jefferies-maintains-hold-on-johnson-johnson-raises-pt-to-85-00,Juan Lopez,2013-04-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709199,johnson johnson receives positive mad moneyjim cramer mention cnbc,https://www.benzinga.com/media/cnbc/13/04/3480249/johnson-johnson-receives-positive-mad-moneyjim-cramer-mention-cnbc,Charles Gross,2013-04-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.55135
709200,jnj finds support at ema macd forming a bearish cross rsi retreats out of overbought territory,https://www.benzinga.com/trading-ideas/technicals/13/04/3479225/jnj-finds-support-at-20-ema-80-29-macd-forming-a-bearish-cros,Zack Armstrong,2013-04-08 00:00:00,JNJ,1,0,0,1,0,0,0,0,0,0.70095
709201,benzingas top premarket losers,https://www.benzinga.com/news/13/04/3478114/benzingas-top-pre-market-losers,Monica Gerson,2013-04-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709202,update jp morgan downgrades johnson johnson to neutral on trading premium,https://www.benzinga.com/analyst-ratings/analyst-color/13/04/3477856/update-j-p-morgan-downgrades-johnson-johnson-to-neutral-,Dwight Einhorn,2013-04-08 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.60115
709203,jp morgan downgrades johnson johnson to neutral raises pt to ,https://www.benzinga.com/news/13/04/3477361/jp-morgan-downgrades-johnson-johnson-to-neutral-raises-pt-to-83-00,Juan Lopez,2013-04-08 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.60115
709204,earnings expectations for the week of april ,https://www.benzinga.com/news/earnings/13/04/3476763/earnings-expectations-for-the-week-of-april-8,Nelson Hem,2013-04-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709205,four dow components due for a dividend hike cvx xom ibm jnj,https://www.benzinga.com/media/cnbc/13/04/3472171/four-dow-components-due-for-a-dividend-hike-cvx-xom-ibm-jnj,Nelson Hem,2013-04-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709206,jj wins reversal of m patent verdict over stents judge says jj didnt infringe doctors patent,https://www.benzinga.com/news/13/04/3471888/j-j-wins-reversal-of-482m-patent-verdict-over-stents-judge-says-j-j-didnt-infring,Paul Quintaro,2013-04-04 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.9037
709207,fda approves jjs invokana tablets for adults with type diabetes,https://www.benzinga.com/news/13/03/3457989/fda-approves-j-js-invokana-tablets-for-adults-with-type-2-diabetes,Charles Gross,2013-03-29 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.70095
709208,short sellers dump amgen focus on celgene gilead sciences,https://www.benzinga.com/trading-ideas/short-ideas/13/03/3454042/short-sellers-dump-amgen-focus-on-celgene-gilead-sciences,Nelson Hem,2013-03-28 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.30910000000000004
709209,embrace these megacap etfs,https://www.benzinga.com/analyst-ratings/analyst-color/13/03/3448431/embrace-these-2-mega-cap-etfs,ETF Professor,2013-03-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
709210, drugs pending fda approval in ,https://www.benzinga.com/news/13/03/3443417/13-drugs-pending-fda-approval-in-2013,Alex Biles,2013-03-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
709211,risk on rally these etfs say no,https://www.benzinga.com/trading-ideas/long-ideas/13/03/3447304/risk-on-rally-these-etfs-say-no,ETF Professor,2013-03-26 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.24469999999999997
709212,ubs maintains buy on johnson johnson raises pt to ,https://www.benzinga.com/news/13/03/3446939/ubs-maintains-buy-on-johnson-johnson-raises-pt-to-87-00,Juan Lopez,2013-03-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709213,what type of dividend etfs are winning in ,https://www.benzinga.com/trading-ideas/long-ideas/13/03/3443830/what-type-of-dividend-etfs-are-winning-in-2013,ETF Professor,2013-03-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.76335
709214,lifescan announces voluntary recall of all onetouch verio iq blood glucose meters,https://www.benzinga.com/news/13/03/3442921/lifescan-announces-voluntary-recall-of-all-onetouch-verio-iq-blood-glucose-meters,Paul Quintaro,2013-03-25 00:00:00,JNJ,1,2,1,0,0,0,1,1,1,0.5
709215,johnson johnsons quest to knock botox off the pedestal,https://www.benzinga.com/trading-ideas/long-ideas/13/03/3439971/johnson-johnsons-quest-to-knock-botox-off-the-pedestal,Sam Liu,2013-03-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709216,sp likes a pair of low vol etfs,https://www.benzinga.com/analyst-ratings/analyst-color/13/03/3429416/s-p-likes-a-pair-of-low-vol-etfs,ETF Professor,2013-03-19 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.58895
709217,powershares low volatility etf tops b in aum,https://www.benzinga.com/news/13/03/3425018/powershares-low-volatility-etf-tops-4b-in-aum,ETF Professor,2013-03-18 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.648
709218,short interest swings in biotech stocks amgn celg pcyc,https://www.benzinga.com/trading-ideas/long-ideas/13/03/3409383/short-interest-swings-in-biotech-stocks-amgn-celg-pcyc,Nelson Hem,2013-03-12 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709219,jjs cordis buys flexible stenting solutions no terms disclosed,https://www.benzinga.com/news/13/03/3408483/j-js-cordis-buys-flexible-stenting-solutions-no-terms-disclosed,Paul Quintaro,2013-03-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.55135
709220,are scientists edging closer to a cure for alzheimers,https://www.benzinga.com/news/13/03/3404085/are-scientists-edging-closer-to-a-cure-for-alzheimers,Tim Parker,2013-03-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709221,update jj did not fail to warn but must pay m in damages in hip case,https://www.benzinga.com/news/13/03/3400778/update-j-j-did-not-fail-to-warn-but-must-pay-8-3m-in-damages-in-hip-case,Paul Quintaro,2013-03-08 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.28195000000000003
709222,california jury finds jj defectively designed asr hip device,https://www.benzinga.com/news/13/03/3400772/california-jury-finds-j-j-defectively-designed-asr-hip-device,Paul Quintaro,2013-03-08 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.3634
709223,jj hip implant jury has reached verdict in montana case to read verdict at am pst,https://www.benzinga.com/news/13/03/3400743/j-j-hip-implant-jury-has-reached-verdict-in-montana-case-to-read-verdict-at-9-30a,Paul Quintaro,2013-03-08 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.7787
709224,jjs janssen launches explorer research program,https://www.benzinga.com/news/13/03/3399656/j-js-janssen-launches-explorer-research-program,Paul Quintaro,2013-03-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709225, sector etfs outpacing larger rivals,https://www.benzinga.com/trading-ideas/long-ideas/13/03/3395530/3-sector-etfs-outpacing-larger-rivals,ETF Professor,2013-03-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709226, international dividend etfs your broker forgot to mention,https://www.benzinga.com/trading-ideas/long-ideas/13/03/3395389/3-international-dividend-etfs-your-broker-forgot-to-mention,ETF Professor,2013-03-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709227,hedging the dow at its alltime high,https://www.benzinga.com/markets/options/13/03/3394235/hedging-the-dow-at-its-all-time-high,David Pinsen,2013-03-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709228,an hiv cure is great news for these drug manufacturers,https://www.benzinga.com/news/13/03/3387279/the-news-of-an-hiv-cure-is-great-news-for-these-publicly-traded-companies,Alex Biles,2013-03-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.81245
709229,if the market falls try these low beta etfs,https://www.benzinga.com/trading-ideas/long-ideas/13/02/3379576/if-the-market-falls-try-these-low-beta-etfs,ETF Professor,2013-02-28 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.3634
709230,short interest swings in biotech stocks alxn amgn celg,https://www.benzinga.com/trading-ideas/long-ideas/13/02/3378301/short-interest-swings-in-biotech-stocks-alxn-amgn-celg,Nelson Hem,2013-02-28 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709231,jj jury reaches verdict on punitive win in first mesh trial,https://www.benzinga.com/news/13/02/3377922/j-j-jury-reaches-verdict-on-punitive-win-in-first-mesh-trial,Paul Quintaro,2013-02-28 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.7553000000000001
709232,jj trial expert says infection not defect lead to hip failure,https://www.benzinga.com/news/13/02/3369785/j-j-trial-expert-says-infection-not-defect-lead-to-hip-failure,Paul Quintaro,2013-02-26 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.46599999999999997
709233,bloomberg reporting jj looking to avoid punitive damages after losing mesh trial verdict,https://www.benzinga.com/news/13/02/3368768/bloomberg-reporting-j-j-looking-to-avoid-punitive-damages-after-losing-mesh-trial,Paul Quintaro,2013-02-26 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.0937
709234,bloomberg reporting jj judge rules jury can weigh punitive damages in mesh case,https://www.benzinga.com/news/13/02/3364309/bloomberg-reporting-j-j-judge-rules-jury-can-weigh-punitive-damages-in-mesh-case,Paul Quintaro,2013-02-25 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.18155
709235,jj ordered to pay m to south dakota nurse,https://www.benzinga.com/news/13/02/3363261/j-j-ordered-to-pay-3-35m-to-south-dakota-nurse,Paul Quintaro,2013-02-25 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.57655
709236,nj jury says jj failed to warn of vaginal mesh risks,https://www.benzinga.com/news/13/02/3363241/nj-jury-says-j-j-failed-to-warn-of-vaginal-mesh-risks,Paul Quintaro,2013-02-25 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.20705
709237,hearing jury in jjs new jersey case has verdict in first vaginal mesh case,https://www.benzinga.com/news/13/02/3363226/hearing-jury-in-j-js-new-jersey-case-has-verdict-in-first-vaginal-mesh-case,Paul Quintaro,2013-02-25 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.57655
709238,jj comments on venezuelan currency devaluation sees share charge in q reaffirms fy eps outlook,https://www.benzinga.com/news/13/02/3361924/j-j-comments-on-venezuelan-currency-devaluation-sees-0-04share-charge-in-q4-reaff,Paul Quintaro,2013-02-25 00:00:00,JNJ,1,0,0,1,0,0,1,1,0,0.74695
709239,jj discloses government investigations related to false claims related to hips surgical mesh bloomberg,https://www.benzinga.com/news/13/02/3357236/j-j-discloses-government-investigations-related-to-false-claims-related-to-hips-s,Paul Quintaro,2013-02-22 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.625
709240,under the hood a new dividend etf diva,https://www.benzinga.com/trading-ideas/long-ideas/13/02/3346880/under-the-hood-a-new-dividend-etf-diva,ETF Professor,2013-02-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709241,investment style rankings for etfs mutual funds,https://www.benzinga.com/etfs/sector-etfs/13/02/3345988/investment-style-rankings-for-etfs-mutual-funds,David Trainer,2013-02-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709242,berkshire adds archerdaniels verisign boosts gm stake,https://www.benzinga.com/trading-ideas/long-ideas/13/02/3336410/berkshire-adds-archer-daniels-verisign-boosts-gm-stake,Gordon Wilcox,2013-02-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6591
709243,ap reporting jj unit depuy orthopaedics recalling thousands of adept hip implants,https://www.benzinga.com/news/13/02/3335667/ap-reporting-j-j-unit-depuy-orthopaedics-recalling-thousands-of-adept-hip-implant,Paul Quintaro,2013-02-14 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.625
709244,short interest swings in biotech stocks amgn celg onxx,https://www.benzinga.com/trading-ideas/long-ideas/13/02/3326974/short-interest-swings-in-biotech-stocks-amgn-celg-onxx,Nelson Hem,2013-02-12 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709245,update credit suisse downgrades johnson johnson to underperform on valuation,https://www.benzinga.com/analyst-ratings/analyst-color/13/02/3313904/update-credit-suisse-downgrades-johnson-johnson-to-under,David Johnson,2013-02-07 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.6909
709246,credit suisse downgrades johnson johnson to underperform raises pt to ,https://www.benzinga.com/news/13/02/3313371/credit-suisse-downgrades-johnson-johnson-to-underperform-raises-pt-to-73-00,Juan Lopez,2013-02-07 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.6909
709247,johnson johnson breaks out over resistance,https://www.benzinga.com/trading-ideas/technicals/13/02/3311378/johnson-johnson-breaks-out-over-75-resistance,Zack Armstrong,2013-02-06 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709248,buying what buffett sells sometimes it works,https://www.benzinga.com/trading-ideas/long-ideas/13/02/3298199/buying-what-buffett-sells-sometimes-it-works,Gordon Wilcox,2013-02-03 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709249, attractively valued blue chips,https://www.benzinga.com/trading-ideas/long-ideas/13/01/3277009/2-attractively-valued-blue-chips,Gordon Wilcox,2013-01-27 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.86345
709250,short interest swings in biotech stocks biib celg vvus,https://www.benzinga.com/trading-ideas/long-ideas/13/01/3276790/short-interest-swings-in-biotech-stocks-biib-celg-vvus,Nelson Hem,2013-01-26 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709251,california jury finds jj failed to warn of hip implants risks,https://www.benzinga.com/news/13/01/3275342/california-jury-finds-j-j-failed-to-warn-of-hip-implants-risks,Paul Quintaro,2013-01-25 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.20705
709252,jj sees fy sales b vs b est,https://www.benzinga.com/news/13/01/3262514/j-j-sees-fy13-sales-70-9-71-6b-vs-72b-est,Paul Quintaro,2013-01-22 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.625
709253,from jjs qtr conference call will explore options for ortho clinical diagnostics unit,https://www.benzinga.com/news/13/01/3262305/from-j-js-qtr-conference-call-will-explore-options-for-ortho-clinical-diagnostics,Paul Quintaro,2013-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709254,update johnson johnson posts higher q profit,https://www.benzinga.com/news/earnings/13/01/3261622/update-johnson-johnson-posts-higher-q4-profit,Lisa Levin,2013-01-22 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7202
709255,jj reports velcade sales m remicade sales b prezista sales m,https://www.benzinga.com/news/13/01/3261522/j-j-reports-velcade-sales-502m-remicade-sales-1-504b-prezista-sales-353m,Paul Quintaro,2013-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709256,johnson johnson sees fy eps vs est,https://www.benzinga.com/news/13/01/3261516/johnson-johnson-sees-fy2013-eps-5-35-5-45-vs-5-49-est,Paul Quintaro,2013-01-22 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709257,johnson johnson reports q eps of vs est revenue of b vs b est,https://www.benzinga.com/news/earnings/13/01/3261514/johnson-johnson-reports-q4-eps-of-1-19-vs-1-17-est-revenue-of-17-60b-vs-,Paul Quintaro,2013-01-22 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709258,benzinga market primer tuesday january ,https://www.benzinga.com/markets/bonds/13/01/3261129/benzinga-market-primer-tuesday-january-22,Matthew Kanterman,2013-01-22 00:00:00,JNJ,1,2,0,1,1,1,1,1,1,0.5
709259,us stock futures flat ahead of economic data earnings,https://www.benzinga.com/news/13/01/3261079/us-stock-futures-flat-ahead-of-economic-data-earnings,Monica Gerson,2013-01-22 00:00:00,JNJ,1,1,1,0,1,1,1,1,1,0.5
709260,earnings scheduled for january ,https://www.benzinga.com/news/earnings/13/01/3260368/earnings-scheduled-for-january-22-2013,Monica Gerson,2013-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709261,stocks to watch for january ,https://www.benzinga.com/news/earnings/13/01/3260359/stocks-to-watch-for-january-22-2013,Monica Gerson,2013-01-22 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709262,earnings expectations for the week of january ,https://www.benzinga.com/news/earnings/13/01/3258038/earnings-expectations-for-the-week-of-january-21,Nelson Hem,2013-01-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709263,the week ahead tech earnings in focus,https://www.benzinga.com/analyst-ratings/analyst-color/13/01/3257034/the-week-ahead-tech-earnings-in-focus,Sam Mattera,2013-01-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709264,sp highlights etf for lengthy streaks of dividend increases,https://www.benzinga.com/analyst-ratings/analyst-color/13/01/3256732/s-p-highlights-1-etf-for-lengthy-streaks-of-dividend-inc,ETF Professor,2013-01-18 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709265,jj said to have offered to pay more than k per hip case may total b bloomberg,https://www.benzinga.com/news/13/01/3256610/j-j-said-to-have-offered-to-pay-more-than-200k-per-hip-case-may-total-2b-bloomber,Paul Quintaro,2013-01-18 00:00:00,JNJ,1,2,1,1,0,1,1,0,1,0.57655
709266,update jefferies company reiterates hold rating raises pt on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/13/01/3248022/update-jefferies-company-reiterates-hold-rating-raises-p,Dwight Einhorn,2013-01-16 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709267,jefferies maintains hold on johnson johnson raises pt to ,https://www.benzinga.com/news/13/01/3247859/jefferies-maintains-hold-on-johnson-johnson-raises-pt-to-79-00,Juan Lopez,2013-01-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709268,jjs janssencilag drug zytiga approved in eu for use in treatment of metastatic cancer,https://www.benzinga.com/news/13/01/3235729/j-js-janssen-cilag-drug-zytiga-approved-in-eu-for-use-in-treatment-of-metastatic-,Paul Quintaro,2013-01-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.30910000000000004
709269,ubs maintains buy on johnson johnson raises pt to ,https://www.benzinga.com/news/13/01/3235720/ubs-maintains-buy-on-johnson-johnson-raises-pt-to-78-00,Juan Lopez,2013-01-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709270,fda panel backs jjs new type of diabetes drug,https://www.benzinga.com/news/13/01/3233643/fda-panel-backs-j-js-new-type-of-diabetes-drug,Paul Quintaro,2013-01-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4742
709271,fda panel votes jjs canagliflozin has heart concerns,https://www.benzinga.com/news/13/01/3233479/fda-panel-votes-8-7-j-js-canagliflozin-has-heart-concerns,Paul Quintaro,2013-01-10 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
709272,fda posts briefing documents for jjs canagliflozin,https://www.benzinga.com/news/13/01/3223077/fda-posts-briefing-documents-for-j-js-canagliflozin,Paul Quintaro,2013-01-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709273, health care etfs your broker forgot to mention,https://www.benzinga.com/trading-ideas/long-ideas/13/01/3221049/4-health-care-etfs-your-broker-forgot-to-mention,ETF Professor,2013-01-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
709274,sanofi buys otc antacid rolaids from jjs mcneilppc,https://www.benzinga.com/news/13/01/3218933/sanofi-buys-otc-antacid-rolaids-from-j-js-mcneil-ppc,Paul Quintaro,2013-01-07 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709275,a look ahead this weeks etfs to watch,https://www.benzinga.com/news/earnings/13/01/3217818/a-look-ahead-this-weeks-etfs-to-watch,ETF Professor,2013-01-07 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709276,update deutsche bank upgrades johnson johnson to buy on improving trends,https://www.benzinga.com/analyst-ratings/analyst-color/13/01/3215100/update-deutsche-bank-upgrades-johnson-johnson-to-buy-on-,David Johnson,2013-01-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
709277,a peek into the market before the trading starts,https://www.benzinga.com/news/13/01/3214949/a-peek-into-the-market-before-the-trading-starts,Lisa Levin,2013-01-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709278,benzingas top upgrades,https://www.benzinga.com/analyst-ratings/upgrades/13/01/3214940/benzingas-top-upgrades,Lisa Levin,2013-01-04 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.60115
709279,deutsche bank upgrades johnson johnson to buy raises pt to ,https://www.benzinga.com/news/13/01/3214870/deutsche-bank-upgrades-johnson-johnson-to-buy-raises-pt-to-82-00,Juan Lopez,2013-01-04 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709280,merck pfizer abbott jj sanofi said to show interest in bausch lomb bid bloomberg,https://www.benzinga.com/news/13/01/3213668/merck-pfizer-abbott-j-j-sanofi-said-to-show-interest-in-bausch-lomb-bid-bloomberg,Paul Quintaro,2013-01-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8062
709281,jj declares share q dividend,https://www.benzinga.com/news/13/01/3209136/j-j-declares-0-61share-q1-dividend,Paul Quintaro,2013-01-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
709282,us stock futures higher on fiscalcliff deal,https://www.benzinga.com/news/13/01/3208553/us-stock-futures-higher-on-fiscal-cliff-deal,Monica Gerson,2013-01-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709283,stocks to watch for january ,https://www.benzinga.com/news/earnings/13/01/3208045/stocks-to-watch-for-january-2-2013,Monica Gerson,2013-01-02 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709284,short interest swings in biotech stocks celg gild regn,https://www.benzinga.com/trading-ideas/long-ideas/12/12/3203600/short-interest-swings-in-biotech-stocks-celg-gild-regn,Nelson Hem,2012-12-28 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709285,a growth etf for ,https://www.benzinga.com/analyst-ratings/analyst-color/12/12/3198281/a-growth-etf-for-2013,ETF Professor,2012-12-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
709286,jj to host analyst meeting at am est on jan nd,https://www.benzinga.com/news/12/12/3193761/j-j-to-host-analyst-meeting-at-8-30am-est-on-jan-22nd,Paul Quintaro,2012-12-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709287,how to avoid the worst sector etfs,https://www.benzinga.com/etfs/sector-etfs/12/12/3188038/how-to-avoid-the-worst-sector-etfs,David Trainer,2012-12-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.1285
709288,sp sees better for health insurance providers,https://www.benzinga.com/analyst-ratings/analyst-color/12/12/3184761/s-p-sees-better-2013-for-health-insurance-providers,ETF Professor,2012-12-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7202
709289,these dow laggards could rebound in ,https://www.benzinga.com/trading-ideas/long-ideas/12/12/3176708/these-2-dow-laggards-could-rebound-in-2013,Gordon Wilcox,2012-12-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709290,barrons recap outlook for ,https://www.benzinga.com/media/barrons/12/12/3176486/barrons-recap-121512-outlook-for-2013,Nelson Hem,2012-12-15 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.5
709291,short interest swings in biotech stocks biib celg vvus,https://www.benzinga.com/trading-ideas/long-ideas/12/12/3167675/short-interest-swings-in-biotech-stocks-biib-celg-vvus,Nelson Hem,2012-12-12 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709292,jjs janssen rd submits nda for canagliflozinmetformin fixeddose combo therapy,https://www.benzinga.com/news/12/12/3166620/j-js-janssen-r-d-submits-nda-for-canagliflozinmetformin-fixed-dose-combo-therapy,Paul Quintaro,2012-12-12 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
709293,fda expands jjs zytigas use for latestage prostate cancer,https://www.benzinga.com/news/12/12/3159873/fda-expands-j-js-zytigas-use-for-late-stage-prostate-cancer,Paul Quintaro,2012-12-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.19379999999999997
709294,davenport upgrades johnson johnson to buy,https://www.benzinga.com/news/12/12/3159423/davenport-upgrades-johnson-johnson-to-buy,Paul Quintaro,2012-12-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709295,a look at fortunes health care picks for algn fms gild,https://www.benzinga.com/trading-ideas/long-ideas/12/12/3157051/a-look-at-fortunes-health-care-picks-for-2013-algn-fms-gild,Nelson Hem,2012-12-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
709296,jjs evarrest fibrin sealant patch approved by fda,https://www.benzinga.com/news/12/12/3154655/j-js-evarrest-fibrin-sealant-patch-approved-by-fda,Paul Quintaro,2012-12-07 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.71075
709297,jjs janssen submits applications requesting approval of stelara in us europe,https://www.benzinga.com/news/12/12/3150899/j-js-janssen-submits-applications-requesting-approval-of-stelara-in-us-europe,Paul Quintaro,2012-12-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
709298,jj says new longterm study suggests lower morality in alzheimers patients treated with galantamine vs placebo,https://www.benzinga.com/news/12/12/3149317/j-j-says-new-long-term-study-suggests-lower-morality-in-alzheimers-patients-treat,Paul Quintaro,2012-12-05 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.4742
709299,how to find the best sector etfs,https://www.benzinga.com/etfs/sector-etfs/12/12/3140596/how-to-find-the-best-sector-etfs,David Trainer,2012-12-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
709300,biomarin prestige brands and other top performing health care stocks in november,https://www.benzinga.com/trading-ideas/long-ideas/12/12/3137157/biomarin-prestige-brands-and-other-top-performing-health-care,Nelson Hem,2012-12-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8062
709301,midcap dividend stocks for ,https://www.benzinga.com/trading-ideas/long-ideas/12/12/3136865/mid-cap-dividend-stocks-for-2013,Gordon Wilcox,2012-12-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709302,jj wins reversal of m levaquin punitive verdict,https://www.benzinga.com/news/12/11/3134970/j-j-wins-reversal-of-1-1m-levaquin-punitive-verdict,Paul Quintaro,2012-11-30 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7294
709303,jjs bill weldon to retire as chairman in q names ceo alex gorsky chair,https://www.benzinga.com/news/12/11/3134283/j-js-bill-weldon-to-retire-as-chairman-in-q1-names-ceo-alex-gorsky-chair,Paul Quintaro,2012-11-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709304,jjs janssen announces intent not to enforce patents for darunavir,https://www.benzinga.com/news/12/11/3130265/j-js-janssen-announces-intent-not-to-enforce-patents-for-darunavir,Paul Quintaro,2012-11-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709305,jj says fda panel recommends accelerated approval of bedaquiuline,https://www.benzinga.com/news/12/11/3128186/j-j-says-fda-panel-recommends-accelerated-approval-of-bedaquiuline,Paul Quintaro,2012-11-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8592
709306,update stifel nicolaus initiates johnson johnson at hold fairly valued,https://www.benzinga.com/analyst-ratings/analyst-color/12/11/3107548/update-stifel-nicolaus-initiates-johnson-johnson-at-hold,David Johnson,2012-11-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7202
709307,stifel nicolaus initiates coverage on johnson johnson at hold,https://www.benzinga.com/analyst-ratings/price-target/12/11/3106485/stifel-nicolaus-initiates-coverage-on-johnson-johnson-at-,Juan Lopez,2012-11-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709308,jjs cordis says incraft aaa stentgraft system innovation study shows safety efficacy,https://www.benzinga.com/news/12/11/3104407/j-js-cordis-says-incraft-aaa-stent-graft-system-innovation-study-shows-safety-eff,Paul Quintaro,2012-11-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.82985
709309,jjs janssencilags zytiga receives positive eu recommendation,https://www.benzinga.com/news/12/11/3101840/j-js-janssen-cilags-zytiga-receives-positive-eu-recommendation,Paul Quintaro,2012-11-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
709310,midcap dividend dynamos,https://www.benzinga.com/trading-ideas/long-ideas/12/11/3100836/mid-cap-dividend-dynamos,Gordon Wilcox,2012-11-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5386
709311,sp reiterates bullish view on health care etfs,https://www.benzinga.com/analyst-ratings/analyst-color/12/11/3098876/s-p-reiterates-bullish-view-on-health-care-etfs,ETF Professor,2012-11-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
709312,berkshire dumps most of jj and ge stakes adds deere co,https://www.benzinga.com/news/12/11/3092293/berkshire-dumps-most-of-j-j-and-ge-stakes-adds-deere-co,Scott Rubin,2012-11-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4459
709313,buffetts berkshire hathaway cuts stakes in ge visa jj conoco,https://www.benzinga.com/news/12/11/3091579/buffetts-berkshire-hathaway-cuts-stakes-in-ge-visa-j-j-conoco,Paul Quintaro,2012-11-14 00:00:00,JNJ,1,1,0,0,0,0,1,0,0,0.4742
709314,these etfs offer solid yield in uncertain times,https://www.benzinga.com/markets/bonds/12/11/3088634/these-etfs-offer-solid-yield-in-uncertain-times,Ken Shreve,2012-11-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.42345
709315,new phase findings show stelara significantly reduced signs and symptoms of active psoriatic arthritis,https://www.benzinga.com/news/12/11/3079666/new-phase-3-findings-show-stelara-significantly-reduced-signs-and-symptoms-of-act,Paul Quintaro,2012-11-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
709316,update jefferies downgrades johnson johnson to hold lowers pt,https://www.benzinga.com/analyst-ratings/analyst-color/12/11/3079332/update-jefferies-downgrades-johnson-johnson-to-hold-lowe,Nicholas Kitonyi,2012-11-12 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.436
709317,benzingas top downgrades,https://www.benzinga.com/analyst-ratings/downgrades/12/11/3079337/benzingas-top-downgrades,Lisa Levin,2012-11-12 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
709318,jefferies company downgrades johnson johnson from buy to hold lowers pt from to ,https://www.benzinga.com/analyst-ratings/downgrades/12/11/3079043/jefferies-company-downgrades-johnson-johnson-from-buy-to-ho,Juan Lopez,2012-11-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.436
709319,smart vascular stent systems gets fda approval,https://www.benzinga.com/news/12/11/3073064/smart-vascular-stent-systems-gets-fda-approval,Paul Quintaro,2012-11-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.85015
709320,mylan announces settlement with janssen related to ortho tricyclen lo,https://www.benzinga.com/news/12/11/3072114/mylan-announces-settlement-with-janssen-related-to-ortho-tri-cyclen-lo,Paul Quintaro,2012-11-08 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709321,more pain awaits medical device etfs,https://www.benzinga.com/trading-ideas/long-ideas/12/11/3066684/more-pain-awaits-medical-device-etfs,ETF Professor,2012-11-07 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.26925
709322,jj settles suits related to levaquin and tendon injuries bloomberg,https://www.benzinga.com/news/12/11/3048270/j-j-settles-suits-related-to-levaquin-and-tendon-injuries-bloomberg,Paul Quintaro,2012-11-01 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.625
709323,vertex jnjs janssen enter agreement for phase hepatitis c study,https://www.benzinga.com/news/12/11/3046122/vertex-jnjs-janssen-enter-agreement-for-phase-2-hepatitis-c-study,Charles Gross,2012-11-01 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.74695
709324,more equalweight etfs your broker forgot to mention,https://www.benzinga.com/trading-ideas/long-ideas/12/10/3039328/more-equal-weight-etfs-your-broker-forgot-to-mention,ETF Professor,2012-10-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709325,johnson amp johnson postpones november medical devices amp diagnostics review,https://www.benzinga.com/news/12/10/3038685/johnson-amp-johnson-postpones-november-1-medical-devices-amp-diagnostics-review,Charles Gross,2012-10-30 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.3634
709326,how to find the best etfs,https://www.benzinga.com/trading-ideas/12/10/3027417/how-to-find-the-best-etfs,David Trainer,2012-10-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
709327,sector rankings for etfs mutual funds,https://www.benzinga.com/etfs/broad-u-s-equity-etfs/12/10/3023815/sector-rankings-for-etfs-mutual-funds,David Trainer,2012-10-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709328,rating breakdown best worst etfs mutual funds by sector,https://www.benzinga.com/etfs/broad-u-s-equity-etfs/12/10/3023817/rating-breakdown-best-worst-etfs-mutual-funds-by-sector,David Trainer,2012-10-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5129
709329,top performing dividend payers in health care with the most upside potential trib ste cmn,https://www.benzinga.com/news/earnings/12/10/3019196/top-performing-dividend-payers-in-health-care-with-the-most-upside-poten,Nelson Hem,2012-10-23 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8062
709330,barclays maintains johnson johnson at overweight raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/10/3002689/barclays-maintains-johnson-johnson-at-overweight-raises-p,Juan Lopez,2012-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.3194
709331,update deutsche bank reiterates hold rating raises pt on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/10/3002126/update-deutsche-bank-reiterates-hold-rating-raises-pt-on,Dwight Einhorn,2012-10-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709332,deutsche bank maintains johnson johnson at hold raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/10/3000746/deutsche-bank-maintains-johnson-johnson-at-hold-raises-pt,Juan Lopez,2012-10-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709333,upbeat earnings reports spark triple digit gain in the dow,https://www.benzinga.com/markets/bonds/12/10/2999327/upbeat-earnings-reports-spark-triple-digit-gain-in-the-dow,Scott Rubin,2012-10-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8243
709334,johnson johnson rises after topping estimates raising guidance,https://www.benzinga.com/news/earnings/12/10/2998941/johnson-johnson-rises-1-after-topping-estimates-raising-guidance,Scott Rubin,2012-10-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709335,johnson johnson guides fy revenue b had seen b vs b est,https://www.benzinga.com/news/earnings/12/10/2997436/johnson-johnson-guides-fy-revenue-67-67-6b-had-seen-66-7-67-3b-vs-67-22b,Paul Quintaro,2012-10-16 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
709336,johnson johnson guides fy eps had seen vs est,https://www.benzinga.com/news/earnings/12/10/2996816/johnson-johnson-guides-fy-eps-5-05-5-10-had-seen-5-05-5-07-vs-5-08-est,Paul Quintaro,2012-10-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709337,johnson johnson reports q eps vs est revenues b vs b est,https://www.benzinga.com/news/earnings/12/10/2996813/johnson-johnson-reports-q3-eps-1-25-vs-1-29-est-revenues-17-1b-vs-16-70b,Paul Quintaro,2012-10-16 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709338,benzinga market primer tuesday october ,https://www.benzinga.com/markets/bonds/12/10/2995502/benzinga-market-primer-tuesday-october-16,Matthew Kanterman,2012-10-16 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709339,us stock futures up ahead of earnings economic data,https://www.benzinga.com/news/12/10/2995457/us-stock-futures-up-ahead-of-earnings-economic-data,Monica Gerson,2012-10-16 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709340,earnings scheduled for october ,https://www.benzinga.com/news/earnings/12/10/2995357/earnings-scheduled-for-october-16-2012,Monica Gerson,2012-10-16 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709341,stocks to watch for october ,https://www.benzinga.com/news/earnings/12/10/2995349/stocks-to-watch-for-october-16-2012,Monica Gerson,2012-10-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709342,the gores group extends binding offer to acquire therakos,https://www.benzinga.com/news/12/10/2993316/the-gores-group-extends-binding-offer-to-acquire-therakos,Paul Quintaro,2012-10-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
709343,short interest swings in biotech stocks biib celg gild,https://www.benzinga.com/trading-ideas/long-ideas/12/10/2992188/short-interest-swings-in-biotech-stocks-biib-celg-gild,Nelson Hem,2012-10-15 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.7294
709344,earnings expectations for the week of october ,https://www.benzinga.com/news/earnings/12/10/2992190/earnings-expectations-for-the-week-of-october-15,Nelson Hem,2012-10-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709345,jefferies company maintains johnson johnson at buy raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/10/2989410/jefferies-company-maintains-johnson-johnson-at-buy-raises,Juan Lopez,2012-10-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709346,part i must know etfs for q earnings,https://www.benzinga.com/markets/bonds/12/10/2979411/part-i-must-know-etfs-for-q3-earnings,ETF Professor,2012-10-09 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709347,benzingas top downgrades,https://www.benzinga.com/analyst-ratings/downgrades/12/10/2977512/benzingas-top-downgrades,Monica Gerson,2012-10-09 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
709348,sp index and big weekly outlook,https://www.benzinga.com/markets/12/10/2960347/s-p-index-and-big-10-weekly-outlook,PreMarketInfo,2012-10-02 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709349,from earlier jj says phase trial for canagliflozin met secondary endpoints,https://www.benzinga.com/news/12/10/2959028/from-earlier-j-j-says-phase-3-trial-for-canagliflozin-met-secondary-endpoints,Paul Quintaro,2012-10-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709350,from earlier janssencilag says velcade approved in eu,https://www.benzinga.com/news/12/09/2949467/from-earlier-janssen-cilag-says-velcade-approved-in-eu,Paul Quintaro,2012-09-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
709351,amazon could relinquish key trademark to apple,https://www.benzinga.com/news/12/09/2944262/amazon-could-relinquish-key-trademark-to-apple,Louis Bedigian,2012-09-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.58895
709352,sp highlights election etfs,https://www.benzinga.com/analyst-ratings/analyst-color/12/09/2939541/s-p-highlights-election-etfs,ETF Professor,2012-09-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709353,knee replacements have doubled bloomberg,https://www.benzinga.com/news/12/09/2939498/knee-replacements-have-doubled-bloomberg,Paul Quintaro,2012-09-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709354,janssen research development says will present latest phase results for canagliflozin october ,https://www.benzinga.com/news/12/09/2937874/janssen-research-development-says-will-present-latest-phase-3-results-for-canagli,Paul Quintaro,2012-09-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709355,johnson johnson is facing trial over risperdal lawyer says company hid fact caused female breasts in boys,https://www.benzinga.com/news/12/09/2934952/johnson-johnson-is-facing-trial-over-risperdal-lawyer-says-company-hid-fact-cause,Paul Quintaro,2012-09-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.44865
709356,sp index and big weekly outlookweek of september ,https://www.benzinga.com/12/09/2934372/s-p-500-index-and-big-10-weekly-outlook-week-of-september-24-2012,PreMarketInfo,2012-09-24 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709357,johnson johnson finding support at ,https://www.benzinga.com/intraday-update/12/09/2920003/johnson-johnson-finding-support-at-68,Paul Quintaro,2012-09-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.70095
709358,defensive stocks maintain gains in mixed market,https://www.benzinga.com/trading-ideas/technicals/12/09/2919984/defensive-stocks-maintain-gains-in-mixed-market,Paul Quintaro,2012-09-18 00:00:00,JNJ,1,0,0,1,0,1,1,1,1,0.6806
709359,johnson johnson establishing innovation centers,https://www.benzinga.com/news/12/09/2918247/johnson-johnson-establishing-4-innovation-centers,Paul Quintaro,2012-09-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
709360,sandra peterson to join johnson johnson as group worldwide chairman and member of the executive committee,https://www.benzinga.com/news/12/09/2907781/sandra-peterson-to-join-johnson-johnson-as-group-worldwide-chairman-and-member-of,Eddie Staley,2012-09-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
709361,johnsonjohnson has right to buy vascular after phase ,https://www.benzinga.com/news/12/09/2903685/johnson-johnson-has-right-to-buy-vascular-after-phase-2,Paul Quintaro,2012-09-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709362,credit suisse reinstates coverage on johnson johnson at neutral announces pt of ,https://www.benzinga.com/analyst-ratings/price-target/12/09/2899045/credit-suisse-reinstates-coverage-on-johnson-johnson-at-n,Juan Lopez,2012-09-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6909
709363,these companies have been increasing their dividends for decades,https://www.benzinga.com/trading-ideas/long-ideas/12/09/2897997/4-forgotten-but-stellar-dividend-increase-streaks,Gordon Wilcox,2012-09-10 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709364,this dividend etf isnt the same old song,https://www.benzinga.com/trading-ideas/long-ideas/12/09/2889708/this-dividend-etf-isnt-the-same-old-song,ETF Professor,2012-09-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709365,us fda grants priority review to bedaquiline for multidrug resistant tuberculosis treatment,https://www.benzinga.com/news/12/09/2883492/u-s-fda-grants-priority-review-to-bedaquiline-for-multi-drug-resistant-tuberculos,Paul Quintaro,2012-09-05 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.61315
709366,transvaginal mesh suit filed against johnson johnson,https://www.benzinga.com/news/12/09/2880285/transvaginal-mesh-suit-filed-against-johnson-johnson,Paul Quintaro,2012-09-04 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709367,delaware nets million settlement from johnson johnson subsidiary,https://www.benzinga.com/news/12/08/2875060/delaware-nets-4-2-million-settlement-from-johnson-johnson-subsidiary,Brett Callwood,2012-08-31 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709368,us fda grants priority review of johnson johnsons zytiga,https://www.benzinga.com/news/12/08/2868153/u-s-fda-grants-priority-review-of-johnson-johnsons-zytiga,Paul Quintaro,2012-08-29 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.61315
709369,fda approves johnson and johnsons nucynta er,https://www.benzinga.com/news/12/08/2868057/fda-approves-johnson-and-johnsons-nucynta-er,Paul Quintaro,2012-08-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
709370,xarel helped to stemi heart attack patients xarel group had better survival rate without another attack,https://www.benzinga.com/news/12/08/2860987/xarel-helped-to-stemi-heart-attack-patients-xarel-group-had-better-survival-rate-,Paul Quintaro,2012-08-27 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.24469999999999997
709371,orthocon announces uninterrupted availability of hemasorb resorbable hemostatic bone putty,https://www.benzinga.com/news/12/08/2854463/orthocon-announces-uninterrupted-availability-of-hemasorb-resorbable-hemostatic-b,Paul Quintaro,2012-08-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709372,five practical books investment lessons,https://www.benzinga.com/markets/12/08/2841553/five-practical-books-5-investment-lessons,Gary Cassady,2012-08-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709373,sp still bullish on health care etfs,https://www.benzinga.com/analyst-ratings/analyst-color/12/08/2839847/s-p-still-bullish-on-health-care-etfs,ETF Professor,2012-08-16 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.74695
709374,berkshire hathaway sells intel buys nationaloilwell varco,https://www.benzinga.com/news/12/08/2832650/berkshire-hathaway-sells-intel-buys-national-oilwell-varco,Scott Rubin,2012-08-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709375,update berkshire reduced stake in visa ups jj pg increased stake in lee enterprises ibm,https://www.benzinga.com/news/12/08/2832490/update-berkshire-reduced-stake-in-visa-ups-j-j-p-g-increased-stake-in-lee-enterpr,Paul Quintaro,2012-08-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
709376,elan shares fall afterhours on disappointing pfizer bapineuzumab study,https://www.benzinga.com/news/12/08/2808747/elan-shares-fall-11-after-hours-on-disappointing-pfizer-bapineuzumab-study,Charles Gross,2012-08-06 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.375
709377,teva pharmaceutical subpoenaed by sec in bribery charge,https://www.benzinga.com/news/12/08/2806767/teva-pharmaceutical-subpoenaed-by-sec-in-bribery-charge,Chris Poley,2012-08-06 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
709378,johnson johnson reaches risperdal lawsuit agreement,https://www.benzinga.com/news/12/08/2803954/johnson-johnson-cure-risperdal-lawsuit,Chris Poley,2012-08-03 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.6806
709379,ubs maintains johnson johnson at buy raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/08/2795844/ubs-maintains-johnson-johnson-at-buy-raises-pt-from-70-to,Juan Lopez,2012-08-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709380,long term bull in johnson johnson,https://www.benzinga.com/markets/options/12/07/2791469/long-term-bull-in-johnson-johnson,Patrick Mortimer,2012-07-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709381,option alert johnson johnson january call block trade contracts currently ,https://www.benzinga.com/markets/options/12/07/2791274/option-alert-johnson-johnson-january-2014-77-5-call-block-trade-16-000,Charles Gross,2012-07-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.41105
709382,update dendreon on call says provenge should be sequenced upfront before jjs zytiga,https://www.benzinga.com/news/12/07/2788157/update-dendreon-on-call-says-provenge-should-be-sequenced-upfront-before-j-js-zyt,Paul Quintaro,2012-07-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709383,jjs synthes sued for wrongful deathfraud bloomberg,https://www.benzinga.com/news/12/07/2787047/j-js-synthes-sued-for-wrongful-deathfraud-bloomberg,Paul Quintaro,2012-07-30 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709384,sp likes some young etfs,https://www.benzinga.com/analyst-ratings/analyst-color/12/07/2774920/s-p-likes-some-young-etfs,ETF Professor,2012-07-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
709385,what you need in order to retire before age ,https://www.benzinga.com/general/topics/12/07/2766077/what-you-need-in-order-to-retire-before-age-60,Minyanville,2012-07-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709386,jj doj settlement for as much as billion wsj sources,https://www.benzinga.com/news/12/07/2759559/j-j-doj-settlement-for-as-much-as-2-2-billion-wsj-sources,Allie Wickman,2012-07-19 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.625
709387,kapito we like att vz mrk jnj for yields,https://www.benzinga.com/media/cnbc/12/07/2754928/kapito-we-like-att-vz-mrk-jnj-for-yields,Charles Gross,2012-07-18 00:00:00,JNJ,1,2,0,0,0,0,1,1,1,0.6806
709388,update jefferies reiterates buy rating raises pt on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/07/2754646/update-jefferies-reiterates-buy-rating-raises-pt-on-john,Dwight Einhorn,2012-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709389,piper jaffray maintains johnson johnson at neutral raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/07/2754279/piper-jaffray-maintains-johnson-johnson-at-neutral-raises,Juan Lopez,2012-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709390,johnson and johnsons janssen diagnostics aviga receives complete oncatcb certification by drummond group,https://www.benzinga.com/news/12/07/2753700/johnson-and-johnsons-janssen-diagnostics-aviga-receives-complete-onc-atcb-certifi,Paul Quintaro,2012-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709391,jefferies company maintains johnson johnson at buy raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/07/2752948/jefferies-company-maintains-johnson-johnson-at-buy-raises,Juan Lopez,2012-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709392,deutsche bank maintains johnson johnson at hold raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/07/2752852/deutsche-bank-maintains-johnson-johnson-at-hold-raises-pt,Juan Lopez,2012-07-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709393,johnson johnson beats on eps but fails to impress,https://www.benzinga.com/news/earnings/12/07/2749585/j-j-beats-on-eps-but-hardly-impresses,Michael Matthews,2012-07-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.51935
709394,jj ceo expects more consolidation among hospitals,https://www.benzinga.com/news/12/07/2749917/j-j-ceo-expects-more-consolidation-among-hospitals,Paul Quintaro,2012-07-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.625
709395,update jj sees pretax operating margin improving by basis points,https://www.benzinga.com/news/12/07/2749791/update-j-j-sees-pretax-operating-margin-improving-by-100-150-basis-points,Paul Quintaro,2012-07-17 00:00:00,JNJ,1,0,0,0,1,0,1,1,0,0.79295
709396,jj sees year reported sales billion says any guidance will include forex impact sees future earnings affected by forex sees net interest expense million,https://www.benzinga.com/news/12/07/2749779/j-j-sees-year-reported-sales-66-7-67-3-billion-says-any-2012-guidance-will-includ,Paul Quintaro,2012-07-17 00:00:00,JNJ,1,1,0,1,0,0,1,1,0,0.76335
709397,jj sees million in restructuring charges ahes,https://www.benzinga.com/news/12/07/2749737/j-j-sees-600-million-in-restructuring-charges-ahes,Paul Quintaro,2012-07-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.4871
709398,update jj ceo says pharma ops will continue to be strong driver of sales,https://www.benzinga.com/news/12/07/2749584/update-j-j-ceo-says-pharma-ops-will-continue-to-be-strong-driver-of-sales,Paul Quintaro,2012-07-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8243
709399,update johnson and johnson to report topline results on bapineuzumab this quarter at meeting in september,https://www.benzinga.com/news/12/07/2749455/update-johnson-and-johnson-to-report-top-line-results-on-bapineuzumab-this-quarte,Paul Quintaro,2012-07-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709400,johnson and johnson plans to resume supply of doxil in q,https://www.benzinga.com/news/12/07/2749449/johnson-and-johnson-plans-to-resume-supply-of-doxil-in-q4,Paul Quintaro,2012-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709401,johnson johnson falls on weak guidance,https://www.benzinga.com/news/earnings/12/07/2749234/johnson-johnson-falls-on-weak-guidance,James Hunter,2012-07-17 00:00:00,JNJ,1,1,0,0,0,0,0,0,0,0.2798
709402,update johnson johnson posts drop in q profit lowers fullyear forecast,https://www.benzinga.com/news/earnings/12/07/2749263/update-johnson-johnson-posts-drop-in-q2-profit-lowers-full-year-forecast,Lisa Levin,2012-07-17 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.5386
709403,benzingas top premarket losers,https://www.benzinga.com/news/12/07/2749244/benzingas-top-pre-market-losers,Lisa Levin,2012-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709404,johnson johnson guides fy eps vs est,https://www.benzinga.com/news/12/07/2748937/johnson-johnson-guides-fy-eps-5-00-5-07-vs-5-14-est,Allie Wickman,2012-07-17 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709405,popular drug manufacturing stocks among hedge funds,https://www.benzinga.com/trading-ideas/long-ideas/12/07/2746905/popular-drug-manufacturing-stocks-among-hedge-funds,Viktor Puskorius,2012-07-17 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.71075
709406,johnson johnson reports q eps vs est revenues b vs b est,https://www.benzinga.com/news/earnings/12/07/2748920/johnson-johnson-reports-q2-eps-1-30-vs-1-29-est-revenues-16-5b-vs-16-69b,Allie Wickman,2012-07-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709407,benzinga market primer tuesday july ,https://www.benzinga.com/markets/bonds/12/07/2748614/benzinga-market-primer-tuesday-july-17,Matthew Kanterman,2012-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709408,us stock futures up all eyes on bernanke,https://www.benzinga.com/news/12/07/2748612/us-stock-futures-up-all-eyes-on-bernanke,Monica Gerson,2012-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709409,earnings scheduled for july ,https://www.benzinga.com/news/earnings/12/07/2747872/earnings-scheduled-for-july-17,Monica Gerson,2012-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709410,stocks to watch for july ,https://www.benzinga.com/news/earnings/12/07/2747858/stocks-to-watch-for-july-17,Monica Gerson,2012-07-17 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709411,earnings expectations for the week of july ,https://www.benzinga.com/news/earnings/12/07/2744180/earnings-expectations-for-the-week-of-july-16-bac-ko-msft-ge,Nelson Hem,2012-07-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709412,low volume high returns for these etfs bib fhc drw,https://www.benzinga.com/trading-ideas/long-ideas/12/07/2742958/low-volume-high-returns-for-these-etfs-bib-fhc-drw,ETF Professor,2012-07-13 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.3634
709413,jefferies company maintains johnson johnson at buy raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/07/2741564/jefferies-company-maintains-johnson-johnson-at-buy-raises,Juan Lopez,2012-07-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709414,jj agrees to corporate governance changes drug marketing changes as part of nj settlement bloomberg headlines,https://www.benzinga.com/news/12/07/2736142/j-j-agrees-to-corporate-governance-changes-drug-marketing-changes-as-part-of-nj-s,Allie Wickman,2012-07-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
709415,johnson johnson receives positive mad moneyjim cramer mention cnbc,https://www.benzinga.com/media/cnbc/12/07/2728537/johnson-johnson-receives-positive-mad-moneyjim-cramer-mention-cnbc,Charles Gross,2012-07-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.55135
709416,jj unit stent thrombosis snda contingent on acs snda,https://www.benzinga.com/news/12/07/2725858/j-j-unit-stent-thrombosis-snda-contingent-on-acs-snda,Allie Wickman,2012-07-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709417,jj fda grants priority review for xarelto supplemental ndas,https://www.benzinga.com/news/12/07/2725854/j-j-fda-grants-priority-review-for-xarelto-supplemental-ndas,Allie Wickman,2012-07-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
709418,benzingas ma chatter for tuesday july ,https://www.benzinga.com/trading-ideas/long-ideas/12/07/2718988/benzingas-m-a-chatter-for-tuesday-july-3-2012,Charles Gross,2012-07-04 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709419,elan spokesperson would not comment on earlier chatter of jnj offer,https://www.benzinga.com/news/12/07/2716653/elan-spokesperson-would-not-comment-on-earlier-chatter-of-jnj-offer,Charles Gross,2012-07-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709420,hearing unconfirmed chatter of johnson and johnson offer for elan share,https://www.benzinga.com/news/12/07/2716589/hearing-unconfirmed-chatter-of-johnson-and-johnson-offer-for-elan-19share,Charles Gross,2012-07-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.58895
709421,alps unveils dogs of the dow etf,https://www.benzinga.com/trading-ideas/long-ideas/12/06/2709715/alps-unveils-dogs-of-the-dow-etf,ETF Professor,2012-06-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709422,leveraged etfs for the obamacare ruling,https://www.benzinga.com/trading-ideas/long-ideas/12/06/2699379/leveraged-etfs-for-the-obamacare-ruling,ETF Professor,2012-06-26 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709423,the new high frequency trading landscape man versus machine,https://www.benzinga.com/news/12/06/2695634/the-new-high-frequency-trading-landscape-man-versus-machine,Hilary Farrell,2012-06-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709424,ahead of obamacare ruling sp likes health care spdr,https://www.benzinga.com/analyst-ratings/analyst-color/12/06/2694761/ahead-of-obamacare-ruling-s-p-likes-health-care-spdr,ETF Professor,2012-06-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8592
709425,saving more vs seeking higher returns for retirement,https://www.benzinga.com/economics/12/06/2694428/saving-more-vs-seeking-higher-returns-for-retirement,Minyanville,2012-06-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709426,premarket stock talk sell the market buy facebook,https://www.benzinga.com/trading-ideas/long-ideas/12/06/2690079/premarket-stock-talk-sell-the-market-buy-facebook,PreMarketInfo,2012-06-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709427,premarket stock talk beyond a best bed and bath buy,https://www.benzinga.com/personal-finance/financial-advisors/12/06/2686872/premarket-stock-talk-beyond-a-best-bed-and-bath-bu,PreMarketInfo,2012-06-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
709428,study says jj vaginal sling cuts incontinence risk in half,https://www.benzinga.com/news/12/06/2685070/study-says-j-j-vaginal-sling-cuts-incontinence-risk-in-half,Paul Quintaro,2012-06-20 00:00:00,JNJ,1,0,0,1,0,0,0,0,0,0.3409
709429,arkansas judge who fined jj billion denies request for new trial in risperdal case ap,https://www.benzinga.com/news/12/06/2684329/arkansas-judge-who-fined-j-j-1-2-billion-denies-request-for-new-trial-in-risperda,Allie Wickman,2012-06-20 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.39885
709430,goldman sachs raises pt on johnson johnson from to maintains neutral,https://www.benzinga.com/analyst-ratings/price-target/12/06/2673039/goldman-sachs-raises-pt-on-johnson-johnson-from-65-to-67-,Joe Young,2012-06-15 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709431,johnson johnson to complete synthes acquisition,https://www.benzinga.com/news/12/06/2668536/johnson-johnson-to-complete-synthes-acquisition,Brett Callwood,2012-06-14 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709432,update jefferies upgrades johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/06/2665675/update-jefferies-upgrades-johnson-johnson,Joe Young,2012-06-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709433,update jp morgan upgrades johnson johnson to overweight discounted valuation compared to peers,https://www.benzinga.com/analyst-ratings/analyst-color/12/06/2665377/update-jp-morgan-upgrades-johnson-johnson-to-overweight-,David Johnson,2012-06-13 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.436
709434,financial breakfast morning news summary for june ,https://www.benzinga.com/news/earnings/12/06/2664714/financial-breakfast-morning-news-summary-for-june-13-2012,James Hunter,2012-06-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709435,jefferies company upgrades johnson johnson from hold to buy raises pt from to ,https://www.benzinga.com/analyst-ratings/upgrades/12/06/2664635/jefferies-company-upgrades-johnson-johnson-from-hold-to-buy-r,Joe Young,2012-06-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709436,jp morgan upgrades johnson johnson from neutral to overweight pt raised from to ,https://www.benzinga.com/analyst-ratings/upgrades/12/06/2664345/jp-morgan-upgrades-johnson-johnson-from-neutral-to-overweight,Joe Young,2012-06-13 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.41105
709437,johnson johnson receives us regulatory clearance for synthes acquisition,https://www.benzinga.com/news/12/06/2663406/johnson-johnson-receives-us-regulatory-clearance-for-synthes-acquisition,Paul Quintaro,2012-06-12 00:00:00,JNJ,1,0,1,1,0,0,1,1,1,0.5
709438,johnson and johnson receives us regulatory approval for synthes acquisition closing date for acquisition set for june ,https://www.benzinga.com/news/12/06/2663403/johnson-and-johnson-receives-us-regulatory-approval-for-synthes-acquisition-closi,Paul Quintaro,2012-06-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7383500000000001
709439,johnson and johnson announces b accelerated buyback plan,https://www.benzinga.com/news/12/06/2663400/johnson-and-johnson-announces-12-9b-accelerated-buyback-plan,Paul Quintaro,2012-06-12 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.5
709440, healthcare stocks with the highest revenue,https://www.benzinga.com/trading-ideas/12/06/2660851/5-healthcare-stocks-with-the-highest-revenue,Lisa Levin,2012-06-12 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709441,johnsonjohnson reports positive results from first human clinical trials of a firstgeneration artificial pancreas system,https://www.benzinga.com/news/12/06/2657615/positive-results-from-first-human-clinical-trials-of-a-first-generation-artificia,Paul Quintaro,2012-06-11 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
709442,johnson johnson to incur special charge in q due to legal matters k,https://www.benzinga.com/news/12/06/2655267/johnson-johnson-to-incur-special-charge-in-q2-due-to-legal-matters-8k,Charles Gross,2012-06-08 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.7553000000000001
709443,elan spokesperson says company is not involved in actual data of alzheimer treatment says data is handled by johnson johnson and pfizer,https://www.benzinga.com/analyst-ratings/analyst-color/12/06/2651457/elan-spokesperson-says-company-is-not-involved-in-actual,Charles Gross,2012-06-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709444,three keys to finding good dividend stocks,https://www.benzinga.com/trading-ideas/long-ideas/12/06/2648034/three-keys-to-finding-good-dividend-stocks,Minyanville,2012-06-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
709445,dendreon jumps ,https://www.benzinga.com/intraday-update/12/06/2644461/dendreon-jumps-10,Scott Rubin,2012-06-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709446,the us economy and the united nations bold strategies needed tax reform and benefits reform,https://www.benzinga.com/personal-finance/financial-advisors/12/06/2637998/the-us-economy-and-the-united-nations-bold-strateg,George Mentz,2012-06-04 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.8953
709447,update jjs zytiga slows cancer growth in men with prostate cancer negative for dendreon positive for medivation,https://www.benzinga.com/news/12/06/2639381/update-j-js-zytiga-slows-cancer-growth-in-men-with-prostate-cancer-negative-for-d,Allie Wickman,2012-06-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.0963
709448,zytiga plus prednisone show improvements in asymptomatic or mildly symptomatic chemotherapynaive patients with metastatic castrationresistant prostate cancer,https://www.benzinga.com/news/12/06/2637735/zytiga-plus-prednisone-show-improvements-in-asymptomatic-or-mildly-symptomatic-ch,Charles Gross,2012-06-02 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.26165
709449,johnson johnson receives positive mad moneyjim cramer mention cnbc,https://www.benzinga.com/media/cnbc/12/06/2637305/johnson-johnson-receives-positive-mad-moneyjim-cramer-mention-cnbc,Charles Gross,2012-06-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.55135
709450, risky dividend stocks win exc ftr has jnj,https://www.benzinga.com/trading-ideas/dividends/12/05/2633665/5-risky-dividend-stocks-win-exc-ftr-has-jnj,Matthew Kanterman,2012-05-31 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7294
709451,goldman sachs comments on breaking up of johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/05/2630743/goldman-sachs-comments-on-breaking-up-of-johnson-johnson,Juan Lopez,2012-05-31 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709452,fda issues complete response letter for mg prezista,https://www.benzinga.com/news/12/05/2623334/fda-issues-complete-response-letter-for-800mg-prezista,Paul Quintaro,2012-05-29 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709453, healthcare stocks with the highest cash,https://www.benzinga.com/trading-ideas/12/05/2622809/5-healthcare-stocks-with-the-highest-cash,Lisa Levin,2012-05-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709454,sp undex and big weekly outlookweek of may th,https://www.benzinga.com/trading-ideas/long-ideas/12/05/2620952/s-p-500-undex-and-big-10-weekly-outlook-week-of-may-28th,PreMarketInfo,2012-05-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709455,three stocks from goldmans hedge fund short list will they pop or flop,https://www.benzinga.com/news/12/05/2617465/three-stocks-from-goldmans-hedge-fund-short-list-pop-or-flop,Matt Jackson,2012-05-24 00:00:00,JNJ,0,2,0,0,0,0,0,0,0,0.32999999999999996
709456,fda advisory panel votes against the approval of johnson johnsons and bayers xareto pill,https://www.benzinga.com/news/12/05/2613645/fda-advisory-panel-votes-6-4-1-against-the-approval-of-johnson-johnsons-and-bayer,Eddie Staley,2012-05-23 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7383500000000001
709457,health care spdr in focus ahead of obamacare decision,https://www.benzinga.com/analyst-ratings/analyst-color/12/05/2606901/health-care-spdr-in-focus-ahead-of-obamacare-decision,ETF Professor,2012-05-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
709458,prostate cancer companies suffer when they ignore urologists,https://www.benzinga.com/news/fda/12/05/2606876/prostate-cancer-companies-suffer-when-they-ignore-urologists,Minyanville,2012-05-22 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.056999999999999995
709459,sp index and big weekly outlookweek of may th,https://www.benzinga.com/news/global/12/05/2585352/s-p-500-index-and-big-10-weekly-outlook-week-of-may-14th,PreMarketInfo,2012-05-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709460,etfs on the market that will line your pockets times a year,https://www.benzinga.com/markets/bonds/12/05/2573295/more-monthly-dividend-etfs-emlc-pey-eld,ETF Professor,2012-05-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709461,option alert johnson johnson july calls block trade contracts currently ,https://www.benzinga.com/markets/options/12/05/2572838/option-alert-johnson-johnson-july-67-5-calls-block-trade-10-000-contra,Charles Gross,2012-05-09 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.41105
709462,buffetts holdings beat the sp one month after meeting,https://www.benzinga.com/trading-ideas/long-ideas/12/05/2565248/buffetts-holdings-beat-the-s-p-500-one-month-after-meeting,Paul Quintaro,2012-05-07 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.5
709463,sp index and big ten analysis week of may ,https://www.benzinga.com/trading-ideas/long-ideas/12/05/2565233/s-p-500-index-and-big-ten-analysis-week-of-may-7-2012,PreMarketInfo,2012-05-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709464,sp index and big ten weekly outlook april th,https://www.benzinga.com/markets/12/04/2541399/s-p-500-index-and-big-ten-weekly-outlook-april-30th,PreMarketInfo,2012-04-30 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709465,johnson johnson announces dividend increase of to ,https://www.benzinga.com/news/12/04/2532775/johnson-johnson-announces-dividend-increase-of-7-0-to-0-61,Eddie Staley,2012-04-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
709466,fitch removes johnson johnson from watch negative,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2529781/fitch-removes-johnson-johnson-from-watch-negative,Charles Gross,2012-04-25 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.21405000000000002
709467,five cheap stocks under bac nak sd rimm eln,https://www.benzinga.com/trading-ideas/long-ideas/12/04/2528970/five-cheap-stocks-under-15-bac-nak-sd-rimm-eln,General,2012-04-25 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709468,colgatepalmolive earnings preview q eps sales expected to be higher,https://www.benzinga.com/news/earnings/12/04/2526545/colgate-palmolive-earnings-preview-q1-eps-sales-expected-to-be-higher,Nelson Hem,2012-04-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709469,sp futures and big weekly analysis week of april ,https://www.benzinga.com/trading-ideas/long-ideas/12/04/2519571/s-p-futures-and-big-10-weekly-analysis-week-of-april-23,PreMarketInfo,2012-04-23 00:00:00,JNJ,1,2,0,0,1,0,1,1,1,0.5
709470,street yearning for better earnings,https://www.benzinga.com/news/earnings/12/04/2513501/street-yearning-for-better-earnings,PreMarketInfo,2012-04-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.76335
709471,sp bullish on pharma etfs longterm,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2512735/s-p-bullish-on-pharma-etfs-long-term,ETF Professor,2012-04-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709472,ubs maintains johnson johnson at buy lowers pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/04/2507921/ubs-maintains-johnson-johnson-at-buy-lowers-pt-from-71-to,webmaster,2012-04-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.436
709473,update goldman sachs lowers johnson johnsons pt,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2507792/update-goldman-sachs-lowers-johnson-johnsons-pt,Delores Land,2012-04-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.436
709474,update citigroup reiterates buy rating raises pt on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2507541/update-citigroup-reiterates-buy-rating-raises-pt-on-john,Dwight Einhorn,2012-04-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709475,citigroup maintains johnson johnson at buy raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/04/2506434/citigroup-maintains-johnson-johnson-at-buy-raises-pt-from,webmaster,2012-04-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709476,goldman sachs maintains johnson johnson at neutral lowers pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/04/2506302/goldman-sachs-maintains-johnson-johnson-at-neutral-lowers,webmaster,2012-04-18 00:00:00,JNJ,1,2,1,0,0,1,1,1,1,0.436
709477,checking in turn down the vol lvol splv,https://www.benzinga.com/trading-ideas/long-ideas/12/04/2505485/checking-in-turn-down-the-vol-lvol-splv,ETF Professor,2012-04-17 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.5
709478,deutsche bank johnson johnson beat eps misses sales,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2503149/deutsche-bank-johnson-johnson-beat-eps-misses-sales,Delores Land,2012-04-17 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.38685
709479,jj says will file motion to dismiss risperdal ruling will appeal if dismissal fails,https://www.benzinga.com/news/12/04/2503107/j-j-says-will-file-motion-to-dismiss-risperdal-ruling-will-appeal-if-dismissal-fa,Paul Quintaro,2012-04-17 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.39885
709480,earnings roundup,https://www.benzinga.com/news/earnings/12/04/2502919/earnings-roundup,Lisa Levin,2012-04-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709481,update johnson johnson posts rise in q earnings lifts forecast,https://www.benzinga.com/news/earnings/12/04/2502595/update-johnson-johnson-posts-12-rise-in-q1-earnings-lifts-forecast,Lisa Levin,2012-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709482,johnson amp johnson reports q eps vs est revenues b vs b est,https://www.benzinga.com/news/earnings/12/04/2502330/johnson-amp-johnson-reports-q1-eps-1-37-vs-1-35-est-revenues-16-1b-vs-16,webmaster,2012-04-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709483,stocks to watch for april ,https://www.benzinga.com/news/earnings/12/04/2501991/stocks-to-watch-for-april-17,Monica Gerson,2012-04-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709484,earnings scheduled for april ,https://www.benzinga.com/news/earnings/12/04/2501989/earnings-scheduled-for-april-17,Monica Gerson,2012-04-17 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709485,us stock futures up ahead of earnings,https://www.benzinga.com/news/12/04/2501983/us-stock-futures-up-ahead-of-earnings,Monica Gerson,2012-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709486,us stock futures up ahead of earnings,https://www.benzinga.com/news/12/04/2501904/us-stock-futures-up-ahead-of-earnings,Monica Gerson,2012-04-17 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709487,earnings scheduled for april ,https://www.benzinga.com/news/earnings/12/04/2501708/earnings-scheduled-for-april-17,Monica Gerson,2012-04-17 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709488,earnings scheduled for april ,https://www.benzinga.com/news/earnings/12/04/2501705/earnings-scheduled-for-april-17,Monica Gerson,2012-04-17 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709489,stocks to watch for april ,https://www.benzinga.com/news/earnings/12/04/2501681/stocks-to-watch-for-april-17,Monica Gerson,2012-04-17 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709490,sp futures and big weekly analysis week of april ,https://www.benzinga.com/news/earnings/12/04/2498670/s-p-futures-and-big-10-weekly-analysis-week-of-april-16,PreMarketInfo,2012-04-16 00:00:00,JNJ,1,2,0,0,1,0,1,1,1,0.5
709491,update citi raises johnson johnsons pt,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2498143/update-citi-raises-johnson-johnsons-pt,Delores Land,2012-04-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709492,citigroup maintains johnson johnson at buy raises pt from to ,https://www.benzinga.com/analyst-ratings/price-target/12/04/2497495/citigroup-maintains-johnson-johnson-at-buy-raises-pt-from,webmaster,2012-04-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709493,earnings expectations for the week of april gs msft mcd,https://www.benzinga.com/news/earnings/12/04/2497155/earnings-expectations-for-the-week-of-april-16-gs-msft-mcd,Nelson Hem,2012-04-15 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709494,volatility is not risk,https://www.benzinga.com/markets/12/04/2492734/volatility-is-not-risk,Chuck Carnevale,2012-04-12 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.60285
709495,judge awards arkansas b over johnson johnsons risperdal sales,https://www.benzinga.com/news/12/04/2488483/judge-awards-arkansas-1-1b-over-johnson-johnsons-risperdal-sales,Paul Quintaro,2012-04-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.7294
709496,we like these proven performers in this market,https://www.benzinga.com/markets/12/04/2486344/we-like-these-proven-performers-in-this-market,Covestor,2012-04-10 00:00:00,JNJ,1,0,0,1,1,0,1,1,1,0.6806
709497,sp index and big ten analysis week of april th,https://www.benzinga.com/trading-ideas/long-ideas/12/04/2481406/s-p-500-index-and-big-ten-analysis-week-of-april-9th,PreMarketInfo,2012-04-09 00:00:00,JNJ,1,2,0,1,1,0,1,1,1,0.5
709498,avons new ceo to cleanse brand image as loreal sparks upgrade rumors,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2481262/avons-new-ceo-to-cleanse-brand-image-as-loreal-sparks-up,Katey Stapleton,2012-04-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709499,morgan stanley comments on johnson johnsons first days in ,https://www.benzinga.com/analyst-ratings/analyst-color/12/04/2480471/morgan-stanley-comments-on-johnson-johnsons-first-100-da,Delores Land,2012-04-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709500,johnson johnson announces resignation of sheri s mccoy,https://www.benzinga.com/news/12/04/2480085/johnson-johnson-announces-resignation-of-sheri-s-mccoy,Allie Wickman,2012-04-09 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.352
709501,biomet in pact to buy jjs depuy trauma business,https://www.benzinga.com/news/12/04/2468384/biomet-in-pact-to-buy-j-js-depuy-trauma-business,Paul Quintaro,2012-04-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.28925
709502,is the top for now,https://www.benzinga.com/markets/futures/12/03/2457942/is-1400-the-top-for-now,PreMarketInfo,2012-03-29 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
709503,arkansas seeking b in penalties over marketing for jj antipsychotic drug,https://www.benzinga.com/news/12/03/2449163/arkansas-seeking-1-25b-in-penalties-over-marketing-for-j-j-antipsychotic-drug,Paul Quintaro,2012-03-27 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
709504,fda approves intelence tablets for treatmentexperienced pediatric patients with hiv,https://www.benzinga.com/news/12/03/2448507/fda-approves-intelence-tablets-for-treatment-experienced-pediatric-patients-with-,Paul Quintaro,2012-03-27 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.70095
709505,brean murray carret johnson johnsons einsteinpe results overshadowed,https://www.benzinga.com/analyst-ratings/analyst-color/12/03/2448387/brean-murray-carret-johnson-johnsons-einstein-pe-results,Delores Land,2012-03-27 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709506,sp index and big weekly outlook march th,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2447753/s-p-500-index-and-big-10-weekly-outlook-march-26th,PreMarketInfo,2012-03-26 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.5
709507,update bayers xarelto comparable to standard therapy blood thinner treats blood clots with less bleeding,https://www.benzinga.com/news/12/03/2446814/update-bayers-xarelto-comparable-to-standard-therapy-blood-thinner-treats-blood-c,Allie Wickman,2012-03-26 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709508,bayers xarelto comparable to standard therapy blood thinner treats blood clots with less bleeding,https://www.benzinga.com/news/12/03/2446797/bayers-xarelto-comparable-to-standard-therapy-blood-thinner-treats-blood-clots-wi,Paul Quintaro,2012-03-26 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.5
709509,three effective tools for controlling portfolio risk without relying purely on fixed income,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2445224/three-effective-tools-for-controlling-portfolio-risk-without-,Eric Mancini,2012-03-23 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.625
709510,fast money picks for march rd fcx chd jnj,https://www.benzinga.com/media/cnbc/12/03/2444526/fast-money-picks-for-march-23rd-fcx-chd-jnj,Craig Jones,2012-03-22 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709511,st jude novo nordisk and other health care stocks worth a look now,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2440492/st-jude-novo-nordisk-and-other-health-care-stocks-worth-a-loo,Nelson Hem,2012-03-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81245
709512,sp and big weekly outlook march ,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2433916/s-p-500-and-big-10-weekly-outlook-march-19-2012,PreMarketInfo,2012-03-19 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.5
709513,etf showdown dividend dilemma hdv hdiv jnj,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2430857/etf-showdown-dividend-dilemma-hdv-hdiv-jnj,ETF Professor,2012-03-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.41105
709514,accenture covidien seagate and other st patricks stock picks,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2429350/accenture-coviden-seagate-and-other-st-patricks-stock-picks,Nelson Hem,2012-03-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709515,a look at the new russell high yield etf hdiv abt kft,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2427762/a-look-at-the-new-russell-high-yield-etf-hdiv-abt-kft,ETF Professor,2012-03-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709516,investor alert xerox is a cash machine,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2422329/investor-alert-xerox-is-a-cash-machine,Vitaliy Katsenelson,2012-03-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
709517,painkillers win fda panel backing to continue development pfizer jnj regeneron pain drugs should resume halted studies bloomberg,https://www.benzinga.com/news/12/03/2416372/painkillers-win-fda-panel-backing-to-continue-development-pfizer-jnj-regeneron-pa,Matthew Kennedy,2012-03-12 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.57655
709518,option alert johnson johnson july call block trade contracts,https://www.benzinga.com/markets/options/12/03/2416087/option-alert-johnson-johnson-july-70-call-block-trade-10-000-contracts,Charles Gross,2012-03-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.41105
709519,sp and big weekly outlook march th,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2415509/s-p-500-and-big-10-weekly-outlook-march-12th,PreMarketInfo,2012-03-12 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.5
709520,will johnson johnson cure cancer,https://www.benzinga.com/news/earnings/12/03/2408895/will-johnson-johnson-cure-cancer,Jay Wong,2012-03-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.17015000000000002
709521,medivation rises on positive jj zytiga,https://www.benzinga.com/news/12/03/2408454/medivation-rises-17-on-positive-j-j-zytiga,Charles Gross,2012-03-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.8404
709522,medivation shares rise on jjs zytiga data dendreon falls ,https://www.benzinga.com/news/12/03/2407746/medivation-shares-rise-10-on-j-js-zytiga-data-dendreon-falls-12,Charles Gross,2012-03-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
709523,jjs zytiga study to be unblinded on committee recommendation interim data could show clinical benefit could be positive for medivation negative for dendreon,https://www.benzinga.com/news/12/03/2407710/j-js-janssen-study-to-be-unblinded-on-committee-recommendation-interim-data-could,Matthew Kennedy,2012-03-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,0,0.7202
709524,pfizer sues johnson johnson over heat patch patent,https://www.benzinga.com/news/12/03/2397120/pfizer-sues-johnson-johnson-over-heat-patch-patent,Matthew Kennedy,2012-03-05 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.5
709525,sp and big weekly outlook march ,https://www.benzinga.com/trading-ideas/long-ideas/12/03/2394526/s-p-500-and-big-10-weekly-outlook-march-5-2012,PreMarketInfo,2012-03-04 00:00:00,JNJ,1,2,0,1,0,0,1,0,1,0.5
709526,us fda grants priority review for xarelto to reduce secondary cardiovascular events in patients with acute,https://www.benzinga.com/news/12/02/2376656/u-s-fda-grants-priority-review-for-xarelto-to-reduce-secondary-cardiovascular-eve,Matthew Kennedy,2012-02-27 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.61315
709527,sp big analysis week of february ,https://www.benzinga.com/trading-ideas/long-ideas/12/02/2375771/s-p-500-big-10-analysis-week-of-february-27,PreMarketInfo,2012-02-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709528,buffett on johnson johnson still an attractive business at this price but would sell if he needed capital cnbc,https://www.benzinga.com/analyst-ratings/analyst-color/12/02/2374581/buffett-on-johnson-johnson-still-an-attractive-business-,Allie Wickman,2012-02-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6191
709529,option alert johnson johnson january call block trade x x contracts,https://www.benzinga.com/markets/options/12/02/2368548/option-alert-johnson-johnson-january-2013-50-call-block-trade-2x-12-00,Charles Gross,2012-02-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.41105
709530,financial breakfast morning news summary for february ,https://www.benzinga.com/node/2362069,Allie Wickman,2012-02-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709531,johnson johnson says bill weldon will retire in april gorsky will succeed as ceo,https://www.benzinga.com/news/12/02/2360654/johnson-johnson-says-bill-weldon-will-retire-in-april-gorsky-will-succeed-as-ceo,Matthew Kennedy,2012-02-21 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.74695
709532,johnson johnson to name vice chairman gorsky ceo wsj,https://www.benzinga.com/news/12/02/2360519/johnson-johnson-to-name-vice-chairman-gorsky-ceo-wsj,Matthew Kennedy,2012-02-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709533,us high court rejects jjs bid to save patent case against abbott,https://www.benzinga.com/news/12/02/2358818/us-high-court-rejects-j-js-bid-to-save-patent-case-against-abbott,Allie Wickman,2012-02-21 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
709534,sp futures big analysis week of february ,https://www.benzinga.com/trading-ideas/long-ideas/12/02/2356300/s-p-futures-big-10-analysis-week-of-february-20,PreMarketInfo,2012-02-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709535,johnson johnson wins first personal injury trial over risperdal risk,https://www.benzinga.com/news/12/02/2351727/johnson-johnson-wins-first-personal-injury-trial-over-risperdal-risk,Matthew Kennedy,2012-02-16 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.4742
709536,hedge fund f updates berkshire greenlight paulson co appaloosa and more,https://www.benzinga.com/general/hedge-funds/12/02/2344624/hedge-fund-13-f-updates-berkshire-greenlight-capital-paulson-co-ap,Scott Rubin,2012-02-14 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
709537,berkshire filing shows reduced jnj stake,https://www.benzinga.com/news/12/02/2344401/berkshire-filing-shows-reduced-jnj-stake,Matthew Kennedy,2012-02-14 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709538,sp futures big analysis week of february ,https://www.benzinga.com/trading-ideas/long-ideas/12/02/2339350/s-p-futures-big-10-analysis-week-of-february-13,PreMarketInfo,2012-02-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709539,healthcare analyst contraceptive costs are not issue birth statistics can be manipulated,https://www.benzinga.com/news/12/02/2336167/healthcare-analyst-contraceptive-costs-are-not-issue-birth-statistics-can-be-mani,Matthew Kennedy,2012-02-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709540,grandpas etf portfolio,https://www.benzinga.com/trading-ideas/long-ideas/12/02/2335968/grandpas-2012-etf-portfolio,ETF Professor,2012-02-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709541,sp futures big analysis week of feb ,https://www.benzinga.com/news/earnings/12/02/2319879/s-p-futures-big-10-analysis-week-of-feb-6-2012,PreMarketInfo,2012-02-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709542,benzingas ma chatter for thursday february ,https://www.benzinga.com/trading-ideas/long-ideas/12/02/2314270/benzingas-m-a-chatter-for-thursday-february-2-2012,Charles Gross,2012-02-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709543,update first global downgrades johnson johnson to market perform,https://www.benzinga.com/analyst-ratings/analyst-color/12/02/2312155/update-first-global-downgrades-johnson-johnson-to-market,John Harris,2012-02-02 00:00:00,JNJ,1,1,1,1,1,0,1,1,1,0.5
709544,first global downgrades johnson johnson to market perform,https://www.benzinga.com/analyst-ratings/downgrades/12/02/2311875/first-global-downgrades-johnson-johnson-to-market-perform,Juan Lopez,2012-02-02 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709545,sp futures big analysis week of jan th ,https://www.benzinga.com/news/earnings/12/01/2305052/s-p-futures-big-10-analysis-week-of-jan-30th-2012,PreMarketInfo,2012-01-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709546,benzingas ma chatter for thursday january ,https://www.benzinga.com/trading-ideas/long-ideas/12/01/2291823/benzingas-m-a-chatter-for-thursday-january-26-2012,Charles Gross,2012-01-26 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709547,johnson johnson wins jury verdict over levaquin warning claim,https://www.benzinga.com/news/12/01/2291618/johnson-johnson-wins-jury-verdict-over-levaquin-warning-claim,Matthew Kennedy,2012-01-26 00:00:00,JNJ,1,0,0,1,0,0,0,0,0,0.7202
709548,elan spokesperson will not comment on rumor of johnson johnson offer,https://www.benzinga.com/news/12/01/2291270/elan-spokesperson-will-not-comment-on-rumor-of-johnson-johnson-offer,Charles Gross,2012-01-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709549,hearing chatter johnson johnson to bid for elan,https://www.benzinga.com/news/12/01/2291207/hearing-chatter-johnson-johnson-to-bid-for-elan,Charles Gross,2012-01-26 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709550,johnson johnson receives positive mad moneyjim cramer mention cnbc,https://www.benzinga.com/media/cnbc/12/01/2290288/johnson-johnson-receives-positive-mad-moneyjim-cramer-mention-cnbc,Charles Gross,2012-01-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.55135
709551,piper jaffray lowers pt on johnson johnson to ,https://www.benzinga.com/analyst-ratings/price-target/12/01/2287891/piper-jaffray-lowers-pt-on-johnson-johnson-to-68,Juan Lopez,2012-01-25 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.436
709552,morgan stanley concerned with johnson johnson sustaining a path to leverage,https://www.benzinga.com/analyst-ratings/analyst-color/12/01/2287751/morgan-stanley-concerned-with-johnson-johnson-sustaining,Delores Land,2012-01-25 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709553,morgan keegan maintains market perform rating on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/01/2287657/morgan-keegan-maintains-market-perform-rating-on-johnson,John Harris,2012-01-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709554,morgan keegan maintains market perform rating on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/01/2287656/morgan-keegan-maintains-market-perform-rating-on-johnson,John Harris,2012-01-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709555,benzingas ma chatter for tuesday january ,https://www.benzinga.com/trading-ideas/long-ideas/12/01/2286359/benzingas-m-a-chatter-for-tuesday-january-24-2012,Charles Gross,2012-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709556,hearing william blair making negative comments on mako surgical johnson johnson not interested in acquistion,https://www.benzinga.com/analyst-ratings/analyst-color/12/01/2285668/hearing-william-blair-making-negative-comments-on-mako-s,Charles Gross,2012-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,0,0,0.14265
709557,jp morgan reiterates neutral on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/12/01/2285425/jp-morgan-reiterates-neutral-on-johnson-johnson,David Johnson,2012-01-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.60115
709558,earnings roundup,https://www.benzinga.com/news/earnings/12/01/2284398/earnings-roundup,Lisa Levin,2012-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709559,achillion pharmaceuticals spiking higher on renewed takeover chatter,https://www.benzinga.com/news/12/01/2284324/achillion-pharmaceuticals-spiking-higher-on-renewed-takeover-chatter,Charles Gross,2012-01-24 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709560,update johnson johnson q net income drops ,https://www.benzinga.com/news/earnings/12/01/2283599/update-johnson-johnson-q4-net-income-drops-89,Monica Gerson,2012-01-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709561,johnson johnson guides fy eps vs est,https://www.benzinga.com/news/12/01/2283552/johnson-johnson-guides-fy2011-eps-5-05-5-15-vs-5-20-est,Matthew Kennedy,2012-01-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709562,johnson johnson reports q eps vs est revenues b vs b est,https://www.benzinga.com/news/earnings/12/01/2283547/johnson-johnson-reports-q4-eps-1-13-vs-1-10-est-revenues-16-30b-vs-16-28,Matthew Kennedy,2012-01-24 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709563,us stock futures down mcdonalds johnson johnson in focus,https://www.benzinga.com/news/12/01/2283215/us-stock-futures-down-mcdonalds-johnson-johnson-in-focus,Monica Gerson,2012-01-24 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709564,earnings scheduled for january ,https://www.benzinga.com/news/earnings/12/01/2283132/earnings-scheduled-for-january-24,Monica Gerson,2012-01-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709565,stocks to watch for january ,https://www.benzinga.com/news/earnings/12/01/2283093/stocks-to-watch-for-january-24,Monica Gerson,2012-01-24 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709566,johnson johnson earnings preview,https://www.benzinga.com/news/earnings/12/01/2282766/johnson-johnson-earnings-preview,Gordon Wilcox,2012-01-24 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709567,earnings expectations for the week of january ,https://www.benzinga.com/news/earnings/12/01/2278959/earnings-expectations-for-the-week-of-january-23,Nelson Hem,2012-01-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709568,democrats seeks hearing on hazardous medical devices says studies show risks wit jj allergan devices,https://www.benzinga.com/news/12/01/2277608/democrats-seeks-hearing-on-hazardous-medical-devices-says-studies-show-risks-wit-,Matthew Kennedy,2012-01-20 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.4871
709569,benzingas ma chatter for wednesday january ,https://www.benzinga.com/trading-ideas/long-ideas/12/01/2271061/benzingas-m-a-chatter-for-wednesday-january-18-2012,Charles Gross,2012-01-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709570,positive rumors circulate about vertex pharmaceuticals,https://www.benzinga.com/news/rumors/12/01/2269987/positive-rumors-circulate-about-vertex-pharmaceuticals,webmaster,2012-01-18 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.7787
709571,hearing wedbush says idenix pharmaceuticals takeover target of merck johnson johnson abbott labs share,https://www.benzinga.com/analyst-ratings/analyst-color/12/01/2269520/hearing-wedbush-says-idenix-pharmaceuticals-takeover-tar,Charles Gross,2012-01-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
709572,going nuclear on hepatitis c is idenix the next target,https://www.benzinga.com/trading-ideas/long-ideas/12/01/2254086/going-nuc-lear-on-hepatitis-c-is-idenix-the-next-target,Ilir Shkurti,2012-01-10 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709573,dividend champions a rare undervalued opportunity,https://www.benzinga.com/news/dividends/12/01/2246231/dividend-champions-a-rare-undervalued-opportunity,Chuck Carnevale,2012-01-06 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.86755
709574,fda says johnson johnson doribax trial was recently stopped early because of significant safety concerns reuters,https://www.benzinga.com/news/12/01/2242751/fda-says-johnson-johnson-doribax-trial-was-recently-stopped-early-because-of-sign,Eddie Staley,2012-01-05 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.70095
709575,jj said to agree to b accord in risperdal sales probe,https://www.benzinga.com/news/12/01/2242674/j-j-said-to-agree-to-1b-accord-in-risperdal-sales-probe,Matthew Kennedy,2012-01-05 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.77115
709576,jj and cr bard ordered to study injuries from vaginal implants,https://www.benzinga.com/news/12/01/2240395/j-j-and-cr-bard-ordered-to-study-injuries-from-vaginal-implants,Matthew Kennedy,2012-01-04 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.625
709577,bark at the dows dogs with these etfs,https://www.benzinga.com/trading-ideas/long-ideas/12/01/2240195/bark-at-the-dows-dogs-with-these-etfs,ETF Professor,2012-01-04 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709578,etf showdown fun with pharma,https://www.benzinga.com/trading-ideas/long-ideas/11/12/2233813/etf-showdown-fun-with-pharma,ETF Professor,2011-12-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7553000000000001
709579,benzingas top premarket losers,https://www.benzinga.com/news/11/12/2233111/benzingas-top-pre-market-losers,Lisa Levin,2011-12-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709580,five etfs for fans of extreme couponing,https://www.benzinga.com/trading-ideas/long-ideas/11/12/2230753/five-etfs-for-fans-of-extreme-couponing,ETF Professor,2011-12-28 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709581,fast money picks for december th cp tsm slb sbux jnj anf,https://www.benzinga.com/media/cnbc/11/12/2230182/fast-money-picks-for-december-28th-cp-tsm-slb-sbux-jnj-anf,Craig Jones,2011-12-27 00:00:00,JNJ,1,2,0,1,0,0,1,0,0,0.5
709582,will this companys drug cure your allergies,https://www.benzinga.com/news/earnings/11/12/2229667/will-this-companys-drug-cure-your-allergies,Jay Wong,2011-12-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709583,best biotech stocks of ,https://www.benzinga.com/trading-ideas/long-ideas/11/12/2229504/best-biotech-stocks-of-2011,Nelson Hem,2011-12-27 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.81845
709584,fda advisers vote that current label adequately reflects risks and benefits of johnson johnsons ortho evra contraceptive patch,https://www.benzinga.com/news/11/12/2193663/fda-advisers-vote-that-current-label-adequately-reflects-risks-and-benefits-of-jo,Eddie Staley,2011-12-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5640000000000001
709585,mad money lightning round cramer likes johnson johnson,https://www.benzinga.com/media/cnbc/11/12/2191162/mad-money-lightning-round-cramer-likes-johnson-johnson,Monica Gerson,2011-12-09 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.44865
709586,janssen says deal to cut johnson johnson eps by ,https://www.benzinga.com/news/11/12/2190015/janssen-says-deal-to-cut-johnson-johnson-2011-eps-by-0-04-0-05,Allie Wickman,2011-12-08 00:00:00,JNJ,1,1,1,1,0,1,0,1,0,0.3634
709587,pharmacyclics forms pact to develop and commercialize pci for hematologic cancers with janssen biotech,https://www.benzinga.com/news/11/12/2189963/pharmacyclics-forms-pact-to-develop-and-commercialize-pci-32765-for-hematologic-c,Eddie Staley,2011-12-08 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709588,affymax wins fda panel backing on anemia drug to rival amgens,https://www.benzinga.com/news/11/12/2185754/affymax-wins-fda-panel-backing-on-anemia-drug-to-rival-amgens,Matthew Kennedy,2011-12-07 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.79295
709589,biotech stocks on the move,https://www.benzinga.com/markets/11/12/2177474/biotech-stocks-on-the-move,António Costa,2011-12-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709590,are the samsung ma rumors true,https://www.benzinga.com/analyst-ratings/analyst-color/11/12/2169040/are-the-samsung-m-a-rumors-true,Abe Raymond,2011-12-01 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.71075
709591,piper jaffray maintains neutral rating and pt on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/12/2166361/piper-jaffray-maintains-neutral-rating-and-69-pt-on-john,Phil Marsh,2011-12-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709592,these stocks may be better than their dow equivalents,https://www.benzinga.com/trading-ideas/long-ideas/11/12/2165707/these-stocks-may-be-better-than-their-dow-equivalents,Gordon Wilcox,2011-12-01 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7202
709593,update citi lowers pt to on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/11/2157609/update-citi-lowers-pt-to-70-on-johnson-johnson,Phil Marsh,2011-11-29 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.436
709594,citigroup lowers pt on johnson johnson to ,https://www.benzinga.com/analyst-ratings/price-target/11/11/2156889/citigroup-lowers-pt-on-johnson-johnson-to-70,Joe Young,2011-11-29 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.436
709595,stocks going ex dividend the fourth week of november,https://www.benzinga.com/markets/11/11/2135756/stocks-going-ex-dividend-the-fourth-week-of-november,Fred Fuld,2011-11-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709596,moving away from the materials sector toward a growthmomentum style,https://www.benzinga.com/markets/11/11/2131963/moving-away-from-the-materials-sector-toward-a-growthmomentum-style,Covestor,2011-11-16 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709597,invest like buffettwith etfs,https://www.benzinga.com/trading-ideas/long-ideas/11/11/2130699/invest-like-buffett-with-etfs,ETF Professor,2011-11-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.6806
709598,brean murray carret co maintain buy target on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/11/2124800/brean-murray-carret-co-maintain-buy-77-target-on-johnson,Phil Marsh,2011-11-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709599,citi has buy on jj,https://www.benzinga.com/analyst-ratings/analyst-color/11/11/2123059/citi-has-buy-on-j-j,Jonathan Chen,2011-11-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709600,maintaining stability in my dividends and yield portfolio,https://www.benzinga.com/markets/11/11/2118448/maintaining-stability-in-my-dividends-and-yield-portfolio,Covestor,2011-11-11 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709601,four defensive etfs youre not considering but should,https://www.benzinga.com/trading-ideas/long-ideas/11/11/2112124/four-defensive-etfs-youre-not-considering-but-should,ETF Professor,2011-11-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.50645
709602,jnjs sterilmed gets fda letter on lack of approval for device,https://www.benzinga.com/news/11/11/2106541/jnjs-sterilmed-gets-fda-letter-on-lack-of-approval-for-device,Matthew Kennedy,2011-11-08 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.60115
709603,fda approves bayerjjs xarelto for stroke prevention,https://www.benzinga.com/news/earnings/11/11/2098956/fda-approves-bayerj-js-xarelto-for-stroke-prevention,Patrick Henderson,2011-11-04 00:00:00,JNJ,1,0,1,0,1,1,1,1,1,0.70095
709604,jjsynthes deal will get extend eu antitrust review,https://www.benzinga.com/news/11/11/2094793/j-j-synthes-deal-will-get-extend-eu-antitrust-review,Paul Quintaro,2011-11-03 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.58895
709605,mad money lightning round cramer advises investors not to buy microsoft,https://www.benzinga.com/media/cnbc/11/11/2079990/mad-money-lightning-round-cramer-advises-investors-not-to-buy-microsoft,Lisa Levin,2011-11-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.25305
709606,a look at the new drgs etn,https://www.benzinga.com/trading-ideas/long-ideas/11/10/2078940/a-look-at-the-new-drgs-etn,ETF Professor,2011-10-31 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709607,how we pick stocks the case of johnson johnson,https://www.benzinga.com/trading-ideas/11/10/2077759/how-we-pick-stocks-the-case-of-johnson-johnson,Covestor,2011-10-31 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
709608,merck earnings preview analysts expect higher eps revenue,https://www.benzinga.com/news/earnings/11/10/2011512/merck-earnings-preview-analysts-expect-higher-eps-revenue,Benzinga Staff Writer,2011-10-25 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5
709609,bristolmyers squibb earnings preview analysts expect rising revenue falling eps,https://www.benzinga.com/news/earnings/11/10/2007381/bristol-myers-squibb-earnings-preview-analysts-expect-rising-revenue-fal,Benzinga Staff Writer,2011-10-24 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.42345
709610,the donald trump bottom months later,https://www.benzinga.com/trading-ideas/long-ideas/11/10/2004482/the-donald-trump-bottom-2-months-later,Jonathan Chen,2011-10-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709611,earnings preview analysts expect boston scientifics revenue earnings to dip,https://www.benzinga.com/news/earnings/11/10/1998242/earnings-preview-analysts-expect-boston-scientifics-revenue-earnings-to-,Benzinga Staff Writer,2011-10-19 00:00:00,JNJ,1,1,0,1,1,0,1,0,1,0.5
709612,jp morgan maintains neutral on johnson johnsons mixed q results,https://www.benzinga.com/analyst-ratings/analyst-color/11/10/1997275/jp-morgan-maintains-neutral-on-johnson-johnsons-mixed-3q,Joe Young,2011-10-19 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.60115
709613,piper jaffray raises pt on johnson johnson to ,https://www.benzinga.com/analyst-ratings/price-target/11/10/1996526/piper-jaffray-raises-pt-on-johnson-johnson-to-69,Joe Young,2011-10-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709614,morgan stanley maintains equal weight rating on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/10/1996391/morgan-stanley-maintains-equal-weight-rating-on-johnson-,Joe Young,2011-10-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709615,deutsche bank reiterates hold rating on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/10/1996224/deutsche-bank-reiterates-hold-rating-on-johnson-johnson,Steven Anfield,2011-10-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709616,endofday market summary for october ,https://www.benzinga.com/news/11/10/1994913/end-of-day-market-summary-for-october-18-2011,Abe Raymond,2011-10-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709617,earnings roundup for october ,https://www.benzinga.com/news/earnings/11/10/1993428/earnings-roundup-for-october-18,Lisa Levin,2011-10-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709618,johnson johnson sees net income climb,https://www.benzinga.com/news/earnings/11/10/1993231/johnson-johnson-sees-net-income-climb,Benzinga Staff Writer,2011-10-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709619,update johnson johnson reports drop in q profit,https://www.benzinga.com/news/earnings/11/10/1993190/update-johnson-johnson-reports-drop-in-q3-profit,Lisa Levin,2011-10-18 00:00:00,JNJ,1,1,0,1,0,0,0,0,0,0.60115
709620,johnson johnson guides fy eps vs est,https://www.benzinga.com/news/11/10/1993086/johnson-johnson-guides-fy2011-eps-4-95-5-00-vs-4-96-est,Matthew Kennedy,2011-10-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709621,johnson johnson guides fy eps vs est,https://www.benzinga.com/news/11/10/1993085/johnson-johnson-guides-fy2011-eps-4-95-5-00-vs-4-96-est,Matthew Kennedy,2011-10-18 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709622,johnson johnson reports q eps vs est revenues b vs b est,https://www.benzinga.com/news/earnings/11/10/1993074/johnson-johnson-reports-q3-eps-1-24-vs-1-21-est-revenues-16-0b-vs-16-02b,Matthew Kennedy,2011-10-18 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709623,us stock futures mixed ahead of earnings reports ibm shares down in premarket,https://www.benzinga.com/news/11/10/1992620/us-stock-futures-mixed-ahead-of-earnings-reports-ibm-shares-down-in-pre-market,Lisa Levin,2011-10-18 00:00:00,JNJ,1,1,1,1,0,1,1,1,0,0.648
709624,earnings scheduled for october ,https://www.benzinga.com/news/earnings/11/10/1992306/earnings-scheduled-for-october-18,Lisa Levin,2011-10-18 00:00:00,JNJ,1,2,1,1,1,0,1,1,1,0.5
709625,brean murray carret co reiterates buy rating on jj,https://www.benzinga.com/analyst-ratings/analyst-color/11/10/1991431/brean-murray-carret-co-reiterates-buy-rating-on-j-j,Michael J. Zerinskas,2011-10-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.625
709626,ubs lowers pt on johnson johnson to ,https://www.benzinga.com/analyst-ratings/price-target/11/10/1990421/ubs-lowers-pt-on-johnson-johnson-to-72,Joe Young,2011-10-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.436
709627,earnings expectations for the week of october ,https://www.benzinga.com/news/earnings/11/10/1988744/earnings-expectations-for-the-week-of-october-17,Nelson Hem,2011-10-16 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709628,abbott laboratories earnings preview analysts expect higher eps revenue,https://www.benzinga.com/news/earnings/11/10/1987970/abbott-laboratories-earnings-preview-analysts-expect-higher-eps-revenue,Benzinga Staff Writer,2011-10-14 00:00:00,JNJ,1,0,1,1,1,0,1,1,1,0.5
709629,johnson johnson earnings preview analysts expect rising revenue falling eps,https://www.benzinga.com/news/earnings/11/10/1986705/johnson-johnson-earnings-preview-analysts-expect-rising-revenue-falling-,Benzinga Staff Writer,2011-10-14 00:00:00,JNJ,1,1,0,1,0,0,1,0,0,0.42345
709630,under the hood emerging markets health care,https://www.benzinga.com/news/11/10/1984778/under-the-hood-emerging-markets-health-care,ETF Professor,2011-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.74695
709631,piper jaffray neutral on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/10/1984024/piper-jaffray-neutral-on-johnson-johnson,Jonathan Chen,2011-10-13 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709632,boston scientific announces favorable appellate court ruling affirming noninfringement of johnson johnson patent,https://www.benzinga.com/news/11/09/1952376/boston-scientific-announces-favorable-appellate-court-ruling-affirming-non-infrin,Allie Wickman,2011-09-29 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.7383500000000001
709634,charles sizemore quoted in smart money,https://www.benzinga.com/11/09/1940871/charles-sizemore-quoted-in-smart-money,Charles Lewis Sizemore CFA,2011-09-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
709636, exceptional dividend growth stocks lower volatility and higher total return,https://www.benzinga.com/11/09/1937957/5-exceptional-dividend-growth-stocks-lower-volatility-and-higher-total-return,Chuck Carnevale,2011-09-22 00:00:00,JNJ,0,0,1,1,0,1,0,0,0,0.55135
709637,update goldman sachs downgrades johnson johnson to ,https://www.benzinga.com/analyst-ratings/analyst-color/11/09/1936820/update-goldman-sachs-downgrades-johnson-johnson-to-63-13,Steven Anfield,2011-09-22 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
709638,financial breakfast morning news summary for september ,https://www.benzinga.com/analyst-ratings/analyst-color/11/09/1936424/financial-breakfast-morning-news-summary-for-september-2,Allie Wickman,2011-09-22 00:00:00,JNJ,1,2,0,0,1,0,1,1,1,0.5
709639,goldman sachs downgrades johnson johnson to neutral pt,https://www.benzinga.com/analyst-ratings/downgrades/11/09/1936325/goldman-sachs-downgrades-johnson-johnson-to-neutral-74-pt,Joe Young,2011-09-22 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.5
709640,piper jaffray comments on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/09/1927456/piper-jaffray-comments-on-johnson-johnson,Hilary Farrell,2011-09-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709641,johnson johnson ceo weldon says too early to tell on us economy,https://www.benzinga.com/news/11/09/1922500/johnson-johnson-ceo-weldon-says-too-early-to-tell-on-us-economy,Matthew Kennedy,2011-09-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709642,greece the questions investors should be asking,https://www.benzinga.com/trading-ideas/long-ideas/11/09/1918407/greece-the-questions-investors-should-be-asking,Charles Lewis Sizemore CFA,2011-09-14 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709644,sp likes three health care etfs,https://www.benzinga.com/analyst-ratings/analyst-color/11/09/1917987/s-p-likes-three-health-care-etfs,ETF Professor,2011-09-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.8592
709645,update jj unit to pay m fine plead guilty to charge,https://www.benzinga.com/news/11/09/1917925/update-j-j-unit-to-pay-85m-fine-plead-guilty-to-charge,Allie Wickman,2011-09-14 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.44865
709646,jj unit us in plea pact for natrecor marketing probe court filing,https://www.benzinga.com/news/11/09/1917923/j-j-unit-us-in-plea-pact-for-natrecor-marketing-probe-court-filing,Allie Wickman,2011-09-14 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.625
709647,what if im wrong,https://www.benzinga.com/trading-ideas/long-ideas/11/09/1915693/what-if-im-wrong,Charles Lewis Sizemore CFA,2011-09-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.26165
709648,is hansen medical a takeover target,https://www.benzinga.com/trading-ideas/long-ideas/11/09/1913112/is-hansen-medical-a-takeover-target,Abe Raymond,2011-09-12 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709649,citi has buy on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/09/1909161/citi-has-buy-on-johnson-johnson,Jonathan Chen,2011-09-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709650,benzingas top premarket gainers,https://www.benzinga.com/news/11/09/1909154/benzingas-top-pre-market-gainers,Monica Gerson,2011-09-09 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
709652,sp endorses two dividend etfs,https://www.benzinga.com/analyst-ratings/analyst-color/11/09/1904994/s-p-endorses-two-dividend-etfs,ETF Professor,2011-09-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.67
709654,citi maintains buy on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/08/1890792/citi-maintains-buy-on-johnson-johnson,BenzingaStaffJ,2011-08-30 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709655,groupons andrew mason ive never been more confident and excited about the future of our business,https://www.benzinga.com/startups/11/08/1886077/groupons-andrew-mason-ive-never-been-more-confident-and-excited-about-the-fut,Louis Bedigian,2011-08-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.47665
709656, most popular healthcare stocks among hedge funds,https://www.benzinga.com/trading-ideas/long-ideas/11/08/1884640/12-most-popular-healthcare-stocks-among-hedge-funds,Insider Monkey,2011-08-25 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.7377
709657, most popular healthcare stocks among hedge funds,https://www.benzinga.com/trading-ideas/long-ideas/11/08/1883734/12-most-popular-healthcare-stocks-among-hedge-funds,Insider Monkey,2011-08-25 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.7377
709658,the greatest risk we face to again falling into a recession,https://www.benzinga.com/11/08/1878444/the-greatest-risk-we-face-to-again-falling-into-a-recession,Chuck Carnevale,2011-08-23 00:00:00,JNJ,1,1,0,1,0,0,1,1,1,0.4614
709659,the global meltdown of confidence,https://www.benzinga.com/economics/11/08/1858001/the-global-meltdown-of-confidence,George Maniere,2011-08-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.7553000000000001
709661,perrigo earnings preview,https://www.benzinga.com/news/earnings/11/08/1857361/perrigo-earnings-preview,Nelson Hem,2011-08-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709662,the donald trump bottom,https://www.benzinga.com/media/cnbc/11/08/1851348/the-donald-trump-bottom,Jonathan Chen,2011-08-11 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709663,warren buffett said ignore political and economic forecasts,https://www.benzinga.com/11/08/1849320/warren-buffett-said-ignore-political-and-economic-forecasts,Chuck Carnevale,2011-08-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.3194
709664,embrace your inner spock three questions investors should be asking,https://www.benzinga.com/11/08/1848278/embrace-your-inner-spock-three-questions-investors-should-be-asking,Charles Lewis Sizemore CFA,2011-08-10 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.6591
709665,update goldman sachs reiterates buy on johnson johnson reduces pt to ,https://www.benzinga.com/analyst-ratings/price-target/11/08/1844775/update-goldman-sachs-reiterates-buy-on-johnson-johnson-re,Emily Austin,2011-08-09 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709666,goldman sachs lowers pt on johnson johnson to ,https://www.benzinga.com/analyst-ratings/price-target/11/08/1844495/goldman-sachs-lowers-pt-on-johnson-johnson-to-74,Joe Young,2011-08-09 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.436
709667,where to invest when the market crashes,https://www.benzinga.com/11/08/1843328/where-to-invest-when-the-market-crashes,Fred Fuld,2011-08-08 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709668,sp states that recent us downgrade wont affect rating of these six toptier companies adp xom jnj msft ge gww,https://www.benzinga.com/news/11/08/1842253/s-p-states-that-recent-us-downgrade-wont-affect-rating-of-these-six-top-tier-comp,Allie Wickman,2011-08-08 00:00:00,JNJ,1,2,0,1,0,0,1,1,1,0.5
709669,citi reiterates buy and pt of on johnson johnson,https://www.benzinga.com/analyst-ratings/reiteration/11/08/1828874/citi-reiterates-buy-and-pt-of-73-on-johnson-johnson,Emily Austin,2011-08-03 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709670,the new world order of global sovereigns,https://www.benzinga.com/11/08/1827959/the-new-world-order-of-global-sovereigns,EconMatters,2011-08-02 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709671,hold these funds forever really forever,https://www.benzinga.com/11/08/1821238/hold-these-funds-forever-really-forever,Roger Nusbaum,2011-08-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709672,benzingas top premarket losers,https://www.benzinga.com/news/11/08/1820995/benzingas-top-pre-market-losers,Lisa Levin,2011-08-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709682,high yield birth control stocks,https://www.benzinga.com/11/07/1815431/high-yield-birth-control-stocks,Fred Fuld,2011-07-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709683,how to profit from exploding government healthcare costs,https://www.benzinga.com/trading-ideas/long-ideas/11/07/1812394/how-to-profit-from-exploding-government-healthcare-costs,Daniel Hayden IV,2011-07-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.7202
709684,top yield stocks of warren buffett,https://www.benzinga.com/11/07/1810339/top-yield-stocks-of-warren-buffett,Fred Fuld,2011-07-28 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.60115
709685,hearing supreme court asked to overturn obamas health care reform,https://www.benzinga.com/news/11/07/1809176/hearing-supreme-court-asked-to-overturn-obamas-health-care-reform,Paul Quintaro,2011-07-27 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.88915
709686,earnings preview merck eps revenue expected to rise from previous quarter,https://www.benzinga.com/news/earnings/11/07/1803995/earnings-preview-merck-eps-revenue-expected-to-rise-from-previous-quarte,Benzinga Staff Writer,2011-07-26 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709687,ratchet back the risk with these etfs,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1799138/ratchet-back-the-risk-with-these-etfs,ETF Professor,2011-07-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.3634
709688,boston scientific earnings preview analysts expect rising revenue falling eps over previous quarter,https://www.benzinga.com/news/earnings/11/07/1799083/boston-scientific-earnings-preview-analysts-expect-rising-revenue-fallin,Benzinga Staff Writer,2011-07-25 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.42345
709689,bristolmyers squibb earnings preview analysts expect rising revenue falling eps over previous quarter,https://www.benzinga.com/news/earnings/11/07/1798837/bristol-myers-squibb-earnings-preview-analysts-expect-rising-revenue-fal,Benzinga Staff Writer,2011-07-25 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.42345
709690,nothing to sneeze at here,https://www.benzinga.com/news/earnings/11/07/1797243/nothing-to-sneeze-at-here,Jonathan Chen,2011-07-25 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709691,no respect the rodney dangerfield of the investment world,https://www.benzinga.com/11/07/1794791/no-respect-the-rodney-dangerfield-of-the-investment-world,Investing Caffeine,2011-07-22 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.61315
709692,johnson and johnson fda panel backs additional use of remicade for pediatric patients,https://www.benzinga.com/news/11/07/1790576/johnson-and-johnson-fda-panel-backs-additional-use-of-remicade-for-pediatric-pati,Allie Wickman,2011-07-21 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.4742
709693,fifteen health care etfs trading near week highs,https://www.benzinga.com/trading-ideas/long-ideas/11/07/1790212/fifteen-health-care-etfs-trading-near-52-week-highs,Nelson Hem,2011-07-21 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.74695
709694,earnings preview gilead sciences eps revenue expected to rise from previous quarter,https://www.benzinga.com/news/earnings/11/07/1789923/earnings-preview-gilead-sciences-eps-revenue-expected-to-rise-from-previ,Benzinga Staff Writer,2011-07-21 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709695,deutsche bank comments on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1783500/deutsche-bank-comments-on-johnson-johnson,BenzingaStaffT,2011-07-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709696,gabelli maintains earnings estimates on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1783401/gabelli-maintains-earnings-estimates-on-johnson-johnson,Jonathan Chen,2011-07-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709697,jp morgan reiterates jnj neutral rating,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1783086/jp-morgan-reiterates-jnj-neutral-rating,Anna Gerardi,2011-07-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.60115
709698,update citi raises pt on johnson johnson to ,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1783085/update-citi-raises-pt-on-johnson-johnson-to-73,BenzingaStaffJ,2011-07-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709699,morgan stanley comments on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1782722/morgan-stanley-comments-on-johnson-johnson,BenzingaStaffT,2011-07-20 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709700,citigroup raises pt on johnson johnson to ,https://www.benzinga.com/analyst-ratings/price-target/11/07/1782355/citigroup-raises-pt-on-johnson-johnson-to-73,Joe Young,2011-07-20 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709701,is it time to buy cisco,https://www.benzinga.com/11/07/1781414/is-it-time-to-buy-cisco,LivingOffDividends,2011-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709702,malus domestica produces ,https://www.benzinga.com/11/07/1781224/malus-domestica-produces-07-19-2011,optionsXpress,2011-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709703,will aapl succumb to gravity ,https://www.benzinga.com/11/07/1780341/will-aapl-succumb-to-gravity-07-19-2011,optionsXpress,2011-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709704,dow jones industrial average companies increase expected dividend distribution by from a year ago,https://www.benzinga.com/news/11/07/1778743/dow-jones-industrial-average-companies-increase-expected-dividend-distribution-by,Allie Wickman,2011-07-19 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.6591
709705,earnings roundup,https://www.benzinga.com/news/earnings/11/07/1778093/earnings-roundup,Monica Gerson,2011-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709706,update johnson johnson reports upbeat q profit,https://www.benzinga.com/news/earnings/11/07/1777978/update-johnson-johnson-reports-upbeat-q2-profit,Monica Gerson,2011-07-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.7202
709707,benzingas top premarket losers,https://www.benzinga.com/news/11/07/1777875/benzingas-top-pre-market-losers,Monica Gerson,2011-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709708,fda posts staff review of study of jjs remicade in children,https://www.benzinga.com/news/11/07/1777801/fda-posts-staff-review-of-study-of-j-js-remicade-in-children,Paul Quintaro,2011-07-19 00:00:00,JNJ,0,2,0,1,0,1,0,0,0,0.5
709709,johnson johnson guides eps vs est,https://www.benzinga.com/news/11/07/1777485/johnson-johnson-guides-2011-eps-4-90-5-00-vs-4-96-est,Paul Quintaro,2011-07-19 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709710,johnson johnson reports q eps of vs est revenues b vs b est,https://www.benzinga.com/news/earnings/11/07/1777475/johnson-johnson-reports-q2-eps-of-1-28-vs-1-23-est-revenues-16-6b-vs-16-,Paul Quintaro,2011-07-19 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709711,us stock futures up as investors await earnings reports,https://www.benzinga.com/news/11/07/1776998/us-stock-futures-up-as-investors-await-earnings-reports,Monica Gerson,2011-07-19 00:00:00,JNJ,1,0,1,1,0,1,1,1,1,0.55135
709712,earnings scheduled for july ,https://www.benzinga.com/news/earnings/11/07/1776607/earnings-scheduled-for-july-19,Monica Gerson,2011-07-19 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709713,johnson johnson announces thirdquarter quarterly dividend of share,https://www.benzinga.com/news/11/07/1775124/johnson-johnson-announces-third-quarter-2011-quarterly-dividend-of-0-57share,Allie Wickman,2011-07-18 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.648
709714,earnings expectations for the week of july ,https://www.benzinga.com/news/earnings/11/07/1771585/earnings-expectations-for-the-week-of-july-18,Nelson Hem,2011-07-17 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709715,boston scientific earnings preview revenue earnings expected to fall from previous quarter,https://www.benzinga.com/news/earnings/11/07/1769135/boston-scientific-earnings-preview-revenue-earnings-expected-to-fall-fro,General,2011-07-15 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.5
709716,forest laboratories earnings preview analysts expect rising revenue,https://www.benzinga.com/news/earnings/11/07/1769084/forest-laboratories-earnings-preview-analysts-expect-rising-revenue,General,2011-07-15 00:00:00,JNJ,1,0,0,1,0,0,1,0,1,0.5
709717,earnings preview johnson johnson eps revenue expected to rise from previous quarter,https://www.benzinga.com/news/earnings/11/07/1769035/earnings-preview-johnson-johnson-eps-revenue-expected-to-rise-from-previ,General,2011-07-15 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.5
709718,earnings preview analysts expect abbott laboratories revenue earnings to dip from previous quarter,https://www.benzinga.com/news/earnings/11/07/1768928/earnings-preview-analysts-expect-abbott-laboratories-revenue-earnings-to,General,2011-07-15 00:00:00,JNJ,1,1,0,1,0,0,1,0,1,0.5
709719,benzingas top premarket losers,https://www.benzinga.com/news/11/07/1768316/benzingas-top-pre-market-losers,Monica Gerson,2011-07-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.30910000000000004
709720, high dividend names for sound sleeping,https://www.benzinga.com/trading-ideas/long-ideas/11/07/1766669/5-high-dividend-names-for-sound-sleeping,Jonathan Chen,2011-07-14 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709721,boston scientific earnings preview revenue earnings expected to fall from previous quarter,https://www.benzinga.com/news/earnings/11/07/1763132/boston-scientific-earnings-preview-revenue-earnings-expected-to-fall-fro,Paul Quintaro,2011-07-13 00:00:00,JNJ,0,1,0,1,0,0,0,0,0,0.5
709722,twelve health care etfs trading near week highs,https://www.benzinga.com/trading-ideas/long-ideas/11/07/1761358/twelve-health-care-etfs-trading-near-52-week-highs,Nelson Hem,2011-07-13 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.74695
709723,jp morgan previews q results for jnj,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1757038/j-p-morgan-previews-2q-results-for-jnj,BenzingaStaffT,2011-07-12 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.60115
709724,twelve etfs trading near week highs,https://www.benzinga.com/trading-ideas/long-ideas/11/07/1756935/twelve-etfs-trading-near-52-week-highs,Nelson Hem,2011-07-12 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5
709725,update deutsche bank initiates johnson johnson at hold,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1748307/update-deutsche-bank-initiates-johnson-johnson-at-hold,BenzingaStaffJ,2011-07-08 00:00:00,JNJ,1,2,1,0,0,0,1,1,1,0.5
709726,deutsche bank initiates johnson johnson at hold pt,https://www.benzinga.com/analyst-ratings/price-target/11/07/1748068/deutsche-bank-initiates-johnson-johnson-at-hold-73-pt,Joe Young,2011-07-08 00:00:00,JNJ,1,2,1,1,0,0,1,1,1,0.5
709727,stocks to watch for fresh week highs and lows,https://www.benzinga.com/trading-ideas/long-ideas/11/07/1747463/stocks-to-watch-for-07811-fresh-52-week-highs-and-lows,Benjamin Lee,2011-07-07 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.5640000000000001
709728,court of appeals affirms million judgment against johnson johnson in defective fentanyl patch case,https://www.benzinga.com/news/11/07/1746676/court-of-appeals-affirms-16-56-million-judgment-against-johnson-johnson-in-defect,Eddie Staley,2011-07-07 00:00:00,JNJ,1,1,1,1,0,0,1,1,1,0.2798
709729,johnson johnson announces global sponsorship of the fifa world cup brazil,https://www.benzinga.com/news/11/07/1744840/johnson-johnson-announces-global-sponsorship-of-the-2014-fifa-world-cup-brazil,Eddie Staley,2011-07-07 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709730,can stocks be safer than bonds,https://www.benzinga.com/11/07/1740021/can-stocks-be-safer-than-bonds,Roger Nusbaum,2011-07-06 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.71075
709731,piper jaffray remains neutral on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/07/1614970/piper-jaffray-remains-neutral-on-johnson-johnson,BenzingaStaffB,2011-07-05 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709732,update johnson johnson fda approves xarelto,https://www.benzinga.com/news/11/07/1222062/update-johnson-johnson-fda-approves-xarelto,Allie Wickman,2011-07-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.70095
709733,time to look at boston scientific,https://www.benzinga.com/media/cnbc/11/07/1221539/time-to-look-at-boston-scientific,Jonathan Chen,2011-07-01 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709734,high yield big pharmaceutical stocks,https://www.benzinga.com/11/06/1198305/high-yield-big-pharmaceutical-stocks,Fred Fuld,2011-06-24 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709735,morgan stanley provides color on johnson johnson equalweight,https://www.benzinga.com/analyst-ratings/analyst-color/11/06/1195029/morgan-stanley-provides-color-on-johnson-johnson-equal-w,Emily Austin,2011-06-23 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709736, high dividend stocks the smart money is buying,https://www.benzinga.com/trading-ideas/long-ideas/11/06/1183851/3-high-dividend-stocks-the-smart-money-is-buying,Jonathan Chen,2011-06-20 00:00:00,JNJ,1,2,1,0,1,1,1,1,1,0.70095
709737,orthomcneiljanssen pharmaceuticals voluntarily recalls one lot of risperdal tablets and one lot of risperidone tablets,https://www.benzinga.com/news/11/06/1179588/ortho-mcneil-janssen-pharmaceuticals-voluntarily-recalls-one-lot-of-risperdal%C2%AE-ta,Theo Kratz,2011-06-17 00:00:00,JNJ,1,1,1,1,0,1,1,1,1,0.5
709738,goldman sachs maintains buy on johnson johnson,https://www.benzinga.com/analyst-ratings/analyst-color/11/06/1174224/goldman-sachs-maintains-buy-on-johnson-johnson,BenzingaStaffJ,2011-06-16 00:00:00,JNJ,1,2,1,1,0,1,1,1,1,0.5
709739,johnson johnson announces special charge of million related to restructuring plans for cordis corporation subsidiary,https://www.benzinga.com/news/guidance/11/06/1170459/johnson-johnson-announces-special-charge-of-500-600-million-related-to-r,Benzinga Staff,2011-06-15 00:00:00,JNJ,1,1,1,1,1,1,1,1,1,0.70095
709740,the most appropriate strategies,https://www.benzinga.com/11/06/1170171/the-8-most-appropriate-strategies,Roger Nusbaum,2011-06-15 00:00:00,JNJ,1,2,1,1,1,1,1,1,1,0.5
709741,hearing that jjs depuy has won us approval for the first ceramiconmetal hip,https://www.benzinga.com/news/11/06/1167272/hearing-that-j-js-depuy-has-won-u-s-approval-for-the-first-ceramic-on-metal-hip,Theo Kratz,2011-06-14 00:00:00,JNJ,1,0,1,1,1,1,1,1,1,0.88915
